BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= psy7167
(897 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|4DGJ|A Chain A, Structure Of A Human Enteropeptidase Light Chain Variant
pdb|4DGJ|B Chain B, Structure Of A Human Enteropeptidase Light Chain Variant
pdb|4DGJ|C Chain C, Structure Of A Human Enteropeptidase Light Chain Variant
pdb|4DGJ|D Chain D, Structure Of A Human Enteropeptidase Light Chain Variant
Length = 235
Score = 163 bits (413), Expect = 4e-40, Method: Compositional matrix adjust.
Identities = 91/249 (36%), Positives = 146/249 (58%), Gaps = 20/249 (8%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNID--EWTV 706
I+GG ++ G WP++ L + C L+S W+++AAHCV G N++ +WT
Sbjct: 1 IVGGSDAKEGAWPWVVGLYYDDRLL--CGASLVSSDWLVSAAHCV---YGRNLEPSKWTA 55
Query: 707 QLGVTRRNSYAFFGTRFK-VRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLP 765
LG+ +++ T + + + + YN + DNDIA+ L+ KV + D++ P+ LP
Sbjct: 56 ILGLHMKSNLTSPQTVPRLIDEIVINPHYN-RRRKDNDIAMMHLEFKVNYTDYIQPISLP 114
Query: 766 PPNYELAPGTRCTVIGWGKREDTRVSEYETA--VNEVEVPIITRDICNKWLNNRELNVTL 823
N PG C++ GWG T V + TA + E +VP+++ + C + + E N+T
Sbjct: 115 EENQVFPPGRNCSIAGWG----TVVYQGTTADILQEADVPLLSNERCQQQM--PEYNITE 168
Query: 824 GMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPK 883
M+CAGY EGG D+CQGDSGGPL+C+ ++ +WF+ G+ S+G +CA P+ PGVYA V +
Sbjct: 169 NMICAGYEEGGIDSCQGDSGGPLMCQENN---RWFLAGVTSFGYECALPNRPGVYARVSR 225
Query: 884 YVTWIQDIM 892
+ WIQ +
Sbjct: 226 FTEWIQSFL 234
>pdb|1EKB|B Chain B, The Serine Protease Domain Of Enteropeptidase Bound To
Inhibitor Val- Asp-asp-asp-asp-lys-chloromethane
Length = 235
Score = 163 bits (412), Expect = 5e-40, Method: Compositional matrix adjust.
Identities = 92/250 (36%), Positives = 145/250 (58%), Gaps = 22/250 (8%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNID--EWTV 706
I+GG +S G WP++ AL + V C L+S W+++AAHCV G N++ +W
Sbjct: 1 IVGGSDSREGAWPWVVALYFDDQQV--CGASLVSRDWLVSAAHCV---YGRNMEPSKWKA 55
Query: 707 QLGVTRRNSYAF--FGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCL 764
LG+ ++ TR + + + YN + +NDIA+ L+ KV + D++ P+CL
Sbjct: 56 VLGLHMASNLTSPQIETRL-IDQIVINPHYN-KRRKNNDIAMMHLEMKVNYTDYIQPICL 113
Query: 765 PPPNYELAPGTRCTVIGWGKREDTRVSEYETA--VNEVEVPIITRDICNKWLNNRELNVT 822
P N PG C++ GWG + + TA + E +VP+++ + C + + E N+T
Sbjct: 114 PEENQVFPPGRICSIAGWG----ALIYQGSTADVLQEADVPLLSNEKCQQQM--PEYNIT 167
Query: 823 LGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVP 882
MVCAGY GG D+CQGDSGGPL+C+ ++ +W + G+ S+G +CA P+ PGVYA VP
Sbjct: 168 ENMVCAGYEAGGVDSCQGDSGGPLMCQENN---RWLLAGVTSFGYQCALPNRPGVYARVP 224
Query: 883 KYVTWIQDIM 892
++ WIQ +
Sbjct: 225 RFTEWIQSFL 234
>pdb|2F83|A Chain A, Crystal Structure At 2.9 Angstroms Resolution Of Human
Plasma Coagulation Factor Xi Zymogen
Length = 625
Score = 162 bits (409), Expect = 9e-40, Method: Compositional matrix adjust.
Identities = 95/246 (38%), Positives = 131/246 (53%), Gaps = 11/246 (4%)
Query: 644 KARKRIIGGFESNPGDWPFLAAL-LGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNID 702
K + RI+GG S G+WP+ L P C G +I +QW+LTAAHC + I
Sbjct: 383 KIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKIL 442
Query: 703 EWTVQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPV 762
V G+ ++ + F V+ + H QY + A+ DIAL +L+ V + D P+
Sbjct: 443 R--VYSGILNQSEIKEDTSFFGVQEIIIHDQYKM-AESGYDIALLKLETTVNYTDSQRPI 499
Query: 763 CLPPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVT 822
CLP T C V GWG R+ + + + + ++P++T + C K R +T
Sbjct: 500 CLPSKGDRNVIYTDCWVTGWGYRK--LRDKIQNTLQKAKIPLVTNEECQK--RYRGHKIT 555
Query: 823 LGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVP 882
M+CAGY EGGKDAC+GDSGGPL C+ HN E W + GI SWG CA PGVY V
Sbjct: 556 HKMICAGYREGGKDACKGDSGGPLSCK--HN-EVWHLVGITSWGEGCAQRERPGVYTNVV 612
Query: 883 KYVTWI 888
+YV WI
Sbjct: 613 EYVDWI 618
>pdb|3DFJ|A Chain A, Crystal Structure Of Human Prostasin
pdb|3DFL|A Chain A, Crystal Structure Of Human Prostasin Complexed To 4-
Guanidinobenzoic Acid
Length = 263
Score = 157 bits (398), Expect = 2e-38, Method: Compositional matrix adjust.
Identities = 94/248 (37%), Positives = 130/248 (52%), Gaps = 15/248 (6%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I GG + G WP+ ++ E V C G L+S+QWVL+AAHC + + + + V+L
Sbjct: 1 ITGGSSAVAGQWPWQVSIT--YEGVHVCGGSLVSEQWVLSAAHCFPSEH--HKEAYEVKL 56
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQY-NIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPP 767
G + +SY+ ++ + H Y G+Q DIAL QL + + F+ ++ P+ LP
Sbjct: 57 GAHQLDSYSEDAKVSTLKDIIPHPSYLQEGSQ--GDIALLQLSRPITFSRYIRPISLPAA 114
Query: 768 NYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLN-----NRELNVT 822
N G CTV GWG + + ++EVP+I+R+ CN N V
Sbjct: 115 NASFPNGLHCTVTGWGHVAPSVSLLTPKPLQQLEVPLISRETCNALYNIDAKPEEPHFVQ 174
Query: 823 LGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVP 882
MVCAGY EGGKDACQGDSGGPL C W++ GIVSWG C + PGVY
Sbjct: 175 EDMVCAGYVEGGKDACQGDSGGPLSCPVEG---LWYLTGIVSWGDACGARNRPGVYTLAS 231
Query: 883 KYVTWIQD 890
Y +WIQ
Sbjct: 232 SYASWIQS 239
>pdb|3GYL|B Chain B, Structure Of Prostasin At 1.3 Angstroms Resolution In
Complex With A Calcium Ion.
pdb|3GYM|A Chain A, Structure Of Prostasin In Complex With Aprotinin
pdb|3GYM|B Chain B, Structure Of Prostasin In Complex With Aprotinin
Length = 261
Score = 157 bits (396), Expect = 3e-38, Method: Compositional matrix adjust.
Identities = 93/248 (37%), Positives = 129/248 (52%), Gaps = 15/248 (6%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I GG + G WP+ ++ E V C G L+S+QWVL+AAHC + + + + V+L
Sbjct: 1 ITGGSSAVAGQWPWQVSITY--EGVHVCGGSLVSEQWVLSAAHCFPSEH--HKEAYEVKL 56
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQY-NIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPP 767
G + +SY+ ++ + H Y G+Q DIAL QL + + F+ ++ P+ LP
Sbjct: 57 GAHQLDSYSEDAKVSTLKDIIPHPSYLQEGSQ--GDIALLQLSRPITFSRYIRPISLPAA 114
Query: 768 NYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLN-----NRELNVT 822
G CTV GWG + + ++EVP+I+R+ CN N V
Sbjct: 115 QASFPNGLHCTVTGWGHVAPSVSLLTPKPLQQLEVPLISRETCNSLYNIDAKPEEPHFVQ 174
Query: 823 LGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVP 882
MVCAGY EGGKDACQGDSGGPL C W++ GIVSWG C + PGVY
Sbjct: 175 EDMVCAGYVEGGKDACQGDSGGPLSCPVEG---LWYLTGIVSWGDACGARNRPGVYTLAS 231
Query: 883 KYVTWIQD 890
Y +WIQ
Sbjct: 232 SYASWIQS 239
>pdb|3E0P|B Chain B, The X-Ray Structure Of Human Prostasin In Complex With A
Covalent Benzoxazole Inhibitor
pdb|3E16|B Chain B, X-Ray Structure Of Human Prostasin In Complex With
Benzoxazole Warhead Peptidomimic, Lysine In P3
pdb|3E1X|B Chain B, The Crystal Structure Of Apo Prostasin At 1.7 Angstroms
Resolution
pdb|3FVF|B Chain B, The Crystal Structure Of Prostasin Complexed With Camostat
At 1.6 Angstroms Resolution
pdb|3E0N|B Chain B, The X-Ray Structure Of Human Prostasin In Complex With
Dffr- Chloromethyl Ketone Inhibitor
Length = 271
Score = 157 bits (396), Expect = 3e-38, Method: Compositional matrix adjust.
Identities = 93/248 (37%), Positives = 129/248 (52%), Gaps = 15/248 (6%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I GG + G WP+ ++ E V C G L+S+QWVL+AAHC + + + + V+L
Sbjct: 1 ITGGSSAVAGQWPWQVSITY--EGVHVCGGSLVSEQWVLSAAHCFPSEH--HKEAYEVKL 56
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQY-NIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPP 767
G + +SY+ ++ + H Y G+Q DIAL QL + + F+ ++ P+ LP
Sbjct: 57 GAHQLDSYSEDAKVSTLKDIIPHPSYLQEGSQ--GDIALLQLSRPITFSRYIRPISLPAA 114
Query: 768 NYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLN-----NRELNVT 822
G CTV GWG + + ++EVP+I+R+ CN N V
Sbjct: 115 QASFPNGLHCTVTGWGHVAPSVSLLTPKPLQQLEVPLISRETCNSLYNIDAKPEEPHFVQ 174
Query: 823 LGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVP 882
MVCAGY EGGKDACQGDSGGPL C W++ GIVSWG C + PGVY
Sbjct: 175 EDMVCAGYVEGGKDACQGDSGGPLSCPVEG---LWYLTGIVSWGDACGARNRPGVYTLAS 231
Query: 883 KYVTWIQD 890
Y +WIQ
Sbjct: 232 SYASWIQS 239
>pdb|1ZHM|A Chain A, Crystal Structure Of The Catalytic Domain Of The
Coagulation Factor Xia In Complex With Benzamidine
(s434a- T475a-k437 Mutant)
Length = 238
Score = 155 bits (393), Expect = 7e-38, Method: Compositional matrix adjust.
Identities = 94/241 (39%), Positives = 128/241 (53%), Gaps = 11/241 (4%)
Query: 649 IIGGFESNPGDWPFLAAL-LGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQ 707
I+GG S G+WP+ L P C G +I +QW+LTAAHC + I V
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILR--VY 58
Query: 708 LGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPP 767
G+ + A + F V+ + H QY + A+ DIAL +L+ V + D P+CLP
Sbjct: 59 SGILNQAEIAEDTSFFGVQEIIIHDQYKM-AESGYDIALLKLETTVNYADSQRPICLPSK 117
Query: 768 NYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVC 827
T C V GWG R+ + + + + ++P++T + C K R +T M+C
Sbjct: 118 GDRNVIYTDCWVTGWGYRKLR--DKIQNTLQKAKIPLVTNEECQK--RYRGHKITHKMIC 173
Query: 828 AGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTW 887
AGY EGGKDAC+GDSGGPL C+ HN E W + GI SWG CA PGVY V +YV W
Sbjct: 174 AGYREGGKDACKGDSGGPLSCK--HN-EVWHLVGITSWGEGCAQRERPGVYTNVVEYVDW 230
Query: 888 I 888
I
Sbjct: 231 I 231
>pdb|1XX9|A Chain A, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotinm84r
pdb|1XX9|B Chain B, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotinm84r
Length = 238
Score = 155 bits (393), Expect = 8e-38, Method: Compositional matrix adjust.
Identities = 93/241 (38%), Positives = 128/241 (53%), Gaps = 11/241 (4%)
Query: 649 IIGGFESNPGDWPFLAAL-LGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQ 707
I+GG S G+WP+ L P C G +I +QW+LTAAHC + I V
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILR--VY 58
Query: 708 LGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPP 767
G+ ++ + F V+ + H QY + A+ DIAL +L+ V + D P+CLP
Sbjct: 59 SGILNQSEIKEDTSFFGVQEIIIHDQYKM-AESGYDIALLKLETTVNYTDSQRPICLPSK 117
Query: 768 NYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVC 827
T C V GWG R+ + + + + ++P++T + C K R +T M+C
Sbjct: 118 GDRNVIYTDCWVTGWGYRKLR--DKIQNTLQKAKIPLVTNEECQK--RYRGHKITHKMIC 173
Query: 828 AGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTW 887
AGY EGGKDAC+GDSGGPL C+ HN E W + GI SWG CA PGVY V +YV W
Sbjct: 174 AGYREGGKDACKGDSGGPLSCK--HN-EVWHLVGITSWGEGCAQRERPGVYTNVVEYVDW 230
Query: 888 I 888
I
Sbjct: 231 I 231
>pdb|4DUR|A Chain A, The X-Ray Crystal Structure Of Full-Length Type Ii Human
Plasminogen
pdb|4DUR|B Chain B, The X-Ray Crystal Structure Of Full-Length Type Ii Human
Plasminogen
pdb|4DUU|A Chain A, The X-Ray Crystal Structure Of Full-Length Type I Human
Plasminogen
pdb|4A5T|S Chain S, Structural Basis For The Conformational Modulation
Length = 791
Score = 154 bits (389), Expect = 2e-37, Method: Compositional matrix adjust.
Identities = 89/252 (35%), Positives = 134/252 (53%), Gaps = 23/252 (9%)
Query: 644 KARKRIIGGFESNPGDWPFLAALLGGPEF-VFYCAGVLISDQWVLTAAHCVGNLTGLNID 702
K R++GG ++P WP+ +L F + +C G LIS +WVLTAAHC+
Sbjct: 557 KCPGRVVGGCVAHPHSWPWQVSLRT--RFGMHFCGGTLISPEWVLTAAHCLEK--SPRPS 612
Query: 703 EWTVQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPV 762
+ V LG + + +V +F DIAL +L D ++P
Sbjct: 613 SYKVILGAHQEVNLEPHVQEIEVSRLFLEPT-------RKDIALLKLSSPAVITDKVIPA 665
Query: 763 CLPPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKW--LNNRELN 820
CLP PNY +A T C + GWG+ + T + + E ++P+I +CN++ LN R +
Sbjct: 666 CLPSPNYVVADRTECFITGWGETQGTFGA---GLLKEAQLPVIENKVCNRYEFLNGRVQS 722
Query: 821 VTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAY 880
L CAG+ GG D+CQGDSGGPL+C +++ + G+ SWG+ CA P+ PGVY
Sbjct: 723 TEL---CAGHLAGGTDSCQGDSGGPLVCFEK---DKYILQGVTSWGLGCARPNKPGVYVR 776
Query: 881 VPKYVTWIQDIM 892
V ++VTWI+ +M
Sbjct: 777 VSRFVTWIEGVM 788
>pdb|1XXD|A Chain A, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Mutated Ecotin
pdb|1XXD|B Chain B, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Mutated Ecotin
pdb|1XXF|A Chain A, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotin Mutant (Ecotinp)
pdb|1XXF|B Chain B, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotin Mutant (Ecotinp)
Length = 238
Score = 154 bits (389), Expect = 2e-37, Method: Compositional matrix adjust.
Identities = 93/241 (38%), Positives = 127/241 (52%), Gaps = 11/241 (4%)
Query: 649 IIGGFESNPGDWPFLAAL-LGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQ 707
I+GG S G+WP+ L P C G +I +QW+LTAAHC + I V
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILR--VY 58
Query: 708 LGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPP 767
G+ + + F V+ + H QY + A+ DIAL +L+ V + D P+CLP
Sbjct: 59 SGILNQAEIKEDTSFFGVQEIIIHDQYKM-AESGYDIALLKLETTVNYADSQRPICLPSK 117
Query: 768 NYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVC 827
T C V GWG R+ + + + + ++P++T + C K R +T M+C
Sbjct: 118 GDRNVIYTDCWVTGWGYRKLR--DKIQNTLQKAKIPLVTNEECQK--RYRGHKITHKMIC 173
Query: 828 AGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTW 887
AGY EGGKDAC+GDSGGPL C+ HN E W + GI SWG CA PGVY V +YV W
Sbjct: 174 AGYREGGKDACKGDSGGPLSCK--HN-EVWHLVGITSWGEGCAQRERPGVYTNVVEYVDW 230
Query: 888 I 888
I
Sbjct: 231 I 231
>pdb|1ZPZ|A Chain A, Factor Xi Catalytic Domain Complexed With N-((R)-1-(4-
Bromophenyl)ethyl)urea-Asn-Val-Arg-Alpha-Ketothiazole
pdb|1ZRK|A Chain A, Factor Xi Complexed With 3-Hydroxypropyl 3-(7-
Amidinonaphthalene-1-Carboxamido)benzenesulfonate
pdb|1ZSL|A Chain A, Factor Xi Complexed With A Pyrimidinone Inhibitor
Length = 238
Score = 154 bits (388), Expect = 3e-37, Method: Compositional matrix adjust.
Identities = 93/241 (38%), Positives = 128/241 (53%), Gaps = 11/241 (4%)
Query: 649 IIGGFESNPGDWPFLAAL-LGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQ 707
I+GG S G+WP+ L P C G +I +QW+LTAAHC + I V
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILR--VY 58
Query: 708 LGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPP 767
G+ ++ A + F V+ + H QY + A+ DIAL +L+ V + D P+ LP
Sbjct: 59 SGILNQSEIAEDTSFFGVQEIIIHDQYKM-AESGYDIALLKLETTVNYTDSQRPISLPSK 117
Query: 768 NYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVC 827
T C V GWG R+ + + + + ++P++T + C K R +T M+C
Sbjct: 118 GDRNVIYTDCWVTGWGYRKLR--DKIQNTLQKAKIPLVTNEECQK--RYRGHKITHKMIC 173
Query: 828 AGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTW 887
AGY EGGKDAC+GDSGGPL C+ HN E W + GI SWG CA PGVY V +YV W
Sbjct: 174 AGYREGGKDACKGDSGGPLSCK--HN-EVWHLVGITSWGEGCAQRERPGVYTNVVEYVDW 230
Query: 888 I 888
I
Sbjct: 231 I 231
>pdb|1ZHP|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With Benzamidine (S434a-T475a-K505
Mutant)
Length = 238
Score = 153 bits (387), Expect = 3e-37, Method: Compositional matrix adjust.
Identities = 93/241 (38%), Positives = 126/241 (52%), Gaps = 11/241 (4%)
Query: 649 IIGGFESNPGDWPFLAAL-LGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQ 707
I+GG S G+WP+ L P C G +I +QW+LTAAHC + I V
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILR--VY 58
Query: 708 LGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPP 767
G+ + + F V+ + H QY + A+ DIAL +L+ V + D P+CLP
Sbjct: 59 SGILNQAEIKEDTSFFGVQEIIIHDQYKM-AESGYDIALLKLETTVNYADSQRPICLPSK 117
Query: 768 NYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVC 827
T C V GWG R + + + + ++P++T + C K R +T M+C
Sbjct: 118 GDRNVIYTDCWVTGWGYR--ALRDKIQNTLQKAKIPLVTNEECQK--RYRGHKITHKMIC 173
Query: 828 AGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTW 887
AGY EGGKDAC+GDSGGPL C+ HN E W + GI SWG CA PGVY V +YV W
Sbjct: 174 AGYREGGKDACKGDSGGPLSCK--HN-EVWHLVGITSWGEGCAQRERPGVYTNVVEYVDW 230
Query: 888 I 888
I
Sbjct: 231 I 231
>pdb|3BG8|A Chain A, Crystal Structure Of Factor Xia In Complex With
Clavatadine A
Length = 238
Score = 152 bits (385), Expect = 7e-37, Method: Compositional matrix adjust.
Identities = 92/241 (38%), Positives = 127/241 (52%), Gaps = 11/241 (4%)
Query: 649 IIGGFESNPGDWPFLAAL-LGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQ 707
I+GG S G+WP+ L P C G +I +QW+LTAAHC + I V
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILR--VY 58
Query: 708 LGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPP 767
G+ ++ + F V+ + H QY + A+ DIAL +L+ V + D P+ LP
Sbjct: 59 SGILNQSEIKEDTSFFGVQEIIIHDQYKM-AESGYDIALLKLETTVNYTDSQRPISLPSK 117
Query: 768 NYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVC 827
T C V GWG R+ + + + + ++P++T + C K R +T M+C
Sbjct: 118 GERNVIYTDCWVTGWGYRKLR--DKIQNTLQKAKIPLVTNEECQK--RYRGHKITHKMIC 173
Query: 828 AGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTW 887
AGY EGGKDAC+GDSGGPL C+ HN E W + GI SWG CA PGVY V +YV W
Sbjct: 174 AGYREGGKDACKGDSGGPLSCK--HN-EVWHLVGITSWGEGCAQRERPGVYTNVVEYVDW 230
Query: 888 I 888
I
Sbjct: 231 I 231
>pdb|1ZLR|A Chain A, Factor Xi Catalytic Domain Complexed With
2-Guanidino-1-(4-(4,4,5,5-
Tetramethyl-1,3,2-Dioxaborolan-2-Yl)phenyl)ethyl
Nicotinate
Length = 237
Score = 152 bits (384), Expect = 7e-37, Method: Compositional matrix adjust.
Identities = 93/241 (38%), Positives = 127/241 (52%), Gaps = 11/241 (4%)
Query: 649 IIGGFESNPGDWPFLAAL-LGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQ 707
I+GG S G+WP+ L P C G +I +QW+LTAAHC + I V
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILR--VY 58
Query: 708 LGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPP 767
G+ + A + F V+ + H QY + A+ DIAL +L+ V + D P+ LP
Sbjct: 59 SGILNQAEIAEDTSFFGVQEIIIHDQYKM-AESGYDIALLKLETTVNYADSQRPISLPSK 117
Query: 768 NYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVC 827
T C V GWG R+ + + + + ++P++T + C K R +T M+C
Sbjct: 118 GDRNVIYTDCWVTGWGYRKLR--DKIQNTLQKAKIPLVTNEECQK--RYRGHKITHKMIC 173
Query: 828 AGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTW 887
AGY EGGKDAC+GDSGGPL C+ HN E W + GI SWG CA PGVY V +YV W
Sbjct: 174 AGYREGGKDACKGDSGGPLSCK--HN-EVWHLVGITSWGEGCAQRERPGVYTNVVEYVDW 230
Query: 888 I 888
I
Sbjct: 231 I 231
>pdb|1Z8G|A Chain A, Crystal Structure Of The Extracellular Region Of The
Transmembrane Serine Protease Hepsin With Covalently
Bound Preferred Substrate
Length = 372
Score = 152 bits (384), Expect = 8e-37, Method: Compositional matrix adjust.
Identities = 94/255 (36%), Positives = 126/255 (49%), Gaps = 14/255 (5%)
Query: 648 RIIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQ 707
RI+GG +++ G WP+ +L + C G L+S WVLTAAHC + + W V
Sbjct: 117 RIVGGRDTSLGRWPWQVSLR--YDGAHLCGGSLLSGDWVLTAAHCFPERNRV-LSRWRVF 173
Query: 708 LGVTRRNSYAFFGTRFKVRGVFAHSQY-----NIGAQHDNDIALFQLKQKVKFNDHLLPV 762
G + S G + V+ V H Y ++ NDIAL L + +++ PV
Sbjct: 174 AGAVAQASP--HGLQLGVQAVVYHGGYLPFRDPNSEENSNDIALVHLSSPLPLTEYIQPV 231
Query: 763 CLPPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVT 822
CLP L G CTV GWG + + + E VPII+ D+CN + +
Sbjct: 232 CLPAAGQALVDGKICTVTGWGNTQ--YYGQQAGVLQEARVPIISNDVCNG-ADFYGNQIK 288
Query: 823 LGMVCAGYPEGGKDACQGDSGGPLLCRSS-HNFEQWFVGGIVSWGIKCAHPHLPGVYAYV 881
M CAGYPEGG DACQGDSGGP +C S +W + GIVSWG CA PGVY V
Sbjct: 289 PKMFCAGYPEGGIDACQGDSGGPFVCEDSISRTPRWRLCGIVSWGTGCALAQKPGVYTKV 348
Query: 882 PKYVTWIQDIMDKYS 896
+ WI + +S
Sbjct: 349 SDFREWIFQAIKTHS 363
>pdb|1ZHR|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With Benzamidine
(S434a-T475a-C482s-K437a Mutant)
pdb|1ZPB|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With 4-Methyl-Pentanoic Acid {1-[4-
Guanidino-1-(Thiazole-2-Carbonyl)-Butylcarbamoyl]-2-
Methyl- Propyl}-Amide
pdb|1ZPC|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
2-[2-(3-Chloro-Phenyl)-2-Hydroxy-
Acetylamino]-N-[4-Guanidino-1-(Thiazole-2-Carbonyl)-
Butyl]- 3-Methyl-Butyramide
pdb|2FDA|A Chain A, Crystal Structure Of The Catalytic Domain Of Human
Coagulation Factor Xia In Complex With
Alpha-Ketothiazole Arginine Derived Ligand
pdb|1ZMJ|A Chain A, Crystal Structure Of The Catalytic Domain Of Factor Xi In
Complex With 4-(Guanidinomethyl)-Phenylboronic Acid
pdb|1ZML|A Chain A, Crystal Structure Of The Catalytic Domain Of Factor Xi In
Complex With (R)-1-(4-(4-(Hydroxymethyl)-1,3,2-
Dioxaborolan-2-Yl)phenethyl)guanidine
pdb|1ZMN|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
(R)-1-(4-(4-(Hydroxymethyl)-1,3,
2-Dioxaborolan-2-Yl)phenyl)guanidine
pdb|1ZOM|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With A Peptidomimetic Inhibitor
pdb|1ZSJ|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
N-(7-Carbamimidoyl-Naphthalen-1-
Yl)-3-Hydroxy-2-Methyl-Benzamide
pdb|1ZSK|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
6-Carbamimidoyl-4-(3-Hydroxy-2-
Methyl-Benzoylamino)-Naphthalene-2-Carboxylic Acid
Methyl Ester
pdb|1ZTJ|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With 2-(5-Benzylamino-2-
Methylsulfanyl-6-Oxo-6h-Pyrimidin-1-Yl)-N-[4-Guanidino-
1- (Thiazole-2-Carbonyl)-Butyl]-Acetamide
pdb|1ZTK|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With 2-(5-Amino-6-Oxo-2-M-Tolyl-6h-
Pyrimidin-1-Yl)-N-[4-Guanidino-1-(Thiazole-2-Carbonyl)-
Butyl]-Acetamide
pdb|1ZTL|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With N-[4-Guanidino-1-(Thiazole-2-
Carbonyl)-Butyl]-2-{6-Oxo-5-[(Quinolin-8-Ylmethyl)-
Amino]- 2-M-Tolyl-6h-Pyrimidin-1-Yl}-Acetamide
Length = 238
Score = 152 bits (384), Expect = 8e-37, Method: Compositional matrix adjust.
Identities = 93/241 (38%), Positives = 127/241 (52%), Gaps = 11/241 (4%)
Query: 649 IIGGFESNPGDWPFLAAL-LGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQ 707
I+GG S G+WP+ L P C G +I +QW+LTAAHC + I V
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILR--VY 58
Query: 708 LGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPP 767
G+ + A + F V+ + H QY + A+ DIAL +L+ V + D P+ LP
Sbjct: 59 SGILNQAEIAEDTSFFGVQEIIIHDQYKM-AESGYDIALLKLETTVNYADSQRPISLPSK 117
Query: 768 NYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVC 827
T C V GWG R+ + + + + ++P++T + C K R +T M+C
Sbjct: 118 GDRNVIYTDCWVTGWGYRKLR--DKIQNTLQKAKIPLVTNEECQK--RYRGHKITHKMIC 173
Query: 828 AGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTW 887
AGY EGGKDAC+GDSGGPL C+ HN E W + GI SWG CA PGVY V +YV W
Sbjct: 174 AGYREGGKDACKGDSGGPLSCK--HN-EVWHLVGITSWGEGCAQRERPGVYTNVVEYVDW 230
Query: 888 I 888
I
Sbjct: 231 I 231
>pdb|3T2N|A Chain A, Human Hepsin Protease In Complex With The Fab Fragment Of
An Inhibitory Antibody
pdb|3T2N|B Chain B, Human Hepsin Protease In Complex With The Fab Fragment Of
An Inhibitory Antibody
Length = 372
Score = 152 bits (384), Expect = 8e-37, Method: Compositional matrix adjust.
Identities = 94/255 (36%), Positives = 126/255 (49%), Gaps = 14/255 (5%)
Query: 648 RIIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQ 707
RI+GG +++ G WP+ +L + C G L+S WVLTAAHC + + W V
Sbjct: 117 RIVGGRDTSLGRWPWQVSLR--YDGAHLCGGSLLSGDWVLTAAHCFPERNRV-LSRWRVF 173
Query: 708 LGVTRRNSYAFFGTRFKVRGVFAHSQY-----NIGAQHDNDIALFQLKQKVKFNDHLLPV 762
G + S G + V+ V H Y ++ NDIAL L + +++ PV
Sbjct: 174 AGAVAQASP--HGLQLGVQAVVYHGGYLPFRDPNSEENSNDIALVHLSSPLPLTEYIQPV 231
Query: 763 CLPPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVT 822
CLP L G CTV GWG + + + E VPII+ D+CN + +
Sbjct: 232 CLPAAGQALVDGKICTVTGWGNTQ--YYGQQAGVLQEARVPIISNDVCNG-ADFYGNQIK 288
Query: 823 LGMVCAGYPEGGKDACQGDSGGPLLCRSS-HNFEQWFVGGIVSWGIKCAHPHLPGVYAYV 881
M CAGYPEGG DACQGDSGGP +C S +W + GIVSWG CA PGVY V
Sbjct: 289 PKMFCAGYPEGGIDACQGDSGGPFVCEDSISRTPRWRLCGIVSWGTGCALAQKPGVYTKV 348
Query: 882 PKYVTWIQDIMDKYS 896
+ WI + +S
Sbjct: 349 SDFREWIFQAIKTHS 363
>pdb|3SOR|A Chain A, Factor Xia In Complex With A Clorophenyl-tetrazole
Inhibitor
pdb|3SOS|A Chain A, Benzothiazinone Inhibitor In Complex With Fxia
Length = 238
Score = 152 bits (383), Expect = 9e-37, Method: Compositional matrix adjust.
Identities = 92/241 (38%), Positives = 127/241 (52%), Gaps = 11/241 (4%)
Query: 649 IIGGFESNPGDWPFLAAL-LGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQ 707
I+GG S G+WP+ L P C G +I +QW+LTAAHC + I V
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILR--VY 58
Query: 708 LGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPP 767
G+ ++ + F V+ + H QY + A+ DIAL +L+ V + D P+ LP
Sbjct: 59 SGILNQSEIKEDTSFFGVQEIIIHDQYKM-AESGYDIALLKLETTVNYTDSQRPISLPSK 117
Query: 768 NYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVC 827
T C V GWG R+ + + + + ++P++T + C K R +T M+C
Sbjct: 118 GDRNVIYTDCWVTGWGYRKLR--DKIQNTLQKAKIPLVTNEECQK--RYRGHKITHKMIC 173
Query: 828 AGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTW 887
AGY EGGKDAC+GDSGGPL C+ HN E W + GI SWG CA PGVY V +YV W
Sbjct: 174 AGYREGGKDACKGDSGGPLSCK--HN-EVWHLVGITSWGEGCAQRERPGVYTNVVEYVDW 230
Query: 888 I 888
I
Sbjct: 231 I 231
>pdb|1BUI|A Chain A, Structure Of The Ternary
Microplasmin-Staphylokinase-Microplasmin Complex: A
Proteinase-Cofactor-Substrate Complex In Action
pdb|1BUI|B Chain B, Structure Of The Ternary
Microplasmin-Staphylokinase-Microplasmin Complex: A
Proteinase-Cofactor-Substrate Complex In Action
Length = 250
Score = 151 bits (382), Expect = 1e-36, Method: Compositional matrix adjust.
Identities = 89/252 (35%), Positives = 134/252 (53%), Gaps = 23/252 (9%)
Query: 644 KARKRIIGGFESNPGDWPFLAALLGGPEF-VFYCAGVLISDQWVLTAAHCVGNLTGLNID 702
K R++GG ++P WP+ +L F + +C G LIS +WVLTAAHC+
Sbjct: 16 KCPGRVVGGCVAHPHSWPWQVSLR--TRFGMHFCGGTLISPEWVLTAAHCLEKSP--RPS 71
Query: 703 EWTVQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPV 762
+ V LG + + +V +F DIAL +L D ++P
Sbjct: 72 SYKVILGAHQEVNLEPHVQEIEVSRLFLEPT-------RKDIALLKLSSPAVITDKVIPA 124
Query: 763 CLPPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKW--LNNRELN 820
CLP PNY +A T C + GWG+ + T + + E ++P+I +CN++ LN R +
Sbjct: 125 CLPSPNYVVADRTECFITGWGETQGTFGAGL---LKEAQLPVIENKVCNRYEFLNGRVQS 181
Query: 821 VTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAY 880
L CAG+ GG D+CQGDSGGPL+C +++ + G+ SWG+ CA P+ PGVY
Sbjct: 182 TEL---CAGHLAGGTDSCQGDSGGPLVCFEK---DKYILQGVTSWGLGCARPNKPGVYVR 235
Query: 881 VPKYVTWIQDIM 892
V ++VTWI+ +M
Sbjct: 236 VSRFVTWIEGVM 247
>pdb|3UIR|A Chain A, Crystal Structure Of The Plasmin-Textilinin-1 Complex
pdb|3UIR|B Chain B, Crystal Structure Of The Plasmin-Textilinin-1 Complex
Length = 247
Score = 151 bits (381), Expect = 2e-36, Method: Compositional matrix adjust.
Identities = 89/252 (35%), Positives = 134/252 (53%), Gaps = 23/252 (9%)
Query: 644 KARKRIIGGFESNPGDWPFLAALLGGPEF-VFYCAGVLISDQWVLTAAHCVGNLTGLNID 702
K R++GG ++P WP+ +L F + +C G LIS +WVLTAAHC+
Sbjct: 13 KCPGRVVGGCVAHPHSWPWQVSLR--TRFGMHFCGGTLISPEWVLTAAHCLEKSP--RPS 68
Query: 703 EWTVQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPV 762
+ V LG + + +V +F DIAL +L D ++P
Sbjct: 69 SYKVILGAHQEVNLEPHVQEIEVSRLFLEPT-------RKDIALLKLSSPAVITDKVIPA 121
Query: 763 CLPPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKW--LNNRELN 820
CLP PNY +A T C + GWG+ + T + + E ++P+I +CN++ LN R +
Sbjct: 122 CLPSPNYVVADRTECFITGWGETQGTFGAGL---LKEAQLPVIENKVCNRYEFLNGRVQS 178
Query: 821 VTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAY 880
L CAG+ GG D+CQGDSGGPL+C +++ + G+ SWG+ CA P+ PGVY
Sbjct: 179 TEL---CAGHLAGGTDSCQGDSGGPLVCFEK---DKYILQGVTSWGLGCARPNKPGVYVR 232
Query: 881 VPKYVTWIQDIM 892
V ++VTWI+ +M
Sbjct: 233 VSRFVTWIEGVM 244
>pdb|2ANY|A Chain A, Expression, Crystallization And The Three-Dimensional
Structure Of The Catalytic Domain Of Human Plasma
Kallikrein: Implications For Structure-Based Design Of
Protease Inhibitors
Length = 241
Score = 150 bits (380), Expect = 2e-36, Method: Compositional matrix adjust.
Identities = 89/242 (36%), Positives = 133/242 (54%), Gaps = 13/242 (5%)
Query: 649 IIGGFESNPGDWPFLAAL-LGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNI-DEWTV 706
I+GG ES+ G+WP+ +L + C G LI QWVLTAAHC GL + D W +
Sbjct: 1 IVGGTESSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHC---FDGLPLQDVWRI 57
Query: 707 QLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPP 766
G+ + +++ + H Y + ++ ++DIAL +L+ +++ + P+ LP
Sbjct: 58 YSGILELSDITKDTPFSQIKEIIIHQNYKV-SEGNHDIALIKLQAPLEYTEFQKPISLPS 116
Query: 767 PNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMV 826
T C V GWG ++ E + + +V +P++T + C K ++ +T MV
Sbjct: 117 KGDTSTIYTNCWVTGWGFSKEK--GEIQNILQKVNIPLVTNEECQK--RYQDYKITQRMV 172
Query: 827 CAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVT 886
CAGY EGGKDAC+GDSGGPL+C+ HN W + GI SWG CA PGVY V +Y+
Sbjct: 173 CAGYKEGGKDACKGDSGGPLVCK--HN-GMWRLVGITSWGEGCARREQPGVYTKVAEYMD 229
Query: 887 WI 888
WI
Sbjct: 230 WI 231
>pdb|1ZJD|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With Kunitz Protease Inhibitor
Domain Of Protease Nexin Ii
Length = 237
Score = 150 bits (380), Expect = 2e-36, Method: Compositional matrix adjust.
Identities = 92/241 (38%), Positives = 126/241 (52%), Gaps = 11/241 (4%)
Query: 649 IIGGFESNPGDWPFLAAL-LGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQ 707
I+GG S G+WP+ L P C G +I +QW+LTAAHC + I V
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILR--VY 58
Query: 708 LGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPP 767
G+ + + F V+ + H QY + A+ DIAL +L+ V + D P+ LP
Sbjct: 59 SGILNQAEIKEDTSFFGVQEIIIHDQYKM-AESGYDIALLKLETTVNYADSQRPISLPSK 117
Query: 768 NYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVC 827
T C V GWG R+ + + + + ++P++T + C K R +T M+C
Sbjct: 118 GDRNVIYTDCWVTGWGYRKLR--DKIQNTLQKAKIPLVTNEECQK--RYRGHKITHKMIC 173
Query: 828 AGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTW 887
AGY EGGKDAC+GDSGGPL C+ HN E W + GI SWG CA PGVY V +YV W
Sbjct: 174 AGYREGGKDACKGDSGGPLSCK--HN-EVWHLVGITSWGEGCAQRERPGVYTNVVEYVDW 230
Query: 888 I 888
I
Sbjct: 231 I 231
>pdb|1BML|A Chain A, Complex Of The Catalytic Domain Of Human Plasmin And
Streptokinase
pdb|1BML|B Chain B, Complex Of The Catalytic Domain Of Human Plasmin And
Streptokinase
Length = 250
Score = 150 bits (379), Expect = 3e-36, Method: Compositional matrix adjust.
Identities = 88/252 (34%), Positives = 134/252 (53%), Gaps = 23/252 (9%)
Query: 644 KARKRIIGGFESNPGDWPFLAALLGGPEF-VFYCAGVLISDQWVLTAAHCVGNLTGLNID 702
K R++GG ++P WP+ +L F + +C G LIS +WVLTAAHC+
Sbjct: 16 KCPGRVVGGCVAHPHSWPWQVSLR--TRFGMHFCGGTLISPEWVLTAAHCLEKSP--RPS 71
Query: 703 EWTVQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPV 762
+ V LG + + +V +F DIAL +L D ++P
Sbjct: 72 SYKVILGAHQEVNLEPHVQEIEVSRLFLEPT-------RKDIALLKLSSPAVITDKVIPA 124
Query: 763 CLPPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKW--LNNRELN 820
CLP PNY +A T C + GWG+ + T + + E ++P+I +CN++ LN R +
Sbjct: 125 CLPSPNYVVADRTECFITGWGETQGTFGAGL---LKEAQLPVIENKVCNRYEFLNGRVQS 181
Query: 821 VTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAY 880
L CAG+ GG D+CQGD+GGPL+C +++ + G+ SWG+ CA P+ PGVY
Sbjct: 182 TEL---CAGHLAGGTDSCQGDAGGPLVCFEK---DKYILQGVTSWGLGCARPNKPGVYVR 235
Query: 881 VPKYVTWIQDIM 892
V ++VTWI+ +M
Sbjct: 236 VSRFVTWIEGVM 247
>pdb|1L4Z|A Chain A, X-Ray Crystal Structure Of The Complex Of Microplasminogen
With Alpha Domain Of Streptokinase In The Presence
Cadmium Ions
Length = 248
Score = 150 bits (379), Expect = 3e-36, Method: Compositional matrix adjust.
Identities = 88/252 (34%), Positives = 134/252 (53%), Gaps = 23/252 (9%)
Query: 644 KARKRIIGGFESNPGDWPFLAALLGGPEF-VFYCAGVLISDQWVLTAAHCVGNLTGLNID 702
K R++GG ++P WP+ +L F + +C G LIS +WVLTAAHC+
Sbjct: 14 KCPGRVVGGCVAHPHSWPWQVSLR--TRFGMHFCGGTLISPEWVLTAAHCLEKSP--RPS 69
Query: 703 EWTVQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPV 762
+ V LG + + +V +F DIAL +L D ++P
Sbjct: 70 SYKVILGAHQEVNLEPHVQEIEVSRLFLEPT-------RKDIALLKLSSPAVITDKVIPA 122
Query: 763 CLPPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKW--LNNRELN 820
CLP PNY +A T C + GWG+ + T + + E ++P+I +CN++ LN R +
Sbjct: 123 CLPSPNYVVADRTECFITGWGETQGTFGAGL---LKEAQLPVIENKVCNRYEFLNGRVQS 179
Query: 821 VTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAY 880
L CAG+ GG D+CQGD+GGPL+C +++ + G+ SWG+ CA P+ PGVY
Sbjct: 180 TEL---CAGHLAGGTDSCQGDAGGPLVCFEK---DKYILQGVTSWGLGCARPNKPGVYVR 233
Query: 881 VPKYVTWIQDIM 892
V ++VTWI+ +M
Sbjct: 234 VSRFVTWIEGVM 245
>pdb|1DDJ|A Chain A, Crystal Structure Of Human Plasminogen Catalytic Domain
pdb|1DDJ|B Chain B, Crystal Structure Of Human Plasminogen Catalytic Domain
pdb|1DDJ|C Chain C, Crystal Structure Of Human Plasminogen Catalytic Domain
pdb|1DDJ|D Chain D, Crystal Structure Of Human Plasminogen Catalytic Domain
Length = 247
Score = 150 bits (379), Expect = 3e-36, Method: Compositional matrix adjust.
Identities = 88/252 (34%), Positives = 134/252 (53%), Gaps = 23/252 (9%)
Query: 644 KARKRIIGGFESNPGDWPFLAALLGGPEF-VFYCAGVLISDQWVLTAAHCVGNLTGLNID 702
K R++GG ++P WP+ +L F + +C G LIS +WVLTAAHC+
Sbjct: 13 KCPGRVVGGCVAHPHSWPWQVSLR--TRFGMHFCGGTLISPEWVLTAAHCLEKSP--RPS 68
Query: 703 EWTVQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPV 762
+ V LG + + +V +F DIAL +L D ++P
Sbjct: 69 SYKVILGAHQEVNLEPHVQEIEVSRLFLEPT-------RKDIALLKLSSPAVITDKVIPA 121
Query: 763 CLPPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKW--LNNRELN 820
CLP PNY +A T C + GWG+ + T + + E ++P+I +CN++ LN R +
Sbjct: 122 CLPSPNYVVADRTECFITGWGETQGTFGAGL---LKEAQLPVIENKVCNRYEFLNGRVQS 178
Query: 821 VTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAY 880
L CAG+ GG D+CQGD+GGPL+C +++ + G+ SWG+ CA P+ PGVY
Sbjct: 179 TEL---CAGHLAGGTDSCQGDAGGPLVCFEK---DKYILQGVTSWGLGCARPNKPGVYVR 232
Query: 881 VPKYVTWIQDIM 892
V ++VTWI+ +M
Sbjct: 233 VSRFVTWIEGVM 244
>pdb|1L4D|A Chain A, Crystal Structure Of Microplasminogen-streptokinase Alpha
Domain Complex
Length = 249
Score = 150 bits (378), Expect = 3e-36, Method: Compositional matrix adjust.
Identities = 88/252 (34%), Positives = 134/252 (53%), Gaps = 23/252 (9%)
Query: 644 KARKRIIGGFESNPGDWPFLAALLGGPEF-VFYCAGVLISDQWVLTAAHCVGNLTGLNID 702
K R++GG ++P WP+ +L F + +C G LIS +WVLTAAHC+
Sbjct: 15 KCPGRVVGGCVAHPHSWPWQVSLR--TRFGMHFCGGTLISPEWVLTAAHCLEKSP--RPS 70
Query: 703 EWTVQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPV 762
+ V LG + + +V +F DIAL +L D ++P
Sbjct: 71 SYKVILGAHQEVNLEPHVQEIEVSRLFLEPT-------RKDIALLKLSSPAVITDKVIPA 123
Query: 763 CLPPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKW--LNNRELN 820
CLP PNY +A T C + GWG+ + T + + E ++P+I +CN++ LN R +
Sbjct: 124 CLPSPNYVVADRTECFITGWGETQGTFGAGL---LKEAQLPVIENKVCNRYEFLNGRVQS 180
Query: 821 VTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAY 880
L CAG+ GG D+CQGD+GGPL+C +++ + G+ SWG+ CA P+ PGVY
Sbjct: 181 TEL---CAGHLAGGTDSCQGDAGGPLVCFEK---DKYILQGVTSWGLGCARPNKPGVYVR 234
Query: 881 VPKYVTWIQDIM 892
V ++VTWI+ +M
Sbjct: 235 VSRFVTWIEGVM 246
>pdb|1QRZ|A Chain A, Catalytic Domain Of Plasminogen
pdb|1QRZ|B Chain B, Catalytic Domain Of Plasminogen
pdb|1QRZ|C Chain C, Catalytic Domain Of Plasminogen
pdb|1QRZ|D Chain D, Catalytic Domain Of Plasminogen
Length = 246
Score = 149 bits (376), Expect = 7e-36, Method: Compositional matrix adjust.
Identities = 89/253 (35%), Positives = 133/253 (52%), Gaps = 25/253 (9%)
Query: 644 KARKRIIGGFESNPGDWPFLAALLG--GPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNI 701
K R++GG ++P WP+ +L G F C G LIS +WVLTAAHC+
Sbjct: 12 KCPGRVVGGCVAHPHSWPWQVSLRTRFGQHF---CGGTLISPEWVLTAAHCLEKSP--RP 66
Query: 702 DEWTVQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLP 761
+ V LG + + +V +F DIAL +L D ++P
Sbjct: 67 SSYKVILGAHQEVNLEPHVQEIEVSRLFLEPT-------RKDIALLKLSSPAVITDKVIP 119
Query: 762 VCLPPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKW--LNNREL 819
CLP PNY +A T C + GWG+ + T + + E ++P+I +CN++ LN R
Sbjct: 120 ACLPSPNYMVADRTECFITGWGETQGTFGAGL---LKEAQLPVIENKVCNRYEFLNGRVQ 176
Query: 820 NVTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYA 879
+ L CAG+ GG D+CQGDSGGPL+C +++ + G+ SWG+ CA P+ PGVY
Sbjct: 177 STEL---CAGHLAGGTDSCQGDSGGPLVCFEK---DKYILQGVTSWGLGCARPNKPGVYV 230
Query: 880 YVPKYVTWIQDIM 892
V ++VTWI+ ++
Sbjct: 231 RVSRFVTWIEGVL 243
>pdb|1O5E|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (ala190 Upa)
pdb|1O5F|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|1P57|B Chain B, Extracellular Domain Of Human Hepsin
Length = 255
Score = 148 bits (373), Expect = 2e-35, Method: Compositional matrix adjust.
Identities = 93/254 (36%), Positives = 125/254 (49%), Gaps = 14/254 (5%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG +++ G WP+ +L + C G L+S WVLTAAHC + + W V
Sbjct: 1 IVGGRDTSLGRWPWQVSLR--YDGAHLCGGSLLSGDWVLTAAHCFPERNRV-LSRWRVFA 57
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQY-----NIGAQHDNDIALFQLKQKVKFNDHLLPVC 763
G + S G + V+ V H Y ++ NDIAL L + +++ PVC
Sbjct: 58 GAVAQASP--HGLQLGVQAVVYHGGYLPFRDPNSEENSNDIALVHLSSPLPLTEYIQPVC 115
Query: 764 LPPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTL 823
LP L G CTV GWG + + + E VPII+ D+CN + +
Sbjct: 116 LPAAGQALVDGKICTVTGWGNTQ--YYGQQAGVLQEARVPIISNDVCNG-ADFYGNQIKP 172
Query: 824 GMVCAGYPEGGKDACQGDSGGPLLCRSS-HNFEQWFVGGIVSWGIKCAHPHLPGVYAYVP 882
M CAGYPEGG DACQGDSGGP +C S +W + GIVSWG CA PGVY V
Sbjct: 173 KMFCAGYPEGGIDACQGDSGGPFVCEDSISRTPRWRLCGIVSWGTGCALAQKPGVYTKVS 232
Query: 883 KYVTWIQDIMDKYS 896
+ WI + +S
Sbjct: 233 DFREWIFQAIKTHS 246
>pdb|1YBW|A Chain A, Protease Domain Of Hgfa With No Inhibitor
pdb|1YBW|B Chain B, Protease Domain Of Hgfa With No Inhibitor
pdb|1YC0|A Chain A, Short Form Hgfa With First Kunitz Domain From Hai-1
pdb|2R0K|A Chain A, Protease Domain Of Hgfa With Inhibitor Fab58
Length = 283
Score = 148 bits (373), Expect = 2e-35, Method: Compositional matrix adjust.
Identities = 96/262 (36%), Positives = 132/262 (50%), Gaps = 16/262 (6%)
Query: 633 CGTRRHLHNNFKARKRIIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHC 692
CG RRH F R RIIGG S PG P+LAA+ G F CAG L+ WV++AAHC
Sbjct: 22 CG-RRHKKRTF-LRPRIIGGSSSLPGSHPWLAAIYIGDSF---CAGSLVHTCWVVSAAHC 76
Query: 693 VGNLTGLNIDEWTVQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQK 752
+ D +V LG N F + ++ Y++ D+D+ L +LK+K
Sbjct: 77 FSHSP--PRDSVSVVLGQHFFNRTTDVTQTFGIEKYIPYTLYSVFNPSDHDLVLIRLKKK 134
Query: 753 ----VKFNDHLLPVCLPPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRD 808
+ + P+CLP P G +C + GWG D VS Y +++ E VP++
Sbjct: 135 GDRCATRSQFVQPICLPEPGSTFPAGHKCQIAGWGHL-DENVSGYSSSLREALVPLVADH 193
Query: 809 ICNKWLNNRELNVTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIK 868
C+ +++ M+CAGY + DACQGDSGGPL C + ++ GI+SWG
Sbjct: 194 KCSS-PEVYGADISPNMLCAGYFDCKSDACQGDSGGPLACEKN---GVAYLYGIISWGDG 249
Query: 869 CAHPHLPGVYAYVPKYVTWIQD 890
C H PGVY V YV WI D
Sbjct: 250 CGRLHKPGVYTRVANYVDWIND 271
>pdb|2ANW|A Chain A, Expression, Crystallization And Three-Dimensional
Structure Of The Catalytic Domain Of Human Plasma
Kallikrein: Implications For Structure-Based Design Of
Protease Inhibitors
Length = 241
Score = 147 bits (372), Expect = 2e-35, Method: Compositional matrix adjust.
Identities = 88/242 (36%), Positives = 131/242 (54%), Gaps = 13/242 (5%)
Query: 649 IIGGFESNPGDWPFLAAL-LGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNI-DEWTV 706
I+GG S+ G+WP+ +L + C G LI QWVLTAAHC GL + D W +
Sbjct: 1 IVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHC---FDGLPLQDVWRI 57
Query: 707 QLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPP 766
G+ + +++ + H Y + ++ ++DIAL +L+ + + + P+ LP
Sbjct: 58 YSGILNLSDITKDTPFSQIKEIIIHQNYKV-SEGNHDIALIKLQAPLNYTEFQKPISLPS 116
Query: 767 PNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMV 826
T C V GWG ++ E + + +V +P++T + C K ++ +T MV
Sbjct: 117 KGDTSTIYTNCWVTGWGFSKEK--GEIQNILQKVNIPLVTNEECQK--RYQDYKITQRMV 172
Query: 827 CAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVT 886
CAGY EGGKDAC+GDSGGPL+C+ HN W + GI SWG CA PGVY V +Y+
Sbjct: 173 CAGYKEGGKDACKGDSGGPLVCK--HN-GMWRLVGITSWGEGCARREQPGVYTKVAEYMD 229
Query: 887 WI 888
WI
Sbjct: 230 WI 231
>pdb|1RJX|B Chain B, Human Plasminogen Catalytic Domain, K698m Mutant
Length = 247
Score = 147 bits (370), Expect = 3e-35, Method: Compositional matrix adjust.
Identities = 87/247 (35%), Positives = 131/247 (53%), Gaps = 23/247 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEF-VFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQ 707
++GG + P WP+ +L F + +C G LIS +WVLTAAHC+ + V
Sbjct: 18 VVGGCVAYPHSWPWQVSLR--TRFGMHFCGGTLISPEWVLTAAHCLEKSP--RPSSYKVI 73
Query: 708 LGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPP 767
LG + + +V +F DIAL +L D ++P CLP P
Sbjct: 74 LGAHQEVNLEPHVQEIEVSRLFLEPT-------RKDIALLKLSSPAVITDKVIPACLPSP 126
Query: 768 NYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKW--LNNRELNVTLGM 825
NY +A T C + GWG+ + T + + E ++P+I +CN++ LN R + L
Sbjct: 127 NYVVADRTECFITGWGETQGTFGAGL---LMEAQLPVIENKVCNRYEFLNGRVQSTEL-- 181
Query: 826 VCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYV 885
CAG+ GG D+CQGDSGGPL+C +++ + G+ SWG+ CA P+ PGVY V ++V
Sbjct: 182 -CAGHLAGGTDSCQGDSGGPLVCFEK---DKYILQGVTSWGLGCARPNKPGVYVRVSRFV 237
Query: 886 TWIQDIM 892
TWI+ +M
Sbjct: 238 TWIEGVM 244
>pdb|2BM2|A Chain A, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2BM2|B Chain B, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2BM2|C Chain C, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2BM2|D Chain D, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2FWW|A Chain A, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FWW|B Chain B, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FWW|C Chain C, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FWW|D Chain D, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FXR|A Chain A, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FXR|B Chain B, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FXR|C Chain C, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FXR|D Chain D, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FPZ|A Chain A, Human Tryptase With 2-Amino Benzimidazole
pdb|2FPZ|B Chain B, Human Tryptase With 2-Amino Benzimidazole
pdb|2FPZ|C Chain C, Human Tryptase With 2-Amino Benzimidazole
pdb|2FPZ|D Chain D, Human Tryptase With 2-Amino Benzimidazole
pdb|2FS8|A Chain A, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS8|B Chain B, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS8|C Chain C, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS8|D Chain D, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS9|A Chain A, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2FS9|B Chain B, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2FS9|C Chain C, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2FS9|D Chain D, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2GDD|A Chain A, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2GDD|B Chain B, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2GDD|C Chain C, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2GDD|D Chain D, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2ZA5|A Chain A, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|2ZA5|B Chain B, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|2ZA5|C Chain C, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|2ZA5|D Chain D, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|4A6L|A Chain A, Beta-Tryptase Inhibitor
pdb|4A6L|B Chain B, Beta-Tryptase Inhibitor
pdb|4A6L|C Chain C, Beta-Tryptase Inhibitor
pdb|4A6L|D Chain D, Beta-Tryptase Inhibitor
pdb|3V7T|A Chain A, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
pdb|3V7T|B Chain B, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
pdb|3V7T|C Chain C, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
pdb|3V7T|D Chain D, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
Length = 245
Score = 144 bits (364), Expect = 2e-34, Method: Compositional matrix adjust.
Identities = 93/257 (36%), Positives = 131/257 (50%), Gaps = 25/257 (9%)
Query: 649 IIGGFESNPGDWPFLAAL-LGGPEFVFYCAGVLISDQWVLTAAHCVG----NLTGLNIDE 703
I+GG E+ WP+ +L + GP ++ +C G LI QWVLTAAHCVG +L L
Sbjct: 1 IVGGQEAPRSKWPWQVSLRVHGPYWMHFCGGSLIHPQWVLTAAHCVGPDVKDLAALR--- 57
Query: 704 WTVQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVC 763
VQL R + V + H Q+ AQ DIAL +L++ VK + H+ V
Sbjct: 58 --VQL---REQHLYYQDQLLPVSRIIVHPQFYT-AQIGADIALLELEEPVKVSSHVHTVT 111
Query: 764 LPPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICN------KWLNNR 817
LPP + PG C V GWG ++ + +V+VPI+ IC+ + +
Sbjct: 112 LPPASETFPPGMPCWVTGWGDVDNDERLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDD 171
Query: 818 ELNVTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGV 877
V M+CAG +D+CQGDSGGPL+C+ + W G+VSWG CA P+ PG+
Sbjct: 172 VRIVRDDMLCAG--NTRRDSCQGDSGGPLVCKVNGT---WLQAGVVSWGEGCAQPNRPGI 226
Query: 878 YAYVPKYVTWIQDIMDK 894
Y V Y+ WI + K
Sbjct: 227 YTRVTYYLDWIHHYVPK 243
>pdb|1A0L|A Chain A, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
pdb|1A0L|B Chain B, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
pdb|1A0L|C Chain C, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
pdb|1A0L|D Chain D, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
Length = 244
Score = 144 bits (364), Expect = 2e-34, Method: Compositional matrix adjust.
Identities = 93/257 (36%), Positives = 131/257 (50%), Gaps = 25/257 (9%)
Query: 649 IIGGFESNPGDWPFLAAL-LGGPEFVFYCAGVLISDQWVLTAAHCVG----NLTGLNIDE 703
I+GG E+ WP+ +L + GP ++ +C G LI QWVLTAAHCVG +L L
Sbjct: 1 IVGGQEAPRSKWPWQVSLRVHGPYWMHFCGGSLIHPQWVLTAAHCVGPDVKDLAALR--- 57
Query: 704 WTVQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVC 763
VQL R + V + H Q+ AQ DIAL +L++ VK + H+ V
Sbjct: 58 --VQL---REQHLYYQDQLLPVSRIIVHPQFYT-AQIGADIALLELEEPVKVSSHVHTVT 111
Query: 764 LPPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICN------KWLNNR 817
LPP + PG C V GWG ++ + +V+VPI+ IC+ + +
Sbjct: 112 LPPASETFPPGMPCWVTGWGDVDNDERLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDD 171
Query: 818 ELNVTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGV 877
V M+CAG +D+CQGDSGGPL+C+ + W G+VSWG CA P+ PG+
Sbjct: 172 VRIVRDDMLCAGNTR--RDSCQGDSGGPLVCKVNGT---WLQAGVVSWGEGCAQPNRPGI 226
Query: 878 YAYVPKYVTWIQDIMDK 894
Y V Y+ WI + K
Sbjct: 227 YTRVTYYLDWIHHYVPK 243
>pdb|2ZEB|A Chain A, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEB|B Chain B, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEB|C Chain C, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEB|D Chain D, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|A Chain A, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|B Chain B, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|C Chain C, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|D Chain D, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
Length = 243
Score = 144 bits (363), Expect = 2e-34, Method: Compositional matrix adjust.
Identities = 93/257 (36%), Positives = 131/257 (50%), Gaps = 25/257 (9%)
Query: 649 IIGGFESNPGDWPFLAAL-LGGPEFVFYCAGVLISDQWVLTAAHCVG----NLTGLNIDE 703
I+GG E+ WP+ +L + GP ++ +C G LI QWVLTAAHCVG +L L
Sbjct: 1 IVGGQEAPRSKWPWQVSLRVHGPYWMHFCGGSLIHPQWVLTAAHCVGPDVKDLAALR--- 57
Query: 704 WTVQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVC 763
VQL R + V + H Q+ AQ DIAL +L++ VK + H+ V
Sbjct: 58 --VQL---REQHLYYQDQLLPVSRIIVHPQFYT-AQIGADIALLELEEPVKVSSHVHTVT 111
Query: 764 LPPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICN------KWLNNR 817
LPP + PG C V GWG ++ + +V+VPI+ IC+ + +
Sbjct: 112 LPPASETFPPGMPCWVTGWGDVDNDERLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDD 171
Query: 818 ELNVTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGV 877
V M+CAG +D+CQGDSGGPL+C+ + W G+VSWG CA P+ PG+
Sbjct: 172 VRIVRDDMLCAGNTR--RDSCQGDSGGPLVCKVNGT---WLQAGVVSWGEGCAQPNRPGI 226
Query: 878 YAYVPKYVTWIQDIMDK 894
Y V Y+ WI + K
Sbjct: 227 YTRVTYYLDWIHHYVPK 243
>pdb|1Q3X|A Chain A, Crystal Structure Of The Catalytic Region Of Human Masp-2
pdb|1Q3X|B Chain B, Crystal Structure Of The Catalytic Region Of Human Masp-2
Length = 328
Score = 142 bits (359), Expect = 6e-34, Method: Compositional matrix adjust.
Identities = 95/258 (36%), Positives = 133/258 (51%), Gaps = 25/258 (9%)
Query: 648 RIIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCV----GNLTGLNIDE 703
RI GG ++ PGD+P+ +LGG AG L+ D WVLTAAH V + + L+I
Sbjct: 86 RIYGGQKAKPGDFPWQVLILGGTT----AAGALLYDNWVLTAAHAVYEQKHDASALDI-- 139
Query: 704 WTVQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVC 763
++G +R S + T+ VF H Y A DNDIAL +L KV N ++ P+C
Sbjct: 140 ---RMGTLKRLSPHY--TQAWSEAVFIHEGYTHDAGFDNDIALIKLNNKVVINSNITPIC 194
Query: 764 LPPPNYE--LAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNREL-- 819
LP E + T GWG + ++ + V++PI+ C
Sbjct: 195 LPRKEAESFMRTDDIGTASGWGLTQRGFLAR---NLMYVDIPIVDHQKCTAAYEKPPYPR 251
Query: 820 -NVTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWG-IKCAHPHLPGV 877
+VT M+CAG GGKD+C+GDSGG L+ S E+WFVGGIVSWG + C GV
Sbjct: 252 GSVTANMLCAGLESGGKDSCRGDSGGALVFLDSET-ERWFVGGIVSWGSMNCGEAGQYGV 310
Query: 878 YAYVPKYVTWIQDIMDKY 895
Y V Y+ WI++I+ +
Sbjct: 311 YTKVINYIPWIENIISDF 328
>pdb|1MKW|K Chain K, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
pdb|1MKX|K Chain K, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
Length = 308
Score = 141 bits (355), Expect = 2e-33, Method: Compositional matrix adjust.
Identities = 95/282 (33%), Positives = 145/282 (51%), Gaps = 25/282 (8%)
Query: 630 NIQCGTRRHLHNNFKARKRIIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTA 689
+Q T + L ++ RI+ G ++ G P+ L C LISD+WVLTA
Sbjct: 32 QVQDQTEKELFESY-IEGRIVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDRWVLTA 90
Query: 690 AHCV------GNLTGLNIDEWTVQLGVTRRNSYAFFGTRFK-VRGVFAHSQYNIGAQHDN 742
AHC+ N T +D+ V++G R Y + + ++ H +YN D
Sbjct: 91 AHCLLYPPWDKNFT---VDDLLVRIGKHSRTRYERKVEKISMLDKIYIHPRYNWKENLDR 147
Query: 743 DIALFQLKQKVKFNDHLLPVCLPPPNYE---LAPGTRCTVIGWGKRED---TRVSEYETA 796
DIAL +LK+ ++ +D++ PVCLP L G + V GWG R + T V+E + +
Sbjct: 148 DIALLKLKRPIELSDYIHPVCLPDKQTAAKLLHAGFKGRVTGWGNRRETWTTSVAEVQPS 207
Query: 797 VNE-VEVPIITRDICNKWLNNRELNVTLGMVCAGYPEG-GK--DACQGDSGGPLLCRSSH 852
V + V +P++ R +C + + +T M CAGY G GK DAC+GDSGGP + +S +
Sbjct: 208 VLQVVNLPLVERPVCKA---STRIRITDNMFCAGYKPGEGKRGDACEGDSGGPFVMKSPY 264
Query: 853 NFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTWIQDIMDK 894
N +W+ GIVSWG C G Y +V + WIQ ++D+
Sbjct: 265 N-NRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDR 305
>pdb|1ZJK|A Chain A, Crystal Structure Of The Zymogen Catalytic Region Of Human
Masp-2
Length = 403
Score = 140 bits (354), Expect = 2e-33, Method: Compositional matrix adjust.
Identities = 94/258 (36%), Positives = 133/258 (51%), Gaps = 25/258 (9%)
Query: 648 RIIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCV----GNLTGLNIDE 703
+I GG ++ PGD+P+ +LGG AG L+ D WVLTAAH V + + L+I
Sbjct: 161 QIYGGQKAKPGDFPWQVLILGGTT----AAGALLYDNWVLTAAHAVYEQKHDASALDI-- 214
Query: 704 WTVQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVC 763
++G +R S + T+ VF H Y A DNDIAL +L KV N ++ P+C
Sbjct: 215 ---RMGTLKRLSPHY--TQAWSEAVFIHEGYTHDAGFDNDIALIKLNNKVVINSNITPIC 269
Query: 764 LPPPNYE--LAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNREL-- 819
LP E + T GWG + ++ + V++PI+ C
Sbjct: 270 LPRKEAESFMRTDDIGTASGWGLTQRGFLAR---NLMYVDIPIVDHQKCTAAYEKPPYPR 326
Query: 820 -NVTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWG-IKCAHPHLPGV 877
+VT M+CAG GGKD+C+GDSGG L+ S E+WFVGGIVSWG + C GV
Sbjct: 327 GSVTANMLCAGLESGGKDSCRGDSGGALVFLDSET-ERWFVGGIVSWGSMNCGEAGQYGV 385
Query: 878 YAYVPKYVTWIQDIMDKY 895
Y V Y+ WI++I+ +
Sbjct: 386 YTKVINYIPWIENIISDF 403
>pdb|3TVJ|B Chain B, Catalytic Fragment Of Masp-2 In Complex With Its Specific
Inhibitor Developed By Directed Evolution On Sgci
Scaffold
Length = 242
Score = 139 bits (351), Expect = 5e-33, Method: Compositional matrix adjust.
Identities = 94/257 (36%), Positives = 132/257 (51%), Gaps = 25/257 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCV----GNLTGLNIDEW 704
I GG ++ PGD+P+ +LGG AG L+ D WVLTAAH V + + L+I
Sbjct: 1 IYGGQKAKPGDFPWQVLILGGTT----AAGALLYDNWVLTAAHAVYEQKHDASALDI--- 53
Query: 705 TVQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCL 764
++G +R S + T+ VF H Y A DNDIAL +L KV N ++ P+CL
Sbjct: 54 --RMGTLKRLSPHY--TQAWSEAVFIHEGYTHDAGFDNDIALIKLNNKVVINSNITPICL 109
Query: 765 PPPNYE--LAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNREL--- 819
P E + T GWG + ++ + V++PI+ C
Sbjct: 110 PRKEAESFMRTDDIGTASGWGLTQRGFLAR---NLMYVDIPIVDHQKCTAAYEKPPYPRG 166
Query: 820 NVTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWG-IKCAHPHLPGVY 878
+VT M+CAG GGKD+C+GDSGG L+ S E+WFVGGIVSWG + C GVY
Sbjct: 167 SVTANMLCAGLESGGKDSCRGDSGGALVFLDSET-ERWFVGGIVSWGSMNCGEAGQYGVY 225
Query: 879 AYVPKYVTWIQDIMDKY 895
V Y+ WI++I+ +
Sbjct: 226 TKVINYIPWIENIISDF 242
>pdb|2WUB|A Chain A, Crystal Structure Of Hgfa In Complex With The Allosteric
Non-Inhibitory Antibody Fab40.Deltatrp
pdb|2WUB|C Chain C, Crystal Structure Of Hgfa In Complex With The Allosteric
Non-Inhibitory Antibody Fab40.Deltatrp
pdb|2WUC|A Chain A, Crystal Structure Of Hgfa In Complex With The Allosteric
Non- Inhibitory Antibody Fab40.Deltatrp And
Ac-Kqlr-Chloromethylketone
pdb|3K2U|A Chain A, Crystal Structure Of Hgfa In Complex With The Allosteric
Inhibitory Antibody Fab40
Length = 257
Score = 139 bits (350), Expect = 6e-33, Method: Compositional matrix adjust.
Identities = 88/246 (35%), Positives = 124/246 (50%), Gaps = 14/246 (5%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
IIGG S PG P+LAA+ G F CAG L+ WV++AAHC + D +V L
Sbjct: 1 IIGGSSSLPGSHPWLAAIYIGDSF---CAGSLVHTCWVVSAAHCFSHSPPR--DSVSVVL 55
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQK----VKFNDHLLPVCL 764
G N F + ++ Y++ D+D+ L +LK+K + + P+CL
Sbjct: 56 GQHFFNRTTDVTQTFGIEKYIPYTLYSVFNPSDHDLVLIRLKKKGDRCATRSQFVQPICL 115
Query: 765 PPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLG 824
P P G +C + GWG D VS Y +++ E VP++ C+ +++
Sbjct: 116 PEPGSTFPAGHKCQIAGWGHL-DENVSGYSSSLREALVPLVADHKCSS-PEVYGADISPN 173
Query: 825 MVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKY 884
M+CAGY + DACQGDSGGPL C + ++ GI+SWG C H PGVY V Y
Sbjct: 174 MLCAGYFDCKSDACQGDSGGPLACEKN---GVAYLYGIISWGDGCGRLHKPGVYTRVANY 230
Query: 885 VTWIQD 890
V WI D
Sbjct: 231 VDWIND 236
>pdb|2R0L|A Chain A, Short Form Hgfa With Inhibitory Fab75
Length = 248
Score = 139 bits (350), Expect = 6e-33, Method: Compositional matrix adjust.
Identities = 88/246 (35%), Positives = 124/246 (50%), Gaps = 14/246 (5%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
IIGG S PG P+LAA+ G F CAG L+ WV++AAHC + D +V L
Sbjct: 1 IIGGSSSLPGSHPWLAAIYIGDSF---CAGSLVHTCWVVSAAHCFSHSPPR--DSVSVVL 55
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQK----VKFNDHLLPVCL 764
G N F + ++ Y++ D+D+ L +LK+K + + P+CL
Sbjct: 56 GQHFFNRTTDVTQTFGIEKYIPYTLYSVFNPSDHDLVLIRLKKKGDRCATRSQFVQPICL 115
Query: 765 PPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLG 824
P P G +C + GWG D VS Y +++ E VP++ C+ +++
Sbjct: 116 PEPGSTFPAGHKCQIAGWGHL-DENVSGYSSSLREALVPLVADHKCSS-PEVYGADISPN 173
Query: 825 MVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKY 884
M+CAGY + DACQGDSGGPL C + ++ GI+SWG C H PGVY V Y
Sbjct: 174 MLCAGYFDCKSDACQGDSGGPLACEKN---GVAYLYGIISWGDGCGRLHKPGVYTRVANY 230
Query: 885 VTWIQD 890
V WI D
Sbjct: 231 VDWIND 236
>pdb|1UTJ|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTK|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTL|M Chain M, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTM|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
Length = 242
Score = 138 bits (348), Expect = 1e-32, Method: Compositional matrix adjust.
Identities = 89/249 (35%), Positives = 126/249 (50%), Gaps = 27/249 (10%)
Query: 648 RIIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQ 707
+I+GG+E P P +L G F C G L+++ WV++AAHC + + + E ++
Sbjct: 20 KIVGGYECKPYSQPHQVSLNSGYHF---CGGSLVNENWVVSAAHCYKSRVEVRLGEHNIK 76
Query: 708 LGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPP 767
+ S F + +R +S YNI DNDI L +L + N ++ PV LP
Sbjct: 77 V---TEGSEQFISSSRVIRHP-NYSSYNI----DNDIMLIKLSKPATLNTYVQPVALPT- 127
Query: 768 NYELAP-GTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMV 826
AP GT CTV GWG + + + +PI++ CN N+ +T M
Sbjct: 128 --SCAPAGTMCTVSGWGNTMSSTADS--NKLQCLNIPILSYSDCN---NSYPGMITNAMF 180
Query: 827 CAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVT 886
CAGY EGGKD+CQGDSGGP++C + G+VSWG CA P PGVYA V +
Sbjct: 181 CAGYLEGGKDSCQGDSGGPVVCNGE-------LQGVVSWGYGCAEPGNPGVYAKVCIFND 233
Query: 887 WIQDIMDKY 895
W+ M Y
Sbjct: 234 WLTSTMASY 242
>pdb|4FXG|H Chain H, Complement C4 In Complex With Masp-2
pdb|4FXG|J Chain J, Complement C4 In Complex With Masp-2
Length = 242
Score = 138 bits (348), Expect = 1e-32, Method: Compositional matrix adjust.
Identities = 93/257 (36%), Positives = 132/257 (51%), Gaps = 25/257 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCV----GNLTGLNIDEW 704
I GG ++ PGD+P+ +LGG AG L+ D WVLTAAH V + + L+I
Sbjct: 1 IYGGQKAKPGDFPWQVLILGGTT----AAGALLYDNWVLTAAHAVYEQKHDASALDI--- 53
Query: 705 TVQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCL 764
++G +R S + T+ VF H Y A DNDIAL +L KV N ++ P+CL
Sbjct: 54 --RMGTLKRLSPHY--TQAWSEAVFIHEGYTHDAGFDNDIALIKLNNKVVINSNITPICL 109
Query: 765 PPPNYE--LAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNREL--- 819
P E + T GWG + ++ + V++PI+ C
Sbjct: 110 PRKEAESFMRTDDIGTASGWGLTQRGFLAR---NLMYVDIPIVDHQKCTAAYEKPPYPRG 166
Query: 820 NVTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWG-IKCAHPHLPGVY 878
+VT M+CAG GGKD+C+GD+GG L+ S E+WFVGGIVSWG + C GVY
Sbjct: 167 SVTANMLCAGLESGGKDSCRGDAGGALVFLDSET-ERWFVGGIVSWGSMNCGEAGQYGVY 225
Query: 879 AYVPKYVTWIQDIMDKY 895
V Y+ WI++I+ +
Sbjct: 226 TKVINYIPWIENIISDF 242
>pdb|1THP|B Chain B, Structure Of Human Alpha-Thrombin Y225p Mutant Bound To
D-Phe-Pro-Arg- Chloromethylketone
pdb|3S7H|B Chain B, Structure Of Thrombin Mutant Y225p In The E Form
pdb|3S7K|B Chain B, Structure Of Thrombin Mutant Y225p In The E Form
pdb|3S7K|D Chain D, Structure Of Thrombin Mutant Y225p In The E Form
Length = 259
Score = 138 bits (348), Expect = 1e-32, Method: Compositional matrix adjust.
Identities = 90/265 (33%), Positives = 135/265 (50%), Gaps = 24/265 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCV------GNLTGLNID 702
I+ G ++ G P+ L C LISD+WVLTAAHC+ N T ++
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL- 59
Query: 703 EWTVQLGVTRRNSYAFFGTRFK-VRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLP 761
V++G R Y + + ++ H +YN D DIAL +LK+ V F+D++ P
Sbjct: 60 --LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 762 VCLPPPNYE---LAPGTRCTVIGWGKREDTRVSEY----ETAVNEVEVPIITRDICNKWL 814
VCLP L G + V GWG ++T + + + V +PI+ R +C
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK--- 174
Query: 815 NNRELNVTLGMVCAGY-PEGGK--DACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAH 871
++ + +T M CAGY P+ GK DAC+GDSGGP + +S N +W+ GIVSWG C
Sbjct: 175 DSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFN-NRWYQMGIVSWGEGCDR 233
Query: 872 PHLPGVYAYVPKYVTWIQDIMDKYS 896
PG Y +V + WIQ ++D++
Sbjct: 234 DGKPGFYTHVFRLKKWIQKVIDQFG 258
>pdb|1MH0|A Chain A, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
pdb|1MH0|B Chain B, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
Length = 287
Score = 138 bits (347), Expect = 2e-32, Method: Compositional matrix adjust.
Identities = 91/265 (34%), Positives = 135/265 (50%), Gaps = 24/265 (9%)
Query: 648 RIIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCV------GNLTGLNI 701
RI+ G ++ G P+ L C LISD+WVLTAAHC+ N T ++
Sbjct: 30 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL 89
Query: 702 DEWTVQLGVTRRNSY-AFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLL 760
V++G R Y A + ++ H +YN D DIAL +LK+ V F+D++
Sbjct: 90 ---LVRIGKHSRTRYEANIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIH 146
Query: 761 PVCLPPPNYE---LAPGTRCTVIGWGKREDTRVSEY----ETAVNEVEVPIITRDICNKW 813
PVCLP L G + V GWG ++T + + + V +PI+ R +C
Sbjct: 147 PVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK-- 204
Query: 814 LNNRELNVTLGMVCAGY-PEGGK--DACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCA 870
++ + +T M CAGY P+ GK DAC+GDSGGP + +S N +W+ GIVSWG C
Sbjct: 205 -DSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFN-NRWYQMGIVSWGEGCD 262
Query: 871 HPHLPGVYAYVPKYVTWIQDIMDKY 895
G Y +V + WIQ ++D++
Sbjct: 263 RDGKYGFYTHVFRLKKWIQKVIDQF 287
>pdb|1D6W|A Chain A, Structure Of Thrombin Complexed With Selective
Non-Electrophilic Inhibitors Having Cyclohexyl Moieties
At P1
pdb|1G37|A Chain A, Crystal Structure Of Human Alpha-thrombin Complexed With
Bch-10556 And Exosite-directed Peptide
Length = 287
Score = 137 bits (346), Expect = 2e-32, Method: Compositional matrix adjust.
Identities = 90/265 (33%), Positives = 135/265 (50%), Gaps = 24/265 (9%)
Query: 648 RIIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCV------GNLTGLNI 701
RI+ G ++ G P+ L C LISD+WVLTAAHC+ N T ++
Sbjct: 30 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL 89
Query: 702 DEWTVQLGVTRRNSYAFFGTRFK-VRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLL 760
V++G R Y + + ++ H +YN D DIAL +LK+ V F+D++
Sbjct: 90 ---LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIH 146
Query: 761 PVCLPPPNYE---LAPGTRCTVIGWGKREDTRVSEY----ETAVNEVEVPIITRDICNKW 813
PVCLP L G + V GWG ++T + + + V +PI+ R +C
Sbjct: 147 PVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK-- 204
Query: 814 LNNRELNVTLGMVCAGY-PEGGK--DACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCA 870
++ + +T M CAGY P+ GK DAC+GDSGGP + +S N +W+ GIVSWG C
Sbjct: 205 -DSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFN-NRWYQMGIVSWGEGCD 262
Query: 871 HPHLPGVYAYVPKYVTWIQDIMDKY 895
G Y +V + WIQ ++D++
Sbjct: 263 RDGKYGFYTHVFRLKKWIQKVIDQF 287
>pdb|1ID5|H Chain H, Crystal Structure Of Bovine Thrombin Complex With Protease
Inhibitor Ecotin
Length = 256
Score = 137 bits (346), Expect = 2e-32, Method: Compositional matrix adjust.
Identities = 91/263 (34%), Positives = 137/263 (52%), Gaps = 24/263 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCV------GNLTGLNID 702
I+ G ++ G P+ L C LISD+WVLTAAHC+ N T +D
Sbjct: 1 IVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFT---VD 57
Query: 703 EWTVQLGVTRRNSYAFFGTRFK-VRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLP 761
+ V++G R Y + + ++ H +YN D DIAL +LK+ ++ +D++ P
Sbjct: 58 DLLVRIGKHSRTRYERKVEKISMLDKIYIHPRYNWKENLDRDIALLKLKRPIELSDYIHP 117
Query: 762 VCLPPPNYE---LAPGTRCTVIGWGKRED---TRVSEYETAVNE-VEVPIITRDICNKWL 814
VCLP L G + V GWG R + T V+E + +V + V +P++ R +C
Sbjct: 118 VCLPDKQTAAKLLHAGFKGRVTGWGNRRETWTTSVAEVQPSVLQVVNLPLVERPVCKA-- 175
Query: 815 NNRELNVTLGMVCAGYPEG-GK--DACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAH 871
+ + +T M CAGY G GK DAC+GDSGGP + +S +N +W+ GIVSWG C
Sbjct: 176 -STRIRITDNMFCAGYKPGEGKRGDACEGDSGGPFVMKSPYN-NRWYQMGIVSWGEGCDR 233
Query: 872 PHLPGVYAYVPKYVTWIQDIMDK 894
G Y +V + WIQ ++D+
Sbjct: 234 DGKYGFYTHVFRLKKWIQKVIDR 256
>pdb|2XRC|A Chain A, Human Complement Factor I
pdb|2XRC|B Chain B, Human Complement Factor I
pdb|2XRC|C Chain C, Human Complement Factor I
pdb|2XRC|D Chain D, Human Complement Factor I
Length = 565
Score = 137 bits (346), Expect = 2e-32, Method: Compositional matrix adjust.
Identities = 90/262 (34%), Positives = 126/262 (48%), Gaps = 21/262 (8%)
Query: 631 IQCGTRRHLHNNFKARKRIIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAA 690
+ CG + +H RKRI+GG + GD P+ A+ C G+ I W+LTAA
Sbjct: 307 LSCGVKNRMHIR---RKRIVGGKRAQLGDLPWQVAIKDASGIT--CGGIYIGGCWILTAA 361
Query: 691 HCVGNLTGLNIDEWTVQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLK 750
HC+ WT + + + R +F H YN G + NDIAL ++K
Sbjct: 362 HCLRASKTHRYQIWTTVVDWIHPDLKRIV-IEYVDRIIF-HENYNAGT-YQNDIALIEMK 418
Query: 751 QKVKFND----HLLPVCLPPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIIT 806
+ D +P C+P Y P C V GWG+ +D +E ++ EV +I+
Sbjct: 419 KDGNKKDCELPRSIPACVPWSPYLFQPNDTCIVSGWGREKD---NERVFSLQWGEVKLIS 475
Query: 807 RDICNKWLNNRELNVTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWG 866
C+K+ NR M CAG +G DAC+GDSGGPL+C ++N +V G+VSWG
Sbjct: 476 N--CSKFYGNRFYEKE--MECAGTYDGSIDACKGDSGGPLVCMDANNVT--YVWGVVSWG 529
Query: 867 IKCAHPHLPGVYAYVPKYVTWI 888
C P PGVY V Y WI
Sbjct: 530 ENCGKPEFPGVYTKVANYFDWI 551
Score = 57.8 bits (138), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 29/73 (39%), Positives = 39/73 (53%)
Query: 456 FQCDVNRCIPLDWQCDGHIDCQDQTDELNCEPCKADEIHCGLNKCISDYHVCDGKVDCPW 515
FQC + I CDG DC DQ+DEL C+ C+ HC CI + C+G+VDC
Sbjct: 209 FQCVNGKYISQMKACDGINDCGDQSDELCCKACQGKGFHCKSGVCIPSQYQCNGEVDCIT 268
Query: 516 GQDERNCLQLSGM 528
G+DE C + +
Sbjct: 269 GEDEVGCAGFASV 281
Score = 36.2 bits (82), Expect = 0.075, Method: Compositional matrix adjust.
Identities = 14/32 (43%), Positives = 19/32 (59%)
Query: 454 EGFQCDVNRCIPLDWQCDGHIDCQDQTDELNC 485
+GF C CIP +QC+G +DC DE+ C
Sbjct: 244 KGFHCKSGVCIPSQYQCNGEVDCITGEDEVGC 275
>pdb|1NM6|A Chain A, Thrombin In Complex With Selective Macrocyclic Inhibitor
At 1.8a
pdb|1NT1|A Chain A, Thrombin In Complex With Selective Macrocyclic Inhibitor
pdb|1TA2|A Chain A, Crystal Structure Of Thrombin In Complex With Compound 1
pdb|1TA6|A Chain A, Crystal Structure Of Thrombin In Complex With Compound 14b
pdb|1SL3|A Chain A, Crystal Structue Of Thrombin In Complex With A Potent P1
Heterocycle- Aryl Based Inhibitor
pdb|1Z71|A Chain A, Thrombin And P2 Pyridine N-oxide Inhibitor Complex
Structure
pdb|1ZRB|A Chain A, Thrombin In Complex With An Azafluorenyl Inhibitor 23b
pdb|1ZGI|A Chain A, Thrombin In Complex With An Oxazolopyridine Inhibitor 21
pdb|1ZGV|A Chain A, Thrombin In Complex With An Oxazolopyridine Inhibitor 2
pdb|3C1K|A Chain A, Crystal Structure Of Thrombin In Complex With Inhibitor 15
Length = 287
Score = 137 bits (346), Expect = 2e-32, Method: Compositional matrix adjust.
Identities = 90/266 (33%), Positives = 135/266 (50%), Gaps = 24/266 (9%)
Query: 648 RIIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCV------GNLTGLNI 701
RI+ G ++ G P+ L C LISD+WVLTAAHC+ N T ++
Sbjct: 29 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL 88
Query: 702 DEWTVQLGVTRRNSYAFFGTRFK-VRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLL 760
V++G R Y + + ++ H +YN D DIAL +LK+ V F+D++
Sbjct: 89 ---LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIH 145
Query: 761 PVCLPPPNYE---LAPGTRCTVIGWGKREDTRVSEY----ETAVNEVEVPIITRDICNKW 813
PVCLP L G + V GWG ++T + + + V +PI+ R +C
Sbjct: 146 PVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK-- 203
Query: 814 LNNRELNVTLGMVCAGY-PEGGK--DACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCA 870
++ + +T M CAGY P+ GK DAC+GDSGGP + +S N +W+ GIVSWG C
Sbjct: 204 -DSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFN-NRWYQMGIVSWGEGCD 261
Query: 871 HPHLPGVYAYVPKYVTWIQDIMDKYS 896
G Y +V + WIQ ++D++
Sbjct: 262 RDGKYGFYTHVFRLKKWIQKVIDQFG 287
>pdb|1JWT|A Chain A, Crystal Structure Of Thrombin In Complex With A Novel
Bicyclic Lactam Inhibitor
Length = 305
Score = 137 bits (346), Expect = 2e-32, Method: Compositional matrix adjust.
Identities = 93/284 (32%), Positives = 143/284 (50%), Gaps = 25/284 (8%)
Query: 630 NIQCGTRRHLHNNFKARKRIIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTA 689
+++ T R L ++ RI+ G ++ G P+ L C LISD+WVLTA
Sbjct: 19 SLEDKTERELLESY-IDGRIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTA 77
Query: 690 AHCV------GNLTGLNIDEWTVQLGVTRRNSYAFFGTRFK-VRGVFAHSQYNIGAQHDN 742
AHC+ N T ++ V++G R Y + + ++ H +YN D
Sbjct: 78 AHCLLYPPWDKNFTENDL---LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDR 134
Query: 743 DIALFQLKQKVKFNDHLLPVCLPPPNYE---LAPGTRCTVIGWGKREDTRVSEY----ET 795
DIAL +LK+ V F+D++ PVCLP L G + V GWG ++T + +
Sbjct: 135 DIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPS 194
Query: 796 AVNEVEVPIITRDICNKWLNNRELNVTLGMVCAGY-PEGGK--DACQGDSGGPLLCRSSH 852
+ V +PI+ R +C ++ + +T M CAGY P+ GK DAC+GDSGGP + +S
Sbjct: 195 VLQVVNLPIVERPVCK---DSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPF 251
Query: 853 NFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTWIQDIMDKYS 896
N +W+ GIVSWG C G Y +V + WIQ ++D++
Sbjct: 252 N-NRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFG 294
>pdb|1BBR|K Chain K, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1BBR|N Chain N, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1ETR|H Chain H, Refined 2.3 Angstroms X-Ray Crystal Structure Of Bovine
Thrombin Complexes Formed With The Benzamidine And
Arginine-Based Thrombin Inhibitors Napap, 4-Tapap And
Mqpa: A Starting Point For Improving Antithrombotics
pdb|1ETS|H Chain H, Refined 2.3 Angstroms X-Ray Crystal Structure Of Bovine
Thrombin Complexes Formed With The Benzamidine And
Arginine-Based Thrombin Inhibitors Napap, 4-Tapap And
Mqpa: A Starting Point For Improving Antithrombotics
pdb|1ETT|H Chain H, Refined 2.3 Angstroms X-Ray Crystal Structure Of Bovine
Thrombin Complexes Formed With The Benzamidine And
Arginine-Based Thrombin Inhibitors Napap, 4-Tapap And
Mqpa: A Starting Point For Improving Antithrombotics
pdb|1HRT|H Chain H, The Structure Of A Complex Of Bovine Alpha-Thrombin And
Recombinant Hirudin At 2.8 Angstroms Resolution
pdb|1TBR|H Chain H, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1TBR|K Chain K, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1TBQ|H Chain H, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1TBQ|K Chain K, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1UCY|K Chain K, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1UCY|N Chain N, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1VIT|H Chain H, Thrombin:hirudin 51-65 Complex
pdb|1MKW|H Chain H, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
pdb|1MKX|H Chain H, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
pdb|1TOC|B Chain B, Structure Of Serine Proteinase
pdb|1TOC|D Chain D, Structure Of Serine Proteinase
pdb|1TOC|F Chain F, Structure Of Serine Proteinase
pdb|1TOC|H Chain H, Structure Of Serine Proteinase
pdb|1UVT|H Chain H, Bovine Thrombin--Bm14.1248 Complex
pdb|1UVU|H Chain H, Bovine Thrombin--Bm12.1700 Complex
pdb|1YCP|H Chain H, The Crystal Structure Of Fibrinogen-Aa Peptide 1-23 (F8y)
Bound To Bovine Thrombin Explains Why The Mutation Of
Phe-8 To Tyrosine Strongly Inhibits Normal Cleavage At
Arginine-16
pdb|1A0H|B Chain B, The X-Ray Crystal Structure Of Ppack-Meizothrombin Desf1:
KringleTHROMBIN AND CARBOHYDRATEKRINGLETHROMBIN
INTERACTIONS AND Location Of The Linker Chain
pdb|1A0H|E Chain E, The X-Ray Crystal Structure Of Ppack-Meizothrombin Desf1:
KringleTHROMBIN AND CARBOHYDRATEKRINGLETHROMBIN
INTERACTIONS AND Location Of The Linker Chain
pdb|1AVG|H Chain H, Thrombin Inhibitor From Triatoma Pallidipennis
pdb|2A1D|B Chain B, Staphylocoagulase Bound To Bovine Thrombin
pdb|2A1D|F Chain F, Staphylocoagulase Bound To Bovine Thrombin
pdb|2ODY|B Chain B, Thrombin-bound Boophilin Displays A Functional And
Accessible Reactive-site Loop
pdb|2ODY|D Chain D, Thrombin-bound Boophilin Displays A Functional And
Accessible Reactive-site Loop
pdb|3PMA|B Chain B, 2.2 Angstrom Crystal Structure Of The Complex Between
Bovine Thrombin And Sucrose Octasulfate
pdb|3PMA|D Chain D, 2.2 Angstrom Crystal Structure Of The Complex Between
Bovine Thrombin And Sucrose Octasulfate
pdb|3PMB|B Chain B, 2.9 Angstrom Crystal Structure Of Bovine Thrombin In
Tetragonal Spacegroup
pdb|3PMB|D Chain D, 2.9 Angstrom Crystal Structure Of Bovine Thrombin In
Tetragonal Spacegroup
Length = 259
Score = 137 bits (346), Expect = 2e-32, Method: Compositional matrix adjust.
Identities = 91/263 (34%), Positives = 137/263 (52%), Gaps = 24/263 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCV------GNLTGLNID 702
I+ G ++ G P+ L C LISD+WVLTAAHC+ N T +D
Sbjct: 1 IVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFT---VD 57
Query: 703 EWTVQLGVTRRNSYAFFGTRFK-VRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLP 761
+ V++G R Y + + ++ H +YN D DIAL +LK+ ++ +D++ P
Sbjct: 58 DLLVRIGKHSRTRYERKVEKISMLDKIYIHPRYNWKENLDRDIALLKLKRPIELSDYIHP 117
Query: 762 VCLPPPNYE---LAPGTRCTVIGWGKRED---TRVSEYETAVNE-VEVPIITRDICNKWL 814
VCLP L G + V GWG R + T V+E + +V + V +P++ R +C
Sbjct: 118 VCLPDKQTAAKLLHAGFKGRVTGWGNRRETWTTSVAEVQPSVLQVVNLPLVERPVCKA-- 175
Query: 815 NNRELNVTLGMVCAGYPEG-GK--DACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAH 871
+ + +T M CAGY G GK DAC+GDSGGP + +S +N +W+ GIVSWG C
Sbjct: 176 -STRIRITDNMFCAGYKPGEGKRGDACEGDSGGPFVMKSPYN-NRWYQMGIVSWGEGCDR 233
Query: 872 PHLPGVYAYVPKYVTWIQDIMDK 894
G Y +V + WIQ ++D+
Sbjct: 234 DGKYGFYTHVFRLKKWIQKVIDR 256
>pdb|1BZX|E Chain E, The Crystal Structure Of Anionic Salmon Trypsin In Complex
With Bovine Pancreatic Trypsin Inhibitor
pdb|2STA|E Chain E, Anionic Salmon Trypsin In Complex With Squash Seed
Inhibitor (Cucurbita Maxima Trypsin Inhibitor I)
pdb|2STB|E Chain E, Anionic Salmon Trypsin In Complex With Squash Seed
Inhibitor (cucurbita Pepo Trypsin Inhibitor Ii)
Length = 222
Score = 137 bits (346), Expect = 2e-32, Method: Compositional matrix adjust.
Identities = 89/248 (35%), Positives = 125/248 (50%), Gaps = 27/248 (10%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+E P P +L G F C G L+++ WV++AAHC + + + E +++
Sbjct: 1 IVGGYECKPYSQPHQVSLNSGYHF---CGGSLVNENWVVSAAHCYKSRVEVRLGEHNIKV 57
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
S F + +R +S YNI DNDI L +L + N ++ PV LP
Sbjct: 58 ---TEGSEQFISSSRVIRHP-NYSSYNI----DNDIMLIKLSKPATLNTYVQPVALPT-- 107
Query: 769 YELAP-GTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVC 827
AP GT CTV GWG + + + +PI++ CN N+ +T M C
Sbjct: 108 -SCAPAGTMCTVSGWGNTMSSTADS--NKLQCLNIPILSYSDCN---NSYPGMITNAMFC 161
Query: 828 AGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTW 887
AGY EGGKD+CQGDSGGP++C + G+VSWG CA P PGVYA V + W
Sbjct: 162 AGYLEGGKDSCQGDSGGPVVCNGE-------LQGVVSWGYGCAEPGNPGVYAKVCIFNDW 214
Query: 888 IQDIMDKY 895
+ M Y
Sbjct: 215 LTSTMASY 222
>pdb|1NU9|A Chain A, Staphylocoagulase-prethrombin-2 Complex
pdb|1NU9|D Chain D, Staphylocoagulase-prethrombin-2 Complex
Length = 291
Score = 137 bits (345), Expect = 2e-32, Method: Compositional matrix adjust.
Identities = 90/266 (33%), Positives = 135/266 (50%), Gaps = 24/266 (9%)
Query: 648 RIIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCV------GNLTGLNI 701
RI+ G ++ G P+ L C LISD+WVLTAAHC+ N T ++
Sbjct: 32 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL 91
Query: 702 DEWTVQLGVTRRNSYAFFGTRFK-VRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLL 760
V++G R Y + + ++ H +YN D DIAL +LK+ V F+D++
Sbjct: 92 ---LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIH 148
Query: 761 PVCLPPPNYE---LAPGTRCTVIGWGKREDTRVSEYE----TAVNEVEVPIITRDICNKW 813
PVCLP L G + V GWG ++T + + + V +PI+ R +C
Sbjct: 149 PVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK-- 206
Query: 814 LNNRELNVTLGMVCAGY-PEGGK--DACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCA 870
++ + +T M CAGY P+ GK DAC+GDSGGP + +S N +W+ GIVSWG C
Sbjct: 207 -DSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFN-NRWYQMGIVSWGEGCD 264
Query: 871 HPHLPGVYAYVPKYVTWIQDIMDKYS 896
G Y +V + WIQ ++D++
Sbjct: 265 RDGKYGFYTHVFRLKKWIQKVIDQFG 290
>pdb|1D9I|A Chain A, Structure Of Thrombin Complexed With Selective
Non-Electophilic Inhibitors Having Cyclohexyl Moieties
At P1
Length = 288
Score = 137 bits (345), Expect = 2e-32, Method: Compositional matrix adjust.
Identities = 90/266 (33%), Positives = 135/266 (50%), Gaps = 24/266 (9%)
Query: 648 RIIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCV------GNLTGLNI 701
RI+ G ++ G P+ L C LISD+WVLTAAHC+ N T ++
Sbjct: 30 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL 89
Query: 702 DEWTVQLGVTRRNSYAFFGTRFK-VRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLL 760
V++G R Y + + ++ H +YN D DIAL +LK+ V F+D++
Sbjct: 90 ---LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIH 146
Query: 761 PVCLPPPNYE---LAPGTRCTVIGWGKREDTRVSEY----ETAVNEVEVPIITRDICNKW 813
PVCLP L G + V GWG ++T + + + V +PI+ R +C
Sbjct: 147 PVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK-- 204
Query: 814 LNNRELNVTLGMVCAGY-PEGGK--DACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCA 870
++ + +T M CAGY P+ GK DAC+GDSGGP + +S N +W+ GIVSWG C
Sbjct: 205 -DSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFN-NRWYQMGIVSWGEGCD 262
Query: 871 HPHLPGVYAYVPKYVTWIQDIMDKYS 896
G Y +V + WIQ ++D++
Sbjct: 263 RDGKYGFYTHVFRLKKWIQKVIDQFG 288
>pdb|2OQ5|A Chain A, Crystal Structure Of Desc1, A New Member Of The Type Ii
Transmembrane Serine Proteinases Family
Length = 232
Score = 137 bits (345), Expect = 2e-32, Method: Compositional matrix adjust.
Identities = 89/240 (37%), Positives = 125/240 (52%), Gaps = 14/240 (5%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG E G+WP+ A+L + C LI+ W+++AAHC T N WT
Sbjct: 1 IVGGTEVEEGEWPWQASLQW--DGSHRCGATLINATWLVSAAHCF--TTYKNPARWTASF 56
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
GVT + S G +R + H +Y HD DI+L +L V + + + VCLP +
Sbjct: 57 GVTIKPSKMKRG----LRRIIVHEKYK-HPSHDYDISLAELSSPVPYTNAVHRVCLPDAS 111
Query: 769 YELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVCA 828
YE PG V G+G ++ S+ + + +V +I CN+ +T M+CA
Sbjct: 112 YEFQPGDVMFVTGFGALKNDGYSQNH--LRQAQVTLIDATTCNE-PQAYNDAITPRMLCA 168
Query: 829 GYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTWI 888
G EG DACQGDSGGPL+ SS + W++ GIVSWG +CA P+ PGVY V WI
Sbjct: 169 GSLEGKTDACQGDSGGPLV--SSDARDIWYLAGIVSWGDECAKPNKPGVYTRVTALRDWI 226
>pdb|3NXP|A Chain A, Crystal Structure Of Human Prethrombin-1
Length = 424
Score = 137 bits (345), Expect = 2e-32, Method: Compositional matrix adjust.
Identities = 93/279 (33%), Positives = 140/279 (50%), Gaps = 25/279 (8%)
Query: 635 TRRHLHNNFKARKRIIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCV- 693
T R L ++ RI+ G ++ G P+ L C LISD+WVLTAAHC+
Sbjct: 153 TERELLESY-IDGRIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLL 211
Query: 694 -----GNLTGLNIDEWTVQLGVTRRNSYAFFGTRFK-VRGVFAHSQYNIGAQHDNDIALF 747
N T ++ V++G R Y + + ++ H +YN D DIAL
Sbjct: 212 YPPWDKNFTENDL---LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALM 268
Query: 748 QLKQKVKFNDHLLPVCLPPPNYE---LAPGTRCTVIGWGKREDTRVSEYE----TAVNEV 800
+LK+ V F+D++ PVCLP L G + V GWG ++T + + + V
Sbjct: 269 KLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVV 328
Query: 801 EVPIITRDICNKWLNNRELNVTLGMVCAGY-PEGGK--DACQGDSGGPLLCRSSHNFEQW 857
+PI+ R +C ++ + +T M CAGY P+ GK DAC+GDSGGP + +S N +W
Sbjct: 329 NLPIVERPVCK---DSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFN-NRW 384
Query: 858 FVGGIVSWGIKCAHPHLPGVYAYVPKYVTWIQDIMDKYS 896
+ GIVSWG C G Y +V + WIQ ++D++
Sbjct: 385 YQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFG 423
>pdb|2BDY|A Chain A, Thrombin In Complex With Inhibitor
Length = 289
Score = 137 bits (345), Expect = 3e-32, Method: Compositional matrix adjust.
Identities = 90/266 (33%), Positives = 135/266 (50%), Gaps = 24/266 (9%)
Query: 648 RIIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCV------GNLTGLNI 701
RI+ G ++ G P+ L C LISD+WVLTAAHC+ N T ++
Sbjct: 30 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL 89
Query: 702 DEWTVQLGVTRRNSYAFFGTRFK-VRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLL 760
V++G R Y + + ++ H +YN D DIAL +LK+ V F+D++
Sbjct: 90 ---LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIH 146
Query: 761 PVCLPPPNYE---LAPGTRCTVIGWGKREDTRVSEY----ETAVNEVEVPIITRDICNKW 813
PVCLP L G + V GWG ++T + + + V +PI+ R +C
Sbjct: 147 PVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK-- 204
Query: 814 LNNRELNVTLGMVCAGY-PEGGK--DACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCA 870
++ + +T M CAGY P+ GK DAC+GDSGGP + +S N +W+ GIVSWG C
Sbjct: 205 -DSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFN-NRWYQMGIVSWGEGCD 262
Query: 871 HPHLPGVYAYVPKYVTWIQDIMDKYS 896
G Y +V + WIQ ++D++
Sbjct: 263 RDGKYGFYTHVFRLKKWIQKVIDQFG 288
>pdb|1HAG|E Chain E, The Isomorphous Structures Of Prethrombin2, Hirugen-And
Ppack- Thrombin: Changes Accompanying Activation And
Exosite Binding To Thrombin
pdb|1DOJ|A Chain A, Crystal Structure Of Human Alpha-ThrombinRwj-51438 Complex
At 1.7 A
pdb|1XM1|A Chain A, Nonbasic Thrombin Inhibitor Complex
Length = 295
Score = 137 bits (345), Expect = 3e-32, Method: Compositional matrix adjust.
Identities = 90/266 (33%), Positives = 135/266 (50%), Gaps = 24/266 (9%)
Query: 648 RIIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCV------GNLTGLNI 701
RI+ G ++ G P+ L C LISD+WVLTAAHC+ N T ++
Sbjct: 36 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL 95
Query: 702 DEWTVQLGVTRRNSYAFFGTRFK-VRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLL 760
V++G R Y + + ++ H +YN D DIAL +LK+ V F+D++
Sbjct: 96 ---LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIH 152
Query: 761 PVCLPPPNYE---LAPGTRCTVIGWGKREDTRVSEYE----TAVNEVEVPIITRDICNKW 813
PVCLP L G + V GWG ++T + + + V +PI+ R +C
Sbjct: 153 PVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK-- 210
Query: 814 LNNRELNVTLGMVCAGY-PEGGK--DACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCA 870
++ + +T M CAGY P+ GK DAC+GDSGGP + +S N +W+ GIVSWG C
Sbjct: 211 -DSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFN-NRWYQMGIVSWGEGCD 268
Query: 871 HPHLPGVYAYVPKYVTWIQDIMDKYS 896
G Y +V + WIQ ++D++
Sbjct: 269 RDGKYGFYTHVFRLKKWIQKVIDQFG 294
>pdb|1EOJ|A Chain A, Design Of P1' And P3' Residues Of Trivalent Thrombin
Inhibitors And Their Crystal Structures
pdb|1EOL|A Chain A, Design Of P1' And P3' Residues Of Trivalent Thrombin
Inhibitors And Their Crystal Structures
Length = 289
Score = 137 bits (345), Expect = 3e-32, Method: Compositional matrix adjust.
Identities = 90/265 (33%), Positives = 135/265 (50%), Gaps = 24/265 (9%)
Query: 648 RIIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCV------GNLTGLNI 701
RI+ G ++ G P+ L C LISD+WVLTAAHC+ N T ++
Sbjct: 32 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL 91
Query: 702 DEWTVQLGVTRRNSYAFFGTRFK-VRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLL 760
V++G R Y + + ++ H +YN D DIAL +LK+ V F+D++
Sbjct: 92 ---LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIH 148
Query: 761 PVCLPPPNYE---LAPGTRCTVIGWGKREDTRVSEYE----TAVNEVEVPIITRDICNKW 813
PVCLP L G + V GWG ++T + + + V +PI+ R +C
Sbjct: 149 PVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK-- 206
Query: 814 LNNRELNVTLGMVCAGY-PEGGK--DACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCA 870
++ + +T M CAGY P+ GK DAC+GDSGGP + +S N +W+ GIVSWG C
Sbjct: 207 -DSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFN-NRWYQMGIVSWGEGCD 264
Query: 871 HPHLPGVYAYVPKYVTWIQDIMDKY 895
G Y +V + WIQ ++D++
Sbjct: 265 RDGKYGFYTHVFRLKKWIQKVIDQF 289
>pdb|2CGA|A Chain A, Bovine Chymotrypsinogen A. X-Ray Crystal Structure
Analysis And Refinement Of A New Crystal Form At 1.8
Angstroms Resolution
pdb|2CGA|B Chain B, Bovine Chymotrypsinogen A. X-Ray Crystal Structure
Analysis And Refinement Of A New Crystal Form At 1.8
Angstroms Resolution
pdb|1ACB|E Chain E, Crystal And Molecular Structure Of The Bovine
Alpha-Chymotrypsin-Eglin C Complex At 2.0 Angstroms
Resolution
pdb|1CGI|E Chain E, Three-Dimensional Structure Of The Complexes Between
Bovine ChymotrypsinogenA And Two Recombinant Variants Of
Human Pancreatic Secretory Trypsin Inhibitor
(Kazal-Type)
pdb|1CGJ|E Chain E, Three-Dimensional Structure Of The Complexes Between
Bovine ChymotrypsinogenA And Two Recombinant Variants Of
Human Pancreatic Secretory Trypsin Inhibitor
(Kazal-Type)
pdb|1EX3|A Chain A, Crystal Structure Of Bovine Chymotrypsinogen A
(Tetragonal)
pdb|1GL1|A Chain A, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-C, An Inhibitor From The Insect Locusta
Migratoria
pdb|1GL1|B Chain B, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-C, An Inhibitor From The Insect Locusta
Migratoria
pdb|1GL1|C Chain C, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-C, An Inhibitor From The Insect Locusta
Migratoria
pdb|1GL0|E Chain E, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-D2v, An Inhibitor From The Insect Locusta
Migratoria
pdb|1K2I|1 Chain 1, Crystal Structure Of Gamma-Chymotrypsin In Complex With 7-
Hydroxycoumarin
pdb|1P2M|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2M|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2N|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2N|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2O|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2O|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2Q|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2Q|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1OXG|A Chain A, Crystal Structure Of A Complex Formed Between Organic
Solvent Treated Bovine Alpha-Chymotrypsin And Its
Autocatalytically Produced Highly Potent 14-Residue
Peptide At 2.2 Resolution
pdb|1T7C|A Chain A, Crystal Structure Of The P1 Glu Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T7C|C Chain C, Crystal Structure Of The P1 Glu Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8L|A Chain A, Crystal Structure Of The P1 Met Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8L|C Chain C, Crystal Structure Of The P1 Met Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8M|A Chain A, Crystal Structure Of The P1 His Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8M|C Chain C, Crystal Structure Of The P1 His Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8N|A Chain A, Crystal Structure Of The P1 Thr Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8N|C Chain C, Crystal Structure Of The P1 Thr Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8O|A Chain A, Crystal Structure Of The P1 Trp Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8O|C Chain C, Crystal Structure Of The P1 Trp Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1CHG|A Chain A, Chymotrypsinogen,2.5 Angstroms Crystal Structure,
Comparison With Alpha-Chymotrypsin,And Implications For
Zymogen Activation
pdb|1GCD|A Chain A, Refined Crystal Structure Of "aged" And "non-Aged"
Organophosphoryl Conjugates Of Gamma-Chymotrypsin
pdb|2Y6T|A Chain A, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|2Y6T|B Chain B, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|2Y6T|C Chain C, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|2Y6T|D Chain D, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|3T62|A Chain A, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Chymotrypsin
pdb|3T62|B Chain B, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Chymotrypsin
pdb|3T62|C Chain C, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Chymotrypsin
Length = 245
Score = 137 bits (344), Expect = 3e-32, Method: Composition-based stats.
Identities = 85/247 (34%), Positives = 124/247 (50%), Gaps = 21/247 (8%)
Query: 648 RIIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQ 707
RI+ G E+ PG WP+ +L F F C G LI++ WV+TAAHC G+ + V
Sbjct: 15 RIVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC-----GVTTSDVVVA 68
Query: 708 LGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPP 767
G + S + + K+ VF +S+YN +NDI L +L F+ + VCLP
Sbjct: 69 -GEFDQGSSSEKIQKLKIAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLPSA 126
Query: 768 NYELAPGTRCTVIGWGKREDTRVSEYETA--VNEVEVPIITRDICNKWLNNRELNVTLGM 825
+ + A GT C GWG TR + T + + +P+++ C K+ + + M
Sbjct: 127 SDDFAAGTTCVTTGWGL---TRYTNANTPDRLQQASLPLLSNTNCKKYWGTK---IKDAM 180
Query: 826 VCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYV 885
+CAG G +C GDSGGPL+C+ + W + GIVSWG PGVYA V V
Sbjct: 181 ICAG--ASGVSSCMGDSGGPLVCKKNG---AWTLVGIVSWGSSTCSTSTPGVYARVTALV 235
Query: 886 TWIQDIM 892
W+Q +
Sbjct: 236 NWVQQTL 242
>pdb|1TWX|B Chain B, Crystal Structure Of The Thrombin Mutant D221aD222K
Length = 259
Score = 137 bits (344), Expect = 4e-32, Method: Compositional matrix adjust.
Identities = 90/265 (33%), Positives = 135/265 (50%), Gaps = 24/265 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCV------GNLTGLNID 702
I+ G ++ G P+ L C LISD+WVLTAAHC+ N T ++
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL- 59
Query: 703 EWTVQLGVTRRNSYAFFGTRFK-VRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLP 761
V++G R Y + + ++ H +YN D DIAL +LK+ V F+D++ P
Sbjct: 60 --LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 762 VCLPPPNYE---LAPGTRCTVIGWGKREDTRVSEY----ETAVNEVEVPIITRDICNKWL 814
VCLP L G + V GWG ++T + + + V +PI+ R +C
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK--- 174
Query: 815 NNRELNVTLGMVCAGY-PEGGK--DACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAH 871
++ + +T M CAGY P+ GK DAC+GDSGGP + +S N +W+ GIVSWG CA
Sbjct: 175 DSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFN-NRWYQMGIVSWGEGCAR 233
Query: 872 PHLPGVYAYVPKYVTWIQDIMDKYS 896
G Y +V + WIQ ++D++
Sbjct: 234 KGKYGFYTHVFRLKKWIQKVIDQFG 258
>pdb|3SQE|E Chain E, Crystal Structure Of Prethrombin-2 Mutant S195a In The
Alternative Form
pdb|3SQH|E Chain E, Crystal Structure Of Prethrombin-2 Mutant S195a In The The
Open Form
Length = 290
Score = 136 bits (343), Expect = 4e-32, Method: Compositional matrix adjust.
Identities = 89/266 (33%), Positives = 135/266 (50%), Gaps = 24/266 (9%)
Query: 648 RIIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCV------GNLTGLNI 701
RI+ G ++ G P+ L C LISD+WVLTAAHC+ N T ++
Sbjct: 31 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL 90
Query: 702 DEWTVQLGVTRRNSYAFFGTRFK-VRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLL 760
V++G R Y + + ++ H +YN D DIAL +LK+ V F+D++
Sbjct: 91 ---LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIH 147
Query: 761 PVCLPPPNYE---LAPGTRCTVIGWGKREDTRVSEY----ETAVNEVEVPIITRDICNKW 813
PVCLP L G + V GWG ++T + + + V +PI+ R +C
Sbjct: 148 PVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK-- 205
Query: 814 LNNRELNVTLGMVCAGY-PEGGK--DACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCA 870
++ + +T M CAGY P+ GK DAC+GD+GGP + +S N +W+ GIVSWG C
Sbjct: 206 -DSTRIRITDNMFCAGYKPDEGKRGDACEGDAGGPFVMKSPFN-NRWYQMGIVSWGEGCD 263
Query: 871 HPHLPGVYAYVPKYVTWIQDIMDKYS 896
G Y +V + WIQ ++D++
Sbjct: 264 RDGKYGFYTHVFRLKKWIQKVIDQFG 289
>pdb|3R3G|B Chain B, Structure Of Human Thrombin With Residues 145-150 Of
Murine Thrombin
Length = 259
Score = 136 bits (343), Expect = 5e-32, Method: Compositional matrix adjust.
Identities = 91/269 (33%), Positives = 136/269 (50%), Gaps = 32/269 (11%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCV------GNLTGLNID 702
I+ G ++ G P+ L C LISD+WVLTAAHC+ N T ++
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL- 59
Query: 703 EWTVQLGVTRRNSYAFFGTRFK-VRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLP 761
V++G R Y + + ++ H +YN D DIAL +LK+ V F+D++ P
Sbjct: 60 --LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 762 VCLPPPNYE---LAPGTRCTVIGWGKREDTRVSEYETAVNEVE--------VPIITRDIC 810
VCLP L G + V GWG +T + T +NE++ +PI+ R +C
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLRET----WTTNINEIQPSVLQVVNLPIVERPVC 173
Query: 811 NKWLNNRELNVTLGMVCAGY-PEGGK--DACQGDSGGPLLCRSSHNFEQWFVGGIVSWGI 867
++ + +T M CAGY P+ GK DAC+GDSGGP + +S N +W+ GIVSWG
Sbjct: 174 K---DSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFN-NRWYQMGIVSWGE 229
Query: 868 KCAHPHLPGVYAYVPKYVTWIQDIMDKYS 896
C G Y +V + WIQ ++D++
Sbjct: 230 GCDRDGKYGFYTHVFRLKKWIQKVIDQFG 258
>pdb|3K65|B Chain B, Crystal Structure Of Prethombin-2FRAGMENT-2 Complex
Length = 308
Score = 136 bits (343), Expect = 5e-32, Method: Compositional matrix adjust.
Identities = 89/266 (33%), Positives = 135/266 (50%), Gaps = 24/266 (9%)
Query: 648 RIIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCV------GNLTGLNI 701
RI+ G ++ G P+ L C LISD+WVLTAAHC+ N T ++
Sbjct: 49 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL 108
Query: 702 DEWTVQLGVTRRNSYAFFGTRFK-VRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLL 760
V++G R Y + + ++ H +YN D DIAL +LK+ V F+D++
Sbjct: 109 ---LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIH 165
Query: 761 PVCLPPPNYE---LAPGTRCTVIGWGKREDTRVSEYE----TAVNEVEVPIITRDICNKW 813
PVCLP L G + V GWG ++T + + + V +PI+ R +C
Sbjct: 166 PVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK-- 223
Query: 814 LNNRELNVTLGMVCAGY-PEGGK--DACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCA 870
++ + +T M CAGY P+ GK DAC+GD+GGP + +S N +W+ GIVSWG C
Sbjct: 224 -DSTRIRITDNMFCAGYKPDEGKRGDACEGDAGGPFVMKSPFN-NRWYQMGIVSWGEGCD 281
Query: 871 HPHLPGVYAYVPKYVTWIQDIMDKYS 896
G Y +V + WIQ ++D++
Sbjct: 282 RDGKYGFYTHVFRLKKWIQKVIDQFG 307
>pdb|1VZQ|H Chain H, Complex Of Thrombin With Designed Inhibitor 7165
Length = 250
Score = 135 bits (341), Expect = 7e-32, Method: Compositional matrix adjust.
Identities = 90/260 (34%), Positives = 133/260 (51%), Gaps = 23/260 (8%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCV------GNLTGLNID 702
I+ G ++ G P+ L C LISD+WVLTAAHC+ N T ++
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL- 59
Query: 703 EWTVQLGVTRRNSYAFFGTRFK-VRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLP 761
V++G R +Y + + ++ H +YN D DIAL +LK+ V F+D++ P
Sbjct: 60 --LVRIGKHSRTAYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 762 VCLPPPNYE---LAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRE 818
VCLP L G + V GWG ++T VN +PI+ R +C ++
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKETGQPSVLQVVN---LPIVERPVCK---DSTR 171
Query: 819 LNVTLGMVCAGY-PEGGK--DACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLP 875
+ +T M CAGY P+ GK DAC+GDSGGP + +S N +W+ GIVSWG C
Sbjct: 172 IRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFN-NRWYQMGIVSWGEGCDRDGKY 230
Query: 876 GVYAYVPKYVTWIQDIMDKY 895
G Y +V + WIQ ++D++
Sbjct: 231 GFYTHVFRLKKWIQKVIDQF 250
>pdb|1BTH|H Chain H, Structure Of Thrombin Complexed With Bovine Pancreatic
Trypsin Inhibitor
pdb|1BTH|K Chain K, Structure Of Thrombin Complexed With Bovine Pancreatic
Trypsin Inhibitor
Length = 259
Score = 135 bits (341), Expect = 7e-32, Method: Compositional matrix adjust.
Identities = 90/265 (33%), Positives = 134/265 (50%), Gaps = 24/265 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCV------GNLTGLNID 702
I+ G ++ G P+ L C LISD+WVLTAAHC+ N T ++
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL- 59
Query: 703 EWTVQLGVTRRNSYAFFGTRFK-VRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLP 761
V++G R Y + + ++ H +YN D DIAL +LK+ V F+D++ P
Sbjct: 60 --LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 762 VCLPPPNYE---LAPGTRCTVIGWGKREDTRVSEY----ETAVNEVEVPIITRDICNKWL 814
VCLP L G + V GWG ++T + + + V +PI+ R +C
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKETWTTNVGKGQPSVLQVVNLPIVERPVCK--- 174
Query: 815 NNRELNVTLGMVCAGY-PEGGK--DACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAH 871
++ + +T M CAGY P+ GK DACQGDSGGP + +S N +W+ GIVSWG C
Sbjct: 175 DSTRIRITDNMFCAGYKPDEGKRGDACQGDSGGPFVMKSPFN-NRWYQMGIVSWGEGCDR 233
Query: 872 PHLPGVYAYVPKYVTWIQDIMDKYS 896
G Y +V + WIQ ++D++
Sbjct: 234 DGKYGFYTHVFRLKKWIQKVIDQFG 258
>pdb|1DLK|B Chain B, Crystal Structure Analysis Of Delta-Chymotrypsin Bound To
A Peptidyl Chloromethyl Ketone Inhibitor
pdb|1DLK|D Chain D, Crystal Structure Analysis Of Delta-Chymotrypsin Bound To
A Peptidyl Chloromethyl Ketone Inhibitor
Length = 230
Score = 135 bits (341), Expect = 9e-32, Method: Composition-based stats.
Identities = 84/246 (34%), Positives = 123/246 (50%), Gaps = 21/246 (8%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+ G E+ PG WP+ +L F F C G LI++ WV+TAAHC G+ + V
Sbjct: 1 IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC-----GVTTSDVVVA- 53
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
G + S + + K+ VF +S+YN +NDI L +L F+ + VCLP +
Sbjct: 54 GEFDQGSSSEKIQKLKIAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLPSAS 112
Query: 769 YELAPGTRCTVIGWGKREDTRVSEYETA--VNEVEVPIITRDICNKWLNNRELNVTLGMV 826
+ A GT C GWG TR + T + + +P+++ C K+ + + M+
Sbjct: 113 DDFAAGTTCVTTGWGL---TRYTNANTPDRLQQASLPLLSNTNCKKYWGTK---IKDAMI 166
Query: 827 CAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVT 886
CAG G +C GDSGGPL+C+ + W + GIVSWG PGVYA V V
Sbjct: 167 CAG--ASGVSSCMGDSGGPLVCKKNG---AWTLVGIVSWGSSTCSTSTPGVYARVTALVN 221
Query: 887 WIQDIM 892
W+Q +
Sbjct: 222 WVQQTL 227
>pdb|1DM4|B Chain B, Ser195ala Mutant Of Human Thrombin Complexed With
Fibrinopeptide A (7- 16)
pdb|1JMO|H Chain H, Crystal Structure Of The Heparin Cofactor Ii-S195a
Thrombin Complex
Length = 260
Score = 135 bits (340), Expect = 9e-32, Method: Compositional matrix adjust.
Identities = 89/266 (33%), Positives = 135/266 (50%), Gaps = 24/266 (9%)
Query: 648 RIIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCV------GNLTGLNI 701
RI+ G ++ G P+ L C LISD+WVLTAAHC+ N T ++
Sbjct: 1 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL 60
Query: 702 DEWTVQLGVTRRNSYAFFGTRFK-VRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLL 760
V++G R Y + + ++ H +YN D DIAL +LK+ V F+D++
Sbjct: 61 ---LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIH 117
Query: 761 PVCLPPPNYE---LAPGTRCTVIGWGKREDTRVSEY----ETAVNEVEVPIITRDICNKW 813
PVCLP L G + V GWG ++T + + + V +PI+ R +C
Sbjct: 118 PVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK-- 175
Query: 814 LNNRELNVTLGMVCAGY-PEGGK--DACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCA 870
++ + +T M CAGY P+ GK DAC+GD+GGP + +S N +W+ GIVSWG C
Sbjct: 176 -DSTRIRITDNMFCAGYKPDEGKRGDACEGDAGGPFVMKSPFN-NRWYQMGIVSWGEGCD 233
Query: 871 HPHLPGVYAYVPKYVTWIQDIMDKYS 896
G Y +V + WIQ ++D++
Sbjct: 234 RDGKYGFYTHVFRLKKWIQKVIDQFG 259
>pdb|2ZPS|A Chain A, Crystal Structure Of Anionic Trypsin Isoform 3 From Chum
Salmon
Length = 222
Score = 135 bits (340), Expect = 1e-31, Method: Compositional matrix adjust.
Identities = 88/248 (35%), Positives = 124/248 (50%), Gaps = 27/248 (10%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+E P +L G F C G L+++ WV++AAHC + + E +++
Sbjct: 1 IVGGYECKAYSQPHQVSLNSGYHF---CGGSLVNENWVVSAAHCYKTRVEVRLGEHNIKV 57
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
S F + +R +S YNI DNDI L +L + N ++ PV LP
Sbjct: 58 ---TEGSEQFISSSRVIRHP-NYSSYNI----DNDIMLIKLSKPATLNTYVQPVALPS-- 107
Query: 769 YELAP-GTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVC 827
AP GT CTV GWG + + + + +PI++ CN N+ +T M C
Sbjct: 108 -SCAPAGTMCTVSGWGNTMSSTADK--NKLQCLNIPILSYSDCN---NSYPGMITNAMFC 161
Query: 828 AGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTW 887
AGY EGGKD+CQGDSGGP++C + G+VSWG CA P PGVYA V + W
Sbjct: 162 AGYLEGGKDSCQGDSGGPVVCNGE-------LQGVVSWGYGCAEPGNPGVYAKVCIFNNW 214
Query: 888 IQDIMDKY 895
+ M Y
Sbjct: 215 LTSTMATY 222
>pdb|2ZPQ|A Chain A, Crystal Structure Of Anionic Trypsin Isoform 1 From Chum
Salmon
pdb|2ZPQ|B Chain B, Crystal Structure Of Anionic Trypsin Isoform 1 From Chum
Salmon
Length = 222
Score = 135 bits (339), Expect = 1e-31, Method: Compositional matrix adjust.
Identities = 88/248 (35%), Positives = 125/248 (50%), Gaps = 27/248 (10%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+E P +L G F C G L+++ WV++AAHC + + + E +++
Sbjct: 1 IVGGYECKAYSQPHQVSLNSGYHF---CGGSLVNENWVVSAAHCYKSRVEVRLGEHNIKV 57
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
S F + +R +S YNI DNDI L +L + N ++ PV LP
Sbjct: 58 ---TEGSEQFISSSRVIRHP-NYSSYNI----DNDIMLIKLSKPATLNTYVQPVALPS-- 107
Query: 769 YELAP-GTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVC 827
AP GT CTV GWG + + + + +PI++ CN N+ +T M C
Sbjct: 108 -SCAPAGTMCTVSGWGNTMSSTADK--NKLQCLNIPILSYSDCN---NSYPGMITNAMFC 161
Query: 828 AGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTW 887
AGY EGGKD+CQGDSGGP++C + G+VSWG CA P PGVYA V + W
Sbjct: 162 AGYLEGGKDSCQGDSGGPVVCNGE-------LQGVVSWGYGCAEPGNPGVYAKVCIFNDW 214
Query: 888 IQDIMDKY 895
+ M Y
Sbjct: 215 LTSTMATY 222
>pdb|1H8D|H Chain H, X-Ray Structure Of The Human Alpha-Thrombin Complex With A
Tripeptide Phosphonate Inhibitor
Length = 260
Score = 135 bits (339), Expect = 1e-31, Method: Compositional matrix adjust.
Identities = 90/261 (34%), Positives = 132/261 (50%), Gaps = 23/261 (8%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCV------GNLTGLNID 702
I+ G ++ G P+ L C LISD+WVLTAAHC+ N T ++
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL- 59
Query: 703 EWTVQLGVTRRNSYAFFGTRFK-VRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLP 761
V++G R Y + + ++ H +YN D DIAL +LK+ V F+D++ P
Sbjct: 60 --LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 762 VCLPPPNYE---LAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRE 818
VCLP L G + V GWG ++T VN +PI+ R +C ++
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKETGQPSVLQVVN---LPIVERPVCK---DSTR 171
Query: 819 LNVTLGMVCAGY-PEGGK--DACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLP 875
+ +T M CAGY P+ GK DAC+GDSGGP + +S N +W+ GIVSWG C
Sbjct: 172 IRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFN-NRWYQMGIVSWGEGCDRDGKY 230
Query: 876 GVYAYVPKYVTWIQDIMDKYS 896
G Y +V + WIQ ++D++
Sbjct: 231 GFYTHVFRLKKWIQKVIDQFG 251
>pdb|2A0Q|B Chain B, Structure Of Thrombin In 400 Mm Potassium Chloride
pdb|2A0Q|D Chain D, Structure Of Thrombin In 400 Mm Potassium Chloride
Length = 257
Score = 135 bits (339), Expect = 1e-31, Method: Compositional matrix adjust.
Identities = 90/264 (34%), Positives = 134/264 (50%), Gaps = 24/264 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCV------GNLTGLNID 702
I+ G ++ G P+ L C LISD+WVLTAAHC+ N T ++
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL- 59
Query: 703 EWTVQLGVTRRNSY-AFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLP 761
V++G R Y A + ++ H +YN D DIAL +LK+ V F+D++ P
Sbjct: 60 --LVRIGKHSRTRYEANIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 762 VCLPPPNYE---LAPGTRCTVIGWGKREDTRVSEY----ETAVNEVEVPIITRDICNKWL 814
VCLP L G + V GWG ++T + + + V +PI+ R +C
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK--- 174
Query: 815 NNRELNVTLGMVCAGY-PEGGK--DACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAH 871
++ + +T M CAGY P+ GK DAC+GDSGGP + +S N +W+ GIVSWG C
Sbjct: 175 DSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFN-NRWYQMGIVSWGEGCDR 233
Query: 872 PHLPGVYAYVPKYVTWIQDIMDKY 895
G Y +V + WIQ ++D++
Sbjct: 234 DGKYGFYTHVFRLKKWIQKVIDQF 257
>pdb|1RD3|B Chain B, 2.5a Structure Of Anticoagulant Thrombin Variant E217k
pdb|1RD3|D Chain D, 2.5a Structure Of Anticoagulant Thrombin Variant E217k
Length = 259
Score = 134 bits (338), Expect = 2e-31, Method: Compositional matrix adjust.
Identities = 89/265 (33%), Positives = 134/265 (50%), Gaps = 24/265 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCV------GNLTGLNID 702
I+ G ++ G P+ L C LISD+WVLTAAHC+ N T ++
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL- 59
Query: 703 EWTVQLGVTRRNSYAFFGTRFK-VRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLP 761
V++G R Y + + ++ H +YN D DIAL +LK+ V F+D++ P
Sbjct: 60 --LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 762 VCLPPPNYE---LAPGTRCTVIGWGKREDTRVSEY----ETAVNEVEVPIITRDICNKWL 814
VCLP L G + V GWG ++T + + + V +PI+ R +C
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK--- 174
Query: 815 NNRELNVTLGMVCAGY-PEGGK--DACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAH 871
++ + +T M CAGY P+ GK DAC+GDSGGP + +S N +W+ GIVSWG C
Sbjct: 175 DSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFN-NRWYQMGIVSWGKGCDR 233
Query: 872 PHLPGVYAYVPKYVTWIQDIMDKYS 896
G Y +V + WIQ ++D++
Sbjct: 234 DGKYGFYTHVFRLKKWIQKVIDQFG 258
>pdb|1SFQ|B Chain B, Fast Form Of Thrombin Mutant R(77a)a Bound To Ppack
pdb|1SFQ|E Chain E, Fast Form Of Thrombin Mutant R(77a)a Bound To Ppack
pdb|1SG8|B Chain B, Crystal Structure Of The Procoagulant Fast Form Of
Thrombin
pdb|1SG8|E Chain E, Crystal Structure Of The Procoagulant Fast Form Of
Thrombin
pdb|1SGI|B Chain B, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
pdb|1SGI|E Chain E, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
pdb|1SHH|B Chain B, Slow Form Of Thrombin Bound With Ppack
pdb|1SHH|E Chain E, Slow Form Of Thrombin Bound With Ppack
pdb|2HWL|B Chain B, Crystal Structure Of Thrombin In Complex With Fibrinogen
Gamma' Peptide
pdb|2HWL|D Chain D, Crystal Structure Of Thrombin In Complex With Fibrinogen
Gamma' Peptide
pdb|3BV9|B Chain B, Structure Of Thrombin Bound To The Inhibitor Fm19
Length = 259
Score = 134 bits (338), Expect = 2e-31, Method: Compositional matrix adjust.
Identities = 90/265 (33%), Positives = 134/265 (50%), Gaps = 24/265 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCV------GNLTGLNID 702
I+ G ++ G P+ L C LISD+WVLTAAHC+ N T ++
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL- 59
Query: 703 EWTVQLGVTRRNSY-AFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLP 761
V++G R Y A + ++ H +YN D DIAL +LK+ V F+D++ P
Sbjct: 60 --LVRIGKHSRTRYEANIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 762 VCLPPPNYE---LAPGTRCTVIGWGKREDTRVSEY----ETAVNEVEVPIITRDICNKWL 814
VCLP L G + V GWG ++T + + + V +PI+ R +C
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK--- 174
Query: 815 NNRELNVTLGMVCAGY-PEGGK--DACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAH 871
++ + +T M CAGY P+ GK DAC+GDSGGP + +S N +W+ GIVSWG C
Sbjct: 175 DSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFN-NRWYQMGIVSWGEGCDR 233
Query: 872 PHLPGVYAYVPKYVTWIQDIMDKYS 896
G Y +V + WIQ ++D++
Sbjct: 234 DGKYGFYTHVFRLKKWIQKVIDQFG 258
>pdb|1B7X|B Chain B, Structure Of Human Alpha-Thrombin Y225i Mutant Bound To D-
Phe-Pro-Arg-Chloromethylketone
Length = 259
Score = 134 bits (338), Expect = 2e-31, Method: Compositional matrix adjust.
Identities = 89/265 (33%), Positives = 134/265 (50%), Gaps = 24/265 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCV------GNLTGLNID 702
I+ G ++ G P+ L C LISD+WVLTAAHC+ N T ++
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL- 59
Query: 703 EWTVQLGVTRRNSYAFFGTRFK-VRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLP 761
V++G R Y + + ++ H +YN D DIAL +LK+ V F+D++ P
Sbjct: 60 --LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 762 VCLPPPNYE---LAPGTRCTVIGWGKREDTRVSEY----ETAVNEVEVPIITRDICNKWL 814
VCLP L G + V GWG ++T + + + V +PI+ R +C
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK--- 174
Query: 815 NNRELNVTLGMVCAGY-PEGGK--DACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAH 871
++ + +T M CAGY P+ GK DAC+GDSGGP + +S N +W+ GIVSWG C
Sbjct: 175 DSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFN-NRWYQMGIVSWGEGCDR 233
Query: 872 PHLPGVYAYVPKYVTWIQDIMDKYS 896
G Y +V + WIQ ++D++
Sbjct: 234 DGKIGFYTHVFRLKKWIQKVIDQFG 258
>pdb|1QUR|H Chain H, Human Alpha-Thrombin In Complex With Bivalent,
Benzamidine-Based Synthetic Inhibitor
pdb|1D3D|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
Benzothiophene Inhibitor 4
pdb|1EB1|H Chain H, Complex Structure Of Human Thrombin With N-Methyl-Arginine
Inhibitor
pdb|1GHV|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1YPE|H Chain H, Thrombin Inhibitor Complex
pdb|1YPG|H Chain H, Thrombin Inhibitor Complex
pdb|1YPJ|H Chain H, Thrombin Inhibitor Complex
pdb|1YPK|H Chain H, Thrombin Inhibitor Complex
pdb|1YPL|H Chain H, X-Ray Crystal Structure Of Thrombin Inhibited By Synthetic
Cyanopeptide Analogue Ra-1008
pdb|1YPM|H Chain H, X-ray Crystal Structure Of Thrombin Inhibited By Synthetic
Cyanopeptide Analogue Ra-1014
pdb|2ANM|H Chain H, Ternary Complex Of An Orally Active Thrombin Inhibitor
With Human Thrombin And A C-Terminal Hirudin Derived
Exo-Sit Inhibitor
pdb|2CF9|H Chain H, Complex Of Recombinant Human Thrombin With A Inhibitor
pdb|1GHX|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GHY|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|2CF8|H Chain H, Complex Of Recombinant Human Thrombin With A Inhibitor
pdb|2CN0|H Chain H, Complex Of Recombinant Human Thrombin With A Designed
Inhibitor
pdb|3BIU|H Chain H, Human Thrombin-In Complex With Ub-Thr10
pdb|3BIV|H Chain H, Human Thrombin-In Complex With Ub-Thr11
pdb|2V3H|H Chain H, Thrombin With 3-Cycle No F
pdb|2V3O|H Chain H, Thrombin With 3-Cycle With F
pdb|4AX9|H Chain H, Human Thrombin Complexed With Napsagatran, Ro0466240
pdb|4AYV|B Chain B, Human Thrombin - Inhibitor Complex
pdb|4AYY|B Chain B, Human Thrombin - Inhibitor Complex
pdb|4AZ2|B Chain B, Human Thrombin - Inhibitor Complex
pdb|1GHW|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-centered Short Hydrogen Bonding Network At The
Active Site
Length = 257
Score = 134 bits (338), Expect = 2e-31, Method: Compositional matrix adjust.
Identities = 89/264 (33%), Positives = 134/264 (50%), Gaps = 24/264 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCV------GNLTGLNID 702
I+ G ++ G P+ L C LISD+WVLTAAHC+ N T ++
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL- 59
Query: 703 EWTVQLGVTRRNSYAFFGTRFK-VRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLP 761
V++G R Y + + ++ H +YN D DIAL +LK+ V F+D++ P
Sbjct: 60 --LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 762 VCLPPPNYE---LAPGTRCTVIGWGKREDTRVSEY----ETAVNEVEVPIITRDICNKWL 814
VCLP L G + V GWG ++T + + + V +PI+ R +C
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK--- 174
Query: 815 NNRELNVTLGMVCAGY-PEGGK--DACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAH 871
++ + +T M CAGY P+ GK DAC+GDSGGP + +S N +W+ GIVSWG C
Sbjct: 175 DSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFN-NRWYQMGIVSWGEGCDR 233
Query: 872 PHLPGVYAYVPKYVTWIQDIMDKY 895
G Y +V + WIQ ++D++
Sbjct: 234 DGKYGFYTHVFRLKKWIQKVIDQF 257
>pdb|1ABI|H Chain H, Structure Of The Hirulog 3-Thrombin Complex And Nature Of
The S' Subsites Of Substrates And Inhibitors
pdb|1ABJ|H Chain H, Structure Of The Hirulog 3-Thrombin Complex And Nature Of
The S' Subsites Of Substrates And Inhibitors
pdb|1DWB|H Chain H, Crystallographic Analysis At 3.0-angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-directed Inhibitors
pdb|1DWC|H Chain H, Crystallographic Analysis At 3.0-Angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-Directed Inhibitors
pdb|1DWD|H Chain H, Crystallographic Analysis At 3.0-Angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-Directed Inhibitors
pdb|1DWE|H Chain H, Crystallographic Analysis At 3.0-Angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-Directed Inhibitors
pdb|1FPH|H Chain H, The Interaction Of Thrombin With Fibrinogen: A Structural
Basis For Its Specificity
pdb|1HGT|H Chain H, Structure Of The Hirugen And Hirulog 1 Complexes Of Alpha-
Thrombin
pdb|1IHS|H Chain H, Crystal Structure Of The Complex Of Human Alpha-thrombin
And Non- Hydrolyzable Bifunctional Inhibitors,
Hirutonin-2 And Hirutonin-6
pdb|1IHT|H Chain H, Crystal Structure Of The Complex Of Human Alpha-Thrombin
And Non- Hydrolyzable Bifunctional Inhibitors,
Hirutonin-2 And Hirutonin-6
pdb|1PPB|H Chain H, The Refined 1.9 Angstroms Crystal Structure Of Human
Alpha-Thrombin: Interaction With D-Phe-Pro-Arg
Chloromethylketone And Significance Of The
Tyr-Pro-Pro-Trp Insertion Segment
pdb|1THR|H Chain H, Structures Of Thrombin Complexes With A Designed And A
Natural Exosite Inhibitor
pdb|1THS|H Chain H, Structures Of Thrombin Complexes With A Designed And A
Natural Exosite Inhibitor
pdb|1TMB|H Chain H, Molecular Basis For The Inhibition Of Human Alpha-thrombin
By The Macrocyclic Peptide Cyclotheonamide A
pdb|2HGT|H Chain H, Structure Of The Hirugen And Hirulog 1 Complexes Of
Alpha-Thrombin
pdb|2HPP|H Chain H, Structures Of The Noncovalent Complexes Of Human And
Bovine Prothrombin Fragment 2 With Human Ppack-Thrombin
pdb|2HPQ|H Chain H, Structures Of The Noncovalent Complexes Of Human And
Bovine Prothrombin Fragment 2 With Human Ppack-thrombin
pdb|3HTC|H Chain H, The Structure Of A Complex Of Recombinant Hirudin And
Human Alpha-Thrombin
pdb|4HTC|H Chain H, The Refined Structure Of The Hirudin-Thrombin Complex
pdb|1HUT|H Chain H, The Structure Of Alpha-Thrombin Inhibited By A 15-Mer
Single-Stranded Dna Aptamer
pdb|1NRN|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRO|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRP|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRQ|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRR|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRS|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1TMT|H Chain H, Changes In Interactions In Complexes Of Hirudin
Derivatives And Human Alpha-Thrombin Due To Different
Crystal Forms
pdb|1TMU|H Chain H, Changes In Interactions In Complexes Of Hirudin
Derivatives And Human Alpha-Thrombin Due To Different
Crystal Forms
pdb|1HLT|H Chain H, The Structure Of A Nonadecapeptide Of The Fifth Egf Domain
Of Thrombomodulin Complexed With Thrombin
pdb|1HLT|K Chain K, The Structure Of A Nonadecapeptide Of The Fifth Egf Domain
Of Thrombomodulin Complexed With Thrombin
pdb|1HAH|H Chain H, The Isomorphous Structures Of Prethrombin2, Hirugen-And
Ppack- Thrombin: Changes Accompanying Activation And
Exosite Binding To Thrombin
pdb|1HAI|H Chain H, The Isomorphous Structures Of Prethrombin2, Hirugen-And
Ppack- Thrombin: Changes Accompanying Activation And
Exosite Binding To Thrombin
pdb|3HAT|H Chain H, Active Site Mimetic Inhibition Of Thrombin
pdb|1FPC|H Chain H, Active Site Mimetic Inhibition Of Thrombin
pdb|1HBT|H Chain H, Human Alpha-Thrombin Complexed With A Peptidyl Pyridinium
Methyl Ketone Containing Bivalent Inhibitor
pdb|1HDT|H Chain H, Structure Of A Retro-Binding Peptide Inhibitor Complexed
With Human Alpha-Thrombin
pdb|1HAO|H Chain H, Complex Of Human Alpha-thrombin With A 15mer
Oligonucleotide Ggttggtgtggttgg (based On Nmr Model Of
Dna)
pdb|1HAP|H Chain H, Complex Of Human Alpha-Thrombin With A 15mer
Oligonucleotide Ggttggtgtggttgg (Based On X-Ray Model Of
Dna)
pdb|1AHT|H Chain H, Crystal Structure Of Human Alpha-Thrombin Complexed With
Hirugen And P-Amidinophenylpyruvate At 1.6 Angstroms
Resolution
pdb|1DIT|H Chain H, Complex Of A Divalent Inhibitor With Thrombin
pdb|1TOM|H Chain H, Alpha-Thrombin Complexed With Hirugen
pdb|1HXF|H Chain H, Human Thrombin Complex With Hirudin Variant
pdb|1BMM|H Chain H, Human Alpha-Thrombin Complexed With
[s-(R,R)]-4-[(Aminoiminomethyl)
Amino]-N-[[1-[3-Hydroxy-2-[(2-
Naphthalenylsulfonyl)amino]-1-
Oxopropyl]-2-Pyrrolidinyl] Methyl]butanamide
(Bms-186282)
pdb|1BMN|H Chain H, Human Alpha-Thrombin Complexed With
[s-(R,R)]-1-(Aminoiminomethyl)-
N-[[1-[n-[(2-Naphthalenylsulfonyl)-L-Seryl]-
Pyrrolidinyl]methyl]-3- Piperidenecarboxamide
(Bms-189090)
pdb|1UMA|H Chain H, Alpha-Thrombin (Hirugen) Complexed With
Na-(N,N-Dimethylcarbamoyl)- Alpha-Azalysine
pdb|1LHD|H Chain H, Human Alpha-thrombin Complexed With
Ac-(d)phe-pro-borolys-oh
pdb|1LHE|H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-Boro-N-
Butyl-Amidino-Glycine-Oh
pdb|1LHF|H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-Boro-
Homolys-Oh
pdb|1LHG|H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-
Boroornithine-Oh
pdb|1LHC|H Chain H, Human Alpha-Thrombin Complexed With
Ac-(D)phe-Pro-Boroarg-Oh
pdb|1AD8|H Chain H, Complex Of Thrombin With And Inhibitor Containing A Novel
P1 Moiety
pdb|1AI8|H Chain H, Human Alpha-Thrombin Ternary Complex With The Exosite
Inhibitor Hirugen And Active Site Inhibitor
Phch2oco-D-Dpa-Pro-Borompg
pdb|1AIX|H Chain H, Human Alpha-Thrombin Ternary Complex With Exosite
Inhibitor Hirugen And Active Site Inhibitor
Phch2oco-D-Dpa-Pro-Boroval
pdb|1AE8|H Chain H, Human Alpha-Thrombin Inhibition By
Eoc-D-Phe-Pro-Azalys-Onp
pdb|1AFE|H Chain H, Human Alpha-Thrombin Inhibition By Cbz-Pro-Azalys-Onp
pdb|1UVS|H Chain H, Bovine Thrombin--Bm51.1011 Complex
pdb|5GDS|H Chain H, Hirunorms Are True Hirudin Mimetics. The Crystal Structure
Of Human Alpha-Thrombin:hirunorm V Complex
pdb|1AY6|H Chain H, Thrombin Inhibitor From Theonalla, Cyclotheanamide-Based
Macrocyclic Tripeptide Motif
pdb|1A46|H Chain H, Thrombin Complexed With Hirugen And A Beta-Strand Mimetic
Inhibitor
pdb|1A4W|H Chain H, Crystal Structures Of Thrombin With Thiazole-Containing
Inhibitors: Probes Of The S1' Binding Site
pdb|1A5G|H Chain H, Human Thrombin Complexed With Novel Synthetic Peptide
Mimetic Inhibitor And Hirugen
pdb|1B5G|H Chain H, Human Thrombin Complexed With Novel Synthetic Peptide
Mimetic Inhibitor And Hirugen
pdb|1TBZ|H Chain H, Human Thrombin With Active Site N-Methyl-D
Phenylalanyl-N-[5-
(Aminoiminomethyl)amino]-1-{{benzothiazolyl)carbonyl]
Butyl]-L- Prolinamide Trifluroacetate And
Exosite-Hirugen
pdb|1A2C|H Chain H, Structure Of Thrombin Inhibited By Aeruginosin298-A From A
Blue-Green Alga
pdb|1A61|H Chain H, Thrombin Complexed With A Beta-Mimetic Thiazole-Containing
Inhibitor
pdb|1A3B|H Chain H, Complex Of Human Alpha-Thrombin With The Bifunctional
Boronate Inhibitor Borolog1
pdb|1A3E|H Chain H, Complex Of Human Alpha-Thrombin With The Bifunctional
Boronate Inhibitor Borolog2
pdb|1AWF|H Chain H, Novel Covalent Thrombin Inhibitor From Plant Extract
pdb|1AWH|B Chain B, Novel Covalent Thrombin Inhibitor From Plant Extract
pdb|1AWH|D Chain D, Novel Covalent Thrombin Inhibitor From Plant Extract
pdb|1BCU|H Chain H, Alpha-Thrombin Complexed With Hirugen And Proflavin
pdb|8KME|2 Chain 2, Crystal Structure Of Human Alpha-thrombin Inhibited With
Sel2770.
pdb|1BA8|B Chain B, Thrombin Inhibitor With A Rigid Tripeptidyl Aldehydes
pdb|1BB0|B Chain B, Thrombin Inhibitors With Rigid Tripeptidyl Aldehydes
pdb|1CA8|B Chain B, Thrombin Inhibitors With Rigid Tripeptidyl Aldehydes
pdb|4THN|H Chain H, The Crystal Structure Of Alpha-Thrombin-Hirunorm Iv
Complex Reveals A Novel Specificity Site Recognition
Mode.
pdb|1QBV|H Chain H, Crystal Structure Of Thrombin Complexed With An
Guanidine-Mimetic Inhibitor
pdb|1D4P|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
5- Amidinoindole-4-benzylpiperidine Inhibitor
pdb|7KME|H Chain H, Crystal Structure Of Human Alpha-Thrombin Inhibited With
Sel2711.
pdb|1QHR|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1QJ1|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1QJ6|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1QJ7|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1D3P|B Chain B, Crystal Structure Of Human Aplha-Thrombin In Complex With
Benzo[b]thiophene Inhibitor 3
pdb|1D3Q|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
Benzo[b]thiophene Inhibitor 2
pdb|1D3T|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
Benzo[b]thiophene Inhibitor 1
pdb|1C4U|2 Chain 2, Selective Non Electrophilic Thrombin Inhibitors With
Cyclohexyl Moieties.
pdb|1C4V|2 Chain 2, Selective Non Electrophilic Thrombin Inhibitors With
Cyclohexyl Moieties.
pdb|1C4Y|2 Chain 2, Selective Non-Electrophilic Thrombin Inhibitors
pdb|1DE7|H Chain H, Interaction Of Factor Xiii Activation Peptide With
Alpha-Thrombin: Crystal Structure Of The
Enzyme-Substrate Complex
pdb|1DE7|K Chain K, Interaction Of Factor Xiii Activation Peptide With
Alpha-Thrombin: Crystal Structure Of The
Enzyme-Substrate Complex
pdb|1G30|B Chain B, Thrombin Inhibitor Complex
pdb|1G32|B Chain B, Thrombin Inhibitor Complex
pdb|1KTS|B Chain B, Thrombin Inhibitor Complex
pdb|1KTT|B Chain B, Thrombin Inhibitor Complex
pdb|1K21|H Chain H, Human Thrombin-Inhibitor Complex
pdb|1K22|H Chain H, Human Thrombin-inhibitor Complex
pdb|1NY2|2 Chain 2, Human Alpha Thrombin Inhibited By Rppgf And Hirugen
pdb|1O2G|H Chain H, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1OYT|H Chain H, Complex Of Recombinant Human Thrombin With A Designed
Fluorinated Inhibitor
pdb|1NO9|H Chain H, Design Of Weakly Basic Thrombin Inhibitors Incorporating
Novel P1 Binding Functions: Molecular And X-Ray
Crystallographic Studies.
pdb|1OOK|B Chain B, Crystal Structure Of The Complex Of Platelet Receptor
Gpib-alpha And Human Alpha-thrombin
pdb|1P8V|C Chain C, Crystal Structure Of The Complex Of Platelet Receptor
Gpib-alpha And Alpha-thrombin At 2.6a
pdb|1NU7|B Chain B, Staphylocoagulase-Thrombin Complex
pdb|1NU7|F Chain F, Staphylocoagulase-Thrombin Complex
pdb|1NZQ|H Chain H, D-Phe-Pro-Arg-Type Thrombin Inhibitor
pdb|1O0D|H Chain H, Human Thrombin Complexed With A D-Phe-Pro-Arg-Type
Inhibitor And A C- Terminal Hirudin Derived Exo-Site
Inhibitor
pdb|1MU6|B Chain B, Crystal Structure Of Thrombin In Complex With L-378,622
pdb|1MU8|B Chain B, Thrombin-Hirugen_l-378,650
pdb|1MUE|B Chain B, Thrombin-Hirugen-L405,426
pdb|1SR5|C Chain C, Antithrombin-Anhydrothrombin-Heparin Ternary Complex
Structure
pdb|1O5G|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|1XMN|B Chain B, Crystal Structure Of Thrombin Bound To Heparin
pdb|1XMN|D Chain D, Crystal Structure Of Thrombin Bound To Heparin
pdb|1XMN|F Chain F, Crystal Structure Of Thrombin Bound To Heparin
pdb|1XMN|H Chain H, Crystal Structure Of Thrombin Bound To Heparin
pdb|1WAY|B Chain B, Active Site Thrombin Inhibitors
pdb|1T4U|H Chain H, Crystal Structure Analysis Of A Novel Oxyguanidine Bound
To Thrombin
pdb|1T4V|H Chain H, Crystal Structure Analysis Of A Novel Oxyguanidine Bound
To Thrombin
pdb|2AFQ|B Chain B, 1.9 Angstrom Crytal Structure Of Wild-Type Human Thrombin
In The Sodium Free State
pdb|2AFQ|D Chain D, 1.9 Angstrom Crytal Structure Of Wild-Type Human Thrombin
In The Sodium Free State
pdb|2A45|B Chain B, Crystal Structure Of The Complex Between Thrombin And The
Central "e" Region Of Fibrin
pdb|2A45|E Chain E, Crystal Structure Of The Complex Between Thrombin And The
Central "e" Region Of Fibrin
pdb|1W7G|H Chain H, Alpha-Thrombin Complex With Sulfated Hirudin (Residues
54-65) And L- Arginine Template Inhibitor Cs107
pdb|2FES|H Chain H, Orally Active Thrombin Inhibitors
pdb|2C8W|B Chain B, Thrombin Inhibitors
pdb|2C8X|B Chain B, Thrombin Inhibitors
pdb|2C8Y|B Chain B, Thrombin Inhibitors
pdb|2C8Z|B Chain B, Thrombin Inhibitors
pdb|2C90|B Chain B, Thrombin Inhibitors
pdb|2C93|B Chain B, Thrombin Inhibitors
pdb|2FEQ|H Chain H, Orally Active Thrombin Inhibitors
pdb|2BVS|H Chain H, Human Thrombin Complexed With Fragment-Based Small
Molecules Occupying The S1 Pocket
pdb|2BVX|H Chain H, Design And Discovery Of Novel, Potent Thrombin Inhibitors
With A Solubilizing Cationic P1-P2-Linker
pdb|2BXT|H Chain H, Design And Discovery Of Novel, Potent Thrombin Inhibitors
With A Solubilizing Cationic P1-p2-linker
pdb|2BXU|H Chain H, Design And Discovery Of Novel, Potent Thrombin Inhibitors
With A Solubilizing Cationic P1-p2-linker
pdb|2A2X|H Chain H, Orally Active Thrombin Inhibitors In Complex With Thrombin
Inh12
pdb|2ANK|H Chain H, Orally Active Thrombin Inhibitors In Complex With Thrombin
And An Exosite Decapeptide
pdb|2GDE|H Chain H, Thrombin In Complex With Inhibitor
pdb|2H9T|H Chain H, Crystal Structure Of Human Alpha-Thrombin In Complex With
Suramin
pdb|2JH0|D Chain D, Human Thrombin Hirugen Inhibitor Complex
pdb|2JH5|D Chain D, Human Thrombin Hirugen Inhibitor Complex
pdb|2JH6|D Chain D, Human Thrombin Hirugen Inhibitor Complex
pdb|1C1U|H Chain H, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1V|H Chain H, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1W|H Chain H, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C5L|H Chain H, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5N|H Chain H, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5O|H Chain H, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1HXE|H Chain H, Serine Protease
pdb|2UUF|B Chain B, Thrombin-Hirugen Binary Complex At 1.26a Resolution
pdb|2UUJ|B Chain B, Thrombin-Hirugen-Gw473178 Ternary Complex At 1.32a
Resolution
pdb|2UUK|B Chain B, Thrombin-Hirugen-Gw420128 Ternary Complex At 1.39a
Resolution
pdb|3BF6|H Chain H, Thrombin:suramin Complex
pdb|2R2M|B Chain B, 2-(2-chloro-6-fluorophenyl)acetamides As Potent Thrombin
Inhibitors
pdb|3EGK|H Chain H, Knoble Inhibitor
pdb|2ZC9|H Chain H, Thrombin In Complex With Inhibitor
pdb|2ZDA|H Chain H, Exploring Thrombin S1 Pocket
pdb|2ZDV|H Chain H, Exploring Thrombin S1 Pocket
pdb|2ZF0|H Chain H, Exploring Thrombin S1 Pocket
pdb|3E6P|H Chain H, Crystal Structure Of Human Meizothrombin Desf1
pdb|2ZFF|H Chain H, Exploring Thrombin S1-Pocket
pdb|2ZFP|H Chain H, Thrombin Inibition
pdb|2ZGB|H Chain H, Thrombin Inhibition
pdb|2ZGX|H Chain H, Thrombin Inhibition
pdb|2ZFQ|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZFR|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHQ|H Chain H, Thrombin Inhibition
pdb|2ZI2|H Chain H, Thrombin Inhibition
pdb|2ZIQ|H Chain H, Thrombin Inhibition
pdb|2ZG0|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHE|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHF|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHW|H Chain H, Exploring Thrombin S3 Pocket
pdb|3C27|B Chain B, Cyanofluorophenylacetamides As Orally Efficacious Thrombin
Inhibitors
pdb|2ZNK|H Chain H, Thrombin Inhibition
pdb|2ZO3|H Chain H, Bisphenylic Thrombin Inhibitors
pdb|3D49|H Chain H, Thrombin Inhibition
pdb|3DA9|B Chain B, Crystal Structure Of Thrombin In Complex With Inhibitor
pdb|3DHK|H Chain H, Bisphenylic Thrombin Inhibitors
pdb|3DT0|H Chain H, Understanding Thrombin Inhibition
pdb|3DUX|H Chain H, Understanding Thrombin Inhibition
pdb|3EQ0|H Chain H, Thrombin Inhibitor
pdb|3F68|H Chain H, Thrombin Inhibition
pdb|3PMH|B Chain B, Mechanism Of Sulfotyrosine-Mediated Glycoprotein Ib
Interaction With Two Distinct Alpha-Thrombin Sites
pdb|3P6Z|B Chain B, Structural Basis Of Thrombin Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P6Z|H Chain H, Structural Basis Of Thrombin Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3LDX|H Chain H, Discovery And Clinical Evaluation Of Rwj-671818, A
Thrombin Inhibitor With An Oxyguanidine P1 Motif
pdb|3P70|B Chain B, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P70|D Chain D, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P70|F Chain F, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P70|H Chain H, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3TU7|H Chain H, Human Alpha-Thrombin Complexed With
N-(Methylsulfonyl)-D-Phenylalanyl-
N-((1-Carbamimidoyl-4-Piperidinyl)methyl)-L-Prolinamide
(Bms-189664)
pdb|3QLP|H Chain H, X-Ray Structure Of The Complex Between Human Alpha
Thrombin And A Modified Thrombin Binding Aptamer (Mtba)
pdb|3P17|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3B23|B Chain B, Crystal Structure Of Thrombin-Variegin Complex: Insights
Of A Novel Mechanism Of Inhibition And Design Of Tunable
Thrombin Inhibitors
pdb|3QTO|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3QTV|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3QX5|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3QWC|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3U69|H Chain H, Unliganded Wild-Type Human Thrombin
pdb|3U8T|H Chain H, Human Thrombin Complexed With D-Phe-Pro-D-Arg-Cys
pdb|3RLW|H Chain H, Human Thrombin In Complex With Mi328
pdb|3RLY|H Chain H, Human Thrombin In Complex With Mi329
pdb|3RM0|H Chain H, Human Thrombin In Complex With Mi354
pdb|3RM2|H Chain H, Human Thrombin In Complex With Mi003
pdb|3RML|H Chain H, Human Thrombin In Complex With Mi331
pdb|3RMM|H Chain H, Human Thrombin In Complex With Mi332
pdb|3RMN|H Chain H, Human Thrombin In Complex With Mi341
pdb|3RMO|H Chain H, Human Thrombin In Complex With Mi004
pdb|3U8O|H Chain H, Human Thrombin Complexed With D-Phe-Pro-D-Arg-D-Thr
pdb|3U8R|H Chain H, Human Thrombin Complexed With D-Phe-Pro-D-Arg-Ile
pdb|3SHA|H Chain H, Human Thrombin In Complex With Ubthr97
pdb|3SHC|H Chain H, Human Thrombin In Complex With Ubthr101
pdb|3SI3|H Chain H, Human Thrombin In Complex With Ubthr103
pdb|3SI4|H Chain H, Human Thrombin In Complex With Ubthr104
pdb|3SV2|H Chain H, Human Thrombin In Complex With Ubthr105
pdb|4E7R|H Chain H, Thrombin In Complex With 3-Amidinophenylalanine Inhibitor
pdb|4E7R|G Chain G, Thrombin In Complex With 3-Amidinophenylalanine Inhibitor
pdb|4DIH|H Chain H, X-Ray Structure Of The Complex Between Human Alpha
Thrombin And Thrombin Binding Aptamer In The Presence Of
Sodium Ions
pdb|4DII|H Chain H, X-Ray Structure Of The Complex Between Human Alpha
Thrombin And Thrombin Binding Aptamer In The Presence Of
Potassium Ions
pdb|3T5F|H Chain H, Human Thrombin In Complex With Mi340
pdb|3UTU|H Chain H, High Affinity Inhibitor Of Human Thrombin
pdb|3U98|H Chain H, Human Thrombin In Complex With Mi001
pdb|3U9A|H Chain H, Human Thrombin In Complex With Mi330
pdb|4E05|H Chain H, Anophelin From The Malaria Vector Inhibits Thrombin
Through A Novel Reverse-Binding Mechanism
pdb|4E06|H Chain H, Anophelin From The Malaria Vector Inhibits Thrombin
Through A Novel Reverse-Binding Mechanism
pdb|3UWJ|H Chain H, Human Thrombin In Complex With Mi353
pdb|4BAH|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAK|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAM|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAN|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAO|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAQ|B Chain B, Thrombin In Complex With Inhibitor
Length = 259
Score = 134 bits (338), Expect = 2e-31, Method: Compositional matrix adjust.
Identities = 89/265 (33%), Positives = 134/265 (50%), Gaps = 24/265 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCV------GNLTGLNID 702
I+ G ++ G P+ L C LISD+WVLTAAHC+ N T ++
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL- 59
Query: 703 EWTVQLGVTRRNSYAFFGTRFK-VRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLP 761
V++G R Y + + ++ H +YN D DIAL +LK+ V F+D++ P
Sbjct: 60 --LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 762 VCLPPPNYE---LAPGTRCTVIGWGKREDTRVSEY----ETAVNEVEVPIITRDICNKWL 814
VCLP L G + V GWG ++T + + + V +PI+ R +C
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK--- 174
Query: 815 NNRELNVTLGMVCAGY-PEGGK--DACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAH 871
++ + +T M CAGY P+ GK DAC+GDSGGP + +S N +W+ GIVSWG C
Sbjct: 175 DSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFN-NRWYQMGIVSWGEGCDR 233
Query: 872 PHLPGVYAYVPKYVTWIQDIMDKYS 896
G Y +V + WIQ ++D++
Sbjct: 234 DGKYGFYTHVFRLKKWIQKVIDQFG 258
>pdb|2OLG|A Chain A, Crystal Structure Of The Serine Protease Domain Of
Prophenoloxidase Activating Factor-I In A Zymogen Form
Length = 278
Score = 134 bits (337), Expect = 2e-31, Method: Compositional matrix adjust.
Identities = 86/261 (32%), Positives = 135/261 (51%), Gaps = 28/261 (10%)
Query: 648 RIIGGFESNPGDWPFLAAL--LGGPEF-VFYCAGVLISDQWVLTAAHCV--------GNL 696
+I+ G ++ P ++P+ A + F F C G LI++++++TAAHCV G L
Sbjct: 22 KILNGDDTVPEEFPWTAMIGYKNSSNFEQFACGGSLINNRYIVTAAHCVAGRVLRVVGAL 81
Query: 697 TGLNIDEWTVQLGVTRRNSYAFFGT-------RFKVRGVFAHSQYNIGAQHD-NDIALFQ 748
+ + EW T + Y + H Y G++ +DIAL +
Sbjct: 82 NKVRLGEWNT---ATDPDCYGAVRVCVPDKPIDLGIEETIQHPDYVDGSKDRYHDIALIR 138
Query: 749 LKQKVKFNDHLLPVCLPPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRD 808
L ++V+F +++ PVCLP PN E+ G R TV+GWG+ T +Y T ++ VP++ +
Sbjct: 139 LNRQVEFTNYIRPVCLPQPNEEVQVGQRLTVVGWGR---TETGQYSTIKQKLAVPVVHAE 195
Query: 809 ICNKWLNNRELNVTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIK 868
C K + V +CAG E KD+C GDSGGPLL ++ +Q+F+ G+VS+G
Sbjct: 196 QCAKTFGAAGVRVRSSQLCAG-GEKAKDSCGGDSGGPLLAERAN--QQFFLEGLVSFGAT 252
Query: 869 CAHPHLPGVYAYVPKYVTWIQ 889
C PG+Y V KY WI+
Sbjct: 253 CGTEGWPGIYTKVGKYRDWIE 273
>pdb|2THF|B Chain B, Structure Of Human Alpha-thrombin Y225f Mutant Bound To
D-phe-pro-arg- Chloromethylketone
Length = 259
Score = 134 bits (337), Expect = 2e-31, Method: Compositional matrix adjust.
Identities = 89/265 (33%), Positives = 134/265 (50%), Gaps = 24/265 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCV------GNLTGLNID 702
I+ G ++ G P+ L C LISD+WVLTAAHC+ N T ++
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL- 59
Query: 703 EWTVQLGVTRRNSYAFFGTRFK-VRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLP 761
V++G R Y + + ++ H +YN D DIAL +LK+ V F+D++ P
Sbjct: 60 --LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 762 VCLPPPNYE---LAPGTRCTVIGWGKREDTRVSEY----ETAVNEVEVPIITRDICNKWL 814
VCLP L G + V GWG ++T + + + V +PI+ R +C
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK--- 174
Query: 815 NNRELNVTLGMVCAGY-PEGGK--DACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAH 871
++ + +T M CAGY P+ GK DAC+GDSGGP + +S N +W+ GIVSWG C
Sbjct: 175 DSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFN-NRWYQMGIVSWGEGCDR 233
Query: 872 PHLPGVYAYVPKYVTWIQDIMDKYS 896
G Y +V + WIQ ++D++
Sbjct: 234 DGKFGFYTHVFRLKKWIQKVIDQFG 258
>pdb|1H8I|H Chain H, X-Ray Crystal Structure Of Human Alpha-Thrombin With A
Tripeptide Phosphonate Inhibitor
Length = 253
Score = 134 bits (337), Expect = 2e-31, Method: Compositional matrix adjust.
Identities = 89/261 (34%), Positives = 133/261 (50%), Gaps = 22/261 (8%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCV------GNLTGLNID 702
I+ G ++ G P+ L C LISD+WVLTAAHC+ N T ++
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL- 59
Query: 703 EWTVQLGVTRRNSYAFFGTRFK-VRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLP 761
V++G R Y + + ++ H +YN D DIAL +LK+ V F+D++ P
Sbjct: 60 --LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 762 VCLPPPNYE---LAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRE 818
VCLP L G + V GWG ++T + + V +PI+ R +C ++
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKETWGQ--PSVLQVVNLPIVERPVCK---DSTR 172
Query: 819 LNVTLGMVCAGY-PEGGK--DACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLP 875
+ +T M CAGY P+ GK DAC+GDSGGP + +S N +W+ GIVSWG C
Sbjct: 173 IRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFN-NRWYQMGIVSWGEGCDRDGKY 231
Query: 876 GVYAYVPKYVTWIQDIMDKYS 896
G Y +V + WIQ ++D++
Sbjct: 232 GFYTHVFRLKKWIQKVIDQFG 252
>pdb|1GJ5|H Chain H, Selectivity At S1, H2o Displacement, Upa, Tpa,
Ser190ALA190 PROTEASE, Structure-Based Drug Design
pdb|1SB1|H Chain H, Novel Non-Covalent Thrombin Inhibitors Incorporating P1
4,5,6,7- Tetrahydrobenzothiazole Arginine Side Chain
Mimetics
pdb|2PW8|H Chain H, Crystal Structure Of Sulfo-Hirudin Complexed To Thrombin
pdb|3DD2|H Chain H, Crystal Structure Of An Rna Aptamer Bound To Human
Thrombin
pdb|1GJ4|H Chain H, Selectivity At S1, H2o Displacement, Upa, Tpa,
Ser190/ala190 Protease, Structure-based Drug Design
Length = 258
Score = 134 bits (337), Expect = 2e-31, Method: Compositional matrix adjust.
Identities = 89/265 (33%), Positives = 134/265 (50%), Gaps = 24/265 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCV------GNLTGLNID 702
I+ G ++ G P+ L C LISD+WVLTAAHC+ N T ++
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL- 59
Query: 703 EWTVQLGVTRRNSYAFFGTRFK-VRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLP 761
V++G R Y + + ++ H +YN D DIAL +LK+ V F+D++ P
Sbjct: 60 --LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 762 VCLPPPNYE---LAPGTRCTVIGWGKREDTRVSEY----ETAVNEVEVPIITRDICNKWL 814
VCLP L G + V GWG ++T + + + V +PI+ R +C
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK--- 174
Query: 815 NNRELNVTLGMVCAGY-PEGGK--DACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAH 871
++ + +T M CAGY P+ GK DAC+GDSGGP + +S N +W+ GIVSWG C
Sbjct: 175 DSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFN-NRWYQMGIVSWGEGCDR 233
Query: 872 PHLPGVYAYVPKYVTWIQDIMDKYS 896
G Y +V + WIQ ++D++
Sbjct: 234 DGKYGFYTHVFRLKKWIQKVIDQFG 258
>pdb|2ZPR|A Chain A, Crystal Structure Of Anionic Trypsin Isoform 2 From Chum
Salmon
pdb|2ZPR|B Chain B, Crystal Structure Of Anionic Trypsin Isoform 2 From Chum
Salmon
Length = 222
Score = 134 bits (337), Expect = 2e-31, Method: Compositional matrix adjust.
Identities = 88/248 (35%), Positives = 124/248 (50%), Gaps = 27/248 (10%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+E P +L G F C G L+++ WV++AAHC + + + E +++
Sbjct: 1 IVGGYECKAYSQPHQVSLNSGYHF---CGGSLVNENWVVSAAHCYKSRVAVRLGEHNIKV 57
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
S F + +R +S YNI DNDI L +L + N ++ PV LP
Sbjct: 58 ---TEGSEQFISSSRVIRHP-NYSSYNI----DNDIMLIKLSKPATLNTYVQPVALPS-- 107
Query: 769 YELAP-GTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVC 827
AP GT CTV GWG + + + +PI++ CN N+ +T M C
Sbjct: 108 -SCAPAGTMCTVSGWGNTMSSTADG--DKLQCLNIPILSYSDCN---NSYPGMITNAMFC 161
Query: 828 AGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTW 887
AGY EGGKD+CQGDSGGP++C + G+VSWG CA P PGVYA V + W
Sbjct: 162 AGYLEGGKDSCQGDSGGPVVCNGE-------LQGVVSWGYGCAEPGNPGVYAKVCIFNDW 214
Query: 888 IQDIMDKY 895
+ M Y
Sbjct: 215 LTSTMATY 222
>pdb|1WBG|B Chain B, Active Site Thrombin Inhibitors
Length = 259
Score = 134 bits (337), Expect = 2e-31, Method: Compositional matrix adjust.
Identities = 89/265 (33%), Positives = 134/265 (50%), Gaps = 24/265 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCV------GNLTGLNID 702
I+ G ++ G P+ L C LISD+WVLTAAHC+ N T ++
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL- 59
Query: 703 EWTVQLGVTRRNSYAFFGTRFK-VRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLP 761
V++G R Y + + ++ H +YN D DIAL +LK+ V F+D++ P
Sbjct: 60 --LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 762 VCLPPPNYE---LAPGTRCTVIGWGKREDTRVSEY----ETAVNEVEVPIITRDICNKWL 814
VCLP L G + V GWG ++T + + + V +PI+ R +C
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK--- 174
Query: 815 NNRELNVTLGMVCAGY-PEGGK--DACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAH 871
++ + +T M CAGY P+ GK DAC+GDSGGP + +S N +W+ GIVSWG C
Sbjct: 175 DSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFN-NRWYQMGIVSWGEGCRD 233
Query: 872 PHLPGVYAYVPKYVTWIQDIMDKYS 896
G Y +V + WIQ ++D++
Sbjct: 234 DGKYGFYTHVFRLKKWIQKVIDQFG 258
>pdb|2F9N|A Chain A, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
pdb|2F9N|B Chain B, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
pdb|2F9N|C Chain C, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
pdb|2F9N|D Chain D, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
Length = 245
Score = 134 bits (337), Expect = 2e-31, Method: Compositional matrix adjust.
Identities = 85/254 (33%), Positives = 130/254 (51%), Gaps = 19/254 (7%)
Query: 649 IIGGFESNPGDWPFLAAL-LGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQ 707
I+GG E+ WP+ +L + ++ +C G LI QWVLTAAHCVG ++ +
Sbjct: 1 IVGGQEAPRSKWPWQVSLRVRDRYWMHFCGGSLIHPQWVLTAAHCVGP----DVKD-LAT 55
Query: 708 LGVTRRNSYAFFGTRF-KVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPP 766
L V R + ++ + V + H Q+ I Q DIAL +L++ V + + V LPP
Sbjct: 56 LRVQLREQHLYYQDQLLPVSRIIVHPQFYI-IQTGADIALLELEEPVNISSRVHTVMLPP 114
Query: 767 PNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICN------KWLNNRELN 820
+ PG C V GWG ++ + +V+VPI+ IC+ + +
Sbjct: 115 ASETFPPGMPCWVTGWGDVDNDEPLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRI 174
Query: 821 VTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAY 880
+ M+CAG + +D+CQGDSGGPL+C+ + W G+VSWG CA P+ PG+Y
Sbjct: 175 IRDDMLCAGNSQ--RDSCQGDSGGPLVCKVNGT---WLQAGVVSWGEGCAQPNRPGIYTR 229
Query: 881 VPKYVTWIQDIMDK 894
V Y+ WI + K
Sbjct: 230 VTYYLDWIHHYVPK 243
>pdb|3JZ1|B Chain B, Crystal Structure Of Human Thrombin Mutant N143p In E:na+
Form
pdb|3JZ2|B Chain B, Crystal Structure Of Human Thrombin Mutant N143p In E Form
pdb|3QGN|B Chain B, The Allosteric E-E Equilibrium Is A Key Property Of The
Trypsin Fold
Length = 259
Score = 134 bits (336), Expect = 3e-31, Method: Compositional matrix adjust.
Identities = 89/265 (33%), Positives = 134/265 (50%), Gaps = 24/265 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCV------GNLTGLNID 702
I+ G ++ G P+ L C LISD+WVLTAAHC+ N T ++
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL- 59
Query: 703 EWTVQLGVTRRNSYAFFGTRFK-VRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLP 761
V++G R Y + + ++ H +YN D DIAL +LK+ V F+D++ P
Sbjct: 60 --LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 762 VCLPPPNYE---LAPGTRCTVIGWGKREDTRVSEY----ETAVNEVEVPIITRDICNKWL 814
VCLP L G + V GWG ++T + + + V +PI+ R +C
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGPLKETWTANVGKGQPSVLQVVNLPIVERPVCK--- 174
Query: 815 NNRELNVTLGMVCAGY-PEGGK--DACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAH 871
++ + +T M CAGY P+ GK DAC+GDSGGP + +S N +W+ GIVSWG C
Sbjct: 175 DSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFN-NRWYQMGIVSWGEGCDR 233
Query: 872 PHLPGVYAYVPKYVTWIQDIMDKYS 896
G Y +V + WIQ ++D++
Sbjct: 234 DGKYGFYTHVFRLKKWIQKVIDQFG 258
>pdb|2QXG|A Chain A, Crystal Structure Of Human Kallikrein 7 In Complex With
Ala- Ala-phe-chloromethylketone
pdb|2QXG|B Chain B, Crystal Structure Of Human Kallikrein 7 In Complex With
Ala- Ala-phe-chloromethylketone
pdb|2QXH|A Chain A, Crystal Structure Of Human Kallikrein 7 In Complex With
Suc- Ala-Ala-Pro-Phe-Chloromethylketone
pdb|2QXI|A Chain A, High Resolution Structure Of Human Kallikrein 7 In Complex
With Suc-Ala-Ala-Pro-Phe-Chloromethylketone
pdb|2QXJ|A Chain A, Crystal Structure Of Human Kallikrein 7 In Complex With
Suc- Ala-ala-pro-phe-chloromethylketone And Copper
Length = 224
Score = 134 bits (336), Expect = 3e-31, Method: Compositional matrix adjust.
Identities = 90/248 (36%), Positives = 126/248 (50%), Gaps = 26/248 (10%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
II G G P+ ALL G + +C GVL++++WVLTAAHC ++E+TV L
Sbjct: 1 IIDGAPCARGSHPWQVALLSGNQL--HCGGVLVNERWVLTAAHC-------KMNEYTVHL 51
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
G R K F H Y+ H ND+ L +L + + + + V LP +
Sbjct: 52 GSDTLGDRR--AQRIKASKSFRHPGYST-QTHVNDLMLVKLNSQARLSSMVKKVRLP--S 106
Query: 769 YELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVCA 828
PGT CTV GWG V+ + + + V+V +I+ C K + N M+CA
Sbjct: 107 RCEPPGTTCTVSGWGTTTSPDVT-FPSDLMCVDVKLISPQDCTKVYKDLLEN---SMLCA 162
Query: 829 GYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWG-IKCAHPHLPGVYAYVPKYVTW 887
G P+ K+AC GDSGGPL+CR + + G+VSWG C P+ PGVY V K+ W
Sbjct: 163 GIPDSKKNACNGDSGGPLVCRGT-------LQGLVSWGTFPCGQPNDPGVYTQVCKFTKW 215
Query: 888 IQDIMDKY 895
I D M K+
Sbjct: 216 INDTMKKH 223
>pdb|1MBQ|A Chain A, Anionic Trypsin From Pacific Chum Salmon
Length = 220
Score = 133 bits (335), Expect = 4e-31, Method: Compositional matrix adjust.
Identities = 87/245 (35%), Positives = 124/245 (50%), Gaps = 27/245 (11%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+E P +L G F C G L+++ WV++AAHC + + + E +++
Sbjct: 1 IVGGYECKAYSQPHQVSLNSGYHF---CGGSLVNENWVVSAAHCYKSRVEVRLGEHNIKV 57
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
S F + +R +S YNI DNDI L +L + N ++ PV LP
Sbjct: 58 ---TEGSEQFISSSRVIRHP-NYSSYNI----DNDIMLIKLSKSATLNTYVQPVALPS-- 107
Query: 769 YELAP-GTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVC 827
AP GT CTV GWG + + + + +PI++ CN N+ +T M C
Sbjct: 108 -SCAPAGTMCTVSGWGNTMSSTADK--NKLQCLNIPILSYSDCN---NSYPGMITNAMFC 161
Query: 828 AGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTW 887
AGY EGGKD+CQGDSGGP++C + G+VSWG CA P PGVYA V + W
Sbjct: 162 AGYLEGGKDSCQGDSGGPVVCNGE-------LQGVVSWGYGCAEPGNPGVYAKVCIFNDW 214
Query: 888 IQDIM 892
+ M
Sbjct: 215 LTSTM 219
>pdb|1JOU|B Chain B, Crystal Structure Of Native S195a Thrombin With An
Unoccupied Active Site
pdb|1JOU|D Chain D, Crystal Structure Of Native S195a Thrombin With An
Unoccupied Active Site
pdb|1JOU|F Chain F, Crystal Structure Of Native S195a Thrombin With An
Unoccupied Active Site
pdb|1TB6|H Chain H, 2.5a Crystal Structure Of The
Antithrombin-Thrombin-Heparin Ternary Complex
pdb|2B5T|B Chain B, 2.1 Angstrom Structure Of A Nonproductive Complex Between
Antithrombin, Synthetic Heparin Mimetic Sr123781 And Two
S195a Thrombin Molecules
pdb|2B5T|D Chain D, 2.1 Angstrom Structure Of A Nonproductive Complex Between
Antithrombin, Synthetic Heparin Mimetic Sr123781 And Two
S195a Thrombin Molecules
pdb|3B9F|H Chain H, 1.6 A Structure Of The Pci-Thrombin-Heparin Complex
pdb|3GIS|B Chain B, Crystal Structure Of Na-Free Thrombin In Complex With
Thrombomodulin
pdb|3GIS|D Chain D, Crystal Structure Of Na-Free Thrombin In Complex With
Thrombomodulin
pdb|3GIS|F Chain F, Crystal Structure Of Na-Free Thrombin In Complex With
Thrombomodulin
pdb|3LU9|B Chain B, Crystal Structure Of Human Thrombin Mutant S195a In
Complex Extracellular Fragment Of Human Par1
pdb|3LU9|E Chain E, Crystal Structure Of Human Thrombin Mutant S195a In
Complex Extracellular Fragment Of Human Par1
pdb|4DT7|B Chain B, Crystal Structure Of Thrombin Bound To The Activation
Domain Qedqvdprlidgkmtrrgds Of Protein C
pdb|4DT7|D Chain D, Crystal Structure Of Thrombin Bound To The Activation
Domain Qedqvdprlidgkmtrrgds Of Protein C
pdb|4DY7|B Chain B, Crystal Structures Of Protease Nexin-1 In Complex With
S195a Thrombin
pdb|4DY7|E Chain E, Crystal Structures Of Protease Nexin-1 In Complex With
S195a Thrombin
Length = 259
Score = 133 bits (335), Expect = 4e-31, Method: Compositional matrix adjust.
Identities = 88/265 (33%), Positives = 134/265 (50%), Gaps = 24/265 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCV------GNLTGLNID 702
I+ G ++ G P+ L C LISD+WVLTAAHC+ N T ++
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL- 59
Query: 703 EWTVQLGVTRRNSYAFFGTRFK-VRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLP 761
V++G R Y + + ++ H +YN D DIAL +LK+ V F+D++ P
Sbjct: 60 --LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 762 VCLPPPNYE---LAPGTRCTVIGWGKREDTRVSEY----ETAVNEVEVPIITRDICNKWL 814
VCLP L G + V GWG ++T + + + V +PI+ R +C
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK--- 174
Query: 815 NNRELNVTLGMVCAGY-PEGGK--DACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAH 871
++ + +T M CAGY P+ GK DAC+GD+GGP + +S N +W+ GIVSWG C
Sbjct: 175 DSTRIRITDNMFCAGYKPDEGKRGDACEGDAGGPFVMKSPFN-NRWYQMGIVSWGEGCDR 233
Query: 872 PHLPGVYAYVPKYVTWIQDIMDKYS 896
G Y +V + WIQ ++D++
Sbjct: 234 DGKYGFYTHVFRLKKWIQKVIDQFG 258
>pdb|2BVR|H Chain H, Human Thrombin Complexed With Fragment-based Small
Molecules Occupying The S1 Pocket
Length = 252
Score = 133 bits (334), Expect = 5e-31, Method: Compositional matrix adjust.
Identities = 88/261 (33%), Positives = 132/261 (50%), Gaps = 23/261 (8%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCV------GNLTGLNID 702
I+ G ++ G P+ L C LISD+WVLTAAHC+ N T ++
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL- 59
Query: 703 EWTVQLGVTRRNSYAFFGTRFK-VRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLP 761
V++G R Y + + ++ H +YN D DIAL +LK+ V F+D++ P
Sbjct: 60 --LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 762 VCLPPPNYE---LAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRE 818
VCLP L G + V GWG + + + + V +PI+ R +C ++
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWG---NLKEKGQPSVLQVVNLPIVERPVCK---DSTR 171
Query: 819 LNVTLGMVCAGY-PEGGK--DACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLP 875
+ +T M CAGY P+ GK DAC+GDSGGP + +S N +W+ GIVSWG C
Sbjct: 172 IRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFN-NRWYQMGIVSWGEGCDRDGKY 230
Query: 876 GVYAYVPKYVTWIQDIMDKYS 896
G Y +V + WIQ ++D++
Sbjct: 231 GFYTHVFRLKKWIQKVIDQFG 251
>pdb|2OCV|B Chain B, Structural Basis Of Na+ Activation Mimicry In Murine
Thrombin
Length = 259
Score = 133 bits (334), Expect = 5e-31, Method: Compositional matrix adjust.
Identities = 87/269 (32%), Positives = 132/269 (49%), Gaps = 32/269 (11%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCV------GNLTGLNID 702
I+ G+++ G P+ L C LISD+WVLTAAHC+ N T ++
Sbjct: 1 IVEGWDAEKGIAPWQVMLFRKSPQELLCGASLISDRWVLTAAHCILYPPWDKNFTENDL- 59
Query: 703 EWTVQLGVTRRNSYAFFGTRFK-VRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLP 761
V++G R Y + + ++ H +YN D DIAL +LK+ V F+D++ P
Sbjct: 60 --LVRIGKHSRTRYERNVEKISMLEKIYVHPRYNWRENLDRDIALLKLKKPVPFSDYIHP 117
Query: 762 VCLPPPNYE---LAPGTRCTVIGWGKREDTRVSEYETAVNEVE--------VPIITRDIC 810
VCLP L G + V GWG +T + T +NE++ +PI+ R +C
Sbjct: 118 VCLPDKQTVTSLLRAGYKGRVTGWGNLRET----WTTNINEIQPSVLQVVNLPIVERPVC 173
Query: 811 NKWLNNRELNVTLGMVCAGYPEGGK---DACQGDSGGPLLCRSSHNFEQWFVGGIVSWGI 867
+ + +T M CAG+ DAC+GDSGGP + +S N +W+ GIVSWG
Sbjct: 174 KA---STRIRITDNMFCAGFKVNDTKRGDACEGDSGGPFVMKSPFN-NRWYQMGIVSWGE 229
Query: 868 KCAHPHLPGVYAYVPKYVTWIQDIMDKYS 896
C G Y +V + WIQ ++D++
Sbjct: 230 GCDRKGKYGFYTHVFRLKAWIQKVIDQFG 258
>pdb|1A0J|A Chain A, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species.
pdb|1A0J|B Chain B, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species.
pdb|1A0J|C Chain C, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species.
pdb|1A0J|D Chain D, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species
Length = 223
Score = 133 bits (334), Expect = 5e-31, Method: Compositional matrix adjust.
Identities = 85/246 (34%), Positives = 118/246 (47%), Gaps = 24/246 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+E + A+L G F C G LIS WV++AAHC + + + E + +
Sbjct: 1 IVGGYECRKNSASYQASLQSGYHF---CGGSLISSTWVVSAAHCYKSRIQVRLGEHNIAV 57
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
F KV H YN DNDI L +L + N ++ V LP
Sbjct: 58 NEGTEQ----FIDSVKV---IMHPSYN-SRNLDNDIMLIKLSKPASLNSYVSTVALPSSC 109
Query: 769 YELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVCA 828
+ GTRC V GWG + S Y + +++PI++ CN + +T M CA
Sbjct: 110 --ASSGTRCLVSGWGNLSGSS-SNYPDTLRCLDLPILSSSSCNSAYPGQ---ITSNMFCA 163
Query: 829 GYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTWI 888
G+ EGGKD+CQGDSGGP++C + G+VSWG CA + PGVY V Y +WI
Sbjct: 164 GFMEGGKDSCQGDSGGPVVCNGQ-------LQGVVSWGYGCAQRNKPGVYTKVCNYRSWI 216
Query: 889 QDIMDK 894
M
Sbjct: 217 SSTMSS 222
>pdb|1BIT|A Chain A, The Crystal Structure Of Anionic Salmon Trypsin In A
Second Crystal Form
Length = 237
Score = 132 bits (333), Expect = 6e-31, Method: Compositional matrix adjust.
Identities = 87/249 (34%), Positives = 124/249 (49%), Gaps = 27/249 (10%)
Query: 648 RIIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQ 707
+I+GG+E +L G F C G L+++ WV++AAHC + + + E ++
Sbjct: 15 KIVGGYECKAYSQAHQVSLNSGYHF---CGGSLVNENWVVSAAHCYKSRVEVRLGEHNIK 71
Query: 708 LGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPP 767
+ S F + +R +S YNI DNDI L +L + N ++ PV LP
Sbjct: 72 V---TEGSEQFISSSRVIRHP-NYSSYNI----DNDIMLIKLSKPATLNTYVQPVALPT- 122
Query: 768 NYELAP-GTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMV 826
AP GT CTV GWG + + + +PI++ CN N+ +T M
Sbjct: 123 --SCAPAGTMCTVSGWGNTMSSTADS--NKLQCLNIPILSYSDCN---NSYPGMITNAMF 175
Query: 827 CAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVT 886
CAGY EGGKD+CQGDSGGP++C + G+VSWG CA P PGVYA V +
Sbjct: 176 CAGYLEGGKDSCQGDSGGPVVCNGE-------LQGVVSWGYGCAEPGNPGVYAKVCIFND 228
Query: 887 WIQDIMDKY 895
W+ M Y
Sbjct: 229 WLTSTMASY 237
>pdb|1Z8I|B Chain B, Crystal Structure Of The Thrombin Mutant G193a Bound To
Ppack
Length = 259
Score = 132 bits (333), Expect = 7e-31, Method: Compositional matrix adjust.
Identities = 88/265 (33%), Positives = 133/265 (50%), Gaps = 24/265 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCV------GNLTGLNID 702
I+ G ++ G P+ L C LISD+WVLTAAHC+ N T ++
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL- 59
Query: 703 EWTVQLGVTRRNSYAFFGTRFK-VRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLP 761
V++G R Y + + ++ H +YN D DIAL +LK+ V F+D++ P
Sbjct: 60 --LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 762 VCLPPPNYE---LAPGTRCTVIGWGKREDTRVSEY----ETAVNEVEVPIITRDICNKWL 814
VCLP L G + V GWG ++T + + + V +PI+ R +C
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK--- 174
Query: 815 NNRELNVTLGMVCAGY-PEGGK--DACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAH 871
++ + +T M CAGY P+ GK DAC+ DSGGP + +S N +W+ GIVSWG C
Sbjct: 175 DSTRIRITDNMFCAGYKPDEGKRGDACEADSGGPFVMKSPFN-NRWYQMGIVSWGEGCDR 233
Query: 872 PHLPGVYAYVPKYVTWIQDIMDKYS 896
G Y +V + WIQ ++D++
Sbjct: 234 DGKYGFYTHVFRLKKWIQKVIDQFG 258
>pdb|2GP9|B Chain B, Crystal Structure Of The Slow Form Of Thrombin In A Self-
Inhibited Conformation
pdb|3BEI|B Chain B, Crystal Structure Of The Slow Form Of Thrombin In A
Self_inhibited Conformation
pdb|3BEF|B Chain B, Crystal Structure Of Thrombin Bound To The Extracellular
Fragment Of Par1
pdb|3BEF|E Chain E, Crystal Structure Of Thrombin Bound To The Extracellular
Fragment Of Par1
pdb|3QDZ|B Chain B, Crystal Structure Of The Human Thrombin Mutant D102n In
Complex With The Extracellular Fragment Of Human Par4.
pdb|3QDZ|D Chain D, Crystal Structure Of The Human Thrombin Mutant D102n In
Complex With The Extracellular Fragment Of Human Par4
Length = 259
Score = 132 bits (333), Expect = 7e-31, Method: Compositional matrix adjust.
Identities = 88/265 (33%), Positives = 134/265 (50%), Gaps = 24/265 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCV------GNLTGLNID 702
I+ G ++ G P+ L C LISD+WVLTAAHC+ N T ++
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL- 59
Query: 703 EWTVQLGVTRRNSYAFFGTRFK-VRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLP 761
V++G R Y + + ++ H +YN D +IAL +LK+ V F+D++ P
Sbjct: 60 --LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRNIALMKLKKPVAFSDYIHP 117
Query: 762 VCLPPPNYE---LAPGTRCTVIGWGKREDTRVSEY----ETAVNEVEVPIITRDICNKWL 814
VCLP L G + V GWG ++T + + + V +PI+ R +C
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK--- 174
Query: 815 NNRELNVTLGMVCAGY-PEGGK--DACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAH 871
++ + +T M CAGY P+ GK DAC+GDSGGP + +S N +W+ GIVSWG C
Sbjct: 175 DSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFN-NRWYQMGIVSWGEGCDR 233
Query: 872 PHLPGVYAYVPKYVTWIQDIMDKYS 896
G Y +V + WIQ ++D++
Sbjct: 234 DGKYGFYTHVFRLKKWIQKVIDQFG 258
>pdb|2F9O|A Chain A, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9O|B Chain B, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9O|C Chain C, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9O|D Chain D, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9P|A Chain A, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
pdb|2F9P|B Chain B, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
pdb|2F9P|C Chain C, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
pdb|2F9P|D Chain D, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
Length = 245
Score = 132 bits (332), Expect = 7e-31, Method: Compositional matrix adjust.
Identities = 84/254 (33%), Positives = 130/254 (51%), Gaps = 19/254 (7%)
Query: 649 IIGGFESNPGDWPFLAAL-LGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQ 707
I+GG E+ WP+ +L + ++ +C G LI QWVLTAAHCVG ++ +
Sbjct: 1 IVGGQEAPRSKWPWQVSLRVRDRYWMHFCGGSLIHPQWVLTAAHCVGP----DVKD-LAT 55
Query: 708 LGVTRRNSYAFFGTRF-KVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPP 766
L V R + ++ + V + H Q+ I Q DIAL +L++ V + + V LPP
Sbjct: 56 LRVQLREQHLYYQDQLLPVSRIIVHPQFYI-IQTGADIALLELEEPVNISSRVHTVMLPP 114
Query: 767 PNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICN------KWLNNRELN 820
+ PG C V GWG ++ + +V+VPI+ IC+ + +
Sbjct: 115 ASETFPPGMPCWVTGWGDVDNDEPLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRI 174
Query: 821 VTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAY 880
+ M+CAG + +D+C+GDSGGPL+C+ + W G+VSWG CA P+ PG+Y
Sbjct: 175 IRDDMLCAGNSQ--RDSCKGDSGGPLVCKVNGT---WLQAGVVSWGEGCAQPNRPGIYTR 229
Query: 881 VPKYVTWIQDIMDK 894
V Y+ WI + K
Sbjct: 230 VTYYLDWIHHYVPK 243
>pdb|3GIC|B Chain B, Structure Of Thrombin Mutant Delta(146-149e) In The Free
Form
Length = 250
Score = 132 bits (332), Expect = 8e-31, Method: Compositional matrix adjust.
Identities = 88/261 (33%), Positives = 131/261 (50%), Gaps = 25/261 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCV------GNLTGLNID 702
I+ G ++ G P+ L C LISD+WVLTAAHC+ N T ++
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL- 59
Query: 703 EWTVQLGVTRRNSYAFFGTRFK-VRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLP 761
V++G R Y + + ++ H +YN D DIAL +LK+ V F+D++ P
Sbjct: 60 --LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 762 VCLPPPNYE---LAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRE 818
VCLP L G + V GWG + + + V +PI+ R +C ++
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGN-----LKGQPSVLQVVNLPIVERPVCK---DSTR 169
Query: 819 LNVTLGMVCAGY-PEGGK--DACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLP 875
+ +T M CAGY P+ GK DAC+GDSGGP + +S N +W+ GIVSWG C
Sbjct: 170 IRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFN-NRWYQMGIVSWGEGCDRDGKY 228
Query: 876 GVYAYVPKYVTWIQDIMDKYS 896
G Y +V + WIQ ++D++
Sbjct: 229 GFYTHVFRLKKWIQKVIDQFG 249
>pdb|1HJ8|A Chain A, 1.00 Aa Trypsin From Atlantic Salmon
Length = 222
Score = 132 bits (332), Expect = 8e-31, Method: Compositional matrix adjust.
Identities = 87/245 (35%), Positives = 123/245 (50%), Gaps = 27/245 (11%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+E P +L G F C G L+++ WV++AAHC + + + E +++
Sbjct: 1 IVGGYECKAYSQPHQVSLNSGYHF---CGGSLVNENWVVSAAHCYKSRVEVRLGEHNIKV 57
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
S F + +R +S YNI DNDI L +L + N ++ PV LP
Sbjct: 58 ---TEGSEQFISSSRVIRHP-NYSSYNI----DNDIMLIKLSKPATLNTYVQPVALPT-- 107
Query: 769 YELAP-GTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVC 827
AP GT CTV GWG + + + +PI++ CN N+ +T M C
Sbjct: 108 -SCAPAGTMCTVSGWGNTMSSTADS--NKLQCLNIPILSYSDCN---NSYPGMITNAMFC 161
Query: 828 AGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTW 887
AGY EGGKD+CQGDSGGP++C + G+VSWG CA P PGVYA V + W
Sbjct: 162 AGYLEGGKDSCQGDSGGPVVCNGE-------LQGVVSWGYGCAEPGNPGVYAKVCIFNDW 214
Query: 888 IQDIM 892
+ M
Sbjct: 215 LTSTM 219
>pdb|1DX5|M Chain M, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1DX5|N Chain N, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1DX5|O Chain O, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1DX5|P Chain P, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1E0F|D Chain D, Crystal Structure Of The Human Alpha-Thrombin-Haemadin
Complex: An Exosite Ii-Binding Inhibitor
pdb|1E0F|F Chain F, Crystal Structure Of The Human Alpha-Thrombin-Haemadin
Complex: An Exosite Ii-Binding Inhibitor
pdb|1E0F|E Chain E, Crystal Structure Of The Human Alpha-Thrombin-Haemadin
Complex: An Exosite Ii-Binding Inhibitor
Length = 259
Score = 132 bits (332), Expect = 9e-31, Method: Compositional matrix adjust.
Identities = 88/265 (33%), Positives = 133/265 (50%), Gaps = 24/265 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCV------GNLTGLNID 702
I+ G ++ G P+ L C LISD+WVLTAAHC+ N ++
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFIENDL- 59
Query: 703 EWTVQLGVTRRNSYAFFGTRFK-VRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLP 761
V++G R Y + + ++ H +YN D DIAL +LK+ V F+D++ P
Sbjct: 60 --LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 762 VCLPPPNYE---LAPGTRCTVIGWGKREDTRVSEY----ETAVNEVEVPIITRDICNKWL 814
VCLP L G + V GWG ++T + + + V +PI+ R +C
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK--- 174
Query: 815 NNRELNVTLGMVCAGY-PEGGK--DACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAH 871
++ + +T M CAGY P+ GK DAC+GDSGGP + +S N +W+ GIVSWG C
Sbjct: 175 DSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFN-NRWYQMGIVSWGEGCDR 233
Query: 872 PHLPGVYAYVPKYVTWIQDIMDKYS 896
G Y +V + WIQ ++D++
Sbjct: 234 DGKYGFYTHVFRLKKWIQKVIDQFG 258
>pdb|1J15|A Chain A, Benzamidine In Complex With Rat Trypsin Mutant X99175190RT
pdb|1J16|A Chain A, Benzamidine In Complex With Rat Trypsin Mutant X99175190RT
pdb|1J17|T Chain T, Factor Xa Specific Inhibitor In Complex With Rat Trypsin
Mutant X99175190RT
Length = 223
Score = 132 bits (331), Expect = 1e-30, Method: Compositional matrix adjust.
Identities = 88/245 (35%), Positives = 120/245 (48%), Gaps = 26/245 (10%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+ P+ +L G F C G LI+DQWV++AAHC + + + E +
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGYHF---CGGSLINDQWVVSAAHCYKSRIQVRLGEHNIN- 56
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
V N + F YN NDI L +L VK N + V LP
Sbjct: 57 -VLEGNEQFVNAAKIIKHPNFDRETYN------NDIMLIKLSSPVKLNARVATVALPS-- 107
Query: 769 YELAP-GTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVC 827
AP GT+C + GWG + V+E + + ++ P++ + C + +T MVC
Sbjct: 108 -SCAPAGTQCLISGWGNTLSSGVNEPDL-LQCLDAPLLPQADCEA---SSSFIITDNMVC 162
Query: 828 AGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTW 887
G+ EGGKDACQGDSGGP++C + GIVSWG CA P PGVY V YV W
Sbjct: 163 VGFLEGGKDACQGDSGGPVVCNGE-------LQGIVSWGYGCALPDNPGVYTKVCNYVDW 215
Query: 888 IQDIM 892
IQD +
Sbjct: 216 IQDTI 220
>pdb|1VR1|H Chain H, Specifity For Plasminogen Activator Inhibitor-1
Length = 261
Score = 132 bits (331), Expect = 1e-30, Method: Compositional matrix adjust.
Identities = 90/268 (33%), Positives = 135/268 (50%), Gaps = 28/268 (10%)
Query: 649 IIGGFESNPGDWPFLAALLG----GPEFVFYCAGVLISDQWVLTAAHCV------GNLTG 698
I+ G ++ G P+ L P F C LISD+WVLTAAHC+ N T
Sbjct: 1 IVEGSDAEIGMSPWQVMLFAKHRRSPGERFLCGASLISDRWVLTAAHCLLYPPWDKNFTE 60
Query: 699 LNIDEWTVQLGVTRRNSYAFFGTRFK-VRGVFAHSQYNIGAQHDNDIALFQLKQKVKFND 757
++ V++G R Y + + ++ H +YN D DIAL +LK+ V F+D
Sbjct: 61 NDL---LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSD 117
Query: 758 HLLPVCLPPPNYE---LAPGTRCTVIGWGKREDTRVSEY----ETAVNEVEVPIITRDIC 810
++ PVCLP L G + V GWG ++T + + + V +PI+ R +C
Sbjct: 118 YIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVC 177
Query: 811 NKWLNNRELNVTLGMVCAGY-PEGGK--DACQGDSGGPLLCRSSHNFEQWFVGGIVSWGI 867
++ + +T M CA Y P+ GK DAC+GDSGGP + +S N +W+ GIVSWG
Sbjct: 178 K---DSTRIRITDNMFCAYYKPDEGKRGDACEGDSGGPFVMKSPFN-NRWYQMGIVSWGE 233
Query: 868 KCAHPHLPGVYAYVPKYVTWIQDIMDKY 895
C G Y +V + WIQ ++D++
Sbjct: 234 GCDRDGKYGFYTHVFRLKKWIQKVIDQF 261
>pdb|1Z8J|B Chain B, Crystal Structure Of The Thrombin Mutant G193p Bound To
Ppack
Length = 259
Score = 131 bits (330), Expect = 1e-30, Method: Compositional matrix adjust.
Identities = 88/265 (33%), Positives = 133/265 (50%), Gaps = 24/265 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCV------GNLTGLNID 702
I+ G ++ G P+ L C LISD+WVLTAAHC+ N T ++
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL- 59
Query: 703 EWTVQLGVTRRNSYAFFGTRFK-VRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLP 761
V++G R Y + + ++ H +YN D DIAL +LK+ V F+D++ P
Sbjct: 60 --LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 762 VCLPPPNYE---LAPGTRCTVIGWGKREDTRVSEY----ETAVNEVEVPIITRDICNKWL 814
VCLP L G + V GWG ++T + + + V +PI+ R +C
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK--- 174
Query: 815 NNRELNVTLGMVCAGY-PEGGK--DACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAH 871
++ + +T M CAGY P+ GK DAC+ DSGGP + +S N +W+ GIVSWG C
Sbjct: 175 DSTRIRITDNMFCAGYKPDEGKRGDACEPDSGGPFVMKSPFN-NRWYQMGIVSWGEGCDR 233
Query: 872 PHLPGVYAYVPKYVTWIQDIMDKYS 896
G Y +V + WIQ ++D++
Sbjct: 234 DGKYGFYTHVFRLKKWIQKVIDQFG 258
>pdb|2PUX|B Chain B, Crystal Structure Of Murine Thrombin In Complex With The
Extracellular Fragment Of Murine Par3
pdb|2PV9|B Chain B, Crystal Structure Of Murine Thrombin In Complex With The
Extracellular Fragment Of Murine Par4
Length = 258
Score = 131 bits (330), Expect = 2e-30, Method: Compositional matrix adjust.
Identities = 86/269 (31%), Positives = 132/269 (49%), Gaps = 32/269 (11%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCV------GNLTGLNID 702
I+ G+++ G P+ L C LISD+WVLTAAHC+ N T ++
Sbjct: 1 IVEGWDAEKGIAPWQVMLFRKSPQELLCGASLISDRWVLTAAHCILYPPWDKNFTENDL- 59
Query: 703 EWTVQLGVTRRNSYAFFGTRFK-VRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLP 761
V++G R Y + + ++ H +YN D DIAL +LK+ V F+D++ P
Sbjct: 60 --LVRIGKHSRTRYERNVEKISMLEKIYVHPRYNWRENLDRDIALLKLKKPVPFSDYIHP 117
Query: 762 VCLPPPNYE---LAPGTRCTVIGWGKREDTRVSEYETAVNEVE--------VPIITRDIC 810
VCLP L G + V GWG +T + T +NE++ +PI+ R +C
Sbjct: 118 VCLPDKQTVTSLLRAGYKGRVTGWGNLRET----WTTNINEIQPSVLQVVNLPIVERPVC 173
Query: 811 NKWLNNRELNVTLGMVCAGYPEGGK---DACQGDSGGPLLCRSSHNFEQWFVGGIVSWGI 867
+ + +T M CAG+ DAC+GD+GGP + +S N +W+ GIVSWG
Sbjct: 174 KA---STRIRITDNMFCAGFKVNDTKRGDACEGDAGGPFVMKSPFN-NRWYQMGIVSWGE 229
Query: 868 KCAHPHLPGVYAYVPKYVTWIQDIMDKYS 896
C G Y +V + WIQ ++D++
Sbjct: 230 GCDRKGKYGFYTHVFRLKRWIQKVIDQFG 258
>pdb|3BSQ|A Chain A, Crystal Structure Of Human Kallikrein 7 Produced As A
Secretion Protein In E.Coli
pdb|3BSQ|B Chain B, Crystal Structure Of Human Kallikrein 7 Produced As A
Secretion Protein In E.Coli
pdb|3BSQ|C Chain C, Crystal Structure Of Human Kallikrein 7 Produced As A
Secretion Protein In E.Coli
Length = 227
Score = 131 bits (329), Expect = 2e-30, Method: Compositional matrix adjust.
Identities = 89/245 (36%), Positives = 124/245 (50%), Gaps = 26/245 (10%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
II G G P+ ALL G + +C GVL++++WVLTAAHC ++E+TV L
Sbjct: 1 IIDGAPCARGSHPWQVALLSGNQL--HCGGVLVNERWVLTAAHC-------KMNEYTVHL 51
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
G R K F H Y+ H ND+ L +L + + + + V LP +
Sbjct: 52 GSDTLGDRR--AQRIKASKSFRHPGYST-QTHVNDLMLVKLNSQARLSSMVKKVRLP--S 106
Query: 769 YELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVCA 828
PGT CTV GWG V+ + + + V+V +I+ C K + N M+CA
Sbjct: 107 RCEPPGTTCTVSGWGTTTSPDVT-FPSDLMCVDVKLISPQDCTKVYKDLLEN---SMLCA 162
Query: 829 GYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWG-IKCAHPHLPGVYAYVPKYVTW 887
G P+ K+AC GDSGGPL+CR + + G+VSWG C P+ PGVY V K+ W
Sbjct: 163 GIPDSKKNACNGDSGGPLVCRGT-------LQGLVSWGTFPCGQPNDPGVYTQVCKFTKW 215
Query: 888 IQDIM 892
I D M
Sbjct: 216 INDTM 220
>pdb|1CO7|E Chain E, R117h Mutant Rat Anionic Trypsin Complexed With Bovine
Pancreatic Trypsin Inhibitor (Bpti)
Length = 245
Score = 131 bits (329), Expect = 2e-30, Method: Compositional matrix adjust.
Identities = 87/246 (35%), Positives = 121/246 (49%), Gaps = 26/246 (10%)
Query: 648 RIIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQ 707
+I+GG+ P+ +L G F C G LI+DQWV++AAHC + + + E +
Sbjct: 22 KIVGGYTCQENSVPYQVSLNSGYHF---CGGSLINDQWVVSAAHCYKSRIQVRLGEHNIN 78
Query: 708 LGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPP 767
V N + F N NDI L +L VK N H+ V LP
Sbjct: 79 --VLEGNEQFVNAAKIIKHPNFDRKTLN------NDIMLIKLSSPVKLNAHVATVALPS- 129
Query: 768 NYELAP-GTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMV 826
AP GT+C + GWG + V+E + + ++ P++ + C + +T MV
Sbjct: 130 --SCAPAGTQCLISGWGNTLSSGVNEPDL-LQCLDAPLLPQADCEASYPGK---ITDNMV 183
Query: 827 CAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVT 886
C G+ EGGKD+CQGDSGGP++C + GIVSWG CA P PGVY V YV
Sbjct: 184 CVGFLEGGKDSCQGDSGGPVVCNGE-------LQGIVSWGYGCALPDNPGVYTKVCNYVD 236
Query: 887 WIQDIM 892
WIQD +
Sbjct: 237 WIQDTI 242
>pdb|1BDA|A Chain A, Catalytic Domain Of Human Single Chain Tissue Plasminogen
Activator In Complex With Dansyl-Egr-Cmk
(Dansyl-Glu-Gly-Arg Chloromethyl Ketone)
pdb|1BDA|B Chain B, Catalytic Domain Of Human Single Chain Tissue Plasminogen
Activator In Complex With Dansyl-Egr-Cmk
(Dansyl-Glu-Gly-Arg Chloromethyl Ketone)
Length = 265
Score = 131 bits (329), Expect = 2e-30, Method: Compositional matrix adjust.
Identities = 93/271 (34%), Positives = 128/271 (47%), Gaps = 20/271 (7%)
Query: 633 CGTRRHLHNNFKARKRIIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHC 692
CG R++ F+ + + S+P A P F C G+LIS W+L+AAHC
Sbjct: 2 CGLRQYSQPQFRIKGGLFADIASHPWQAAIFAKHRRSPGERFLCGGILISSCWILSAAHC 61
Query: 693 VGNLTGLNIDEWTVQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQK 752
TV LG T R +F+V H +++ +DNDIAL QLK
Sbjct: 62 FQER--FPPHHLTVILGRTYRVVPGEEEQKFEVEKYIVHKEFD-DDTYDNDIALLQLKSD 118
Query: 753 ----VKFNDHLLPVCLPPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRD 808
+ + + VCLPP + +L T C + G+GK E Y + E V +
Sbjct: 119 SSRCAQESSVVRTVCLPPADLQLPDWTECELSGYGKHE-ALSPFYSERLKEAHVRLYPSS 177
Query: 809 IC-NKWLNNRELNVTLGMVCAGYPEGG------KDACQGDSGGPLLCRSSHNFEQWFVGG 861
C ++ L NR VT M+CAG G DACQGDSGGPL+C N + + G
Sbjct: 178 RCTSQHLLNR--TVTDNMLCAGDTRSGGPQANLHDACQGDSGGPLVCL---NDGRMTLVG 232
Query: 862 IVSWGIKCAHPHLPGVYAYVPKYVTWIQDIM 892
I+SWG+ C +PGVY V Y+ WI+D M
Sbjct: 233 IISWGLGCGQKDVPGVYTKVTNYLDWIRDNM 263
>pdb|1Y59|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
pdb|1Y5A|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
pdb|1Y5B|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
pdb|1Y5U|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
Length = 223
Score = 131 bits (329), Expect = 2e-30, Method: Compositional matrix adjust.
Identities = 82/244 (33%), Positives = 120/244 (49%), Gaps = 24/244 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+ P+ +L G F C G LI+ QWV++AAHC +G+ + +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF---CGGSLINSQWVVSAAHCY--KSGIQVRLGEDNI 55
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
V N ++ V H YN ++NDI L +LK N + + LP
Sbjct: 56 NVVEGNEQFISASKSIV-----HPSYN-SETYNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 769 YELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVCA 828
+ GT+C + GWG + + S Y + ++ PI++ C + +T M CA
Sbjct: 110 --ASAGTQCLISGWGNTKSSGTS-YPDVLKCLKAPILSDSSCKSAYPGQ---ITSNMFCA 163
Query: 829 GYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTWI 888
GY EGGKD+CQGDSGGP++C + GIVSWG CA + PGVY V YV+WI
Sbjct: 164 GYLEGGKDSCQGDSGGPVVCSGK-------LQGIVSWGSGCAQKNKPGVYTKVCNYVSWI 216
Query: 889 QDIM 892
+ +
Sbjct: 217 KQTI 220
>pdb|1TGS|Z Chain Z, Three-Dimensional Structure Of The Complex Between
Pancreatic Secretory Inhibitor (Kazal Type) And
Trypsinogen At 1.8 Angstroms Resolution. Structure
Solution, Crystallographic Refinement And Preliminary
Structural Interpretation
pdb|2TGP|Z Chain Z, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|2TPI|Z Chain Z, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|3TPI|Z Chain Z, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|4TPI|Z Chain Z, The Refined 2.2-angstroms (0.22-nm) X-ray Crystal
Structure Of The Ternary Complex Formed By Bovine
Trypsinogen, Valine-valine And The Arg15 Analogue Of
Bovine Pancreatic Trypsin Inhibitor
pdb|1BTZ|A Chain A, Episelection: Novel Ki ~nanomolar Inhibitors Of Serine
Proteases Selected By Binding Or Chemistry On An Enzyme
Surface
pdb|1BTX|A Chain A, Episelection: Novel Ki ~nanomolar Inhibitors Of Serine
Proteases Selected By Binding Or Chemistry On An Enzyme
Surface
pdb|1BTW|A Chain A, Episelection: Novel Ki ~nanomolar Inhibitors Of Serine
Proteases Selected By Binding Or Chemistry On An Enzyme
Surface
pdb|1BTP|A Chain A, Unique Binding Of A Novel Synthetic Inhibitor, N-[3-[4-[4-
(Amidinophenoxy)-Carbonyl]phenyl]-2-Methyl-2-Propenoyl]-
N- Allylglycine Methanesulfonate To Bovine Trypsin,
Revealed By The Crystal Structure Of The Complex
pdb|1BTY|A Chain A, Crystal Structure Of Beta-Trypsin In Complex With
Benzamidine
pdb|1TGB|A Chain A, Crystal Structure Of Bovine Trypsinogen At 1.8 Angstroms
Resolution. Ii. Crystallographic Refinement, Refined
Crystal Structure And Comparison With Bovine Trypsin
pdb|1TGC|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|1TGN|A Chain A, Structure Of Bovine Trypsinogen At 1.9 Angstroms
Resolution
pdb|1TGT|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|1TNG|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNH|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNI|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNJ|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNK|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNL|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|2TGA|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|2TGD|A Chain A, Lack Of The Transition State Stabilization Site Is A
Factor In The Inactivity Of Trypsinogen, A Serine
Protease Zymogen. Structure Of Dfp Inhibited Bovine
Trypsinogen At 2.1 Angstroms Resolution
pdb|2TGT|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
Length = 229
Score = 130 bits (327), Expect = 3e-30, Method: Compositional matrix adjust.
Identities = 82/245 (33%), Positives = 120/245 (48%), Gaps = 24/245 (9%)
Query: 648 RIIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQ 707
+I+GG+ P+ +L G F C G LI+ QWV++AAHC +G+ +
Sbjct: 6 KIVGGYTCGANTVPYQVSLNSGYHF---CGGSLINSQWVVSAAHCY--KSGIQVRLGEDN 60
Query: 708 LGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPP 767
+ V N ++ V H YN +NDI L +LK N + + LP
Sbjct: 61 INVVEGNEQFISASKSIV-----HPSYN-SNTLNNDIMLIKLKSAASLNSRVASISLPTS 114
Query: 768 NYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVC 827
+ GT+C + GWG + + S Y + ++ PI++ C + +T M C
Sbjct: 115 C--ASAGTQCLISGWGNTKSSGTS-YPDVLKCLKAPILSDSSCKSAYPGQ---ITSNMFC 168
Query: 828 AGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTW 887
AGY EGGKD+CQGDSGGP++C + GIVSWG CA + PGVY V YV+W
Sbjct: 169 AGYLEGGKDSCQGDSGGPVVCSGK-------LQGIVSWGSGCAQKNKPGVYTKVCNYVSW 221
Query: 888 IQDIM 892
I+ +
Sbjct: 222 IKQTI 226
>pdb|1A5I|A Chain A, Catalytic Domain Of Vampire Bat (Desmodus Rotundus) Saliva
Plasminogen Activator In Complex With Egr-Cmk
(Glu-Gly-Arg Chloromethyl Ketone)
Length = 265
Score = 130 bits (327), Expect = 3e-30, Method: Compositional matrix adjust.
Identities = 92/271 (33%), Positives = 130/271 (47%), Gaps = 20/271 (7%)
Query: 633 CGTRRHLHNNFKARKRIIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHC 692
CG R++ + + S+P A F C G+LIS WVLTAAHC
Sbjct: 2 CGLRKYKEPQLHSTGGLFTDITSHPWQAAIFAQNRRSSGERFLCGGILISSCWVLTAAHC 61
Query: 693 VGNLTGLNIDEWTVQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLK-- 750
D+ V LG T R FKV+ H +++ ++NDIAL QLK
Sbjct: 62 FQE--SYLPDQLKVVLGRTYRVKPGEEEQTFKVKKYIVHKEFD-DDTYNNDIALLQLKSD 118
Query: 751 --QKVKFNDHLLPVCLPPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRD 808
Q + +D + +CLP N +L T C + G+GK + + Y + E V +
Sbjct: 119 SPQCAQESDSVRAICLPEANLQLPDWTECELSGYGKHKSSS-PFYSEQLKEGHVRLYPSS 177
Query: 809 ICN-KWLNNRELNVTLGMVCAGYPEGGK------DACQGDSGGPLLCRSSHNFEQWFVGG 861
C K+L N+ VT M+CAG G+ DACQGDSGGPL+C + ++ + G
Sbjct: 178 RCAPKFLFNK--TVTNNMLCAGDTRSGEIYPNVHDACQGDSGGPLVCMNDNHMT---LLG 232
Query: 862 IVSWGIKCAHPHLPGVYAYVPKYVTWIQDIM 892
I+SWG+ C +PGVY V Y+ WI+D M
Sbjct: 233 IISWGVGCGEKDVPGVYTKVTNYLGWIRDNM 263
>pdb|4AN7|A Chain A, Kunitz Type Trypsin Inhibitor Complex With Porcine Trypsin
Length = 231
Score = 130 bits (327), Expect = 3e-30, Method: Compositional matrix adjust.
Identities = 81/245 (33%), Positives = 119/245 (48%), Gaps = 24/245 (9%)
Query: 648 RIIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQ 707
+I+GG+ P+ +L G F C G LI+ QWV++AAHC + + + E +
Sbjct: 8 KIVGGYTCAANSIPYQVSLNSGSHF---CGGSLINSQWVVSAAHCYKSRIQVRLGEHNID 64
Query: 708 LGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPP 767
V N + + H +N G DNDI L +L N + V LP
Sbjct: 65 --VLEGNEQFINAAK-----IITHPNFN-GNTLDNDIMLIKLSSPATLNSRVATVSLP-- 114
Query: 768 NYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVC 827
A GT C + GWG + + S Y + + ++ P+++ C ++ +T M+C
Sbjct: 115 RSCAAAGTECLISGWGNTKSSG-SSYPSLLQCLKAPVLSDSSCK---SSYPGQITGNMIC 170
Query: 828 AGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTW 887
G+ EGGKD+CQGDSGGP++C + GIVSWG CA + PGVY V YV W
Sbjct: 171 VGFLEGGKDSCQGDSGGPVVCNGQ-------LQGIVSWGYGCAQKNKPGVYTKVCNYVNW 223
Query: 888 IQDIM 892
IQ +
Sbjct: 224 IQQTI 228
>pdb|1G3B|A Chain A, Bovine Beta-Trypsin Bound To Meta-Amidino Schiff Base
Magnesium(Ii) Chelate
pdb|1G3C|A Chain A, Bovine Beta-Trypsin Bound To Para-Amidino Schiff Base
Iron(Iii) Chelate
pdb|1G3D|A Chain A, Bovine Beta-Trypsin Bound To Meta-Amidino Schiff Base
Copper (Ii) Chelate
pdb|1G3E|A Chain A, Bovine Beta-Trypsin Bound To Para-Amidino Schiff-Base
Copper (Ii) Chelate
Length = 228
Score = 130 bits (327), Expect = 3e-30, Method: Compositional matrix adjust.
Identities = 82/245 (33%), Positives = 120/245 (48%), Gaps = 24/245 (9%)
Query: 648 RIIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQ 707
+I+GG+ P+ +L G F C G LI+ QWV++AAHC +G+ +
Sbjct: 5 KIVGGYTCGANTVPYQVSLNSGYHF---CGGSLINSQWVVSAAHCY--KSGIQVRLGEDN 59
Query: 708 LGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPP 767
+ V N ++ V H YN +NDI L +LK N + + LP
Sbjct: 60 INVVEGNEQFISASKSIV-----HPSYN-SNTLNNDIMLIKLKSAASLNSRVASISLPTS 113
Query: 768 NYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVC 827
+ GT+C + GWG + + S Y + ++ PI++ C + +T M C
Sbjct: 114 C--ASAGTQCLISGWGNTKSSGTS-YPDVLKCLKAPILSDSSCKSAYPGQ---ITSNMFC 167
Query: 828 AGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTW 887
AGY EGGKD+CQGDSGGP++C + GIVSWG CA + PGVY V YV+W
Sbjct: 168 AGYLEGGKDSCQGDSGGPVVCSGK-------LQGIVSWGSGCAQKNKPGVYTKVCNYVSW 220
Query: 888 IQDIM 892
I+ +
Sbjct: 221 IKQTI 225
>pdb|2TBS|A Chain A, Cold-Adaption Of Enzymes: Structural Comparison Between
Salmon And Bovine Trypsins
Length = 222
Score = 130 bits (327), Expect = 3e-30, Method: Compositional matrix adjust.
Identities = 86/248 (34%), Positives = 123/248 (49%), Gaps = 27/248 (10%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+E +L G F C G L+++ WV++AAHC + + + E +++
Sbjct: 1 IVGGYECKAYSQAHQVSLNSGYHF---CGGSLVNENWVVSAAHCYKSRVEVRLGEHNIKV 57
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
S F + +R +S YNI DNDI L +L + N ++ PV LP
Sbjct: 58 ---TEGSEQFISSSRVIRHP-NYSSYNI----DNDIMLIKLSKPATLNTYVQPVALPT-- 107
Query: 769 YELAP-GTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVC 827
AP GT CTV GWG + + + +PI++ CN ++ +T M C
Sbjct: 108 -SCAPAGTMCTVSGWGNTMSSTADS--DKLQCLNIPILSYSDCN---DSYPGMITNAMFC 161
Query: 828 AGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTW 887
AGY EGGKD+CQGDSGGP++C + G+VSWG CA P PGVYA V + W
Sbjct: 162 AGYLEGGKDSCQGDSGGPVVCNGE-------LQGVVSWGYGCAEPGNPGVYAKVCIFSDW 214
Query: 888 IQDIMDKY 895
+ M Y
Sbjct: 215 LTSTMASY 222
>pdb|1TQ0|B Chain B, Crystal Structure Of The Potent Anticoagulant Thrombin
Mutant W215aE217A IN FREE FORM
pdb|1TQ0|D Chain D, Crystal Structure Of The Potent Anticoagulant Thrombin
Mutant W215aE217A IN FREE FORM
pdb|1TQ7|B Chain B, Crystal Structure Of The Anticoagulant Thrombin Mutant
W215aE217A Bound To Ppack
Length = 257
Score = 130 bits (327), Expect = 4e-30, Method: Compositional matrix adjust.
Identities = 88/264 (33%), Positives = 133/264 (50%), Gaps = 24/264 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCV------GNLTGLNID 702
I+ G ++ G P+ L C LISD+WVLTAAHC+ N T ++
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL- 59
Query: 703 EWTVQLGVTRRNSYAFFGTRFK-VRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLP 761
V++G R Y + + ++ H +YN D DIAL +LK+ V F+D++ P
Sbjct: 60 --LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 762 VCLPPPNYE---LAPGTRCTVIGWGKREDTRVSEY----ETAVNEVEVPIITRDICNKWL 814
VCLP L G + V GWG ++T + + + V +PI+ R +C
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK--- 174
Query: 815 NNRELNVTLGMVCAGY-PEGGK--DACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAH 871
++ + +T M CAGY P+ GK DAC+GDSGGP + +S N +W+ GIVS G C
Sbjct: 175 DSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFN-NRWYQMGIVSAGAGCDR 233
Query: 872 PHLPGVYAYVPKYVTWIQDIMDKY 895
G Y +V + WIQ ++D++
Sbjct: 234 DGKYGFYTHVFRLKKWIQKVIDQF 257
>pdb|1AND|A Chain A, Anionic Trypsin Mutant With Arg 96 Replaced By His
Length = 223
Score = 130 bits (326), Expect = 4e-30, Method: Compositional matrix adjust.
Identities = 87/245 (35%), Positives = 120/245 (48%), Gaps = 26/245 (10%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+ P+ +L G F C G LI+DQWV++AAHC + + + E +
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGYHF---CGGSLINDQWVVSAAHCYKSRIQVRLGEHNIN- 56
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
V N + F H N NDI L +L VK N + V LP
Sbjct: 57 -VLEGNEQFVNAAKIIKHPNFDHKTLN------NDIMLIKLSSPVKLNARVATVALPS-- 107
Query: 769 YELAP-GTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVC 827
AP GT+C + GWG + V+E + + ++ P++ + C + +T MVC
Sbjct: 108 -SCAPAGTQCLISGWGNTLSSGVNEPDL-LQCLDAPLLPQADCEASYPGK---ITDNMVC 162
Query: 828 AGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTW 887
G+ EGGKD+CQGDSGGP++C + GIVSWG CA P PGVY V YV W
Sbjct: 163 VGFLEGGKDSCQGDSGGPVVCNGE-------LQGIVSWGYGCALPDNPGVYTKVCNYVDW 215
Query: 888 IQDIM 892
IQD +
Sbjct: 216 IQDTI 220
>pdb|1QL9|A Chain A, Factor Xa Specific Inhibitor In Complex With Rat Trypsin
Mutant X99rt
pdb|1J14|A Chain A, Benzamidine In Complex With Rat Trypsin Mutant X99rt
Length = 223
Score = 130 bits (326), Expect = 4e-30, Method: Compositional matrix adjust.
Identities = 87/245 (35%), Positives = 120/245 (48%), Gaps = 26/245 (10%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+ P+ +L G F C G LI+DQWV++AAHC + + + E +
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGYHF---CGGSLINDQWVVSAAHCYKSRIQVRLGEHNIN- 56
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
V N + F YN NDI L +L VK N + V LP
Sbjct: 57 -VLEGNEQFVNAAKIIKHPNFDRETYN------NDIMLIKLSSPVKLNARVATVALPS-- 107
Query: 769 YELAP-GTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVC 827
AP GT+C + GWG + V+E + + ++ P++ + C + +T MVC
Sbjct: 108 -SCAPAGTQCLISGWGNTLSSGVNEPDL-LQCLDAPLLPQADCEASYPGK---ITDNMVC 162
Query: 828 AGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTW 887
G+ EGGKD+CQGDSGGP++C + GIVSWG CA P PGVY V YV W
Sbjct: 163 VGFLEGGKDSCQGDSGGPVVCNGE-------LQGIVSWGYGCALPDNPGVYTKVCNYVDW 215
Query: 888 IQDIM 892
IQD +
Sbjct: 216 IQDTI 220
>pdb|3EE0|B Chain B, Crystal Structure Of The W215aE217A MUTANT OF HUMAN
Thrombin (Space Group P2(1)2(1)2(1))
pdb|3HKJ|B Chain B, Crystal Structure Of Human Thrombin Mutant W215aE217A IN
COMPLEX WITH The Extracellular Fragment Of Human Par1
pdb|3HKJ|E Chain E, Crystal Structure Of Human Thrombin Mutant W215aE217A IN
COMPLEX WITH The Extracellular Fragment Of Human Par1
Length = 259
Score = 130 bits (326), Expect = 4e-30, Method: Compositional matrix adjust.
Identities = 88/265 (33%), Positives = 133/265 (50%), Gaps = 24/265 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCV------GNLTGLNID 702
I+ G ++ G P+ L C LISD+WVLTAAHC+ N T ++
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL- 59
Query: 703 EWTVQLGVTRRNSYAFFGTRFK-VRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLP 761
V++G R Y + + ++ H +YN D DIAL +LK+ V F+D++ P
Sbjct: 60 --LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 762 VCLPPPNYE---LAPGTRCTVIGWGKREDTRVSEY----ETAVNEVEVPIITRDICNKWL 814
VCLP L G + V GWG ++T + + + V +PI+ R +C
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK--- 174
Query: 815 NNRELNVTLGMVCAGY-PEGGK--DACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAH 871
++ + +T M CAGY P+ GK DAC+GDSGGP + +S N +W+ GIVS G C
Sbjct: 175 DSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFN-NRWYQMGIVSAGAGCDR 233
Query: 872 PHLPGVYAYVPKYVTWIQDIMDKYS 896
G Y +V + WIQ ++D++
Sbjct: 234 DGKYGFYTHVFRLKKWIQKVIDQFG 258
>pdb|3QK1|A Chain A, Crystal Structure Of Enterokinase-Like Trypsin Variant
Length = 229
Score = 130 bits (326), Expect = 4e-30, Method: Compositional matrix adjust.
Identities = 82/244 (33%), Positives = 120/244 (49%), Gaps = 24/244 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+ P+ +L G F C G LI+ QWV++AAHC +G+ + +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF---CGGSLINSQWVVSAAHCY--KSGIQVRLGEDNI 55
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
V N ++ V H YN + +NDI L +LK N + + LP
Sbjct: 56 NVVEGNEQFISASKSIV-----HPSYN-KRRKNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 769 YELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVCA 828
+ GT+C + GWG + + S Y + ++ PI++ C + +T M CA
Sbjct: 110 --ASAGTQCLISGWGNTKSSGTS-YPDVLKCLKAPILSDSSCKSAYPGQ---ITSNMFCA 163
Query: 829 GYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTWI 888
GY EGGKD+CQGDSGGP++C + GIVSWG CA + PGVY V YV+WI
Sbjct: 164 GYLEGGKDSCQGDSGGPVVCSGK-------LQGIVSWGSGCAQKNKPGVYTKVCNYVSWI 216
Query: 889 QDIM 892
+ +
Sbjct: 217 KQTI 220
>pdb|1ZZZ|A Chain A, Trypsin Inhibitors With Rigid Tripeptidyl Aldehydes
Length = 237
Score = 129 bits (325), Expect = 5e-30, Method: Compositional matrix adjust.
Identities = 82/245 (33%), Positives = 120/245 (48%), Gaps = 24/245 (9%)
Query: 648 RIIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQ 707
+I+GG+ P+ +L G F C G LI+ QWV++AAHC +G+ +
Sbjct: 14 KIVGGYTCGANTVPYQVSLNSGYHF---CGGSLINSQWVVSAAHCY--KSGIQVRLGEDN 68
Query: 708 LGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPP 767
+ V N ++ V H YN +NDI L +LK N + + LP
Sbjct: 69 INVVEGNEQFISASKSIV-----HPSYN-SNTLNNDIMLIKLKSAASLNSRVASISLPTS 122
Query: 768 NYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVC 827
+ GT+C + GWG + + S Y + ++ PI++ C + +T M C
Sbjct: 123 C--ASAGTQCLISGWGNTKSSGTS-YPDVLKCLKAPILSDSSCKSAYPGQ---ITSNMFC 176
Query: 828 AGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTW 887
AGY EGGKD+CQGDSGGP++C + GIVSWG CA + PGVY V YV+W
Sbjct: 177 AGYLEGGKDSCQGDSGGPVVCSGK-------LQGIVSWGSGCAQKNKPGVYTKVCNYVSW 229
Query: 888 IQDIM 892
I+ +
Sbjct: 230 IKQTI 234
>pdb|2B9L|A Chain A, Crystal Structure Of Prophenoloxidase Activating Factor-Ii
From The Beetle Holotrichia Diomphalia
Length = 394
Score = 129 bits (325), Expect = 5e-30, Method: Compositional matrix adjust.
Identities = 90/274 (32%), Positives = 131/274 (47%), Gaps = 23/274 (8%)
Query: 633 CGTRRHLHNNFKARKRIIGGFESNPGDWPFLAALL------GGPEFVFYCAGVLISDQWV 686
CG R +FK + E+ G++P++ A+L G E C G LI+ V
Sbjct: 118 CGIRNERGLDFKITGQT---NEAEYGEFPWMVAVLKANVIPGSGEEQLVCGGSLIAPSVV 174
Query: 687 LTAAHCVGNLTGLNIDEWTVQLG----VTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDN 742
LT AHCV N N+D ++ G +T + + K+R V HS +N N
Sbjct: 175 LTGAHCV-NSYQSNLDAIKIRAGEWDTLTEKERLPY--QERKIRQVIIHSNFNPKTVV-N 230
Query: 743 DIALFQLKQKVKFNDHLLPVCLPPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEV 802
D+AL L + + D++ +CLP + ++ T C GWGK+E Y + ++++
Sbjct: 231 DVALLLLDRPLVQADNIGTICLPQQS-QIFDSTECFASGWGKKEFGSRHRYSNILKKIQL 289
Query: 803 PIITRDICNKWLNNRELNVTLGM----VCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWF 858
P + RD C L N L + + VCAG E GKD C GD G PL C N ++
Sbjct: 290 PTVDRDKCQADLRNTRLGLKFVLDQTFVCAG-GEQGKDTCTGDGGSPLFCPDPRNPSRYM 348
Query: 859 VGGIVSWGIKCAHPHLPGVYAYVPKYVTWIQDIM 892
GIV+WGI C ++PGVYA V + WI M
Sbjct: 349 QMGIVAWGIGCGDENVPGVYANVAHFRNWIDQEM 382
>pdb|1FIZ|A Chain A, Three Dimensional Structure Of Beta-Acrosin From Boar
Spermatozoa
Length = 263
Score = 129 bits (325), Expect = 5e-30, Method: Compositional matrix adjust.
Identities = 93/264 (35%), Positives = 127/264 (48%), Gaps = 40/264 (15%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFY-------CAGVLISDQWVLTAAHCVGNLTGLNI 701
++GG + PG WP++ +L F+++ C G+L++ WVLTAAHC N +
Sbjct: 1 VVGGMSAEPGAWPWMVSLQ---IFMYHNNRRYHTCGGILLNSHWVLTAAHCFKNKK--KV 55
Query: 702 DEWTVQLGV------TRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKF 755
+W + G + + RF V + H +Y G + NDIAL ++ V
Sbjct: 56 TDWRLIFGANEVVWGSNKPVKPPLQERF-VEEIIIHEKYVSGLE-INDIALIKITPPVPC 113
Query: 756 NDHLLPVCLP-----PPNYELAPGTRCTVIGWG--KREDTRVSEYETAVNEVEVPIITRD 808
+ P CLP PP AP T C V GWG K + R S + E V +I +
Sbjct: 114 GPFIGPGCLPQFKAGPPR---APQT-CWVTGWGYLKEKGPRTSP---TLQEARVALIDLE 166
Query: 809 ICN--KWLNNRELNVTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWG 866
+CN +W N R + VCAGYP G D CQGDSGGPL+CR + V GI SWG
Sbjct: 167 LCNSTRWYNGRIRSTN---VCAGYPRGKIDTCQGDSGGPLMCRDRAE-NTFVVVGITSWG 222
Query: 867 IKCAHPHLPGVYAYVPKYVTWIQD 890
+ CA PGVY Y+ WI
Sbjct: 223 VGCARAKRPGVYTSTWPYLNWIAS 246
>pdb|1F0T|A Chain A, Bovine Trypsin Complexed With Rpr131247
pdb|1F0U|A Chain A, Bovine Trypsin Complexed With Rpr128515
pdb|1EZX|C Chain C, Crystal Structure Of A Serpin:protease Complex
pdb|1LQE|A Chain A, Crystal Structure Of Trypsin In Complex With 79.
pdb|1UTN|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTO|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-ray Structures And Association Constant Measurements
pdb|1UTP|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTQ|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|2BY5|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY6|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY7|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY8|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY9|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BYA|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
Length = 243
Score = 129 bits (325), Expect = 6e-30, Method: Compositional matrix adjust.
Identities = 82/245 (33%), Positives = 120/245 (48%), Gaps = 24/245 (9%)
Query: 648 RIIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQ 707
+I+GG+ P+ +L G F C G LI+ QWV++AAHC +G+ +
Sbjct: 20 KIVGGYTCGANTVPYQVSLNSGYHF---CGGSLINSQWVVSAAHCY--KSGIQVRLGEDN 74
Query: 708 LGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPP 767
+ V N ++ V H YN +NDI L +LK N + + LP
Sbjct: 75 INVVEGNEQFISASKSIV-----HPSYN-SNTLNNDIMLIKLKSAASLNSRVASISLPTS 128
Query: 768 NYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVC 827
+ GT+C + GWG + + S Y + ++ PI++ C + +T M C
Sbjct: 129 C--ASAGTQCLISGWGNTKSSGTS-YPDVLKCLKAPILSDSSCKSAYPGQ---ITSNMFC 182
Query: 828 AGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTW 887
AGY EGGKD+CQGDSGGP++C + GIVSWG CA + PGVY V YV+W
Sbjct: 183 AGYLEGGKDSCQGDSGGPVVCSGK-------LQGIVSWGSGCAQKNKPGVYTKVCNYVSW 235
Query: 888 IQDIM 892
I+ +
Sbjct: 236 IKQTI 240
>pdb|3VEQ|B Chain B, A Binary Complex Betwwen Bovine Pancreatic Trypsin And A
Engineered Mutant Trypsin Inhibitor
Length = 223
Score = 129 bits (324), Expect = 8e-30, Method: Compositional matrix adjust.
Identities = 83/244 (34%), Positives = 119/244 (48%), Gaps = 24/244 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+ P+ +L G F C G LI+ QWV++AAHC +G+ + +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF---CGGSLINSQWVVSAAHCY--KSGIQVRLGEDNI 55
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
V N ++ V H YN +NDI L +LK N + V LP
Sbjct: 56 NVVEGNEQFISASKSIV-----HPSYN-SNTLNNDIMLIKLKSAASLNSRVASVSLPTS- 108
Query: 769 YELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVCA 828
+ GT+C + GWG + + S Y + ++ PI++ C + +T M CA
Sbjct: 109 -CASAGTQCLISGWGNTKSSGTS-YPDVLKCLKAPILSDSSCKSAYPGQ---ITSNMFCA 163
Query: 829 GYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTWI 888
GY EGGKD+CQGDSGGP++C + GIVSWG CA + PGVY V YV+WI
Sbjct: 164 GYLEGGKDSCQGDSGGPVVCAGK-------LQGIVSWGSGCAQKNKPGVYTKVCNYVSWI 216
Query: 889 QDIM 892
+ +
Sbjct: 217 KQTI 220
>pdb|1TAW|A Chain A, Bovine Trypsin Complexed To Appi
pdb|1ZR0|A Chain A, Crystal Structure Of Kunitz Domain 1 Of Tissue Factor
Pathway Inhibitor-2 With Bovine Trypsin
pdb|1ZR0|C Chain C, Crystal Structure Of Kunitz Domain 1 Of Tissue Factor
Pathway Inhibitor-2 With Bovine Trypsin
Length = 223
Score = 129 bits (324), Expect = 8e-30, Method: Compositional matrix adjust.
Identities = 82/244 (33%), Positives = 119/244 (48%), Gaps = 24/244 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+ P+ +L G F C G LI+ QWV++AAHC +G+ + +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF---CGGSLINSQWVVSAAHCY--KSGIQVRLGEDNI 55
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
V N ++ V H YN +NDI L +LK N + + LP
Sbjct: 56 NVVEGNEQFISASKSIV-----HPSYN-SNTLNNDIMLIKLKSAASLNSRVASISLPTS- 108
Query: 769 YELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVCA 828
+ GT+C + GWG + + S Y + ++ PI++ C + +T M CA
Sbjct: 109 -CASAGTQCLISGWGNTKSSGTS-YPDVLKCLKAPILSTSSCKSAYPGQ---ITSNMFCA 163
Query: 829 GYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTWI 888
GY EGGKD+CQGDSGGP++C + GIVSWG CA + PGVY V YV+WI
Sbjct: 164 GYLEGGKDSCQGDSGGPVVCSGK-------LQGIVSWGSGCAQKNKPGVYTKVCNYVSWI 216
Query: 889 QDIM 892
+ +
Sbjct: 217 KQTI 220
>pdb|1LTO|A Chain A, Human Alpha1-Tryptase
pdb|1LTO|B Chain B, Human Alpha1-Tryptase
pdb|1LTO|C Chain C, Human Alpha1-Tryptase
pdb|1LTO|D Chain D, Human Alpha1-Tryptase
Length = 245
Score = 129 bits (323), Expect = 9e-30, Method: Compositional matrix adjust.
Identities = 82/254 (32%), Positives = 129/254 (50%), Gaps = 19/254 (7%)
Query: 649 IIGGFESNPGDWPFLAAL-LGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQ 707
I+GG E+ WP+ +L + ++ +C G LI QWVLTAAHC+G ++ +
Sbjct: 1 IVGGQEAPRSKWPWQVSLRVRDRYWMHFCGGSLIHPQWVLTAAHCLGP----DVKD-LAT 55
Query: 708 LGVTRRNSYAFFGTRF-KVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPP 766
L V R + ++ + V + H Q+ I Q DIAL +L++ V + + V LPP
Sbjct: 56 LRVQLREQHLYYQDQLLPVSRIIVHPQFYI-IQTGADIALLELEEPVNISSRVHTVMLPP 114
Query: 767 PNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICN------KWLNNRELN 820
+ PG C V GWG ++ + +V+VPI+ IC+ + +
Sbjct: 115 ASETFPPGMPCWVTGWGDVDNDEPLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRI 174
Query: 821 VTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAY 880
+ M+CAG + +D+C+GDSGGPL+C+ + W G+VSW CA P+ PG+Y
Sbjct: 175 IRDDMLCAGNSQ--RDSCKGDSGGPLVCKVNGT---WLQAGVVSWDEGCAQPNRPGIYTR 229
Query: 881 VPKYVTWIQDIMDK 894
V Y+ WI + K
Sbjct: 230 VTYYLDWIHHYVPK 243
>pdb|1TAB|E Chain E, Structure Of The Trypsin-Binding Domain Of Bowman-Birk
Type Protease Inhibitor And Its Interaction With Trypsin
pdb|1TPA|E Chain E, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|2PTC|E Chain E, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|1PPC|E Chain E, Geometry Of Binding Of The Benzamidine-and Arginine-based
Inhibitors
N-alpha-(2-naphthyl-sulphonyl-glycyl)-dl-p-
amidinophenylalanyl- Piperidine (napap) And
(2r,4r)-4-methyl-1-[n-alpha-(3-methyl-1,2,3,4-
Tetrahydro-8-quinolinesulphonyl)-l-arginyl]-2-piperidine
Carboxylic Acid (mqpa) To Human Alpha-thrombin: X-ray
Crystallographic Determination Of The Napap-trypsin
Complex And Modeling Of Napap- Thrombin And
Mqpa-thrombin
pdb|1PPE|E Chain E, The Refined 2.0 Angstroms X-Ray Crystal Structure Of The
Complex Formed Between Bovine Beta-Trypsin And Cmti-I, A
Trypsin Inhibitor From Squash Seeds (Cucurbita Maxima):
Topological Similarity Of The Squash Seed Inhibitors
With The Carboxypeptidase A Inhibitor From Potatoes
pdb|1PPH|E Chain E, Geometry Of Binding Of The Nalpha-Tosylated Piperidides Of
M-Amidino-, P-Amidino-And P-Guanidino Phenylalanine To
Thrombin And Trypsin: X- Ray Crystal Structures Of Their
Trypsin Complexes And Modeling Of Their Thrombin
Complexes
pdb|1SMF|E Chain E, Studies On An Artificial Trypsin Inhibitor Peptide Derived
From The Mung Bean Inhibitor
pdb|1JRT|A Chain A, Hemiacetal Complex Between Leupeptin And Trypsin
pdb|1JRS|A Chain A, Hemiacetal Complex Between Leupeptin And Trypsin
pdb|1CE5|A Chain A, Bovine Pancreas Beta-Trypsin In Complex With Benzamidine
pdb|2BZA|A Chain A, Bovine Pancreas Beta-Trypsin In Complex With Benzylamine
pdb|1QCP|A Chain A, Crystal Structure Of The Rwj-51084 Bovine Pancreatic Beta-
Trypsin At 1.8 A
pdb|1SBW|A Chain A, Crystal Structure Of Mung Bean Inhibitor Lysine Active
Fragment Complex With Bovine Beta-Trypsin At 1.8a
Resolution
pdb|1YYY|1 Chain 1, Trypsin Inhibitors With Rigid Tripeptidyl Aldehydes
pdb|1SFI|A Chain A, High Resolution Structure Of A Potent, Cyclic Protease
Inhibitor From Sunflower Seeds
pdb|1TIO|A Chain A, High Packing Density Form Of Bovine Beta-trypsin In
Cyclohexane
pdb|2TIO|A Chain A, Low Packing Density Form Of Bovine Beta-Trypsin In
Cyclohexane
pdb|2BTC|E Chain E, Bovine Trypsin In Complex With Squash Seed Inhibitor
(Cucurbita Pepo Trypsin Inhibitor Ii)
pdb|3BTE|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta-Trypsin And Ten P1 Variants Of Bpti.
pdb|3BTD|E Chain E, The Crystal Structures Of The Complexes Between The Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti.
pdb|3BTF|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti.
pdb|3BTG|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTH|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTK|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTM|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTQ|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTT|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTW|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|1QBN|A Chain A, Bovine Trypsin 2-[amino(Imino)methyl]-2-Hydroxyphenoxy]-6-
[3-(4,5-Dihydro-1h-Imidazol-2-Yl)phenoxy]pyridine-4-
Carboxylic Acid (Zk-806688) Complex
pdb|1QBO|A Chain A, Bovine Trypsin
7-[[6-[[1-(1-Iminoethyl)piperidin-4-Yl]oxy]-
2-Methyl-Benzimidazol-1-Yl]methyl]naphthalene-2-
Carboximidamid Zk-806711 Inhibitor Complex
pdb|1QB9|A Chain A, Bovine Trypsin
7-[[2-[[1-(1-Iminoethyl)piperidin-4-Yl]oxy]-
9h-Carbozol-9-Yl] Methyl]naphthalene-2-Carboximidamide
(Zk- 806450) Complex
pdb|1QB1|A Chain A, Bovine Trypsin With 1-[2-[5-[amino(imino)methyl]-2-
Hydroxyphenoxy]-6-[3-(4,
5-dihydro-1-methyl-1h-imidazol-2-
Yl)phenoxy]pyridin-4-yl]piperidine-3-carboxylic Acid
(zk- 806974)
pdb|1QB6|A Chain A, Bovine Trypsin 3,3'-[3,5-Difluoro-4-Methyl-2, 6-
Pyridinediylbis(Oxy)]bis(Benzenecarboximidamide) (Zk-
805623) Complex
pdb|1QA0|A Chain A, Bovine Trypsin 2-Aminobenzimidazole Complex
pdb|1F2S|E Chain E, Crystal Structure Of The Complex Formed Between Bovine
Beta- Trypsin And Mcti-A, A Trypsin Inhibitor Of Squash
Family At 1.8 A Resolution
pdb|1D6R|A Chain A, Crystal Structure Of Cancer Chemopreventive Bowman-Birk
Inhibitor In Ternary Complex With Bovine Trypsin At 2.3
A Resolution. Structural Basis Of Janus-Faced Serine
Protease Inhibitor Specificity
pdb|1C9T|A Chain A, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|B Chain B, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|C Chain C, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|D Chain D, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|E Chain E, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|F Chain F, Complex Of Bdellastasin With Bovine Trypsin
pdb|1QL7|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1QL8|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1G9I|E Chain E, Crystal Structure Of Beta-Trysin Complex In Cyclohexane
pdb|1EJM|A Chain A, Crystal Structure Of The Bpti Ala16leu Mutant In Complex
With Bovine Trypsin
pdb|1EJM|C Chain C, Crystal Structure Of The Bpti Ala16leu Mutant In Complex
With Bovine Trypsin
pdb|1EJM|E Chain E, Crystal Structure Of The Bpti Ala16leu Mutant In Complex
With Bovine Trypsin
pdb|1JIR|A Chain A, Crystal Structure Of Trypsin Complex With Amylamine In
Cyclohexane
pdb|1J8A|A Chain A, Crystal Structure Of Benzamidine Inhibited Bovine
Pancreatic Trypsin At 105k To 1.21a Resolution From
Laboratory Source With High Number Of Waters Modelled
pdb|1G36|A Chain A, Trypsin Inhibitor Complex
pdb|1K1P|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1O|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1N|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1M|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1L|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1J|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1I|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1EB2|A Chain A, Trypsin Inhibitor Complex (Bpo)
pdb|1GJ6|A Chain A, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1N6X|A Chain A, Rip-Phasing On Bovine Trypsin
pdb|1N6Y|A Chain A, Rip-Phasing On Bovine Trypsin
pdb|1OYQ|A Chain A, Trypsin Inhibitor Complex
pdb|1O2H|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2I|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2J|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2K|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2L|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2M|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2N|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O2O|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2P|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2Q|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2R|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2S|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2T|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2U|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2V|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2W|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2X|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2Y|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2Z|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O30|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O31|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O32|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O33|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O34|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O35|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O36|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O37|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O38|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O39|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3A|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3B|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3C|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3D|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3E|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3F|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3G|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3H|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3I|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3J|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3K|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3L|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3M|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O3N|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3O|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1NC6|A Chain A, Potent, Small Molecule Inhibitors Of Human Mast Cell
Tryptase. Anti-Asthmatic Action Of A Dipeptide-Based
Transition State Analogue Containing Benzothiazole
Ketone
pdb|1P2I|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2J|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2K|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1OX1|A Chain A, Crystal Structure Of The Bovine Trypsin Complex With A
Synthetic 11 Peptide Inhibitor
pdb|1RXP|A Chain A, Structure Of Trypsin (Orthorhombic) With 1-(4-Tert-
Butylcarbamoyl- Piperazine-1-Carbonyl)-3-(3-Guanidino-
Propyl)-4-Oxo-Azetidine-2-Carboxylic Acid
pdb|1S0Q|A Chain A, Native Bovine Pancreatic Trypsin
pdb|1S0R|A Chain A, Bovine Pancreatic Trypsin Inhibited With Benzamidine At
Atomic Resolution
pdb|2A7H|A Chain A, On The Routine Use Of Soft X-Rays In Macromolecular
Crystallography, Part Iii- The Optimal Data Collection
Wavelength
pdb|1TX7|A Chain A, Bovine Trypsin Complexed With P-
Amidinophenylmethylphosphinic Acid (Ampa)
pdb|2BLV|A Chain A, Trypsin Before A High Dose X-Ray "burn"
pdb|2BLW|A Chain A, Trypsin After A High Dose X-Ray "burn"
pdb|1TX8|A Chain A, Bovine Trypsin Complexed With Amso
pdb|1Y3U|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3V|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3W|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3X|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3Y|A Chain A, Trypsin Inhibitor Complex
pdb|1YP9|A Chain A, Trypsin Inhibitor Complex
pdb|2AYW|A Chain A, Crystal Structure Of The Complex Formed Between Trypsin
And A Designed Synthetic Highly Potent Inhibitor In The
Presence Of Benzamidine At 0.97 A Resolution
pdb|2FI3|E Chain E, Crystal Structure Of A Bpti Variant (Cys14->ser,
Cys38->ser) In Complex With Trypsin
pdb|2FX4|A Chain A, Bovine Trypsin Bound By 4-piperidinebutyrate To Make
Acylenzyme Complex
pdb|2FX6|A Chain A, Bovine Trypsin Complexed With 2-Aminobenzamidazole
pdb|2AGE|X Chain X, Succinyl-Aapr-Trypsin Acyl-Enzyme At 1.15 A Resolution
pdb|2AGG|X Chain X, Succinyl-Aapk-Trypsin Acyl-Enzyme At 1.28 A Resolution
pdb|2AGI|X Chain X, The Leupeptin-Trypsin Covalent Complex At 1.14 A
Resolution
pdb|2AH4|X Chain X, Guanidinobenzoyl-Trypsin Acyl-Enzyme At 1.13 A Resolution
pdb|2G5N|A Chain A, Indole-Amidine Complexes With Bovine Trypsin
pdb|2G5V|A Chain A, Indole-Amidine Complexes With Bovine Trypsin
pdb|2G8T|A Chain A, Indole-Amidine Complexes With Bovine Trypsin
pdb|2F3C|E Chain E, Crystal Structure Of Infestin 1, A Kazal-Type
Serineprotease Inhibitor, In Complex With Trypsin
pdb|2G81|E Chain E, Crystal Structure Of The Bowman-Birk Inhibitor From Vigna
Unguiculata Seeds In Complex With Beta-Trypsin At 1.55
Angstrons Resolution
pdb|2G55|A Chain A, Anomalous Substructure Of Trypsin (P3121)
pdb|2OTV|A Chain A, Crystal Structure Of The Complex Formed Between Bovine
Trypsin And Nicotinamide At 1.56 A Resolution
pdb|2J9N|A Chain A, Robotically Harvested Trypsin Complexed With Benzamidine
Containing Polypeptide Mediated Crystal Contacts
pdb|2OXS|A Chain A, Crytal Structure Of The Trypsin Complex With Benzamidine
At High Temperature (35 C)
pdb|2UUY|A Chain A, Structure Of A Tick Tryptase Inhibitor In Complex With
Bovine Trypsin
pdb|2ILN|A Chain A, Crystal Structure Of The Bowman-Birk Inhibitor From Snail
Medic Seeds In Complex With Bovine Trypsin
pdb|2ILN|B Chain B, Crystal Structure Of The Bowman-Birk Inhibitor From Snail
Medic Seeds In Complex With Bovine Trypsin
pdb|2CMY|A Chain A, Crystal Complex Between Bovine Trypsin And Veronica
Hederifolia Trypsin Inhibitor
pdb|1AQ7|A Chain A, Trypsin With Inhibitor Aeruginosin 98-b
pdb|1AUJ|A Chain A, Bovine Trypsin Complexed To Meta-Cyano-Benzylic Inhibitor
pdb|1AZ8|A Chain A, Bovine Trypsin Complexed To Bis-Phenylamidine Inhibitor
pdb|1BJU|A Chain A, Beta-Trypsin Complexed With Acpu
pdb|1BJV|A Chain A, Beta-Trypsin Complexed With Appu
pdb|1GBT|A Chain A, Structure Of An Acyl-Enzyme Intermediate During Catalysis:
(Guanidinobenzoyl) Trypsin
pdb|1MAX|A Chain A, Beta-Trypsin Phosphonate Inhibited
pdb|1MAY|A Chain A, Beta-Trypsin Phosphonate Inhibited
pdb|1MTS|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1MTU|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1MTV|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1MTW|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1TLD|A Chain A, Crystal Structure Of Bovine Beta-Trypsin At 1.5 Angstroms
Resolution In A Crystal Form With Low Molecular Packing
Density. Active Site Geometry, Ion Pairs And Solvent
Structure
pdb|1TPO|A Chain A, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|1TPP|A Chain A, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|1TPS|A Chain A, Atomic Structure Of The Trypsin-A90720a Complex: A Unified
Approach To Structure And Function
pdb|1TYN|A Chain A, Atomic Structure Of The Trypsin-cyclotheonamide A Complex:
Lessons For The Design Of Serine Protease Inhibitors
pdb|1XUF|A Chain A, Trypsin-Babim-Zn+2, Ph 8.2
pdb|1XUG|A Chain A, Trypsin-Babim-Zn+2, Ph 8.2
pdb|1XUH|A Chain A, Trypsin-Keto-Babim-Co+2, Ph 8.2
pdb|1XUI|A Chain A, Trypsin-Keto-Babim, Zn+2-Free, Ph 8.2
pdb|1XUJ|A Chain A, Trypsin-Keto-Babim-Zn+2, Ph 8.2
pdb|1XUK|A Chain A, Trypsin-Babim-Sulfate, Ph 5.9
pdb|2PLX|A Chain A, Trypsin Complexed To A Synthetic Peptide From Veronica
Hederifolia
pdb|2PTN|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|3PTB|A Chain A, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|3PTN|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|1C1N|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1O|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1P|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1Q|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1R|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1T|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2D|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2E|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2F|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2G|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2H|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2I|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2J|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2K|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2L|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2M|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C5P|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5Q|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5R|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5S|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5T|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5U|A Chain A, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5V|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1GHZ|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI0|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI1|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI2|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI3|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI4|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI5|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI6|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|2O9Q|A Chain A, The Crystal Structure Of Bovine Trypsin Complexed With A
Small Inhibition Peptide Orb2k
pdb|2QN5|T Chain T, Crystal Structure And Functional Study Of The Bowman-Birk
Inhibitor From Rice Bran In Complex With Bovine Trypsin
pdb|2QYI|A Chain A, Crystal Structure Of A Binary Complex Between An
Engineered Trypsin Inhibitor And Bovine Trypsin
pdb|2QYI|C Chain C, Crystal Structure Of A Binary Complex Between An
Engineered Trypsin Inhibitor And Bovine Trypsin
pdb|2ZDK|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZDL|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZDM|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZDN|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZFS|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZFT|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZHD|A Chain A, Exploring Trypsin S3 Pocket
pdb|3D65|E Chain E, Crystal Structure Of Textilinin-1, A Kunitz-Type Serine
Protease Inhibitor From The Australian Common Brown
Snake Venom, In Complex With Trypsin
pdb|3E8L|A Chain A, The Crystal Structure Of The Double-Headed Arrowhead
Protease Inhibitor A In Complex With Two Trypsins
pdb|3E8L|B Chain B, The Crystal Structure Of The Double-Headed Arrowhead
Protease Inhibitor A In Complex With Two Trypsins
pdb|2ZQ1|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZQ2|A Chain A, Exploring Trypsin S3 Pocket
pdb|3ITI|A Chain A, Structure Of Bovine Trypsin With The Mad Triangle B3c
pdb|3GY2|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY3|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY4|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY5|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY6|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Bis-Benzamidines Diminazene And Pentamidine
pdb|3GY7|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY8|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3AAS|A Chain A, Bovine Beta-Trypsin Bound To Meta-Guanidino Schiff Base
Copper (Ii) Chelate
pdb|3AAU|A Chain A, Bovine Beta-Trypsin Bound To Meta-Diguanidino Schiff Base
Copper (Ii) Chelate
pdb|3AAV|A Chain A, Bovine Beta-Trypsin Bound To Meta-Diamidino Schiff Base
Copper (Ii) Chelate
pdb|3AAV|B Chain B, Bovine Beta-Trypsin Bound To Meta-Diamidino Schiff Base
Copper (Ii) Chelate
pdb|3M35|A Chain A, Trypsin In Complex With The Inhibitor 1-[3-(Aminomethyl)
Phenyl]-N-[3-Fluoro-2'-(Methylsulfonyl)biphenyl-4-Yl]-3-
(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide (Dpc423)
pdb|3MFJ|A Chain A, Bovine Trypsin At 0.8 A Resolution, Restrained Refinement
pdb|3MI4|A Chain A, Bovine Trypsin At 0.8 A Resolution, Non-Restrained
Refinemen
pdb|3I29|A Chain A, Crystal Structure Of A Binary Complex Between An Mutant
Tryp Inhibitor With Bovine Trypsin
pdb|3A7T|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Formylbenzimidamide
pdb|3A7V|A Chain A, Crystal Structure Of Trypsin Complexed With
3-Formylbenzimidamide
pdb|3A7W|A Chain A, Crystal Structure Of Trypsin Complexed With
(E)-4-((Tetrahydro-2h-
Pyran-2-Yloxyimino)methyl)benzimidamide (Soaking 4hours)
pdb|3A7X|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking
45seconds)
pdb|3A7Y|A Chain A, Crystal Structure Of Trypsin Complexed With
(E)-4-((1-Methylpiperidin-
3-Yloxyimino)methyl)benzimidamide (Soaking 2hours)
pdb|3A7Z|A Chain A, Crystal Structure Of Trypsin Complexed With
(E)-4-((1-Methylpiperidin-
4-Yloxyimino)methyl)benzimidamide (Soaking 3hours)
pdb|3A80|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)-2-Methylpropanoic Acid
(Soaking 40seconds)
pdb|3A81|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 8
Hours)
pdb|3A82|A Chain A, Crystal Structure Of Trypsin Complexed With
Pre-Synthesized (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid
pdb|3A83|A Chain A, Crystal Structure Of Trypsin Complexed With
Pre-Synthesized (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide
pdb|3A84|A Chain A, Crystal Structure Of Trypsin Complexed With(E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking 5
Seconds)
pdb|3A85|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking 15
Seconds)
pdb|3A86|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking 30
Seconds)
pdb|3A87|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 5
Minutes)
pdb|3A88|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 30
Minutes)
pdb|3A89|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 4
Hours)
pdb|3A8A|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Formylbenzimidamide And Aniline
pdb|3A8B|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((4-
Bromophenylimino)methyl)benzimidamide
pdb|3A8C|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking
With Mixture Of
[(E)-2-(4-Carbamimidoylbenzylideneaminooxy)acetic Acid]
And [(E)-2-
(4-Carbamimidoylbenzylideneaminooxy)-2-Methylpropanoic
Acid])
pdb|3A8D|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Under
Aniline-Free Condition)
pdb|3LJJ|A Chain A, Bovine Trypsin In Complex With Ub-Thr 10
pdb|3LJO|A Chain A, Bovine Trypsin In Complex With Ub-Thr 11
pdb|2XTT|B Chain B, Bovine Trypsin In Complex With Evolutionary Enhanced
Schistocerca Gregaria Protease Inhibitor 1 (Sgpi-1-P02)
pdb|3NK8|A Chain A, Trypsin In Complex With Fluorine-Containing Fragment
pdb|3NKK|A Chain A, Trypsin In Complex With Fluorine Containing Fragment
pdb|3M7Q|A Chain A, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Pancreatic Trypsin
pdb|3RDZ|A Chain A, Crystal Structure Of Rbti-Trypsin Complex At 2.26 Angstrom
Resolution
pdb|3RDZ|B Chain B, Crystal Structure Of Rbti-Trypsin Complex At 2.26 Angstrom
Resolution
pdb|3ATI|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamine
pdb|3ATK|A Chain A, Crystal Structure Of Trypsin Complexed With
Cycloheptanamine
pdb|3ATL|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamidine
pdb|3ATM|A Chain A, Crystal Structure Of Trypsin Complexed With
2-(1h-Indol-3-Yl) Ethanamine
pdb|3RXA|A Chain A, Crystal Structure Of Trypsin Complexed With
Cycloheptanamine
pdb|3RXB|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Guanidinobutanoic Acid
pdb|3RXC|A Chain A, Crystal Structure Of Trypsin Complexed With
2-Aminopyridine
pdb|3RXD|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamine
pdb|3RXE|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide
pdb|3RXF|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Aminopyridine
pdb|3RXG|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Aminocyclohexanol
pdb|3RXH|A Chain A, Crystal Structure Of Trypsin Complexed With
2-(1h-Imidazol-4-Yl) Ethanamine
pdb|3RXI|A Chain A, Crystal Structure Of Trypsin Complexed With
2-(1h-Indol-3-Yl) Ethanamine
pdb|3RXJ|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Guanidinobenzoic Acid
pdb|3RXK|A Chain A, Crystal Structure Of Trypsin Complexed With Methyl
4-Amino-1-Methyl- Pyrrolidine-2-Carboxylate
pdb|3RXL|A Chain A, Crystal Structure Of Trypsin Complexed With
(2,5-Dimethyl-3-Furyl) Methanamine
pdb|3RXM|A Chain A, Crystal Structure Of Trypsin Complexed With
[2-(2-Thienyl)thiazol-4- Yl]methanamine
pdb|3RXO|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Pyrrol-1-Ylphenyl) Methanamine
pdb|3RXP|A Chain A, Crystal Structure Of Trypsin Complexed With
(1,5-Dimethylpyrazol-3- Yl)methanamine
pdb|3RXQ|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide (F01
And F05, Cocktail Experiment)
pdb|3RXR|A Chain A, Crystal Structure Of Trypsin Complexed With
Cycloheptanamine (F01 And F03, Cocktail Experiment)
pdb|3RXS|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamine (F04 And A06, Cocktail
Experiment)
pdb|3RXT|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamin (F04 And F03, Cocktail
Experiment)
pdb|3RXU|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide (F05
And A06, Cocktail Experiment)
pdb|3RXV|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide (F05
And F03, Cocktail Experiment)
pdb|3T25|A Chain A, Tmao-Grown Orthorhombic Trypsin (Bovine)
pdb|3T26|A Chain A, Orthorhombic Trypsin (Bovine) In The Presence Of Sarcosine
pdb|3T27|A Chain A, Orthorhombic Trypsin (Bovine) In The Presence Of Betaine
pdb|3T28|A Chain A, Tmao-Grown Trypsin (Bovine)-Previously Unreported
Tetragonal Crystal Form
pdb|3T29|A Chain A, Tmao-Grown Trigonal Trypsin (Bovine)
pdb|4AB8|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4AB9|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABA|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABB|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABD|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABE|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABF|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABG|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABH|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABI|A Chain A, Co-Complex Structure Of Bovine Trypsin With A Modified
Bowman-Birk Inhibitor (Pta)sfti-1(1,14), That Was 1,4-
Disubstituted With A 1,2,3-Trizol To Mimic A Trans Amide
Bond
pdb|4ABJ|A Chain A, Co-Complex Structure Of Bovine Trypsin With A Modified
Bowman-Birk Inhibitor (Ica)sfti-1(1,14), That Was 1,5-
Disubstituted With 1,2,3-Trizol To Mimic A Cis Amide
Bond
pdb|3VPK|A Chain A, Crystal Structure Of 6-guanidinohexanoyl Trypsin
pdb|3UNR|A Chain A, Bond Length Analysis Of Asp, Glu And His Residues In
Trypsin At 1.2a Resolution
pdb|3RU4|T Chain T, Crystal Structure Of The Bowman-Birk Serine Protease
Inhibitor Btci In Complex With Trypsin And Chymotrypsin
pdb|1C1S|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|4I8G|A Chain A, Bovine Trypsin At 0.8 Resolution
pdb|4I8H|A Chain A, Bovine Trypsin At 0.75 Resolution
pdb|4I8J|A Chain A, Bovine Trypsin At 0.87 A Resolution
pdb|4I8K|A Chain A, Bovine Trypsin At 0.85 Resolution
pdb|4I8L|A Chain A, Bovine Trypsin At 0.87 Resolution
pdb|4AOQ|A Chain A, Cationic Trypsin In Complex With Mutated Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii) (f14a)
pdb|4AOQ|B Chain B, Cationic Trypsin In Complex With Mutated Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii) (f14a)
pdb|4AOQ|C Chain C, Cationic Trypsin In Complex With Mutated Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii) (f14a)
pdb|4AOR|A Chain A, Cationic Trypsin In Complex With The Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii)
pdb|4AOR|B Chain B, Cationic Trypsin In Complex With The Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii)
pdb|4AOR|C Chain C, Cationic Trypsin In Complex With The Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii)
Length = 223
Score = 129 bits (323), Expect = 9e-30, Method: Compositional matrix adjust.
Identities = 82/244 (33%), Positives = 119/244 (48%), Gaps = 24/244 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+ P+ +L G F C G LI+ QWV++AAHC +G+ + +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF---CGGSLINSQWVVSAAHCY--KSGIQVRLGEDNI 55
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
V N ++ V H YN +NDI L +LK N + + LP
Sbjct: 56 NVVEGNEQFISASKSIV-----HPSYN-SNTLNNDIMLIKLKSAASLNSRVASISLPTS- 108
Query: 769 YELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVCA 828
+ GT+C + GWG + + S Y + ++ PI++ C + +T M CA
Sbjct: 109 -CASAGTQCLISGWGNTKSSGTS-YPDVLKCLKAPILSDSSCKSAYPGQ---ITSNMFCA 163
Query: 829 GYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTWI 888
GY EGGKD+CQGDSGGP++C + GIVSWG CA + PGVY V YV+WI
Sbjct: 164 GYLEGGKDSCQGDSGGPVVCSGK-------LQGIVSWGSGCAQKNKPGVYTKVCNYVSWI 216
Query: 889 QDIM 892
+ +
Sbjct: 217 KQTI 220
>pdb|1TFX|A Chain A, Complex Of The Second Kunitz Domain Of Tissue Factor
Pathway Inhibitor With Porcine Trypsin
pdb|1TFX|B Chain B, Complex Of The Second Kunitz Domain Of Tissue Factor
Pathway Inhibitor With Porcine Trypsin
pdb|1LDT|T Chain T, Complex Of Leech-Derived Tryptase Inhibitor With Porcine
Trypsin
pdb|1AVW|A Chain A, Complex Porcine Pancreatic TrypsinSOYBEAN TRYPSIN
Inhibitor, Orthorhombic Crystal Form
pdb|1AVX|A Chain A, Complex Porcine Pancreatic TrypsinSOYBEAN TRYPSIN
Inhibitor, Tetragonal Crystal Form
pdb|1EJA|A Chain A, Structure Of Porcine Trypsin Complexed With Bdellastasin,
An Antistasin-Type Inhibitor
pdb|1S5S|A Chain A, Porcine Trypsin Complexed With Guanidine-3-Propanol
Inhibitor
pdb|1S6F|A Chain A, Porcine Trypsin Covalent Complex With Borate And
Guanidine- 3 Inhibitor
pdb|1S6H|A Chain A, Porcine Trypsin Complexed With Guanidine-3-Propanol
Inhibitor
pdb|1S81|A Chain A, Porcine Trypsin With No Inhibitor Bound
pdb|1S82|A Chain A, Porcine Trypsin Complexed With Borate And Ethylene Glycol
pdb|1S83|A Chain A, Porcine Trypsin Complexed With 4-amino Propanol
pdb|1S84|A Chain A, Porcine Trypsin Covalent Complex With 4-Amino Butanol,
Borate And Ethylene Glycol
pdb|1S85|A Chain A, Porcine Trypsin Complexed With P-Hydroxymethyl Benzamidine
And Borate
pdb|1H9I|E Chain E, Complex Of Eeti-Ii Mutant With Porcine Trypsin
pdb|1V6D|A Chain A, The Crystal Structure Of The Trypsin Complex With
Synthetic Heterochiral Peptide
pdb|1TX6|A Chain A, Trypsin:bbi Complex
pdb|1TX6|B Chain B, Trypsin:bbi Complex
pdb|1TX6|C Chain C, Trypsin:bbi Complex
pdb|1TX6|D Chain D, Trypsin:bbi Complex
pdb|1Z7K|A Chain A, Crystal Structure Of Trypsin- Ovomucoid Turkey Egg White
Inhibitor Complex
pdb|1YF4|A Chain A, Crystal Structure Of Trypsin-Vasopressin Complex
Length = 223
Score = 129 bits (323), Expect = 9e-30, Method: Compositional matrix adjust.
Identities = 81/244 (33%), Positives = 118/244 (48%), Gaps = 24/244 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+ P+ +L G F C G LI+ QWV++AAHC + + + E +
Sbjct: 1 IVGGYTCAANSIPYQVSLNSGSHF---CGGSLINSQWVVSAAHCYKSRIQVRLGEHNID- 56
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
V N + + H +N G DNDI L +L N + V LP
Sbjct: 57 -VLEGNEQFINAAK-----IITHPNFN-GNTLDNDIMLIKLSSPATLNSRVATVSLPRS- 108
Query: 769 YELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVCA 828
A GT C + GWG + + S Y + + ++ P+++ C ++ +T M+C
Sbjct: 109 -CAAAGTECLISGWGNTKSSG-SSYPSLLQCLKAPVLSDSSCK---SSYPGQITGNMICV 163
Query: 829 GYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTWI 888
G+ EGGKD+CQGDSGGP++C + GIVSWG CA + PGVY V YV WI
Sbjct: 164 GFLEGGKDSCQGDSGGPVVCNGQ-------LQGIVSWGYGCAQKNKPGVYTKVCNYVNWI 216
Query: 889 QDIM 892
Q +
Sbjct: 217 QQTI 220
>pdb|2OD3|B Chain B, Human Thrombin Chimera With Human Residues 184a, 186,
186a, 186b, 186c And 222 Replaced By Murine Thrombin
Equivalents
Length = 259
Score = 129 bits (323), Expect = 9e-30, Method: Compositional matrix adjust.
Identities = 85/265 (32%), Positives = 130/265 (49%), Gaps = 24/265 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCV------GNLTGLNID 702
I+ G ++ G P+ L C LISD+WVLTAAHC+ N T ++
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL- 59
Query: 703 EWTVQLGVTRRNSYAFFGTRFK-VRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLP 761
V++G R Y + + ++ H +YN D DIAL +LK+ V F+D++ P
Sbjct: 60 --LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 762 VCLPPPNYE---LAPGTRCTVIGWGKREDTRVSEYE----TAVNEVEVPIITRDICNKWL 814
VCLP L G + V GWG ++T + + + V +PI+ R +C
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK--- 174
Query: 815 NNRELNVTLGMVCAGYPEGGK---DACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAH 871
++ + +T M CAG+ DAC+GDSGGP + +S N +W+ GIVSWG C
Sbjct: 175 DSTRIRITDNMFCAGFKVNDTKRGDACEGDSGGPFVMKSPFN-NRWYQMGIVSWGEGCDR 233
Query: 872 PHLPGVYAYVPKYVTWIQDIMDKYS 896
G Y +V + WIQ ++D++
Sbjct: 234 KGKYGFYTHVFRLKKWIQKVIDQFG 258
>pdb|3MYW|A Chain A, The Bowman-Birk Type Inhibitor From Mung Bean In Ternary
Complex With Porcine Trypsin
pdb|3MYW|B Chain B, The Bowman-Birk Type Inhibitor From Mung Bean In Ternary
Complex With Porcine Trypsin
Length = 223
Score = 129 bits (323), Expect = 1e-29, Method: Compositional matrix adjust.
Identities = 81/244 (33%), Positives = 117/244 (47%), Gaps = 24/244 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+ P+ +L G F C G LI+ QWV++AAHC + + + E +
Sbjct: 1 IVGGYTCAANSVPYQVSLNSGSHF---CGGSLINSQWVVSAAHCYKSRIQVRLGEHNID- 56
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
V N + + H +N G DNDI L +L N + V LP
Sbjct: 57 -VLEGNEQFINAAK-----IITHPNFN-GNTLDNDIMLIKLSSPATLNSRVATVSLPRS- 108
Query: 769 YELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVCA 828
A GT C + GWG + + S Y + + ++ P+++ C + +T M+C
Sbjct: 109 -CAAAGTECLISGWGNTKSSG-SSYPSLLQCLKAPVLSDSSCKSAYPGQ---ITGNMICV 163
Query: 829 GYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTWI 888
G+ EGGKD+CQGDSGGP++C + GIVSWG CA + PGVY V YV WI
Sbjct: 164 GFLEGGKDSCQGDSGGPVVCNGQ-------LQGIVSWGYGCAQKNKPGVYTKVCNYVNWI 216
Query: 889 QDIM 892
Q +
Sbjct: 217 QQTI 220
>pdb|1OPH|B Chain B, Non-Covalent Complex Between Alpha-1-Pi-Pittsburgh And
S195a Trypsin
Length = 243
Score = 128 bits (322), Expect = 1e-29, Method: Compositional matrix adjust.
Identities = 81/245 (33%), Positives = 120/245 (48%), Gaps = 24/245 (9%)
Query: 648 RIIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQ 707
+I+GG+ P+ +L G F C G LI+ QWV++AAHC +G+ +
Sbjct: 20 KIVGGYTCGANTVPYQVSLNSGYHF---CGGSLINSQWVVSAAHCY--KSGIQVRLGEDN 74
Query: 708 LGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPP 767
+ V N ++ V H YN +NDI L +LK N + + LP
Sbjct: 75 INVVEGNEQFISASKSIV-----HPSYN-SNTLNNDIMLIKLKSAASLNSRVASISLPTS 128
Query: 768 NYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVC 827
+ GT+C + GWG + + S Y + ++ PI++ C + +T M C
Sbjct: 129 C--ASAGTQCLISGWGNTKSSGTS-YPDVLKCLKAPILSDSSCKSAYPGQ---ITSNMFC 182
Query: 828 AGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTW 887
AGY EGGKD+CQGD+GGP++C + GIVSWG CA + PGVY V YV+W
Sbjct: 183 AGYLEGGKDSCQGDAGGPVVCSGK-------LQGIVSWGSGCAQKNKPGVYTKVCNYVSW 235
Query: 888 IQDIM 892
I+ +
Sbjct: 236 IKQTI 240
>pdb|1MCT|A Chain A, The Refined 1.6 Angstroms Resolution Crystal Structure Of
The Complex Formed Between Porcine Beta-trypsin And
Mcti-a, A Trypsin Inhibitor Of Squash Family
pdb|1QQU|A Chain A, Crystal Structure Of Porcine Beta Trypsin With Bound
Acetate Ion
pdb|1FMG|A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.04%
Polydocanol
pdb|1FN6|A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.1%
Polydocanol
pdb|1FNI|A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01%
Polydocanol
Length = 223
Score = 128 bits (322), Expect = 1e-29, Method: Compositional matrix adjust.
Identities = 80/244 (32%), Positives = 117/244 (47%), Gaps = 24/244 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+ P+ +L G F C G LI+ QWV++AAHC + + + E +
Sbjct: 1 IVGGYTCAANSIPYQVSLNSGSHF---CGGSLINSQWVVSAAHCYKSRIQVRLGEHNID- 56
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
V N + + H +N G DNDI L +L N + V LP
Sbjct: 57 -VLEGNEQFINAAK-----IITHPNFN-GNTLDNDIMLIKLSSPATLNSRVATVSLPRS- 108
Query: 769 YELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVCA 828
A GT C + GWG + + S Y + + ++ P+++ C + +T M+C
Sbjct: 109 -CAAAGTECLISGWGNTKSSG-SSYPSLLQCLKAPVLSNSSCKS---SYPGQITGNMICV 163
Query: 829 GYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTWI 888
G+ +GGKD+CQGDSGGP++C + GIVSWG CA + PGVY V YV WI
Sbjct: 164 GFLQGGKDSCQGDSGGPVVCNGQ-------LQGIVSWGYGCAQKNKPGVYTKVCNYVNWI 216
Query: 889 QDIM 892
Q +
Sbjct: 217 QQTI 220
>pdb|2PGB|B Chain B, Inhibitor-Free Human Thrombin Mutant C191a-C220a
pdb|2PGQ|B Chain B, Human Thrombin Mutant C191a-C220a In Complex With The
Inhibitor Ppack
Length = 259
Score = 128 bits (322), Expect = 1e-29, Method: Compositional matrix adjust.
Identities = 87/265 (32%), Positives = 132/265 (49%), Gaps = 24/265 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCV------GNLTGLNID 702
I+ G ++ G P+ L C LISD+WVLTAAHC+ N T ++
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL- 59
Query: 703 EWTVQLGVTRRNSYAFFGTRFK-VRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLP 761
V++G R Y + + ++ H +YN D DIAL +LK+ V F+D++ P
Sbjct: 60 --LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 762 VCLPPPNYE---LAPGTRCTVIGWGKREDTRVSEY----ETAVNEVEVPIITRDICNKWL 814
VCLP L G + V GWG ++T + + + V +PI+ R +C
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK--- 174
Query: 815 NNRELNVTLGMVCAGY-PEGGK--DACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAH 871
++ + +T M CAGY P+ GK DA +GDSGGP + +S N +W+ GIVSWG
Sbjct: 175 DSTRIRITDNMFCAGYKPDEGKRGDAAEGDSGGPFVMKSPFN-NRWYQMGIVSWGEGADR 233
Query: 872 PHLPGVYAYVPKYVTWIQDIMDKYS 896
G Y +V + WIQ ++D++
Sbjct: 234 DGKYGFYTHVFRLKKWIQKVIDQFG 258
>pdb|3EDX|B Chain B, Crystal Structure Of The W215aE217A MUTANT OF MURINE
THROMBIN
pdb|3EDX|D Chain D, Crystal Structure Of The W215aE217A MUTANT OF MURINE
THROMBIN
pdb|3EDX|F Chain F, Crystal Structure Of The W215aE217A MUTANT OF MURINE
THROMBIN
pdb|3HK3|B Chain B, Crystal Structure Of Murine Thrombin Mutant W215aE217A
(ONE Molecule In The Asymmetric Unit)
pdb|3HK6|B Chain B, Crystal Structure Of Murine Thrombin Mutant W215aE217A
(TWO Molecules In The Asymmetric Unit)
pdb|3HK6|D Chain D, Crystal Structure Of Murine Thrombin Mutant W215aE217A
(TWO Molecules In The Asymmetric Unit)
pdb|3HKI|B Chain B, Crystal Structure Of Murine Thrombin Mutant W215a/e217a In
Complex With The Extracellular Fragment Of Human Par1
pdb|3HKI|E Chain E, Crystal Structure Of Murine Thrombin Mutant W215a/e217a In
Complex With The Extracellular Fragment Of Human Par1
Length = 258
Score = 128 bits (321), Expect = 2e-29, Method: Compositional matrix adjust.
Identities = 86/269 (31%), Positives = 131/269 (48%), Gaps = 32/269 (11%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCV------GNLTGLNID 702
I+ G+++ G P+ L C LISD+WVLTAAHC+ N T ++
Sbjct: 1 IVEGWDAEKGIAPWQVMLFRKSPQELLCGASLISDRWVLTAAHCILYPPWDKNFTENDL- 59
Query: 703 EWTVQLGVTRRNSYAFFGTRFK-VRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLP 761
V++G R Y + + ++ H +YN D DIAL +LK+ V F+D++ P
Sbjct: 60 --LVRIGKHSRTRYERNVEKISMLEKIYVHPRYNWRENLDRDIALLKLKKPVPFSDYIHP 117
Query: 762 VCLPPPNYE---LAPGTRCTVIGWGKREDTRVSEYETAVNEVE--------VPIITRDIC 810
VCLP L G + V GWG +T + T +NE++ +PI+ R +C
Sbjct: 118 VCLPDKQTVTSLLRAGYKGRVTGWGNLRET----WTTNINEIQPSVLQVVNLPIVERPVC 173
Query: 811 NKWLNNRELNVTLGMVCAGYPEGGK---DACQGDSGGPLLCRSSHNFEQWFVGGIVSWGI 867
+ + +T M CAG+ DAC+GDSGGP + +S N +W+ GIVS G
Sbjct: 174 KA---STRIRITDNMFCAGFKVNDTKRGDACEGDSGGPFVMKSPFN-NRWYQMGIVSAGA 229
Query: 868 KCAHPHLPGVYAYVPKYVTWIQDIMDKYS 896
C G Y +V + WIQ ++D++
Sbjct: 230 GCDRKGKYGFYTHVFRLKRWIQKVIDQFG 258
>pdb|3TGJ|E Chain E, S195a Trypsinogen Complexed With Bovine Pancreatic Trypsin
Inhibitor (Bpti)
Length = 233
Score = 128 bits (321), Expect = 2e-29, Method: Compositional matrix adjust.
Identities = 85/246 (34%), Positives = 120/246 (48%), Gaps = 26/246 (10%)
Query: 648 RIIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQ 707
+I+GG+ P+ +L G F C G LI+DQWV++AAHC + + + E +
Sbjct: 10 KIVGGYTCQENSVPYQVSLNSGYHF---CGGSLINDQWVVSAAHCYKSRIQVRLGEHNIN 66
Query: 708 LGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPP 767
V N + F N NDI L +L VK N + V LP
Sbjct: 67 --VLEGNEQFVNAAKIIKHPNFDRKTLN------NDIMLIKLSSPVKLNARVATVALPS- 117
Query: 768 NYELAP-GTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMV 826
AP GT+C + GWG + V+E + + ++ P++ + C + +T MV
Sbjct: 118 --SCAPAGTQCLISGWGNTLSSGVNEPDL-LQCLDAPLLPQADCEASYPGK---ITDNMV 171
Query: 827 CAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVT 886
C G+ EGGKD+CQGD+GGP++C + GIVSWG CA P PGVY V YV
Sbjct: 172 CVGFLEGGKDSCQGDAGGPVVCNGE-------LQGIVSWGYGCALPDNPGVYTKVCNYVD 224
Query: 887 WIQDIM 892
WIQD +
Sbjct: 225 WIQDTI 230
>pdb|1F7Z|A Chain A, Rat Trypsinogen K15a Complexed With Bovine Pancreatic
Trypsin Inhibitor
Length = 233
Score = 127 bits (320), Expect = 2e-29, Method: Compositional matrix adjust.
Identities = 86/245 (35%), Positives = 119/245 (48%), Gaps = 26/245 (10%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+ P+ +L G F C G LI+DQWV++AAHC + + + E +
Sbjct: 11 IVGGYTCQENSVPYQVSLNSGYHF---CGGSLINDQWVVSAAHCYKSRIQVRLGEHNIN- 66
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
V N + F N NDI L +L VK N + V LP
Sbjct: 67 -VLEGNEQFVNAAKIIKHPNFDRKTLN------NDIMLIKLSSPVKLNARVATVALPS-- 117
Query: 769 YELAP-GTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVC 827
AP GT+C + GWG + V+E + + ++ P++ + C + +T MVC
Sbjct: 118 -SCAPAGTQCLISGWGNTLSSGVNEPDL-LQCLDAPLLPQADCEASYPGK---ITDNMVC 172
Query: 828 AGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTW 887
G+ EGGKD+CQGDSGGP++C + GIVSWG CA P PGVY V YV W
Sbjct: 173 VGFLEGGKDSCQGDSGGPVVCNGE-------LQGIVSWGYGCALPDNPGVYTKVCNYVDW 225
Query: 888 IQDIM 892
IQD +
Sbjct: 226 IQDTI 230
>pdb|2A31|A Chain A, Trypsin In Complex With Borate
pdb|2A32|A Chain A, Trypsin In Complex With Benzene Boronic Acid
Length = 223
Score = 127 bits (319), Expect = 3e-29, Method: Compositional matrix adjust.
Identities = 80/243 (32%), Positives = 117/243 (48%), Gaps = 24/243 (9%)
Query: 650 IGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQLG 709
+GG+ P+ +L G F C G LI+ QWV++AAHC + + + E +
Sbjct: 2 VGGYTCAANSIPYQVSLNSGSHF---CGGSLINSQWVVSAAHCYKSRIQVRLGEHNID-- 56
Query: 710 VTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPNY 769
V N + + H +N G DNDI L +L N + V LP
Sbjct: 57 VLEGNEQFINAAK-----IITHPNFN-GNTLDNDIMLIKLSSPATLNSRVATVSLPRS-- 108
Query: 770 ELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVCAG 829
A GT C + GWG + + S Y + + ++ P+++ C ++ +T M+C G
Sbjct: 109 CAAAGTECLISGWGNTKSSG-SSYPSLLQCLKAPVLSDSSCK---SSYPGQITGNMICVG 164
Query: 830 YPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTWIQ 889
+ EGGKD+CQGDSGGP++C + GIVSWG CA + PGVY V YV WIQ
Sbjct: 165 FLEGGKDSCQGDSGGPVVCNGQ-------LQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQ 217
Query: 890 DIM 892
+
Sbjct: 218 QTI 220
>pdb|3TGI|E Chain E, Wild-Type Rat Anionic Trypsin Complexed With Bovine
Pancreatic Trypsin Inhibitor (Bpti)
pdb|1ANE|A Chain A, Anionic Trypsin Wild Type
pdb|3FP6|E Chain E, Anionic Trypsin In Complex With Bovine Pancreatic Trypsin
Inhibitor (Bpti) Determined To The 1.49 A Resolution
Limit
Length = 223
Score = 127 bits (319), Expect = 3e-29, Method: Compositional matrix adjust.
Identities = 86/245 (35%), Positives = 119/245 (48%), Gaps = 26/245 (10%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+ P+ +L G F C G LI+DQWV++AAHC + + + E +
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGYHF---CGGSLINDQWVVSAAHCYKSRIQVRLGEHNIN- 56
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
V N + F N NDI L +L VK N + V LP
Sbjct: 57 -VLEGNEQFVNAAKIIKHPNFDRKTLN------NDIMLIKLSSPVKLNARVATVALPS-- 107
Query: 769 YELAP-GTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVC 827
AP GT+C + GWG + V+E + + ++ P++ + C + +T MVC
Sbjct: 108 -SCAPAGTQCLISGWGNTLSSGVNEPDL-LQCLDAPLLPQADCEASYPGK---ITDNMVC 162
Query: 828 AGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTW 887
G+ EGGKD+CQGDSGGP++C + GIVSWG CA P PGVY V YV W
Sbjct: 163 VGFLEGGKDSCQGDSGGPVVCNGE-------LQGIVSWGYGCALPDNPGVYTKVCNYVDW 215
Query: 888 IQDIM 892
IQD +
Sbjct: 216 IQDTI 220
>pdb|4IGD|A Chain A, Crystal Structure Of The Zymogen Catalytic Region Of Human
Masp-1
Length = 406
Score = 127 bits (318), Expect = 3e-29, Method: Compositional matrix adjust.
Identities = 87/262 (33%), Positives = 123/262 (46%), Gaps = 25/262 (9%)
Query: 644 KARKRIIGGFESNPGDWPFLAAL--LGGPEFVFYCAGVLISDQWVLTAAHCVGNLTG--- 698
K +I G + G P++A L L G F C G L+ W++TAAHC+
Sbjct: 151 KLMAQIFNGRPAQKGTTPWIAMLSHLNGQPF---CGGSLLGSSWIVTAAHCLHQSLDPED 207
Query: 699 --------LNIDEWTVQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLK 750
L+ ++ + LG R V+ H QY+ +ND+AL +L
Sbjct: 208 PTLRDSDLLSPSDFKIILGKHWRLRSDENEQHLGVKHTTLHPQYDPNT-FENDVALVELL 266
Query: 751 QKVKFNDHLLPVCLPP-PNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDI 809
+ N ++P+CLP P E G V GWGK+ R E + E+E+PI+
Sbjct: 267 ESPVLNAFVMPICLPEGPQQE---GAMVIVSGWGKQFLQRFPE---TLMEIEIPIVDHST 320
Query: 810 CNKWLNNRELNVTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKC 869
C K + VT M+CAG EGGKDAC GDSGGP++ + QW++ G VSWG C
Sbjct: 321 CQKAYAPLKKKVTRDMICAGEKEGGKDACAGDSGGPMVTLNRER-GQWYLVGTVSWGDDC 379
Query: 870 AHPHLPGVYAYVPKYVTWIQDI 891
GVY+Y+ WIQ +
Sbjct: 380 GKKDRYGVYSYIHHNKDWIQRV 401
>pdb|5PTP|A Chain A, Structure Of Hydrolase (Serine Proteinase)
Length = 223
Score = 127 bits (318), Expect = 3e-29, Method: Compositional matrix adjust.
Identities = 81/244 (33%), Positives = 118/244 (48%), Gaps = 24/244 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+ P+ +L G F C G LI+ QWV++AAHC +G+ + +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF---CGGSLINSQWVVSAAHCY--KSGIQVRLGEDNI 55
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
V N ++ V H YN +NDI L +LK N + + LP
Sbjct: 56 NVVEGNEQFISASKSIV-----HPSYN-SNTLNNDIMLIKLKSAASLNSRVASISLPTS- 108
Query: 769 YELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVCA 828
+ GT+C + GWG + + S Y + ++ PI++ C + +T M CA
Sbjct: 109 -CASAGTQCLISGWGNTKSSGTS-YPDVLKCLKAPILSDSSCKSAYPGQ---ITSNMFCA 163
Query: 829 GYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTWI 888
GY EGGKD+CQGD GGP++C + GIVSWG CA + PGVY V YV+WI
Sbjct: 164 GYLEGGKDSCQGDXGGPVVCSGK-------LQGIVSWGSGCAQKNKPGVYTKVCNYVSWI 216
Query: 889 QDIM 892
+ +
Sbjct: 217 KQTI 220
>pdb|3OTJ|E Chain E, A Crystal Structure Of Trypsin Complexed With Bpti (Bovine
Pancreatic Trypsin Inhibitor) By X-RayNEUTRON JOINT
REFINEMENT
Length = 223
Score = 127 bits (318), Expect = 4e-29, Method: Compositional matrix adjust.
Identities = 81/243 (33%), Positives = 118/243 (48%), Gaps = 24/243 (9%)
Query: 650 IGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQLG 709
+GG+ P+ +L G F C G LI+ QWV++AAHC +G+ + +
Sbjct: 2 VGGYTCGANTVPYQVSLNSGYHF---CGGSLINSQWVVSAAHCY--KSGIQVRLGEDNIN 56
Query: 710 VTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPNY 769
V N ++ V H YN +NDI L +LK N + + LP
Sbjct: 57 VVEGNEQFISASKSIV-----HPSYN-SNTLNNDIMLIKLKSAASLNSRVASISLPTSC- 109
Query: 770 ELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVCAG 829
+ GT+C + GWG + + S Y + ++ PI++ C + +T M CAG
Sbjct: 110 -ASAGTQCLISGWGNTKSSGTS-YPDVLKCLKAPILSDSSCKSAYPGQ---ITSNMFCAG 164
Query: 830 YPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTWIQ 889
Y EGGKD+CQGDSGGP++C + GIVSWG CA + PGVY V YV+WI+
Sbjct: 165 YLEGGKDSCQGDSGGPVVCSGK-------LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIK 217
Query: 890 DIM 892
+
Sbjct: 218 QTI 220
>pdb|1V2N|T Chain T, Potent Factor Xa Inhibitor In Complex With Bovine Trypsin
Variant X(99175190)BT
Length = 223
Score = 127 bits (318), Expect = 4e-29, Method: Compositional matrix adjust.
Identities = 83/244 (34%), Positives = 119/244 (48%), Gaps = 24/244 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+ P+ +L G F C G LI+ QWV++AAHC +G+ + +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF---CGGSLINSQWVVSAAHCY--KSGIQVRLGEDNI 55
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
V N ++ V H YN ++NDI L +LK N + + LP
Sbjct: 56 NVVEGNEQFISASKSIV-----HPSYN-SETYNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 769 YELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVCA 828
+ GT+C + GWG + + S Y + ++ PI++ C +T M CA
Sbjct: 110 --ASAGTQCLISGWGNTKSSGTS-YPDVLKCLKAPILSDSSCKS---ASSFIITSNMFCA 163
Query: 829 GYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTWI 888
GY EGGKDACQGDSGGP++C + GIVSWG CA + PGVY V YV+WI
Sbjct: 164 GYLEGGKDACQGDSGGPVVCSGK-------LQGIVSWGSGCAQKNKPGVYTKVCNYVSWI 216
Query: 889 QDIM 892
+ +
Sbjct: 217 KQTI 220
>pdb|1V2K|T Chain T, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin Variant X(Triple.Glu)bt.D2
pdb|1V2L|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant
X(Triple.Glu)bt.D1
pdb|1V2M|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant
X(Triple.Glu)bt.A1
Length = 223
Score = 126 bits (317), Expect = 5e-29, Method: Compositional matrix adjust.
Identities = 83/244 (34%), Positives = 119/244 (48%), Gaps = 24/244 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+ P+ +L G F C G LI+ QWV++AAHC +G+ + +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF---CGGSLINSQWVVSAAHCY--KSGIQVRLGEDNI 55
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
V N ++ V H YN ++NDI L +LK N + + LP
Sbjct: 56 NVVEGNEQFISASKSIV-----HPSYN-SETYNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 769 YELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVCA 828
+ GT+C + GWG + + S Y + ++ PI++ C +T M CA
Sbjct: 110 --ASAGTQCLISGWGNTKSSGTS-YPDVLKCLKAPILSDSSCKS---ASSFIITSNMFCA 163
Query: 829 GYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTWI 888
GY EGGKDACQGDSGGP++C + GIVSWG CA + PGVY V YV+WI
Sbjct: 164 GYLEGGKDACQGDSGGPVVCSGK-------LQGIVSWGEGCAQKNKPGVYTKVCNYVSWI 216
Query: 889 QDIM 892
+ +
Sbjct: 217 KQTI 220
>pdb|1AN1|E Chain E, Leech-Derived Tryptase InhibitorTRYPSIN COMPLEX
pdb|1C9P|A Chain A, Complex Of Bdellastasin With Porcine Trypsin
Length = 223
Score = 126 bits (317), Expect = 5e-29, Method: Compositional matrix adjust.
Identities = 80/244 (32%), Positives = 117/244 (47%), Gaps = 24/244 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+ P+ +L G F C G LI+ QWV++AAHC + + + E +
Sbjct: 1 IVGGYTCAANSIPYQVSLNSGSHF---CGGSLINSQWVVSAAHCYKSRIQVRLGEHNID- 56
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
V N + + H +N G DNDI L +L + V LP
Sbjct: 57 -VLEGNEQFINAAK-----IITHPNFN-GNTLDNDIMLIKLSSPATLXSRVATVSLPRSC 109
Query: 769 YELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVCA 828
A GT C + GWG + + S Y + + ++ P+++ C ++ +T M+C
Sbjct: 110 --AAAGTECLISGWGNTKSSG-SSYPSLLQCLKAPVLSDSSCK---SSYPGQITGNMICV 163
Query: 829 GYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTWI 888
G+ EGGKD+CQGDSGGP++C + GIVSWG CA + PGVY V YV WI
Sbjct: 164 GFLEGGKDSCQGDSGGPVVCNGQ-------LQGIVSWGYGCAQKNKPGVYTKVCNYVNWI 216
Query: 889 QDIM 892
Q +
Sbjct: 217 QQTI 220
>pdb|3PMJ|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
pdb|3PLB|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
pdb|3PLP|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
pdb|3PM3|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 126 bits (317), Expect = 5e-29, Method: Compositional matrix adjust.
Identities = 82/244 (33%), Positives = 119/244 (48%), Gaps = 24/244 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+ P+ +L G F C G LI+ QWV++AAHC +G+ + +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF---CGGSLINSQWVVSAAHCY--KSGIQVRLGEDNI 55
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
V N ++ V H YN ++NDI L +LK N + + LP
Sbjct: 56 NVVEGNEQFISASKSIV-----HPSYN-SETYNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 769 YELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVCA 828
+ GT+C + GWG + + S Y + ++ PI++ C +T M CA
Sbjct: 110 --ASAGTQCLISGWGNTKSSGTS-YPDVLKCLKAPILSDSSCKS---ASSFIITSNMFCA 163
Query: 829 GYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTWI 888
GY EGGKDACQGDSGGP++C + GIVSWG CA + PG+Y V YV+WI
Sbjct: 164 GYLEGGKDACQGDSGGPVVCSGK-------LQGIVSWGSGCAQKNKPGIYTKVCNYVSWI 216
Query: 889 QDIM 892
+ +
Sbjct: 217 KQTI 220
>pdb|2FI4|E Chain E, Crystal Structure Of A Bpti Variant (Cys14->ser) In
Complex With Trypsin
pdb|2FTL|E Chain E, Crystal Structure Of Trypsin Complexed With Bpti At 100k
Length = 223
Score = 126 bits (316), Expect = 6e-29, Method: Compositional matrix adjust.
Identities = 81/244 (33%), Positives = 118/244 (48%), Gaps = 24/244 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+ P+ +L G F C G LI+ QWV++AAHC +G+ + +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF---CGGSLINSQWVVSAAHCY--KSGIQVRLGEDNI 55
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
V N ++ V H YN +NDI L +LK + + LP
Sbjct: 56 NVVEGNEQFISASKSIV-----HPSYN-SNTLNNDIMLIKLKSAASLXSRVASISLPTSC 109
Query: 769 YELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVCA 828
+ GT+C + GWG + + S Y + ++ PI++ C + +T M CA
Sbjct: 110 --ASAGTQCLISGWGNTKSSGTS-YPDVLKCLKAPILSDSSCKSAYPGQ---ITSNMFCA 163
Query: 829 GYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTWI 888
GY EGGKD+CQGDSGGP++C + GIVSWG CA + PGVY V YV+WI
Sbjct: 164 GYLEGGKDSCQGDSGGPVVCSGK-------LQGIVSWGSGCAQKNKPGVYTKVCNYVSWI 216
Query: 889 QDIM 892
+ +
Sbjct: 217 KQTI 220
>pdb|1ORF|A Chain A, The Oligomeric Structure Of Human Granzyme A Reveals The
Molecular Determinants Of Substrate Specificity
Length = 234
Score = 126 bits (316), Expect = 6e-29, Method: Compositional matrix adjust.
Identities = 87/246 (35%), Positives = 125/246 (50%), Gaps = 26/246 (10%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWT-VQ 707
IIGG E P P++ L + + CAG LI+ WVLTAAHC N+++ + V
Sbjct: 1 IIGGNEVTPHSRPYMVLLSLDRKTI--CAGALIAKDWVLTAAHC-------NLNKRSQVI 51
Query: 708 LGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPP 767
LG V+ F + Y+ A + D+ L QL +K K N ++ + LP
Sbjct: 52 LGAHSITREEPTKQIMLVKKEFPYPCYD-PATREGDLKLLQLTEKAKINKYVTILHLPKK 110
Query: 768 NYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGM-- 825
++ PGT C V GWG+ ++ + + + EVE+ II R +CN N+ N +GM
Sbjct: 111 GDDVKPGTMCQVAGWGRTHNS--ASWSDTLREVEITIIDRKVCND-RNHYNFNPVIGMNM 167
Query: 826 VCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGI--KCAHPHLPGVYAYVP- 882
VCAG GG+D+C GDSG PLLC G+ S+G+ KC P PGVY +
Sbjct: 168 VCAGSLRGGRDSCNGDSGSPLLCEGVFR-------GVTSFGLENKCGDPRGPGVYILLSK 220
Query: 883 KYVTWI 888
K++ WI
Sbjct: 221 KHLNWI 226
>pdb|3PWB|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Complex
With Small Molecule Inhibitor
pdb|3PWC|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Complex
With Small Molecule Inhibitor
pdb|3PYH|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Complex
With Small Molecule Inhibitor
pdb|3Q00|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Comlex
With Small Molecule Inhibitor
Length = 223
Score = 126 bits (316), Expect = 7e-29, Method: Compositional matrix adjust.
Identities = 82/244 (33%), Positives = 119/244 (48%), Gaps = 24/244 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+ P+ +L G F C G LI+ QWV++AAHC +G+ + +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF---CGGSLINSQWVVSAAHCY--KSGIQVRLGEDNI 55
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
V N ++ V H YN ++NDI L +LK N + + LP
Sbjct: 56 NVVEGNEQFISASKSIV-----HPSYN-SETYNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 769 YELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVCA 828
+ GT+C + GWG + + S Y + ++ PI++ C +T M CA
Sbjct: 110 --ASAGTQCLISGWGNTKSSGTS-YPDVLKCLKAPILSDSSCKS---ASSFIITSNMFCA 163
Query: 829 GYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTWI 888
GY EGGKDACQGDSGGP++C + GIVSWG CA + PG+Y V YV+WI
Sbjct: 164 GYLEGGKDACQGDSGGPVVCSGK-------LQGIVSWGEGCAQKNKPGIYTKVCNYVSWI 216
Query: 889 QDIM 892
+ +
Sbjct: 217 KQTI 220
>pdb|1K9O|E Chain E, Crystal Structure Of Michaelis Serpin-Trypsin Complex
pdb|1YKT|A Chain A, TrypsinBPTI COMPLEX MUTANT
pdb|1YLC|A Chain A, TrypsinBPTI COMPLEX MUTANT
pdb|1YLD|A Chain A, TrypsinBPTI COMPLEX MUTANT
pdb|3FP7|E Chain E, Anionic Trypsin Variant S195a In Complex With Bovine
Pancreatic Trypsin Inhibitor (Bpti) Cleaved At The
Scissile Bond (Lys15-Ala16) Determined To The 1.46 A
Resolution Limit
pdb|3FP8|E Chain E, Anionic Trypsin Variant S195a In Complex With Bovine
Pancreatic Trypsin Inhibitor (Bpti) Determined To The
1.46 A Resolution Limit
Length = 223
Score = 126 bits (316), Expect = 7e-29, Method: Compositional matrix adjust.
Identities = 85/245 (34%), Positives = 119/245 (48%), Gaps = 26/245 (10%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+ P+ +L G F C G LI+DQWV++AAHC + + + E +
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGYHF---CGGSLINDQWVVSAAHCYKSRIQVRLGEHNIN- 56
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
V N + F N NDI L +L VK N + V LP
Sbjct: 57 -VLEGNEQFVNAAKIIKHPNFDRKTLN------NDIMLIKLSSPVKLNARVATVALPS-- 107
Query: 769 YELAP-GTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVC 827
AP GT+C + GWG + V+E + + ++ P++ + C + +T MVC
Sbjct: 108 -SCAPAGTQCLISGWGNTLSSGVNEPDL-LQCLDAPLLPQADCEASYPGK---ITDNMVC 162
Query: 828 AGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTW 887
G+ EGGKD+CQGD+GGP++C + GIVSWG CA P PGVY V YV W
Sbjct: 163 VGFLEGGKDSCQGDAGGPVVCNGE-------LQGIVSWGYGCALPDNPGVYTKVCNYVDW 215
Query: 888 IQDIM 892
IQD +
Sbjct: 216 IQDTI 220
>pdb|4B1T|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
( Ta) In Complex With Eglin C
pdb|4B1T|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
( Ta) In Complex With Eglin C
Length = 223
Score = 125 bits (315), Expect = 8e-29, Method: Compositional matrix adjust.
Identities = 82/244 (33%), Positives = 119/244 (48%), Gaps = 24/244 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+ P+ +L G F C G LI+ QWV++AAHC +G+ + +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF---CGGSLINSQWVVSAAHCY--KSGIQVRLGEDNI 55
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
V N ++ V H YN ++NDI L +LK N + + LP
Sbjct: 56 NVVEGNEQFISASKSIV-----HPSYN-SETYNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 769 YELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVCA 828
+ GT+C + GWG + + S Y + ++ PI++ C +T M CA
Sbjct: 110 --ASAGTQCLISGWGNTKSSGTS-YPDVLKCLKAPILSDSSCKS---ASSFIITSNMFCA 163
Query: 829 GYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTWI 888
GY EGGKDACQGD+GGP++C + GIVSWG CA + PGVY V YV+WI
Sbjct: 164 GYLEGGKDACQGDAGGPVVCSGK-------LQGIVSWGSGCAQKNKPGVYTKVCNYVSWI 216
Query: 889 QDIM 892
+ +
Sbjct: 217 KQTI 220
>pdb|1ANB|A Chain A, Anionic Trypsin Mutant With Ser 214 Replaced By Glu
Length = 223
Score = 125 bits (315), Expect = 9e-29, Method: Compositional matrix adjust.
Identities = 85/245 (34%), Positives = 118/245 (48%), Gaps = 26/245 (10%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+ P+ +L G F C G LI+DQWV++AAHC + + + E +
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGYHF---CGGSLINDQWVVSAAHCYKSRIQVRLGEHNIN- 56
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
V N + F N NDI L +L VK N + V LP
Sbjct: 57 -VLEGNEQFVNAAKIIKHPNFDRKTLN------NDIMLIKLSSPVKLNARVATVALPS-- 107
Query: 769 YELAP-GTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVC 827
AP GT+C + GWG + V+E + + ++ P++ + C + +T MVC
Sbjct: 108 -SCAPAGTQCLISGWGNTLSSGVNEPDL-LQCLDAPLLPQADCEASYPGK---ITDNMVC 162
Query: 828 AGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTW 887
G+ EGGKD+CQGDSGGP++C + GIV WG CA P PGVY V YV W
Sbjct: 163 VGFLEGGKDSCQGDSGGPVVCNGE-------LQGIVEWGYGCALPDNPGVYTKVCNYVDW 215
Query: 888 IQDIM 892
IQD +
Sbjct: 216 IQDTI 220
>pdb|1ANC|A Chain A, Anionic Trypsin Mutant With Ser 214 Replaced By Lys
Length = 223
Score = 125 bits (315), Expect = 9e-29, Method: Compositional matrix adjust.
Identities = 85/245 (34%), Positives = 118/245 (48%), Gaps = 26/245 (10%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+ P+ +L G F C G LI+DQWV++AAHC + + + E +
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGYHF---CGGSLINDQWVVSAAHCYKSRIQVRLGEHNIN- 56
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
V N + F N NDI L +L VK N + V LP
Sbjct: 57 -VLEGNEQFVNAAKIIKHPNFDRKTLN------NDIMLIKLSSPVKLNARVATVALPS-- 107
Query: 769 YELAP-GTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVC 827
AP GT+C + GWG + V+E + + ++ P++ + C + +T MVC
Sbjct: 108 -SCAPAGTQCLISGWGNTLSSGVNEPDL-LQCLDAPLLPQADCEASYPGK---ITDNMVC 162
Query: 828 AGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTW 887
G+ EGGKD+CQGDSGGP++C + GIV WG CA P PGVY V YV W
Sbjct: 163 VGFLEGGKDSCQGDSGGPVVCNGE-------LQGIVKWGYGCALPDNPGVYTKVCNYVDW 215
Query: 888 IQDIM 892
IQD +
Sbjct: 216 IQDTI 220
>pdb|1FXY|A Chain A, Coagulation Factor Xa-Trypsin Chimera Inhibited With
D-Phe-Pro-Arg- Chloromethylketone
Length = 228
Score = 125 bits (314), Expect = 1e-28, Method: Compositional matrix adjust.
Identities = 79/246 (32%), Positives = 127/246 (51%), Gaps = 24/246 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+ G+ P+ ALL E +C G ++S+ ++LTAAHC+ + V++
Sbjct: 1 IVGGYNCKDGEVPW-QALLINEENEGFCGGTILSEFYILTAAHCL-----YQAKRFKVRV 54
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLP--P 766
G +V V H+++ +D DIA+ +LK + F ++ P LP P
Sbjct: 55 GDRNTEQEEGGEAVHEVEVVIKHNRFT-KETYDFDIAVLRLKTPITFRMNVAPASLPTAP 113
Query: 767 PNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMV 826
P A GT+C + GWG + ++Y + ++ P++++ C + +T M
Sbjct: 114 P----ATGTKCLISGWGNTASSG-ADYPDELQCLDAPVLSQAKCEASYPGK---ITSNMF 165
Query: 827 CAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVT 886
C G+ EGGKD+CQGDSGGP++C + G+VSWG CA + PGVY V YV
Sbjct: 166 CVGFLEGGKDSCQGDSGGPVVCNGQ-------LQGVVSWGDGCAQKNKPGVYTKVYNYVK 218
Query: 887 WIQDIM 892
WI++ +
Sbjct: 219 WIKNTI 224
>pdb|1TRM|A Chain A, The Three-Dimensional Structure Of Asn102 Mutant Of
Trypsin. Role Of Asp102 In Serine Protease Catalysis
pdb|1TRM|B Chain B, The Three-Dimensional Structure Of Asn102 Mutant Of
Trypsin. Role Of Asp102 In Serine Protease Catalysis
pdb|2TRM|A Chain A, The Three-Dimensional Structure Of Asn102 Mutant Of
Trypsin. Role Of Asp102 In Serine Protease Catalysis
Length = 223
Score = 125 bits (314), Expect = 1e-28, Method: Compositional matrix adjust.
Identities = 85/245 (34%), Positives = 119/245 (48%), Gaps = 26/245 (10%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+ P+ +L G F C G LI+DQWV++AAHC + + + E +
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGYHF---CGGSLINDQWVVSAAHCYKSRIQVRLGEHNIN- 56
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
V N + F N N+I L +L VK N + V LP
Sbjct: 57 -VLEGNEQFVNAAKIIKHPNFDRKTLN------NNIMLIKLSSPVKLNARVATVALPS-- 107
Query: 769 YELAP-GTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVC 827
AP GT+C + GWG + V+E + + ++ P++ + C + +T MVC
Sbjct: 108 -SCAPAGTQCLISGWGNTLSSGVNEPDL-LQCLDAPLLPQADCEASYPGK---ITDNMVC 162
Query: 828 AGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTW 887
G+ EGGKD+CQGDSGGP++C + GIVSWG CA P PGVY V YV W
Sbjct: 163 VGFLEGGKDSCQGDSGGPVVCNGE-------LQGIVSWGYGCALPDNPGVYTKVCNYVDW 215
Query: 888 IQDIM 892
IQD +
Sbjct: 216 IQDTI 220
>pdb|3PLK|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 125 bits (314), Expect = 1e-28, Method: Compositional matrix adjust.
Identities = 81/244 (33%), Positives = 119/244 (48%), Gaps = 24/244 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+ P+ +L G F C G L++ QWV++AAHC +G+ + +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF---CGGSLLNSQWVVSAAHCY--KSGIQVRLGEDNI 55
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
V N ++ V H YN ++NDI L +LK N + + LP
Sbjct: 56 NVVEGNEQFISASKSIV-----HPSYN-SETYNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 769 YELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVCA 828
+ GT+C + GWG + + S Y + ++ PI++ C +T M CA
Sbjct: 110 --ASAGTQCLISGWGNTKSSGTS-YPDVLKCLKAPILSDSSCKS---ASSFIITSNMFCA 163
Query: 829 GYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTWI 888
GY EGGKDACQGDSGGP++C + GIVSWG CA + PG+Y V YV+WI
Sbjct: 164 GYLEGGKDACQGDSGGPVVCSGK-------LQGIVSWGSGCAQKNKPGIYTKVCNYVSWI 216
Query: 889 QDIM 892
+ +
Sbjct: 217 KQTI 220
>pdb|4B2A|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tga) In Complex With Eglin C
pdb|4B2A|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tga) In Complex With Eglin C
Length = 223
Score = 125 bits (314), Expect = 1e-28, Method: Compositional matrix adjust.
Identities = 82/244 (33%), Positives = 119/244 (48%), Gaps = 24/244 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+ P+ +L G F C G LI+ QWV++AAHC +G+ + +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF---CGGSLINSQWVVSAAHCY--KSGIQVRLGEDNI 55
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
V N ++ V H YN ++NDI L +LK N + + LP
Sbjct: 56 NVVEGNEQFISASKSIV-----HPSYN-SETYNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 769 YELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVCA 828
+ GT+C + GWG + + S Y + ++ PI++ C +T M CA
Sbjct: 110 --ASAGTQCLISGWGNTKSSGTS-YPDVLKCLKAPILSDSSCKS---ASSFIITSNMFCA 163
Query: 829 GYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTWI 888
GY EGGKDACQGD+GGP++C + GIVSWG CA + PGVY V YV+WI
Sbjct: 164 GYLEGGKDACQGDAGGPVVCSGK-------LQGIVSWGEGCAQKNKPGVYTKVCNYVSWI 216
Query: 889 QDIM 892
+ +
Sbjct: 217 KQTI 220
>pdb|2RA3|A Chain A, Human Cationic Trypsin Complexed With Bovine Pancreatic
Trypsin Inhibitor (bpti)
pdb|2RA3|B Chain B, Human Cationic Trypsin Complexed With Bovine Pancreatic
Trypsin Inhibitor (bpti)
Length = 224
Score = 125 bits (314), Expect = 1e-28, Method: Compositional matrix adjust.
Identities = 77/246 (31%), Positives = 124/246 (50%), Gaps = 28/246 (11%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+ P+ +L G F C G LI++QWV++A HC + + + E +++
Sbjct: 1 IVGGYNCEENSVPYQVSLNSGYHF---CGGSLINEQWVVSAGHCYKSRIQVRLGEHNIEV 57
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLP--P 766
+ F +R H QY+ +NDI L +L + N H+ + LP P
Sbjct: 58 ---LEGNEQFINAAKIIR----HPQYDR-KTLNNDIMLIKLSSRAVINAHVSTISLPTAP 109
Query: 767 PNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMV 826
P A GT+C + GWG + ++Y + ++ P++++ C + +T M
Sbjct: 110 P----ATGTKCLISGWGNTASSG-ADYPDELQCLDAPVLSQAKCEASYPGK---ITSNMF 161
Query: 827 CAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVT 886
C G+ EGGKD+CQGD+GGP++C + G+VSWG CA + PGVY V YV
Sbjct: 162 CVGFLEGGKDSCQGDAGGPVVCNGQ-------LQGVVSWGDGCAQKNKPGVYTKVYNYVK 214
Query: 887 WIQDIM 892
WI++ +
Sbjct: 215 WIKNTI 220
>pdb|1F5R|A Chain A, Rat Trypsinogen Mutant Complexed With Bovine Pancreatic
Trypsin Inhibitor
Length = 231
Score = 125 bits (314), Expect = 1e-28, Method: Compositional matrix adjust.
Identities = 85/243 (34%), Positives = 117/243 (48%), Gaps = 26/243 (10%)
Query: 651 GGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQLGV 710
GG+ P+ +L G F C G LI+DQWV++AAHC + + + E + V
Sbjct: 11 GGYTCQENSVPYQVSLNSGYHF---CGGSLINDQWVVSAAHCYKSRIQVRLGEHNIN--V 65
Query: 711 TRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPNYE 770
N + F N NDI L +L VK N + V LP
Sbjct: 66 LEGNEQFVNAAKIIKHPNFDRKTLN------NDIMLIKLSSPVKLNARVATVALPS---S 116
Query: 771 LAP-GTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVCAG 829
AP GT+C + GWG + V+E + + ++ P++ + C + +T MVC G
Sbjct: 117 CAPAGTQCLISGWGNTLSSGVNEPDL-LKCLDAPLLPQADCEASYPGK---ITDNMVCVG 172
Query: 830 YPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTWIQ 889
+ EGGKD+CQGDSGGP++C + GIVSWG CA P PGVY V YV WIQ
Sbjct: 173 FLEGGKDSCQGDSGGPVVCNGE-------LQGIVSWGYGCALPDNPGVYTKVCNYVDWIQ 225
Query: 890 DIM 892
D +
Sbjct: 226 DTI 228
>pdb|1FY8|E Chain E, Crystal Structure Of The Deltaile16val17 Rat Anionic
Trypsinogen-Bpti Complex
Length = 231
Score = 125 bits (313), Expect = 1e-28, Method: Compositional matrix adjust.
Identities = 85/243 (34%), Positives = 117/243 (48%), Gaps = 26/243 (10%)
Query: 651 GGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQLGV 710
GG+ P+ +L G F C G LI+DQWV++AAHC + + + E + V
Sbjct: 11 GGYTCQENSVPYQVSLNSGYHF---CGGSLINDQWVVSAAHCYKSRIQVRLGEHNIN--V 65
Query: 711 TRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPNYE 770
N + F N NDI L +L VK N + V LP
Sbjct: 66 LEGNEQFVNAAKIIKHPNFDRKTLN------NDIMLIKLSSPVKLNARVATVALPS---S 116
Query: 771 LAP-GTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVCAG 829
AP GT+C + GWG + V+E + + ++ P++ + C + +T MVC G
Sbjct: 117 CAPAGTQCLISGWGNTLSSGVNEPDL-LQCLDAPLLPQADCEASYPGK---ITDNMVCVG 172
Query: 830 YPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTWIQ 889
+ EGGKD+CQGDSGGP++C + GIVSWG CA P PGVY V YV WIQ
Sbjct: 173 FLEGGKDSCQGDSGGPVVCNGE-------LQGIVSWGYGCALPDNPGVYTKVCNYVDWIQ 225
Query: 890 DIM 892
D +
Sbjct: 226 DTI 228
>pdb|2FI5|E Chain E, Crystal Structure Of A Bpti Variant (Cys38->ser) In
Complex With Trypsin
pdb|2FTM|A Chain A, Crystal Structure Of Trypsin Complexed With The Bpti
Variant (Tyr35- >gly)
Length = 224
Score = 125 bits (313), Expect = 1e-28, Method: Compositional matrix adjust.
Identities = 81/244 (33%), Positives = 118/244 (48%), Gaps = 23/244 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+ P+ +L G F C G LI+ QWV++AAHC +G+ + +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF---CGGSLINSQWVVSAAHCY--KSGIQVRLGEDNI 55
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
V N ++ V H YN +NDI L +LK D + + P
Sbjct: 56 NVVEGNEQFISASKSIV-----HPSYN-SNTLNNDIMLIKLKSAASLXDSRVAS-ISLPT 108
Query: 769 YELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVCA 828
+ GT+C + GWG + + S Y + ++ PI++ C + +T M CA
Sbjct: 109 SCASAGTQCLISGWGNTKSSGTS-YPDVLKCLKAPILSDSSCKSAYPGQ---ITSNMFCA 164
Query: 829 GYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTWI 888
GY EGGKD+CQGDSGGP++C + GIVSWG CA + PGVY V YV+WI
Sbjct: 165 GYLEGGKDSCQGDSGGPVVCSGK-------LQGIVSWGSGCAQKNKPGVYTKVCNYVSWI 217
Query: 889 QDIM 892
+ +
Sbjct: 218 KQTI 221
>pdb|1DPO|A Chain A, Structure Of Rat Trypsin
Length = 223
Score = 125 bits (313), Expect = 1e-28, Method: Compositional matrix adjust.
Identities = 85/245 (34%), Positives = 118/245 (48%), Gaps = 26/245 (10%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+ P+ +L G F C G LI+DQWV++AAHC + + + E +
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGYHF---CGGSLINDQWVVSAAHCYKSRIQVRLGEHNIN- 56
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
V N + F N NDI L +L VK N + V LP
Sbjct: 57 -VLEGNEQFVNAAKIIKHPNFDRKTLN------NDIMLIKLSSPVKLNARVATVALPS-- 107
Query: 769 YELAP-GTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVC 827
AP GT+C + GWG + V+E + + ++ P++ + C + +T MVC
Sbjct: 108 -SCAPAGTQCLISGWGNTLSSGVNEPDL-LQCLDAPLLPQADCEASYPGK---ITDNMVC 162
Query: 828 AGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTW 887
G+ EGGKD+CQGD GGP++C + GIVSWG CA P PGVY V YV W
Sbjct: 163 VGFLEGGKDSCQGDCGGPVVCNGE-------LQGIVSWGYGCALPDNPGVYTKVCNYVDW 215
Query: 888 IQDIM 892
IQD +
Sbjct: 216 IQDTI 220
>pdb|3UNS|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UOP|A Chain A, Bovine Trypsin Variant X(triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UQO|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 125 bits (313), Expect = 1e-28, Method: Compositional matrix adjust.
Identities = 82/244 (33%), Positives = 118/244 (48%), Gaps = 24/244 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+ P+ +L G F C G LI+ QWV++AAHC +G+ + +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF---CGGSLINSQWVVSAAHCY--KSGIQVRLGEDNI 55
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
V N ++ V H YN ++NDI L +LK N + + LP
Sbjct: 56 NVVEGNEQFISASKSIV-----HPSYN-SETYNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 769 YELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVCA 828
+ GT+C + GWG + + S Y + ++ PI++ C +T M CA
Sbjct: 110 --ASAGTQCLISGWGNTKSSGTS-YPDVLKCLKAPILSDSSCKS---ASSFIITSNMFCA 163
Query: 829 GYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTWI 888
GY EGGKDACQGDSGGP++C + GIVSWG CA + PG Y V YV+WI
Sbjct: 164 GYLEGGKDACQGDSGGPVVCSGK-------LQGIVSWGSGCAQKNKPGFYTKVCNYVSWI 216
Query: 889 QDIM 892
+ +
Sbjct: 217 KQTI 220
>pdb|1AMH|A Chain A, Uncomplexed Rat Trypsin Mutant With Asp 189 Replaced With
Ser (D189s)
pdb|1AMH|B Chain B, Uncomplexed Rat Trypsin Mutant With Asp 189 Replaced With
Ser (D189s)
Length = 223
Score = 125 bits (313), Expect = 1e-28, Method: Compositional matrix adjust.
Identities = 85/245 (34%), Positives = 118/245 (48%), Gaps = 26/245 (10%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+ P+ +L G F C G LI+DQWV++AAHC + + + E +
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGYHF---CGGSLINDQWVVSAAHCYKSRIQVRLGEHNIN- 56
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
V N + F N NDI L +L VK N + V LP
Sbjct: 57 -VLEGNEQFVNAAKIIKHPNFDRKTLN------NDIMLIKLSSPVKLNARVATVALPS-- 107
Query: 769 YELAP-GTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVC 827
AP GT+C + GWG + V+E + + ++ P++ + C + +T MVC
Sbjct: 108 -SCAPAGTQCLISGWGNTLSSGVNEPDL-LQCLDAPLLPQADCEASYPGK---ITDNMVC 162
Query: 828 AGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTW 887
G+ EGGK +CQGDSGGP++C + GIVSWG CA P PGVY V YV W
Sbjct: 163 VGFLEGGKSSCQGDSGGPVVCNGE-------LQGIVSWGYGCALPDNPGVYTKVCNYVDW 215
Query: 888 IQDIM 892
IQD +
Sbjct: 216 IQDTI 220
>pdb|1RTF|B Chain B, Complex Of Benzamidine With The Catalytic Domain Of Human
Two Chain Tissue Plasminogen Activator [(Tc)-T-Pa]
pdb|1A5H|A Chain A, Catalytic Domain Of Human Two-Chain Tissue Plasminogen
Activator Complex Of A Bis-Benzamidine
pdb|1A5H|B Chain B, Catalytic Domain Of Human Two-Chain Tissue Plasminogen
Activator Complex Of A Bis-Benzamidine
Length = 252
Score = 125 bits (313), Expect = 2e-28, Method: Compositional matrix adjust.
Identities = 92/259 (35%), Positives = 125/259 (48%), Gaps = 24/259 (9%)
Query: 649 IIGGFESNPGDWPFLAALLG----GPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEW 704
I GG ++ P+ AA+ P F C G+LIS W+L+AAHC
Sbjct: 1 IKGGLFADIASHPWQAAIFAKHRRSPGERFLCGGILISSCWILSAAHCFQER--FPPHHL 58
Query: 705 TVQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQK----VKFNDHLL 760
TV LG T R +F+V H +++ +DNDIAL QLK + + +
Sbjct: 59 TVILGRTYRVVPGEEEQKFEVEKYIVHKEFD-DDTYDNDIALLQLKSDSSRCAQESSVVR 117
Query: 761 PVCLPPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDIC-NKWLNNREL 819
VCLPP + +L T C + G+GK E Y + E V + C ++ L NR
Sbjct: 118 TVCLPPADLQLPDWTECELSGYGKHE-ALSPFYSERLKEAHVRLYPSSRCTSQHLLNR-- 174
Query: 820 NVTLGMVCAGYPEGG------KDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPH 873
VT M+CAG G DACQGDSGGPL+C N + + GI+SWG+ C
Sbjct: 175 TVTDNMLCAGDTRSGGPQANLHDACQGDSGGPLVCL---NDGRMTLVGIISWGLGCGQKD 231
Query: 874 LPGVYAYVPKYVTWIQDIM 892
+PGVY V Y+ WI+D M
Sbjct: 232 VPGVYTKVTNYLDWIRDNM 250
>pdb|1SLX|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin;
Zinc-Bound
pdb|1SLV|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin;
Copper- Bound
pdb|1SLU|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin
Length = 223
Score = 124 bits (312), Expect = 2e-28, Method: Compositional matrix adjust.
Identities = 85/245 (34%), Positives = 118/245 (48%), Gaps = 26/245 (10%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+ P+ +L G F C G LI+DQWV++AAHC + + + E +
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGYHF---CGGSLINDQWVVSAAHCYKSRIQVRLGEHNIN- 56
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
V N + F N NDI L +L VK N + V LP
Sbjct: 57 -VLEGNEQFVNAAKIIKHPNFDRKTLN------NDIMLIKLSSPVKLNARVATVALPS-- 107
Query: 769 YELAP-GTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVC 827
AP GT+C + GWG + V+ + + ++ P++ + C + +T MVC
Sbjct: 108 -SCAPAGTQCLISGWGHTLSSGVN-HPDLLQCLDAPLLPQADCEASYPGK---ITDNMVC 162
Query: 828 AGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTW 887
G+ EGGKD+CQGDSGGP++C + GIVSWG CA P PGVY V YV W
Sbjct: 163 VGFLEGGKDSCQGDSGGPVVCNGE-------LQGIVSWGYGCALPDNPGVYTKVCNYVDW 215
Query: 888 IQDIM 892
IQD +
Sbjct: 216 IQDTI 220
>pdb|1EZS|C Chain C, Crystal Structure Of Ecotin Mutant M84r, W67a, G68a, Y69a,
D70a Bound To Rat Anionic Trypsin Ii
pdb|1EZS|D Chain D, Crystal Structure Of Ecotin Mutant M84r, W67a, G68a, Y69a,
D70a Bound To Rat Anionic Trypsin Ii
pdb|1EZU|C Chain C, Ecotin Y69f, D70p Bound To D102n Trypsin
pdb|1EZU|D Chain D, Ecotin Y69f, D70p Bound To D102n Trypsin
Length = 223
Score = 124 bits (312), Expect = 2e-28, Method: Compositional matrix adjust.
Identities = 85/247 (34%), Positives = 122/247 (49%), Gaps = 30/247 (12%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+ P+ +L G F C G LI+DQWV++AAHC + +Q+
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGYHF---CGGSLINDQWVVSAAHCYKS---------RIQV 48
Query: 709 GVTRRNSYAFFGTRFKVRG--VFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPP 766
+ N G V + H ++ +N+I L +L VK N + V LP
Sbjct: 49 RLGEHNINVLEGDEQFVNAAKIIKHPNFDR-KTLNNNIMLIKLSSPVKLNARVATVALPS 107
Query: 767 PNYELAP-GTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGM 825
AP GT+C + GWG + V+E + + ++ P++ + C + +T M
Sbjct: 108 ---SCAPAGTQCLISGWGNTLSSGVNEPDL-LQCLDAPLLPQADCEASYPGK---ITDNM 160
Query: 826 VCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYV 885
VC G+ EGGKD+CQGDSGGP++C + GIVSWG CA P PGVY V YV
Sbjct: 161 VCVGFLEGGKDSCQGDSGGPVVCNGE-------LQGIVSWGYGCALPDNPGVYTKVCNYV 213
Query: 886 TWIQDIM 892
WIQD +
Sbjct: 214 DWIQDTI 220
>pdb|1SLW|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin;
Nickel- Bound
Length = 223
Score = 124 bits (311), Expect = 2e-28, Method: Compositional matrix adjust.
Identities = 84/245 (34%), Positives = 118/245 (48%), Gaps = 26/245 (10%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+ P+ +L G F C G LI+DQWV++AAHC + + + E +
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGYHF---CGGSLINDQWVVSAAHCYKSRIQVRLGEHNIN- 56
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
V N + F N NDI L +L VK N + + LP
Sbjct: 57 -VLEGNEQFVNAAKIIKHPNFDRKTLN------NDIMLIKLSSPVKLNARVATIALPS-- 107
Query: 769 YELAP-GTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVC 827
AP GT+C + GWG + V+ + + ++ P++ + C + +T MVC
Sbjct: 108 -SCAPAGTQCLISGWGHTLSSGVN-HPDLLQCLDAPLLPQADCEASYPGK---ITDNMVC 162
Query: 828 AGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTW 887
G+ EGGKD+CQGDSGGP++C + GIVSWG CA P PGVY V YV W
Sbjct: 163 VGFLEGGKDSCQGDSGGPVVCNGE-------LQGIVSWGYGCALPDNPGVYTKVCNYVDW 215
Query: 888 IQDIM 892
IQD +
Sbjct: 216 IQDTI 220
>pdb|1OP8|A Chain A, Crystal Structure Of Human Granzyme A
pdb|1OP8|B Chain B, Crystal Structure Of Human Granzyme A
pdb|1OP8|C Chain C, Crystal Structure Of Human Granzyme A
pdb|1OP8|D Chain D, Crystal Structure Of Human Granzyme A
pdb|1OP8|E Chain E, Crystal Structure Of Human Granzyme A
pdb|1OP8|F Chain F, Crystal Structure Of Human Granzyme A
Length = 234
Score = 124 bits (310), Expect = 3e-28, Method: Compositional matrix adjust.
Identities = 86/246 (34%), Positives = 124/246 (50%), Gaps = 26/246 (10%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWT-VQ 707
IIGG E P P++ L + + CAG LI+ WVLTAAHC N+++ + V
Sbjct: 1 IIGGNEVTPHSRPYMVLLSLDRKTI--CAGALIAKDWVLTAAHC-------NLNKRSQVI 51
Query: 708 LGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPP 767
LG V+ F + Y+ A + D+ L QL +K K N ++ + LP
Sbjct: 52 LGAHSITREEPTKQIMLVKKEFPYPCYD-PATREGDLKLLQLTEKAKINKYVTILHLPKK 110
Query: 768 NYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGM-- 825
++ PGT C V GWG+ ++ + + + EV + II R +CN N+ N +GM
Sbjct: 111 GDDVKPGTMCQVAGWGRTHNS--ASWSDTLREVNITIIDRKVCND-RNHYNFNPVIGMNM 167
Query: 826 VCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGI--KCAHPHLPGVYAYVP- 882
VCAG GG+D+C GDSG PLLC G+ S+G+ KC P PGVY +
Sbjct: 168 VCAGSLRGGRDSCNGDSGSPLLCEGVFR-------GVTSFGLENKCGDPRGPGVYILLSK 220
Query: 883 KYVTWI 888
K++ WI
Sbjct: 221 KHLNWI 226
>pdb|1MZA|A Chain A, Crystal Structure Of Human Pro-Granzyme K
pdb|1MZD|A Chain A, Crystal Structure Of Human Pro-Granzyme K
Length = 240
Score = 124 bits (310), Expect = 3e-28, Method: Compositional matrix adjust.
Identities = 86/243 (35%), Positives = 123/243 (50%), Gaps = 16/243 (6%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
IIGG E +P PF+A++ G V C GVLI QWVLTAAHC T TV L
Sbjct: 3 IIGGKEVSPHSRPFMASIQYGGHHV--CGGVLIDPQWVLTAAHCQYRFT--KGQSPTVVL 58
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
G + +++ S+ Q NDI L +L+ K N H+ + +
Sbjct: 59 GAHSLSKNEASKQTLEIKKFIPFSRVTSDPQ-SNDIMLVKLQTAAKLNKHVKMLHIRSKT 117
Query: 769 YELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICN-KWLNNRELNVTLGMVC 827
L GT+C V GWG + + +T + EV V +++R +CN + N + +T MVC
Sbjct: 118 -SLRSGTKCKVTGWGATDPDSLRPSDT-LREVTVTVLSRKLCNSQSYYNGDPFITKDMVC 175
Query: 828 AGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYV-PKYVT 886
AG +G KD+C+GD+GGPL+C+ + IVS G +C PG+Y + KY T
Sbjct: 176 AGDAKGQKDSCKGDAGGPLICKGVFH-------AIVSGGHECGVATKPGIYTLLTKKYQT 228
Query: 887 WIQ 889
WI+
Sbjct: 229 WIK 231
>pdb|4B2C|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tpa) In Complex With Eglin C
pdb|4B2C|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tpa) In Complex With Eglin C
Length = 223
Score = 124 bits (310), Expect = 3e-28, Method: Compositional matrix adjust.
Identities = 81/244 (33%), Positives = 118/244 (48%), Gaps = 24/244 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+ P+ +L G F C G LI+ QWV++AAHC +G+ + +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF---CGGSLINSQWVVSAAHCY--KSGIQVRLGEDNI 55
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
V N ++ V H YN ++NDI L +LK N + + LP
Sbjct: 56 NVVEGNEQFISASKSIV-----HPSYN-SETYNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 769 YELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVCA 828
+ GT+C + GWG + + S Y + ++ PI++ C +T M CA
Sbjct: 110 --ASAGTQCLISGWGNTKSSGTS-YPDVLKCLKAPILSDSSCKS---ASSFIITSNMFCA 163
Query: 829 GYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTWI 888
GY EGGKDACQGD+GGP++C + GIVSWG CA + PG Y V YV+WI
Sbjct: 164 GYLEGGKDACQGDAGGPVVCSGK-------LQGIVSWGSGCAQKNKPGFYTKVCNYVSWI 216
Query: 889 QDIM 892
+ +
Sbjct: 217 KQTI 220
>pdb|3UQV|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 124 bits (310), Expect = 3e-28, Method: Compositional matrix adjust.
Identities = 81/244 (33%), Positives = 118/244 (48%), Gaps = 24/244 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+ P+ +L G F C G LI+ QWV++AAHC +G+ + +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF---CGGSLINSQWVVSAAHCY--KSGIQVRLGEDNI 55
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
V N ++ V H YN ++NDI L +LK N + + LP
Sbjct: 56 NVVEGNEQFISASKSIV-----HPSYN-SETYNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 769 YELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVCA 828
+ GT+C + GWG + + S Y + ++ PI++ C +T M CA
Sbjct: 110 --ASAGTQCLISGWGNTKSSGTS-YPDVLKCLKAPILSDSSCKS---ASSFIITSNMFCA 163
Query: 829 GYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTWI 888
GY EGGKD+CQGDSGGP++C + GIVSWG CA + PG Y V YV+WI
Sbjct: 164 GYLEGGKDSCQGDSGGPVVCSGK-------LQGIVSWGSGCAQKNKPGFYTKVCNYVSWI 216
Query: 889 QDIM 892
+ +
Sbjct: 217 KQTI 220
>pdb|3GOV|B Chain B, Crystal Structure Of The Catalytic Region Of Human Masp-1
pdb|4DJZ|B Chain B, Catalytic Fragment Of Masp-1 In Complex With Its Specific
Inhibitor Developed By Directed Evolution On Sgci
Scaffold
pdb|4DJZ|D Chain D, Catalytic Fragment Of Masp-1 In Complex With Its Specific
Inhibitor Developed By Directed Evolution On Sgci
Scaffold
Length = 251
Score = 124 bits (310), Expect = 3e-28, Method: Compositional matrix adjust.
Identities = 86/257 (33%), Positives = 121/257 (47%), Gaps = 25/257 (9%)
Query: 649 IIGGFESNPGDWPFLAAL--LGGPEFVFYCAGVLISDQWVLTAAHCVGNLTG-------- 698
I G + G P++A L L G F C G L+ W++TAAHC+
Sbjct: 1 IFNGRPAQKGTTPWIAMLSHLNGQPF---CGGSLLGSSWIVTAAHCLHQSLDPKDPTLRD 57
Query: 699 ---LNIDEWTVQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKF 755
L+ ++ + LG R V+ H QY+ +ND+AL +L +
Sbjct: 58 SDLLSPSDFKIILGKHWRLRSDENEQHLGVKHTTLHPQYDPNT-FENDVALVELLESPVL 116
Query: 756 NDHLLPVCLPP-PNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWL 814
N ++P+CLP P E G V GWGK+ R E + E+E+PI+ C K
Sbjct: 117 NAFVMPICLPEGPQQE---GAMVIVSGWGKQFLQRFPE---TLMEIEIPIVDHSTCQKAY 170
Query: 815 NNRELNVTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHL 874
+ VT M+CAG EGGKDAC GDSGGP++ + QW++ G VSWG C
Sbjct: 171 APLKKKVTRDMICAGEKEGGKDACAGDSGGPMVTLNRER-GQWYLVGTVSWGDDCGKKDR 229
Query: 875 PGVYAYVPKYVTWIQDI 891
GVY+Y+ WIQ +
Sbjct: 230 YGVYSYIHHNKDWIQRV 246
>pdb|3UNQ|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UPE|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UUZ|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UUZ|B Chain B, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 124 bits (310), Expect = 3e-28, Method: Compositional matrix adjust.
Identities = 81/244 (33%), Positives = 118/244 (48%), Gaps = 24/244 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+ P+ +L G F C G LI+ QWV++AAHC +G+ + +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF---CGGSLINSQWVVSAAHCY--KSGIQVRLGEDNI 55
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
V N ++ V H YN ++NDI L +LK N + + LP
Sbjct: 56 NVVEGNEQFISASKSIV-----HPSYN-SETYNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 769 YELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVCA 828
+ GT+C + GWG + + S Y + ++ PI++ C +T M CA
Sbjct: 110 --ASAGTQCLISGWGNTKSSGTS-YPDVLKCLKAPILSDSSCKS---ASSFIITSNMFCA 163
Query: 829 GYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTWI 888
GY EGGKDACQGDSGGP++C + GIVSWG CA + PG Y + YV+WI
Sbjct: 164 GYLEGGKDACQGDSGGPVVCSGK-------LQGIVSWGSGCAQKNKPGFYTKLCNYVSWI 216
Query: 889 QDIM 892
+ +
Sbjct: 217 KQTI 220
>pdb|4B2B|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tgpa) In Complex With Eglin C
pdb|4B2B|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tgpa) In Complex With Eglin C
Length = 223
Score = 123 bits (309), Expect = 4e-28, Method: Compositional matrix adjust.
Identities = 81/244 (33%), Positives = 118/244 (48%), Gaps = 24/244 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+ P+ +L G F C G LI+ QWV++AAHC +G+ + +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF---CGGSLINSQWVVSAAHCY--KSGIQVRLGEDNI 55
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
V N ++ V H YN ++NDI L +LK N + + LP
Sbjct: 56 NVVEGNEQFISASKSIV-----HPSYN-SETYNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 769 YELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVCA 828
+ GT+C + GWG + + S Y + ++ PI++ C +T M CA
Sbjct: 110 --ASAGTQCLISGWGNTKSSGTS-YPDVLKCLKAPILSDSSCKS---ASSFIITSNMFCA 163
Query: 829 GYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTWI 888
GY EGGKDACQGD+GGP++C + GIVSWG CA + PG Y V YV+WI
Sbjct: 164 GYLEGGKDACQGDAGGPVVCSGK-------LQGIVSWGEGCAQKNKPGFYTKVCNYVSWI 216
Query: 889 QDIM 892
+ +
Sbjct: 217 KQTI 220
>pdb|1NPM|A Chain A, Neuropsin, A Serine Protease Expressed In The Limbic
System Of Mouse Brain
pdb|1NPM|B Chain B, Neuropsin, A Serine Protease Expressed In The Limbic
System Of Mouse Brain
Length = 225
Score = 123 bits (309), Expect = 4e-28, Method: Compositional matrix adjust.
Identities = 86/248 (34%), Positives = 116/248 (46%), Gaps = 26/248 (10%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+ G E P P+ AAL G + C GVL+ D+WVLTAAHC +++V+L
Sbjct: 1 ILEGRECIPHSQPWQAALFQGERLI--CGGVLVGDRWVLTAAHC-------KKQKYSVRL 51
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIG--AQHDNDIALFQLKQKVKFNDHLLPVCLPP 766
G S +V H YN H +DI L +L+ D + PV L
Sbjct: 52 GDHSLQSRDQPEQEIQVAQSIQHPCYNNSNPEDHSHDIMLIRLQNSANLGDKVKPVQL-- 109
Query: 767 PNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMV 826
N G +C + GWG + + +N EV I +++ C + + +T GMV
Sbjct: 110 ANLCPKVGQKCIISGWGTVTSPQ-ENFPNTLNCAEVKIYSQNKCERAYPGK---ITEGMV 165
Query: 827 CAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIK-CAHPHLPGVYAYVPKYV 885
CAG G D CQGDSGGPL+C + GI SWG C P PGVY + +Y
Sbjct: 166 CAGSSNGA-DTCQGDSGGPLVCDG-------MLQGITSWGSDPCGKPEKPGVYTKICRYT 217
Query: 886 TWIQDIMD 893
TWI+ MD
Sbjct: 218 TWIKKTMD 225
>pdb|1FIW|A Chain A, Three-Dimensional Structure Of Beta-Acrosin From Ram
Spermatozoa
Length = 290
Score = 123 bits (309), Expect = 4e-28, Method: Compositional matrix adjust.
Identities = 91/261 (34%), Positives = 127/261 (48%), Gaps = 38/261 (14%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFY-------CAGVLISDQWVLTAAHCVGNLTGLNI 701
IIGG ++ G WP++ +L F ++ C G L++ QW+LTAAHC +
Sbjct: 1 IIGGQDAAHGAWPWMVSLQ---IFTYHNNRRYHVCGGSLLNSQWLLTAAHCF--RIKKKV 55
Query: 702 DEWTVQLGV------TRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKF 755
+W + G T + R+ V + H +Y+ ++ NDIAL ++ V
Sbjct: 56 TDWRLIFGAKEVEWGTNKPVKPPLQERY-VEKIIIHEKYSASSE-ANDIALMKITPPVTC 113
Query: 756 NDHLLPVCLP-----PPNYELAPGTRCTVIGWG-KREDTRVSEYETAVNEVEVPIITRDI 809
+ P CLP PP P T C V GWG +E+ R + + E V +I +
Sbjct: 114 GHFIGPGCLPQFRAGPPR---VPQT-CWVAGWGFLQENARRTS--PMLQEARVDLIDLGL 167
Query: 810 CN--KWLNNRELNVTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGI 867
CN +W N R + VCAGYPEG D CQGDSGGPL+C+ S + V GI SWG+
Sbjct: 168 CNSTRWYNGRIRSTN---VCAGYPEGKIDTCQGDSGGPLMCKDSAE-NSYVVVGITSWGV 223
Query: 868 KCAHPHLPGVYAYVPKYVTWI 888
CA PGVY Y+ WI
Sbjct: 224 GCARAKRPGVYTSTWSYLNWI 244
>pdb|2D8W|A Chain A, Structure Of Hyper-Vil-Trypsin
Length = 223
Score = 123 bits (309), Expect = 4e-28, Method: Compositional matrix adjust.
Identities = 80/244 (32%), Positives = 118/244 (48%), Gaps = 24/244 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+ P+ +L G F C G LI+ QWV++AAHC +G+ + +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF---CGGSLINSQWVVSAAHCX--KSGIQVRLGEDNI 55
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
V N ++ V H YN +NDI L +LK N + + LP
Sbjct: 56 NVVEGNEQFISASKSIV-----HPSYN-SNTLNNDIMLIKLKSAASLNSRVASISLPTS- 108
Query: 769 YELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVCA 828
+ GT+C + GWG + + S + + ++ PI++ C + +T M CA
Sbjct: 109 -CASAGTQCLISGWGNTKSSGTSXPDV-LKCLKAPILSDSSCKSAYPGQ---ITSNMFCA 163
Query: 829 GYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTWI 888
G EGGKD+CQGDSGGP++C + GIVSWG CA + PGVY V YV+WI
Sbjct: 164 GXLEGGKDSCQGDSGGPVVCSGK-------LQGIVSWGSGCAQKNKPGVYTKVCNYVSWI 216
Query: 889 QDIM 892
+ +
Sbjct: 217 KQTI 220
>pdb|3TGK|E Chain E, Trypsinogen Mutant D194n And Deletion Of Ile 16-Val 17
Complexed With Bovine Pancreatic Trypsin Inhibitor
(Bpti)
Length = 231
Score = 123 bits (309), Expect = 4e-28, Method: Compositional matrix adjust.
Identities = 84/243 (34%), Positives = 117/243 (48%), Gaps = 26/243 (10%)
Query: 651 GGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQLGV 710
GG+ P+ +L G F C G LI+DQWV++AAHC + + + E + V
Sbjct: 11 GGYTCQENSVPYQVSLNSGYHF---CGGSLINDQWVVSAAHCYKSRIQVRLGEHNIN--V 65
Query: 711 TRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPNYE 770
N + F N NDI L +L VK N + V LP
Sbjct: 66 LEGNEQFVNAAKIIKHPNFDRKTLN------NDIMLIKLSSPVKLNARVATVALPS---S 116
Query: 771 LAP-GTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVCAG 829
AP GT+C + GWG + V+E + + ++ P++ + C + +T MVC G
Sbjct: 117 CAPAGTQCLISGWGNTLSSGVNEPDL-LQCLDAPLLPQADCEASYPGK---ITDNMVCVG 172
Query: 830 YPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTWIQ 889
+ EGGKD+CQG+SGGP++C + GIVSWG CA P PGVY V YV WIQ
Sbjct: 173 FLEGGKDSCQGNSGGPVVCNGE-------LQGIVSWGYGCALPDNPGVYTKVCNYVDWIQ 225
Query: 890 DIM 892
D +
Sbjct: 226 DTI 228
>pdb|1V2Q|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Sswi)bt.B4
Length = 223
Score = 123 bits (308), Expect = 5e-28, Method: Compositional matrix adjust.
Identities = 83/247 (33%), Positives = 120/247 (48%), Gaps = 30/247 (12%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+ P+ +L G F C G LI+ QWV++AAHC +G+ + +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF---CGGSLINSQWVVSAAHCY--KSGIQVRLGEDNI 55
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
V N ++ V H YN +NDI L +LK N + + LP
Sbjct: 56 NVVEGNEQFISASKSIV-----HPSYN-SNTLNNDIMLIKLKSAASLNSRVASISLPTS- 108
Query: 769 YELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNK---WLNNRELNVTLGM 825
+ GT+C + GWG + + S Y + ++ PI++ C W+ +T M
Sbjct: 109 -CASAGTQCLISGWGNTKSSGTS-YPDVLKCLKAPILSDSSCKSASSWI------ITSNM 160
Query: 826 VCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYV 885
CAGY EGGKD+CQGDSGGP++C + GIVSWG CA + PGVY V YV
Sbjct: 161 FCAGYLEGGKDSCQGDSGGPVVCSGK-------LQGIVSWGSGCAQKNKPGVYTKVCNYV 213
Query: 886 TWIQDIM 892
+WI+ +
Sbjct: 214 SWIKQTI 220
>pdb|1V2S|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant
X(Ssfi.Glu)bt.D1
pdb|1V2T|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(ssfi.glu)bt.b4
Length = 223
Score = 123 bits (308), Expect = 5e-28, Method: Compositional matrix adjust.
Identities = 82/244 (33%), Positives = 118/244 (48%), Gaps = 24/244 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+ P+ +L G F C G LI+ QWV++AAHC +G+ + +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF---CGGSLINSQWVVSAAHCY--KSGIQVRLGEDNI 55
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
V N ++ V H YN +NDI L +LK N + + LP
Sbjct: 56 NVVEGNEQFISASKSIV-----HPSYN-SNTLNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 769 YELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVCA 828
+ GT+C + GWG + + S Y + ++ PI++ C +T M CA
Sbjct: 110 --ASAGTQCLISGWGNTKSSGTS-YPDVLKCLKAPILSDSSCKS---ASSFIITSNMFCA 163
Query: 829 GYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTWI 888
GY EGGKD+CQGDSGGP++C + GIVSWG CA + PGVY V YV+WI
Sbjct: 164 GYLEGGKDSCQGDSGGPVVCSGK-------LQGIVSWGEGCAQKNKPGVYTKVCNYVSWI 216
Query: 889 QDIM 892
+ +
Sbjct: 217 KQTI 220
>pdb|1AUT|C Chain C, Human Activated Protein C
Length = 250
Score = 123 bits (308), Expect = 5e-28, Method: Compositional matrix adjust.
Identities = 87/254 (34%), Positives = 124/254 (48%), Gaps = 21/254 (8%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
+I G + GD P+ LL + C VLI WVLTAAHC+ L V+L
Sbjct: 1 LIDGKMTRRGDSPWQVVLLDSKK-KLACGAVLIHPSWVLTAAHCMDESKKL-----LVRL 54
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
G + + ++ VF H Y+ + DNDIAL L Q + ++P+CLP
Sbjct: 55 GEYDLRRWEKWELDLDIKEVFVHPNYS-KSTTDNDIALLHLAQPATLSQTIVPICLPDSG 113
Query: 769 Y---EL-APGTRCTVIGWG---KREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNV 821
EL G V GWG RE +N +++P++ + C++ ++N V
Sbjct: 114 LAERELNQAGQETLVTGWGYHSSREKEAKRNRTFVLNFIKIPVVPHNECSEVMSNM---V 170
Query: 822 TLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYV 881
+ M+CAG +DAC+GDSGGP++ S H WF+ G+VSWG C H GVY V
Sbjct: 171 SENMLCAGILGDRQDACEGDSGGPMVA-SFHG--TWFLVGLVSWGEGCGLLHNYGVYTKV 227
Query: 882 PKYVTWIQD-IMDK 894
+Y+ WI I DK
Sbjct: 228 SRYLDWIHGHIRDK 241
>pdb|1NTP|A Chain A, Use Of The Neutron Diffraction HD EXCHANGE TECHNIQUE TO
Determine The Conformational Dynamics Of Trypsin
Length = 223
Score = 123 bits (308), Expect = 5e-28, Method: Compositional matrix adjust.
Identities = 78/243 (32%), Positives = 116/243 (47%), Gaps = 24/243 (9%)
Query: 650 IGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQLG 709
+GG+ P+ +L G F C G LI QWV++AAHC +G+ + +
Sbjct: 2 VGGYTCGANTVPYQVSLNSGYHF---CGGSLIDSQWVVSAAHCY--KSGIQVRLGEDNIN 56
Query: 710 VTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPNY 769
V N ++ V + + N NDI L +LK + + + LP
Sbjct: 57 VVEGNEQFISASKSIVHPSYDSNTLN------NDIMLIKLKSAASLDSRVASISLPTSC- 109
Query: 770 ELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVCAG 829
+ GT+C + GWG + + S Y + ++ PI++ C + +T M CAG
Sbjct: 110 -ASAGTQCLISGWGNTKSSGTS-YPDVLKCLKAPILSDSSCKSAYPGQ---ITSNMFCAG 164
Query: 830 YPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTWIQ 889
Y EGGKD+CQGDSGGP++C + GIVSWG CA + PGVY V YV+WI+
Sbjct: 165 YLEGGKDSCQGDSGGPVVCSGK-------LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIK 217
Query: 890 DIM 892
+
Sbjct: 218 QTI 220
>pdb|3F6U|H Chain H, Crystal Structure Of Human Activated Protein C (Apc)
Complexed With Ppack
Length = 240
Score = 123 bits (308), Expect = 5e-28, Method: Compositional matrix adjust.
Identities = 84/248 (33%), Positives = 121/248 (48%), Gaps = 20/248 (8%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
+I G + GD P+ LL + C VLI WVLTAAHC+ L V+L
Sbjct: 1 LIDGKMTRRGDSPWQVVLLDSKK-KLACGAVLIHPSWVLTAAHCMDESKKL-----LVRL 54
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
G + + ++ VF H Y+ + DNDIAL L Q + ++P+CLP
Sbjct: 55 GEYDLRRWEKWELDLDIKEVFVHPNYS-KSTTDNDIALLHLAQPATLSQTIVPICLPDSG 113
Query: 769 Y---EL-APGTRCTVIGWG---KREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNV 821
EL G V GWG RE +N +++P++ + C++ ++N V
Sbjct: 114 LAERELNQAGQETLVTGWGYHSSREKEAKRNRTFVLNFIKIPVVPHNECSEVMSNM---V 170
Query: 822 TLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYV 881
+ M+CAG +DAC+GDSGGP++ S H WF+ G+VSWG C H GVY V
Sbjct: 171 SENMLCAGILGDRQDACEGDSGGPMVA-SFHG--TWFLVGLVSWGEGCGLLHNYGVYTKV 227
Query: 882 PKYVTWIQ 889
+Y+ WI
Sbjct: 228 SRYLDWIH 235
>pdb|1V2U|T Chain T, Benzamidine In Complex With Bovine Trypsin Varinat X(Ssai)
Bt.D1
pdb|1V2V|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant X(Ssai)
Bt.C1
pdb|1V2W|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssai)bt.B4
Length = 223
Score = 123 bits (308), Expect = 6e-28, Method: Compositional matrix adjust.
Identities = 82/244 (33%), Positives = 118/244 (48%), Gaps = 24/244 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+ P+ +L G F C G LI+ QWV++AAHC +G+ + +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF---CGGSLINSQWVVSAAHCY--KSGIQVRLGEDNI 55
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
V N ++ V H YN +NDI L +LK N + + LP
Sbjct: 56 NVVEGNEQFISASKSIV-----HPSYN-SNTLNNDIMLIKLKSAASLNSRVASISLPTS- 108
Query: 769 YELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVCA 828
+ GT+C + GWG + + S Y + ++ PI++ C +T M CA
Sbjct: 109 -CASAGTQCLISGWGNTKSSGTS-YPDVLKCLKAPILSDSSCKS---ASSAIITSNMFCA 163
Query: 829 GYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTWI 888
GY EGGKD+CQGDSGGP++C + GIVSWG CA + PGVY V YV+WI
Sbjct: 164 GYLEGGKDSCQGDSGGPVVCSGK-------LQGIVSWGSGCAQKNKPGVYTKVCNYVSWI 216
Query: 889 QDIM 892
+ +
Sbjct: 217 KQTI 220
>pdb|1V2O|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssyi)bt.B4
pdb|1V2P|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssyi)bt.A4
Length = 223
Score = 123 bits (308), Expect = 6e-28, Method: Compositional matrix adjust.
Identities = 82/244 (33%), Positives = 118/244 (48%), Gaps = 24/244 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+ P+ +L G F C G LI+ QWV++AAHC +G+ + +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF---CGGSLINSQWVVSAAHCY--KSGIQVRLGEDNI 55
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
V N ++ V H YN +NDI L +LK N + + LP
Sbjct: 56 NVVEGNEQFISASKSIV-----HPSYN-SNTLNNDIMLIKLKSAASLNSRVASISLPTS- 108
Query: 769 YELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVCA 828
+ GT+C + GWG + + S Y + ++ PI++ C +T M CA
Sbjct: 109 -CASAGTQCLISGWGNTKSSGTS-YPDVLKCLKAPILSDSSCKS---ASSYIITSNMFCA 163
Query: 829 GYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTWI 888
GY EGGKD+CQGDSGGP++C + GIVSWG CA + PGVY V YV+WI
Sbjct: 164 GYLEGGKDSCQGDSGGPVVCSGK-------LQGIVSWGSGCAQKNKPGVYTKVCNYVSWI 216
Query: 889 QDIM 892
+ +
Sbjct: 217 KQTI 220
>pdb|1V2J|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant X(Ssri)
Bt.C1
pdb|1V2R|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssri)bt.B4
Length = 223
Score = 122 bits (307), Expect = 7e-28, Method: Compositional matrix adjust.
Identities = 82/244 (33%), Positives = 118/244 (48%), Gaps = 24/244 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+ P+ +L G F C G LI+ QWV++AAHC +G+ + +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF---CGGSLINSQWVVSAAHCY--KSGIQVRLGEDNI 55
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
V N ++ V H YN +NDI L +LK N + + LP
Sbjct: 56 NVVEGNEQFISASKSIV-----HPSYN-SNTLNNDIMLIKLKSAASLNSRVASISLPTS- 108
Query: 769 YELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVCA 828
+ GT+C + GWG + + S Y + ++ PI++ C +T M CA
Sbjct: 109 -CASAGTQCLISGWGNTKSSGTS-YPDVLKCLKAPILSDSSCKS---ASSRIITSNMFCA 163
Query: 829 GYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTWI 888
GY EGGKD+CQGDSGGP++C + GIVSWG CA + PGVY V YV+WI
Sbjct: 164 GYLEGGKDSCQGDSGGPVVCSGK-------LQGIVSWGSGCAQKNKPGVYTKVCNYVSWI 216
Query: 889 QDIM 892
+ +
Sbjct: 217 KQTI 220
>pdb|3UWI|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|B Chain B, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|C Chain C, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|D Chain D, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|E Chain E, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|F Chain F, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|G Chain G, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|H Chain H, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|I Chain I, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|J Chain J, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|K Chain K, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|L Chain L, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|M Chain M, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|N Chain N, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|O Chain O, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|P Chain P, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3V12|A Chain A, Bovine Trypsin Variant X(tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3V13|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
Length = 223
Score = 122 bits (307), Expect = 7e-28, Method: Compositional matrix adjust.
Identities = 81/244 (33%), Positives = 117/244 (47%), Gaps = 24/244 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+ P+ +L G F C G LI+ QWV++AAHC +G+ + +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF---CGGSLINSQWVVSAAHCY--KSGIQVRLGEDNI 55
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
V N ++ V H YN ++NDI L +LK N + + LP
Sbjct: 56 NVVEGNEQFISASKSIV-----HPSYN-SETYNNDIMLIKLKSAASLNSRVASISLPTSC 109
Query: 769 YELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVCA 828
+ GT+C + GWG + + S Y + ++ PI++ C +T M C
Sbjct: 110 --ASAGTQCLISGWGNTKSSGTS-YPDVLKCLKAPILSDSSCKS---ASSFIITSNMFCV 163
Query: 829 GYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTWI 888
GY EGGKDACQGDSGGP++C + GIVSWG CA + PG Y V YV+WI
Sbjct: 164 GYLEGGKDACQGDSGGPVVCSGK-------LQGIVSWGEGCAQKNKPGFYTKVCNYVSWI 216
Query: 889 QDIM 892
+ +
Sbjct: 217 KQTI 220
>pdb|2WPI|S Chain S, Factor Ixa Superactive Double Mutant
Length = 235
Score = 122 bits (306), Expect = 8e-28, Method: Compositional matrix adjust.
Identities = 81/250 (32%), Positives = 128/250 (51%), Gaps = 28/250 (11%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
++GG ++ PG +P+ L G + +C G +++++W++TAAHCV TG+ I TV
Sbjct: 1 VVGGEDAKPGQFPWQVVLNGKVDA--FCGGSIVNEKWIVTAAHCV--ETGVKI---TVVA 53
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQ-HDNDIALFQLKQKVKFNDHLLPVCLPPP 767
G + V + H YN +++DIAL +L + + N ++ P+C+
Sbjct: 54 GEHNIEETEHTEQKRNVIRIIPHHNYNAAINTYNHDIALLELDEPLVLNSYVTPICIADK 113
Query: 768 NYE---LAPGTRCTVIGWG----KREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELN 820
Y L G+ V GWG K V +Y + VP++ R C L + +
Sbjct: 114 EYTNIFLKFGSG-YVSGWGRVFHKGRSALVLQY------LRVPLVDRATC---LRSTKFT 163
Query: 821 VTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAY 880
+T M CAG+ EGG+D+CQGDSGGP + F+ GI+SWG +CA G+Y
Sbjct: 164 ITNNMFCAGFHEGGRDSCQGDSGGPHVTEVEGTS---FLTGIISWGEECAMKGKYGIYTK 220
Query: 881 VPKYVTWIQD 890
V +YV WI++
Sbjct: 221 VSRYVNWIKE 230
>pdb|1BRB|E Chain E, Crystal Structures Of Rat Anionic Trypsin Complexed With
The Protein Inhibitors Appi And Bpti
pdb|1BRC|E Chain E, Relocating A Negative Charge In The Binding Pocket Of
Trypsin
pdb|1BRA|A Chain A, Relocating A Negative Charge In The Binding Pocket Of
Trypsin
Length = 223
Score = 122 bits (305), Expect = 1e-27, Method: Compositional matrix adjust.
Identities = 84/245 (34%), Positives = 117/245 (47%), Gaps = 26/245 (10%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+ P+ +L G F C G LI+DQWV++AAHC + + + E +
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGYHF---CGGSLINDQWVVSAAHCYKSRIQVRLGEHNIN- 56
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
V N + F N NDI L +L VK N + V LP
Sbjct: 57 -VLEGNEQFVNAAKIIKHPNFDRKTLN------NDIMLIKLSSPVKLNARVATVALPS-- 107
Query: 769 YELAP-GTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVC 827
AP GT+C + GWG + V+E + + ++ P++ + C + +T MVC
Sbjct: 108 -SCAPAGTQCLISGWGNTLSSGVNEPDL-LQCLDAPLLPQADCEASYPGK---ITDNMVC 162
Query: 828 AGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTW 887
G+ EGGK +CQGDSGGP++C + GIVSWG CA P P VY V YV W
Sbjct: 163 VGFLEGGKGSCQGDSGGPVVCNGE-------LQGIVSWGYGCALPDNPDVYTKVCNYVDW 215
Query: 888 IQDIM 892
IQD +
Sbjct: 216 IQDTI 220
>pdb|2F91|A Chain A, 1.2a Resolution Structure Of A Crayfish Trypsin Complexed
With A Peptide Inhibitor, Sgti
Length = 237
Score = 121 bits (303), Expect = 2e-27, Method: Composition-based stats.
Identities = 81/251 (32%), Positives = 124/251 (49%), Gaps = 28/251 (11%)
Query: 649 IIGGFESNPGDWP----FLAALLGGPEFVF-YCAGVLISDQWVLTAAHCV-----GNLTG 698
I+GG ++ G++P F +G F F +C + ++ + +TA HCV N +G
Sbjct: 1 IVGGTDATLGEFPYQLSFQETFIG---FSFHFCGASIYNENYAITAGHCVYGDDYENPSG 57
Query: 699 LNIDEWTVQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDH 758
L I + + V + V + H ++ DNDI+L +L + FND+
Sbjct: 58 LQIVAGELDMSVNEGSEQII-----TVSKIILHENFDYNLL-DNDISLLKLSGSLTFNDN 111
Query: 759 LLPVCLPPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRE 818
+ P+ LP + A G V GWG + + +V VP+++ + C E
Sbjct: 112 VAPIALPEQGHT-ATGD-VIVTGWGTTSEG--GNTPDVLQKVTVPLVSDEDCRADYGADE 167
Query: 819 LNVTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVY 878
+ M+CAG PEGGKD+CQGDSGGPL ++ + ++ GIVSWG CA P PGVY
Sbjct: 168 --ILDSMICAGVPEGGKDSCQGDSGGPL---AASDTGSTYLAGIVSWGYGCARPGYPGVY 222
Query: 879 AYVPKYVTWIQ 889
V +V WI+
Sbjct: 223 TEVSYHVDWIK 233
>pdb|2WPH|S Chain S, Factor Ixa Superactive Triple Mutant
pdb|2WPJ|S Chain S, Factor Ixa Superactive Triple Mutant, Nacl-Soaked
pdb|2WPK|S Chain S, Factor Ixa Superactive Triple Mutant, Ethylene
Glycol-Soaked
pdb|2WPL|S Chain S, Factor Ixa Superactive Triple Mutant, Edta-Soaked
Length = 235
Score = 121 bits (303), Expect = 2e-27, Method: Compositional matrix adjust.
Identities = 80/250 (32%), Positives = 128/250 (51%), Gaps = 28/250 (11%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
++GG ++ PG +P+ L G + +C G +++++W++TAAHCV TG+ I TV
Sbjct: 1 VVGGEDAKPGQFPWQVVLNGKVDA--FCGGSIVNEKWIVTAAHCV--ETGVKI---TVVA 53
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQ-HDNDIALFQLKQKVKFNDHLLPVCLPPP 767
G + V + H +N +++DIAL +L + + N ++ P+C+
Sbjct: 54 GEHNIEETEHTEQKRNVIRIIPHHNFNAAINTYNHDIALLELDEPLVLNSYVTPICIADK 113
Query: 768 NYE---LAPGTRCTVIGWG----KREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELN 820
Y L G+ V GWG K V +Y + VP++ R C L + +
Sbjct: 114 EYTNIFLKFGSG-YVSGWGRVFHKGRSALVLQY------LRVPLVDRATC---LRSTKFT 163
Query: 821 VTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAY 880
+T M CAG+ EGG+D+CQGDSGGP + F+ GI+SWG +CA G+Y
Sbjct: 164 ITNNMFCAGFHEGGRDSCQGDSGGPHVTEVEGTS---FLTGIISWGEECAMKGKYGIYTK 220
Query: 881 VPKYVTWIQD 890
V +YV WI++
Sbjct: 221 VSRYVNWIKE 230
>pdb|1H4W|A Chain A, Structure Of Human Trypsin Iv (Brain Trypsin)
Length = 224
Score = 120 bits (302), Expect = 2e-27, Method: Compositional matrix adjust.
Identities = 81/246 (32%), Positives = 119/246 (48%), Gaps = 28/246 (11%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+ P+ +L G F C G LIS+QWV++AAHC + + E +++
Sbjct: 1 IVGGYTCEENSLPYQVSLNSGSHF---CGGSLISEQWVVSAAHCYKTRIQVRLGEHNIKV 57
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLP--P 766
+ F +R H +YN DNDI L +L N + + LP P
Sbjct: 58 ---LEGNEQFINAVKIIR----HPKYNRDTL-DNDIMLIKLSSPAVINARVSTISLPTAP 109
Query: 767 PNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMV 826
P A GT C + GWG ++Y + ++ P++T+ C + +T M
Sbjct: 110 P----AAGTECLISGWGNTLSFG-ADYPDELKCLDAPVLTQAECKASYPGK---ITNSMF 161
Query: 827 CAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVT 886
C G+ EGGKD+CQ DSGGP++C + G+VSWG CA + PGVY V YV
Sbjct: 162 CVGFLEGGKDSCQRDSGGPVVCNGQ-------LQGVVSWGHGCAWKNRPGVYTKVYNYVD 214
Query: 887 WIQDIM 892
WI+D +
Sbjct: 215 WIKDTI 220
>pdb|1PFX|C Chain C, Porcine Factor Ixa
pdb|1X7A|C Chain C, Porcine Factor Ixa Complexed To 1-{3-[amino(Imino)
Methyl]phenyl}-N-[4-(1h-Benzimidazol-1-Yl)-2-
Fluorophenyl]-
3-(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide
Length = 235
Score = 120 bits (302), Expect = 3e-27, Method: Compositional matrix adjust.
Identities = 82/246 (33%), Positives = 126/246 (51%), Gaps = 20/246 (8%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG + PG +P+ L G + +C G +I+++WV+TAAHC+ G+ I TV
Sbjct: 1 IVGGENAKPGQFPWQVLLNG--KIDAFCGGSIINEKWVVTAAHCI--EPGVKI---TVVA 53
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGA-QHDNDIALFQLKQKVKFNDHLLPVCLPPP 767
G R V H YN ++ +DIAL +L + + N ++ P+C+
Sbjct: 54 GEYNTEETEPTEQRRNVIRAIPHHSYNATVNKYSHDIALLELDEPLTLNSYVTPICIADK 113
Query: 768 NYE---LAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLG 824
Y L G+ V GWG+ + S T + ++VP++ R C L + + +
Sbjct: 114 EYTNIFLKFGSG-YVSGWGRVFNRGRSA--TILQYLKVPLVDRATC---LRSTKFTIYSN 167
Query: 825 MVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKY 884
M CAG+ EGGKD+CQGDSGGP + F+ GI+SWG +CA G+Y V +Y
Sbjct: 168 MFCAGFHEGGKDSCQGDSGGPHVTEVEGTS---FLTGIISWGEECAVKGKYGIYTKVSRY 224
Query: 885 VTWIQD 890
V WI++
Sbjct: 225 VNWIKE 230
>pdb|1RFN|A Chain A, Human Coagulation Factor Ixa In Complex With P-Amino
Benzamidine
pdb|3LC3|A Chain A, Benzothiophene Inhibitors Of Factor Ixa
pdb|3LC3|C Chain C, Benzothiophene Inhibitors Of Factor Ixa
pdb|3LC5|A Chain A, Selective Benzothiophine Inhibitors Of Factor Ixa
Length = 235
Score = 120 bits (302), Expect = 3e-27, Method: Compositional matrix adjust.
Identities = 80/250 (32%), Positives = 128/250 (51%), Gaps = 28/250 (11%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
++GG ++ PG +P+ L G + +C G +++++W++TAAHCV TG+ I TV
Sbjct: 1 VVGGEDAKPGQFPWQVVLNGKVDA--FCGGSIVNEKWIVTAAHCV--ETGVKI---TVVA 53
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGA-QHDNDIALFQLKQKVKFNDHLLPVCLPPP 767
G + V + H YN ++++DIAL +L + + N ++ P+C+
Sbjct: 54 GEHNIEETEHTEQKRNVIRIIPHHNYNAAINKYNHDIALLELDEPLVLNSYVTPICIADK 113
Query: 768 NYE---LAPGTRCTVIGWG----KREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELN 820
Y L G+ V GWG K V +Y + VP++ R C L + +
Sbjct: 114 EYTNIFLKFGSG-YVSGWGRVFHKGRSALVLQY------LRVPLVDRATC---LRSTKFT 163
Query: 821 VTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAY 880
+ M CAG+ EGG+D+CQGDSGGP + F+ GI+SWG +CA G+Y
Sbjct: 164 IYNNMFCAGFHEGGRDSCQGDSGGPHVTEVEGTS---FLTGIISWGEECAMKGKYGIYTK 220
Query: 881 VPKYVTWIQD 890
V +YV WI++
Sbjct: 221 VSRYVNWIKE 230
>pdb|2WPM|S Chain S, Factor Ixa Superactive Mutant, Egr-Cmk Inhibited
Length = 235
Score = 120 bits (301), Expect = 3e-27, Method: Compositional matrix adjust.
Identities = 80/250 (32%), Positives = 128/250 (51%), Gaps = 28/250 (11%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
++GG ++ PG +P+ L G + +C G +++++W++TAAHCV TG+ I TV
Sbjct: 1 VVGGEDAKPGQFPWQVVLNGKVDA--FCGGSIVNEKWIVTAAHCV--ETGVKI---TVVA 53
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQ-HDNDIALFQLKQKVKFNDHLLPVCLPPP 767
G + V + H +N +++DIAL +L + + N ++ P+C+
Sbjct: 54 GEHNIEETEHTEQKRNVIRIIPHHNFNAAINTYNHDIALLELDEPLVLNSYVTPICIADK 113
Query: 768 NYE---LAPGTRCTVIGWG----KREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELN 820
Y L G+ V GWG K V +Y + VP++ R C L + +
Sbjct: 114 EYTNIFLKFGSG-YVSGWGRVFHKGRAALVLQY------LRVPLVDRATC---LRSTKFT 163
Query: 821 VTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAY 880
+T M CAG+ EGG+D+CQGDSGGP + F+ GI+SWG +CA G+Y
Sbjct: 164 ITNNMFCAGFHEGGRDSCQGDSGGPHVTEVEGTS---FLTGIISWGEECAMKGKYGIYTK 220
Query: 881 VPKYVTWIQD 890
V +YV WI++
Sbjct: 221 VSRYVNWIKE 230
>pdb|1TRN|A Chain A, Crystal Structure Of Human Trypsin 1: Unexpected
Phosphorylation Of Tyrosine 151
pdb|1TRN|B Chain B, Crystal Structure Of Human Trypsin 1: Unexpected
Phosphorylation Of Tyrosine 151
Length = 224
Score = 120 bits (301), Expect = 3e-27, Method: Compositional matrix adjust.
Identities = 76/246 (30%), Positives = 122/246 (49%), Gaps = 28/246 (11%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+ P+ +L G F C G LI++QWV++A HC + + + E +++
Sbjct: 1 IVGGYNCEENSVPYQVSLNSGYHF---CGGSLINEQWVVSAGHCYKSRIQVRLGEHNIEV 57
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLP--P 766
+ F +R H QY+ +NDI L +L + N + + LP P
Sbjct: 58 ---LEGNEQFINAAKIIR----HPQYDR-KTLNNDIMLIKLSSRAVINARVSTISLPTAP 109
Query: 767 PNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMV 826
P A GT+C + GWG + ++ + ++ P++++ C + +T M
Sbjct: 110 P----ATGTKCLISGWGNTASSG-ADXPDELQCLDAPVLSQAKCEASYPGK---ITSNMF 161
Query: 827 CAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVT 886
C G+ EGGKD+CQGDSGGP++C + G+VSWG CA + PGVY V YV
Sbjct: 162 CVGFLEGGKDSCQGDSGGPVVCNGQ-------LQGVVSWGDGCAQKNKPGVYTKVYNYVK 214
Query: 887 WIQDIM 892
WI++ +
Sbjct: 215 WIKNTI 220
>pdb|2R9P|A Chain A, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|2R9P|B Chain B, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|2R9P|C Chain C, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|2R9P|D Chain D, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|3L33|A Chain A, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L33|B Chain B, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L33|C Chain C, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L33|D Chain D, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L3T|A Chain A, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3L3T|B Chain B, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3L3T|C Chain C, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3L3T|D Chain D, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3P92|A Chain A, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor Variant (Bpti-K15rR17G)
pdb|3P95|A Chain A, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor Variant (Bpti-K15rR17D)
Length = 224
Score = 120 bits (301), Expect = 4e-27, Method: Compositional matrix adjust.
Identities = 80/246 (32%), Positives = 119/246 (48%), Gaps = 28/246 (11%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+ P+ +L G F C G LIS+QWV++AAHC + + E +++
Sbjct: 1 IVGGYTCEENSLPYQVSLNSGSHF---CGGSLISEQWVVSAAHCYKTRIQVRLGEHNIKV 57
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLP--P 766
+ F +R H +YN DNDI L +L N + + LP P
Sbjct: 58 ---LEGNEQFINAAKIIR----HPKYNRDTL-DNDIMLIKLSSPAVINARVSTISLPTAP 109
Query: 767 PNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMV 826
P A GT C + GWG ++Y + ++ P++T+ C + +T M
Sbjct: 110 P----AAGTECLISGWGNTLSFG-ADYPDELKCLDAPVLTQAECKASYPGK---ITNSMF 161
Query: 827 CAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVT 886
C G+ EGGKD+CQ D+GGP++C + G+VSWG CA + PGVY V YV
Sbjct: 162 CVGFLEGGKDSCQRDAGGPVVCNGQ-------LQGVVSWGHGCAWKNRPGVYTKVYNYVD 214
Query: 887 WIQDIM 892
WI+D +
Sbjct: 215 WIKDTI 220
>pdb|3V0X|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
Length = 223
Score = 120 bits (300), Expect = 5e-27, Method: Compositional matrix adjust.
Identities = 80/244 (32%), Positives = 116/244 (47%), Gaps = 24/244 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+ P+ +L G F C G LI+ QWV++AAHC +G+ + +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF---CGGSLINSQWVVSAAHCY--KSGIQVRLGEDNI 55
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
V N ++ V H YN ++NDI L +LK + + LP
Sbjct: 56 NVVEGNEQFISASKSIV-----HPSYN-SETYNNDIMLIKLKSAASLXSRVASISLPTSC 109
Query: 769 YELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVCA 828
+ GT+C + GWG + + S Y + ++ PI++ C +T M C
Sbjct: 110 --ASAGTQCLISGWGNTKSSGTS-YPDVLKCLKAPILSDSSCKS---ASSFIITSNMFCV 163
Query: 829 GYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTWI 888
GY EGGKDACQGDSGGP++C + GIVSWG CA + PG Y V YV+WI
Sbjct: 164 GYLEGGKDACQGDSGGPVVCSGK-------LQGIVSWGEGCAQKNKPGFYTKVCNYVSWI 216
Query: 889 QDIM 892
+ +
Sbjct: 217 KQTI 220
>pdb|4DG4|A Chain A, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
pdb|4DG4|B Chain B, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
pdb|4DG4|D Chain D, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
pdb|4DG4|G Chain G, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
Length = 224
Score = 119 bits (299), Expect = 6e-27, Method: Compositional matrix adjust.
Identities = 80/246 (32%), Positives = 119/246 (48%), Gaps = 28/246 (11%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+ P+ +L G F C G LIS+QWV++AAHC + + E +++
Sbjct: 1 IVGGYTCEENSLPYQVSLNSGYHF---CGGSLISEQWVVSAAHCYKTRIQVRLGEHNIKV 57
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLP--P 766
+ F +R H +YN DNDI L +L N + + LP P
Sbjct: 58 ---LEGNEQFINAAKIIR----HPKYNRDTL-DNDIMLIKLSSPAVINARVSTISLPTAP 109
Query: 767 PNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMV 826
P A GT C + GWG ++Y + ++ P++T+ C + +T M
Sbjct: 110 P----AAGTECLISGWGNTLSFG-ADYPDELKCLDAPVLTQAECKASYPGK---ITNSMF 161
Query: 827 CAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVT 886
C G+ EGGKD+CQ D+GGP++C + G+VSWG CA + PGVY V YV
Sbjct: 162 CVGFLEGGKDSCQRDAGGPVVCNGQ-------LQGVVSWGHGCAWKNRPGVYTKVYNYVD 214
Query: 887 WIQDIM 892
WI+D +
Sbjct: 215 WIKDTI 220
>pdb|3KCG|H Chain H, Crystal Structure Of The Antithrombin-Factor Ixa-
Pentasaccharide Complex
Length = 235
Score = 119 bits (299), Expect = 6e-27, Method: Compositional matrix adjust.
Identities = 79/250 (31%), Positives = 128/250 (51%), Gaps = 28/250 (11%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
++GG ++ PG +P+ L G + +C G +++++W++TAAHCV TG+ I TV
Sbjct: 1 VVGGEDAKPGQFPWQVVLNGKVDA--FCGGSIVNEKWIVTAAHCV--ETGVKI---TVVA 53
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGA-QHDNDIALFQLKQKVKFNDHLLPVCLPPP 767
G + V + H YN ++++DIAL +L + + N ++ P+C+
Sbjct: 54 GEHNIEETEHTEQKRNVIRIIPHHNYNAAINKYNHDIALLELDEPLVLNSYVTPICIADK 113
Query: 768 NYE---LAPGTRCTVIGWG----KREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELN 820
Y L G+ V GWG K V +Y + VP++ R C L + +
Sbjct: 114 EYTNIFLKFGSG-YVSGWGRVFHKGRSALVLQY------LRVPLVDRATC---LRSTKFT 163
Query: 821 VTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAY 880
+ M CAG+ EGG+D+CQGD+GGP + F+ GI+SWG +CA G+Y
Sbjct: 164 IYNNMFCAGFHEGGRDSCQGDAGGPHVTEVEGTS---FLTGIISWGEECAMKGKYGIYTK 220
Query: 881 VPKYVTWIQD 890
V +YV WI++
Sbjct: 221 VSRYVNWIKE 230
>pdb|2VNT|A Chain A, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|B Chain B, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|C Chain C, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|D Chain D, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|E Chain E, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|F Chain F, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
Length = 276
Score = 119 bits (298), Expect = 7e-27, Method: Compositional matrix adjust.
Identities = 84/269 (31%), Positives = 129/269 (47%), Gaps = 20/269 (7%)
Query: 630 NIQCGTRRHLHNNFKARKRIIGGFESNPGDWPFLAALLG---GPEFVFYCAGVLISDQWV 686
QCG + + R +IIGG + + P+ AA+ G + C G L+S WV
Sbjct: 10 KFQCGQK-----TLRPRFKIIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWV 64
Query: 687 LTAAHCVGNLTGLNIDEWTVQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGA-QHDNDIA 745
++A HC + +++ V LG +R NS +F+V + H Y+ H NDIA
Sbjct: 65 ISATHCFIDYP--KKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIA 122
Query: 746 LFQLKQK----VKFNDHLLPVCLPPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVE 801
L +++ K + + + +CLP + GT C + G+GK E++ Y +
Sbjct: 123 LLKIRSKEGRCAQPSRTIQTICLPSMYNDPQFGTSCEITGFGK-ENSTDYLYPEQLKMTV 181
Query: 802 VPIITRDICNKWLNNRELNVTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGG 861
V +I+ C + + VT M+CA P+ D+CQGDSGGPL+C + G
Sbjct: 182 VKLISHRECQQ-PHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMT---LTG 237
Query: 862 IVSWGIKCAHPHLPGVYAYVPKYVTWIQD 890
IVSWG CA PGVY V ++ WI+
Sbjct: 238 IVSWGRGCALKDKPGVYTRVSHFLPWIRS 266
>pdb|1KIG|H Chain H, Bovine Factor Xa
Length = 241
Score = 119 bits (298), Expect = 8e-27, Method: Compositional matrix adjust.
Identities = 85/250 (34%), Positives = 128/250 (51%), Gaps = 24/250 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG + G+ P+ ALL E +C G ++++ +VLTAAHC+ +TV++
Sbjct: 1 IVGGRDCAEGECPW-QALLVNEENEGFCGGTILNEFYVLTAAHCL-----HQAKRFTVRV 54
Query: 709 GVTRRNSYAFFGTRF--KVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPP 766
G RN+ G +V HS++ + +D DIA+ +LK ++F ++ P CLP
Sbjct: 55 G--DRNTEQEEGNEMAHEVEMTVKHSRF-VKETYDFDIAVLRLKTPIRFRRNVAPACLPE 111
Query: 767 PNYE---LAPGTRCTVIGWGK-REDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVT 822
++ L V G+G+ E R+S + + +EVP + R C + +T
Sbjct: 112 KDWAEATLMTQKTGIVSGFGRTHEKGRLS---STLKMLEVPYVDRSTCKL---SSSFTIT 165
Query: 823 LGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVP 882
M CAGY +DACQGDSGGP + R + +FV GIVSWG CA GVY V
Sbjct: 166 PNMFCAGYDTQPEDACQGDSGGPHVTRFK---DTYFVTGIVSWGEGCARKGKFGVYTKVS 222
Query: 883 KYVTWIQDIM 892
++ WI IM
Sbjct: 223 NFLKWIDKIM 232
>pdb|3P8G|A Chain A, Crystal Structure Of Mt-Sp1 In Complex With Benzamidine
pdb|3P8F|A Chain A, Crystal Structure Of Mt-Sp1 In Complex With Sfti-1
Length = 241
Score = 118 bits (295), Expect = 2e-26, Method: Compositional matrix adjust.
Identities = 76/248 (30%), Positives = 128/248 (51%), Gaps = 17/248 (6%)
Query: 649 IIGGFESNPGDWPFLAAL--LGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNID---E 703
++GG +++ G+WP+ +L LG C LIS W+++AAHC + G +
Sbjct: 1 VVGGTDADEGEWPWQVSLHALGQGHI---CGASLISPNWLVSAAHCYIDDRGFRYSDPTQ 57
Query: 704 WTVQLGVTRRNSYAFFGTR-FKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPV 762
WT LG+ ++ + G + +++ + +H +N D DIAL +L++ +++ + P+
Sbjct: 58 WTAFLGLHDQSQRSAPGVQERRLKRIISHPFFN-DFTFDYDIALLELEKPAEYSSMVRPI 116
Query: 763 CLPPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVT 822
CLP ++ G V GWG + + + E+ +I + C L + +T
Sbjct: 117 CLPDASHVFPAGKAIWVTGWGHTQYGGTGAL--ILQKGEIRVIQQTTCENLLPQQ---IT 171
Query: 823 LGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVP 882
M+C G+ GG D+CQGDSGGPL S + F G+VSWG CA + PGVY +P
Sbjct: 172 PRMMCVGFLSGGVDSCQGDSGGPL--SSVEADGRIFQAGVVSWGDGCAQRNKPGVYTRLP 229
Query: 883 KYVTWIQD 890
+ WI++
Sbjct: 230 LFRDWIKE 237
>pdb|1EAW|A Chain A, Crystal Structure Of The Mtsp1 (Matriptase)-Bpti
(Aprotinin) Complex
pdb|1EAW|C Chain C, Crystal Structure Of The Mtsp1 (Matriptase)-Bpti
(Aprotinin) Complex
pdb|1EAX|A Chain A, Crystal Structure Of Mtsp1 (Matriptase)
pdb|2GV6|A Chain A, Crystal Structure Of Matriptase With Inhibitor Cj-730
pdb|2GV7|A Chain A, Structure Of Matriptase In Complex With Inhibitor Cj-672
Length = 241
Score = 118 bits (295), Expect = 2e-26, Method: Compositional matrix adjust.
Identities = 76/248 (30%), Positives = 128/248 (51%), Gaps = 17/248 (6%)
Query: 649 IIGGFESNPGDWPFLAAL--LGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNID---E 703
++GG +++ G+WP+ +L LG C LIS W+++AAHC + G +
Sbjct: 1 VVGGTDADEGEWPWQVSLHALGQGHI---CGASLISPNWLVSAAHCYIDDRGFRYSDPTQ 57
Query: 704 WTVQLGVTRRNSYAFFGTR-FKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPV 762
WT LG+ ++ + G + +++ + +H +N D DIAL +L++ +++ + P+
Sbjct: 58 WTAFLGLHDQSQRSAPGVQERRLKRIISHPFFN-DFTFDYDIALLELEKPAEYSSMVRPI 116
Query: 763 CLPPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVT 822
CLP ++ G V GWG + + + E+ +I + C L + +T
Sbjct: 117 CLPDASHVFPAGKAIWVTGWGHTQYGGTGAL--ILQKGEIRVINQTTCENLLPQQ---IT 171
Query: 823 LGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVP 882
M+C G+ GG D+CQGDSGGPL S + F G+VSWG CA + PGVY +P
Sbjct: 172 PRMMCVGFLSGGVDSCQGDSGGPL--SSVEADGRIFQAGVVSWGDGCAQRNKPGVYTRLP 229
Query: 883 KYVTWIQD 890
+ WI++
Sbjct: 230 LFRDWIKE 237
>pdb|1DAN|H Chain H, Complex Of Active Site Inhibited Human Blood Coagulation
Factor Viia With Human Recombinant Soluble Tissue Factor
pdb|1QFK|H Chain H, Structure Of Human Factor Viia And Its Implications For
The Triggering Of Blood Coagulation
pdb|1CVW|H Chain H, Crystal Structure Of Active Site-inhibited Human
Coagulation Factor Viia (des-gla)
pdb|1FAK|H Chain H, Human Tissue Factor Complexed With Coagulation Factor Viia
Inhibited With A Bpti-Mutant
pdb|1DVA|H Chain H, Crystal Structure Of The Complex Between The Peptide
Exosite Inhibitor E-76 And Coagulation Factor Viia
pdb|1DVA|I Chain I, Crystal Structure Of The Complex Between The Peptide
Exosite Inhibitor E-76 And Coagulation Factor Viia
pdb|1JBU|H Chain H, Coagulation Factor Vii Zymogen (Egf2PROTEASE) IN COMPLEX
WITH Inhibitory Exosite Peptide A-183
pdb|1KLI|H Chain H, Cofactor-And Substrate-Assisted Activation Of Factor Viia
pdb|1KLJ|H Chain H, Crystal Structure Of Uninhibited Factor Viia
pdb|1J9C|H Chain H, Crystal Structure Of Tissue Factor-Factor Viia Complex
pdb|1W0Y|H Chain H, Tf7a_3771 Complex
pdb|1YGC|H Chain H, Short Factor Viia With A Small Molecule Inhibitor
pdb|1Z6J|H Chain H, Crystal Structure Of A Ternary Complex Of Factor
Viia/tissue Factor/pyrazinone Inhibitor
pdb|1W2K|H Chain H, Tf7a_4380 Complex
pdb|1WQV|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Propylsulfonamide-D- Thr-Met-P-Aminobenzamidine
pdb|1W7X|H Chain H, Factor7- 413 Complex
pdb|1W8B|H Chain H, Factor7 - 413 Complex
pdb|1WSS|H Chain H, Human Factor Viia-Tissue Factor In Complex With Peprid
Mimetic Inhibitor That Has Two Charge Groups In P2 And
P4
pdb|1WTG|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Ethylsulfonamide-D-Biphenylalanine-Gln-P-
Aminobenzamidine
pdb|1WUN|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Ethylsulfonamide-D-Trp-Gln-P-Aminobenzamidine
pdb|1WV7|H Chain H, Human Factor Viia-tissue Factor Complexed With
Ethylsulfonamide-d-5-propoxy-trp-gln-p-aminobenzamidine
pdb|2B7D|H Chain H, Factor Viia Inhibitors: Chemical Optimization, Preclinical
Pharmacokinetics, Pharmacodynamics, And Efficacy In A
Baboon Thrombosis Model
pdb|2F9B|H Chain H, Discovery Of Novel Heterocyclic Factor Viia Inhibitors
pdb|2FLB|H Chain H, Discovery Of A Novel Hydroxy Pyrazole Based Factor Ixa
Inhibitor
pdb|2A2Q|H Chain H, Complex Of Active-Site Inhibited Human Coagulation Factor
Viia With Human Soluble Tissue Factor In The Presence Of
Ca2+, Mg2+, Na+, And Zn2+
pdb|2AER|H Chain H, Crystal Structure Of Benzamidine-Factor ViiaSOLUBLE TISSUE
Factor Complex.
pdb|2AEI|H Chain H, Crystal Structure Of A Ternary Complex Of Factor
ViiaTISSUE FACTOR And
2-[[6-[3-(Aminoiminomethyl)phenoxy]-3,
5-Difluro-4-[(1-Methyl-3-
Phenylpropyl)amino]-2-Pyridinyl]oxy]-Benzoic Acid
pdb|2FIR|H Chain H, Crystal Structure Of Dfpr-ViiaSTF
pdb|2C4F|H Chain H, Crystal Structure Of Factor Vii.Stf Complexed With
Pd0297121
pdb|2FLR|H Chain H, Novel 5-azaindole Factor Viia Inhibitors
pdb|2B8O|H Chain H, Crystal Structure Of Glu-gly-arg-chloromethyl
Ketone-factor Viia/soluble Tissue Factor Complex
pdb|2PUQ|H Chain H, Crystal Structure Of Active Site Inhibited Coagulation
Factor Viia In Complex With Soluble Tissue Factor
pdb|2EC9|H Chain H, Crystal Structure Analysis Of Human Factor Viia , Souluble
Tissue Factor Complexed With Bcx-3607
pdb|2ZP0|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Benzylsulfonamide-D- Ile-Gln-P-Aminobenzamidine
pdb|2ZWL|H Chain H, Human Factor Viia-Tissue Factor Complexed With Highly
Selective Peptide Inhibitor
pdb|2ZZU|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Ethylsulfonamide-D-5-
(3-Carboxybenzyloxy)-Trp-Gln-P-Aminobenzamidine
pdb|3TH2|H Chain H, Mg2+ Is Required For Optimal Folding Of The
Gamma-Carboxyglutamic Acid (Gla) Domains Of Vitamin
K-Dependent Clotting Factors At Physiological Ca2+
pdb|3TH3|H Chain H, Mg2+ Is Required For Optimal Folding Of The
Gamma-Carboxyglutamic Acid (Gla) Domains Of Vitamin
K-Dependent Clotting Factors At Physiological Ca2+
pdb|3TH4|H Chain H, Mg2+ Is Required For Optimal Folding Of The
Gamma-Carboxyglutamic Acid (Gla) Domains Of Vitamin
K-Dependent Clotting Factors At Physiological Ca2+
pdb|1O5D|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|2BZ6|H Chain H, Orally Available Factor7a Inhibitor
pdb|4ISI|H Chain H, Structure Of Factor Viia In Complex With The Inhibitor
(6s)-n-(4-
Carbamimidoylbenzyl)-1-chloro-3-(cyclobutylamino)-8,
8-diethyl-4-oxo-
4,6,7,8-tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamide
Length = 254
Score = 117 bits (293), Expect = 3e-26, Method: Compositional matrix adjust.
Identities = 87/252 (34%), Positives = 125/252 (49%), Gaps = 21/252 (8%)
Query: 649 IIGGFESNPGDWPFLAALL-GGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQ 707
I+GG G+ P+ LL G + C G LI+ WV++AAHC + N
Sbjct: 1 IVGGKVCPKGECPWQVLLLVNGAQL---CGGTLINTIWVVSAAHCFDKIK--NWRNLIAV 55
Query: 708 LGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPP 767
LG + + +V V S Y G ++DIAL +L Q V DH++P+CLP
Sbjct: 56 LGEHDLSEHDGDEQSRRVAQVIIPSTYVPGTT-NHDIALLRLHQPVVLTDHVVPLCLPER 114
Query: 768 NYE---LAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNREL----N 820
+ LA V GWG+ D + E V + VP + C + +R++ N
Sbjct: 115 TFSERTLAFVRFSLVSGWGQLLDRGATALELMV--LNVPRLMTQDCLQ--QSRKVGDSPN 170
Query: 821 VTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAY 880
+T M CAGY +G KD+C+GDSGGP ++H W++ GIVSWG CA GVY
Sbjct: 171 ITEYMFCAGYSDGSKDSCKGDSGGP---HATHYRGTWYLTGIVSWGQGCATVGHFGVYTR 227
Query: 881 VPKYVTWIQDIM 892
V +Y+ W+Q +M
Sbjct: 228 VSQYIEWLQKLM 239
>pdb|2EEK|A Chain A, Crystal Structure Of Atlantic Cod Trypsin Complexed With
Benzamidine
Length = 220
Score = 117 bits (293), Expect = 3e-26, Method: Compositional matrix adjust.
Identities = 81/244 (33%), Positives = 122/244 (50%), Gaps = 25/244 (10%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+E +L G F C G L+S WV++AAHC ++ + + E +++
Sbjct: 1 IVGGYECTKHSQAHQVSLNSGYHF---CGGSLVSKDWVVSAAHCYKSVLRVRLGEHHIRV 57
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
+ + + +R +S YNI +NDI L +L + N ++ V LP
Sbjct: 58 ---NEGTEQYISSSSVIRHP-NYSSYNI----NNDIMLIKLTKPATLNQYVHAVALPTEC 109
Query: 769 YELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVCA 828
A T CTV GWG + V++ + + + +PI++ C N+ +T M CA
Sbjct: 110 --AADATMCTVSGWGNTMSS-VADGDK-LQCLSLPILSHADC---ANSYPGMITQSMFCA 162
Query: 829 GYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTWI 888
GY EGGKD+CQGDSGGP++C + G+VSWG CA PGVYA V W+
Sbjct: 163 GYLEGGKDSCQGDSGGPVVCNG-------VLQGVVSWGYGCAERDHPGVYAKVCVLSGWV 215
Query: 889 QDIM 892
+D M
Sbjct: 216 RDTM 219
>pdb|1SC8|U Chain U, Urokinase Plasminogen Activator B-Chain-J435 Complex
pdb|1VJ9|U Chain U, Urokinase Plasminogen Activator B-Chain-Jt464 Complex
pdb|1VJA|U Chain U, Urokinase Plasminogen Activator B-Chain-Jt463 Complex
Length = 262
Score = 116 bits (290), Expect = 6e-26, Method: Compositional matrix adjust.
Identities = 84/269 (31%), Positives = 128/269 (47%), Gaps = 20/269 (7%)
Query: 630 NIQCGTRRHLHNNFKARKRIIGGFESNPGDWPFLAALLG---GPEFVFYCAGVLISDQWV 686
QCG + + R +IIGG + + P+ AA+ G + C G LIS WV
Sbjct: 2 KFQCGQK-----TLRPRFKIIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWV 56
Query: 687 LTAAHCVGNLTGLNIDEWTVQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGA-QHDNDIA 745
++A HC + +++ V LG +R NS +F+V + H Y+ H NDIA
Sbjct: 57 ISATHCFIDYP--KKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIA 114
Query: 746 LFQLKQK----VKFNDHLLPVCLPPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVE 801
L +++ K + + + + LP + GT C + G+GK E++ Y +
Sbjct: 115 LLKIRSKEGRCAQPSRTIQTISLPSMYNDPQFGTSCEITGFGK-ENSTDYLYPEQLKMTV 173
Query: 802 VPIITRDICNKWLNNRELNVTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGG 861
V +I+ C + + VT M+CA P+ D+CQGDSGGPL+C + G
Sbjct: 174 VKLISHRECQQ-PHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMT---LTG 229
Query: 862 IVSWGIKCAHPHLPGVYAYVPKYVTWIQD 890
IVSWG CA PGVY V ++ WI+
Sbjct: 230 IVSWGRGCALKDKPGVYTRVSHFLPWIRS 258
>pdb|3ELA|H Chain H, Crystal Structure Of Active Site Inhibited Coagulation
Factor Viia Mutant In Complex With Soluble Tissue Factor
Length = 254
Score = 116 bits (290), Expect = 6e-26, Method: Compositional matrix adjust.
Identities = 86/252 (34%), Positives = 125/252 (49%), Gaps = 21/252 (8%)
Query: 649 IIGGFESNPGDWPFLAALL-GGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQ 707
I+GG + G+ P+ LL G + C G LI+ WV++AAHC + N
Sbjct: 1 IVGGKDCPKGECPWQVLLLVNGAQL---CGGTLINTIWVVSAAHCFDKIK--NWRNLIAV 55
Query: 708 LGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPP 767
LG + + +V V S Y G ++DIAL +L Q V DH++P+CLP
Sbjct: 56 LGEHDLSEHDGDEQSRRVAQVIIPSTYVPGTT-NHDIALLRLHQPVVLTDHVVPLCLPER 114
Query: 768 NYE---LAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNREL----N 820
+ LA V GWG+ D + V + VP + C + +R++ N
Sbjct: 115 TFSERTLAFVRFSLVSGWGQLLDRGATALVLQV--LNVPRLMTQDCLQ--QSRKVGDSPN 170
Query: 821 VTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAY 880
+T M CAGY +G KD+C+GDSGGP ++H W++ GIVSWG CA GVY
Sbjct: 171 ITEYMFCAGYSDGSKDSCKGDSGGP---HATHYRGTWYLTGIVSWGQGCATVGHFGVYTR 227
Query: 881 VPKYVTWIQDIM 892
V +Y+ W+Q +M
Sbjct: 228 VSQYIEWLQKLM 239
>pdb|4E7N|A Chain A, Crystal Structure Of Ahv_tl-I, A Glycosylated Snake-Venom
Thrombin- Like Enzyme From Agkistrodon Halys
Length = 238
Score = 115 bits (288), Expect = 1e-25, Method: Compositional matrix adjust.
Identities = 84/246 (34%), Positives = 118/246 (47%), Gaps = 20/246 (8%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
IIGG E N + FL AL +C G LI+ +WVLTAAHC + + ++L
Sbjct: 1 IIGGDECNINEHRFLVALYTSRSRTLFCGGTLINQEWVLTAAHC-------DRKNFRIKL 53
Query: 709 GV-TRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPP 767
G+ +++ TR F S N D DI L +L VK + H+ P LP
Sbjct: 54 GMHSKKVPNEDEQTRVPKEKFFCLSSKNY-TLWDKDIMLIRLDSPVKNSKHIAPFSLPSS 112
Query: 768 NYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVC 827
+ G+ C ++GWG+ T Y + V + ++ ++C EL T +C
Sbjct: 113 PPSV--GSVCRIMGWGRISPTE-GTYPDVPHCVNINLLEYEMCRAPYPEFELPATSRTLC 169
Query: 828 AGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIK-CAHPHLPGVYAYVPKYVT 886
AG EGGKD C+GDSGGPL+C GI SWG CA PH P Y V ++
Sbjct: 170 AGILEGGKDTCKGDSGGPLICNGQFQ-------GIASWGDDPCAQPHKPAAYTKVFDHLD 222
Query: 887 WIQDIM 892
WI++I+
Sbjct: 223 WIENII 228
>pdb|2BQ6|B Chain B, Crystal Structure Of Factor Xa In Complex With 21
pdb|2BQ7|B Chain B, Crystal Structure Of Factor Xa In Complex With 43
pdb|2BQW|B Chain B, Crystal Structure Of Factor Xa In Complex With Compound 45
Length = 249
Score = 115 bits (288), Expect = 1e-25, Method: Compositional matrix adjust.
Identities = 82/250 (32%), Positives = 124/250 (49%), Gaps = 22/250 (8%)
Query: 648 RIIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQ 707
RI+GG E G+ P+ ALL E +C G ++S+ ++LTAAHC+ + V+
Sbjct: 15 RIVGGQECKDGECPW-QALLINEENEGFCGGTILSEFYILTAAHCL-----YQAKRFKVR 68
Query: 708 LGVTRRNSYAFFGTR--FKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLP 765
+G RN+ G +V V H+++ +D DIA+ +LK + F ++ P CLP
Sbjct: 69 VG--DRNTEQEEGGEAVHEVEVVIKHNRFT-KETYDFDIAVLRLKTPITFRMNVAPACLP 125
Query: 766 PPNYE---LAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVT 822
++ L V G+G+ + T + +EVP + R+ C + +T
Sbjct: 126 ERDWAESTLMTQKTGIVSGFGRTHEK--GRQSTRLKMLEVPYVDRNSCKL---SSSFIIT 180
Query: 823 LGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVP 882
M CAGY +DACQGDSGGP + R + +FV GIVSWG CA G+Y V
Sbjct: 181 QNMFCAGYDTKQEDACQGDSGGPHVTRFK---DTYFVTGIVSWGEGCARKGKYGIYTKVT 237
Query: 883 KYVTWIQDIM 892
++ WI M
Sbjct: 238 AFLKWIDRSM 247
>pdb|1FAX|A Chain A, Coagulation Factor Xa Inhibitor Complex
Length = 254
Score = 115 bits (287), Expect = 1e-25, Method: Compositional matrix adjust.
Identities = 82/249 (32%), Positives = 124/249 (49%), Gaps = 22/249 (8%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG E G+ P+ ALL E +C G ++S+ ++LTAAHC+ + V++
Sbjct: 1 IVGGQECKDGECPW-QALLINEENEGFCGGTILSEFYILTAAHCL-----YQAKRFKVRV 54
Query: 709 GVTRRNSYAFFGTR--FKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPP 766
G RN+ A G +V V H+++ +D DIA+ +LK + F ++ P CLP
Sbjct: 55 G--DRNTAAEEGGEAVHEVEVVIKHNRFT-KETYDFDIAVLRLKTPITFRMNVAPACLPE 111
Query: 767 PNYE---LAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTL 823
++ L V G+G+ + T + +EVP + R+ C + +T
Sbjct: 112 RDWAESTLMTQKTGIVSGFGRTHEK--GRQSTRLKMLEVPYVDRNSCKL---SSSFIITQ 166
Query: 824 GMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPK 883
M CAGY +DACQGDSGGP + R + +FV GIVSWG CA G+Y V
Sbjct: 167 NMFCAGYDTKQEDACQGDSGGPHVTRFK---DTYFVTGIVSWGEGCARKGKYGIYTKVTA 223
Query: 884 YVTWIQDIM 892
++ WI M
Sbjct: 224 FLKWIDRSM 232
>pdb|1OWE|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1OWH|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1SQA|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1SQO|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
Length = 245
Score = 115 bits (287), Expect = 2e-25, Method: Compositional matrix adjust.
Identities = 80/249 (32%), Positives = 121/249 (48%), Gaps = 15/249 (6%)
Query: 649 IIGGFESNPGDWPFLAALLG---GPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWT 705
IIGG + + P+ AA+ G + C G L+S WV++A HC + +++
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYP--KKEDYI 58
Query: 706 VQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGA-QHDNDIALFQLKQK----VKFNDHLL 760
V LG +R NS +F+V + H Y+ H NDIAL +++ K + + +
Sbjct: 59 VYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQ 118
Query: 761 PVCLPPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELN 820
+CLP + GT C + G+GK + T Y + V +I+ C + +
Sbjct: 119 TICLPSMYNDPQFGTSCEITGFGKEQSTDYL-YPEQLKMTVVKLISHRECQQ-PHYYGSE 176
Query: 821 VTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAY 880
VT M+CA P+ D+CQGDSGGPL+C + GIVSWG CA PGVY
Sbjct: 177 VTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMT---LTGIVSWGRGCALKDKPGVYTR 233
Query: 881 VPKYVTWIQ 889
V ++ WI+
Sbjct: 234 VSHFLPWIR 242
>pdb|3IG6|B Chain B, Low Molecular Weigth Human Urokinase Type Plasminogen
Activator 2-[6-
(3'-Aminomethyl-Biphenyl-3-Yloxy)-4-(3-Dimethylamino-
Pyrrolidin-1-
Yl)-3,
5-Difluoro-Pyridin-2-Yloxy]-4-Dimethylamino-Benzoic Acid
Complex
pdb|3IG6|D Chain D, Low Molecular Weigth Human Urokinase Type Plasminogen
Activator 2-[6-
(3'-Aminomethyl-Biphenyl-3-Yloxy)-4-(3-Dimethylamino-
Pyrrolidin-1-
Yl)-3,
5-Difluoro-Pyridin-2-Yloxy]-4-Dimethylamino-Benzoic Acid
Complex
Length = 253
Score = 114 bits (286), Expect = 2e-25, Method: Compositional matrix adjust.
Identities = 81/249 (32%), Positives = 122/249 (48%), Gaps = 15/249 (6%)
Query: 649 IIGGFESNPGDWPFLAALLG---GPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWT 705
IIGG + + P+ AA+ G + C G LIS WV++A HC + +++
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYP--KKEDYI 58
Query: 706 VQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGA-QHDNDIALFQLKQK----VKFNDHLL 760
V LG +R NS +F+V + H Y+ H NDIAL +++ K + + +
Sbjct: 59 VYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQ 118
Query: 761 PVCLPPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELN 820
+CLP + GT C + G+GK E++ Y + V +I+ C + +
Sbjct: 119 TICLPSMYNDPQFGTSCEITGFGK-ENSTDYLYPEQLKMTVVKLISHRECQQ-PHYYGSE 176
Query: 821 VTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAY 880
VT M+CA P+ D+CQGDSGGPL+C + GIVSWG CA PGVY
Sbjct: 177 VTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMT---LTGIVSWGRGCALKDKPGVYTR 233
Query: 881 VPKYVTWIQ 889
V ++ WI+
Sbjct: 234 VSHFLPWIR 242
>pdb|3BN9|B Chain B, Crystal Structure Of Mt-Sp1 In Complex With Fab Inhibitor
E2
pdb|3BN9|A Chain A, Crystal Structure Of Mt-Sp1 In Complex With Fab Inhibitor
E2
pdb|3NCL|A Chain A, Crystal Structure Of Mt-Sp1 Bound To Benzamidine
Phosphonate Inhibitor
pdb|3NPS|A Chain A, Crystal Structure Of Membrane-Type Serine Protease 1
(Mt-Sp1) In Complex With The Fab Inhibitor S4
pdb|3SO3|A Chain A, Structures Of Fab-Protease Complexes Reveal A Highly
Specific Non- Canonical Mechanism Of Inhibition
Length = 241
Score = 114 bits (286), Expect = 2e-25, Method: Compositional matrix adjust.
Identities = 75/248 (30%), Positives = 127/248 (51%), Gaps = 17/248 (6%)
Query: 649 IIGGFESNPGDWPFLAAL--LGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNID---E 703
++GG +++ G+WP+ +L LG C LIS W+++AAHC + G +
Sbjct: 1 VVGGTDADEGEWPWQVSLHALGQGHI---CGASLISPNWLVSAAHCYIDDRGFRYSDPTQ 57
Query: 704 WTVQLGVTRRNSYAFFGTR-FKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPV 762
WT LG+ ++ + G + +++ + +H +N D DIAL +L++ +++ + P+
Sbjct: 58 WTAFLGLHDQSQRSAPGVQERRLKRIISHPFFN-DFTFDYDIALLELEKPAEYSSMVRPI 116
Query: 763 CLPPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVT 822
LP ++ G V GWG + + + E+ +I + C L + +T
Sbjct: 117 SLPDASHVFPAGKAIWVTGWGHTQYGGTGAL--ILQKGEIRVINQTTCENLLPQQ---IT 171
Query: 823 LGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVP 882
M+C G+ GG D+CQGDSGGPL S + F G+VSWG CA + PGVY +P
Sbjct: 172 PRMMCVGFLSGGVDSCQGDSGGPL--SSVEADGRIFQAGVVSWGDGCAQRNKPGVYTRLP 229
Query: 883 KYVTWIQD 890
+ WI++
Sbjct: 230 LFRDWIKE 237
>pdb|2BOK|A Chain A, Factor Xa- Cation
pdb|2JKH|A Chain A, Factor Xa - Cation Inhibitor Complex
pdb|2VVC|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VVC|B Chain B, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VVU|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VVV|A Chain A, Aminopyrrolidine-Related Triazole Factor Xa Inhibitor
pdb|2VWL|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWM|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWM|B Chain B, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWN|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWO|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2XBV|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
Length = 241
Score = 114 bits (286), Expect = 2e-25, Method: Compositional matrix adjust.
Identities = 82/249 (32%), Positives = 123/249 (49%), Gaps = 22/249 (8%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG E G+ P+ ALL E +C G ++S+ ++LTAAHC+ + V++
Sbjct: 1 IVGGQECKDGECPW-QALLINEENEGFCGGTILSEFYILTAAHCL-----YQAKRFKVRV 54
Query: 709 GVTRRNSYAFFGTR--FKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPP 766
G RN+ G +V V H+++ +D DIA+ +LK + F ++ P CLP
Sbjct: 55 G--DRNTEQEEGGEAVHEVEVVIKHNRFT-KETYDFDIAVLRLKTPITFRMNVAPACLPE 111
Query: 767 PNYE---LAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTL 823
++ L V G+G+ + E T + +EVP + R+ C + +T
Sbjct: 112 RDWAESTLMTQKTGIVSGFGRTHEK--GEQSTRLKMLEVPYVDRNSCKL---SSSFIITQ 166
Query: 824 GMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPK 883
M CAGY +DACQGDSGGP + R + FV GIVSWG CA G+Y V
Sbjct: 167 NMFCAGYDTKQEDACQGDSGGPHVTRFKDTY---FVTGIVSWGEGCARKGKYGIYTKVTA 223
Query: 884 YVTWIQDIM 892
++ WI M
Sbjct: 224 FLKWIDRSM 232
>pdb|1O5A|B Chain B, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|1O5B|B Chain B, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (ala190 Upa)
pdb|1O5C|B Chain B, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
Length = 253
Score = 114 bits (286), Expect = 2e-25, Method: Compositional matrix adjust.
Identities = 81/249 (32%), Positives = 120/249 (48%), Gaps = 15/249 (6%)
Query: 649 IIGGFESNPGDWPFLAALLG---GPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWT 705
IIGG + + P+ AA+ G + C G L+S WV++A HC + +++
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYP--KKEDYI 58
Query: 706 VQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGA-QHDNDIALFQLKQK----VKFNDHLL 760
V LG +R NS +F+V + H Y+ H NDIAL +++ K + + +
Sbjct: 59 VYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQ 118
Query: 761 PVCLPPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELN 820
+CLP + GT C + G+GK T Y + V +I+ C + +
Sbjct: 119 TICLPSMYNDPQFGTSCEITGFGKEASTDYL-YPEQLKMTVVKLISHRECQQ-PHYYGSE 176
Query: 821 VTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAY 880
VT M+CA P+ DACQGDSGGPL+C + GIVSWG CA PGVY
Sbjct: 177 VTTKMLCAADPQWKTDACQGDSGGPLVCSLQGRMT---LTGIVSWGRGCALKDKPGVYTR 233
Query: 881 VPKYVTWIQ 889
V ++ WI+
Sbjct: 234 VSHFLPWIR 242
>pdb|1GDU|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1PQ5|A Chain A, Trypsin At Ph 5, 0.85 A
pdb|1PQ7|A Chain A, Trypsin At 0.8 A, Ph5 BORAX
pdb|1PQ8|A Chain A, Trypsin At Ph 4 At Atomic Resolution
pdb|2G51|A Chain A, Anomalous Substructure Of Trypsin (P1)
pdb|2G52|A Chain A, Anomalous Substructure Of Trypsin (P21)
pdb|1TRY|A Chain A, Structure Of Inhibited Trypsin From Fusarium Oxysporum At
1.55 Angstroms
pdb|2VU8|E Chain E, Crystal Structure Of An Insect Inhibitor With A Fungal
Trypsin
Length = 224
Score = 114 bits (286), Expect = 2e-25, Method: Composition-based stats.
Identities = 81/237 (34%), Positives = 118/237 (49%), Gaps = 28/237 (11%)
Query: 649 IIGGFESNPGDWPFLAALL--GGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTV 706
I+GG ++ GD+PF+ ++ GGP +C G L++ VLTAAHCV +G + +
Sbjct: 1 IVGGTSASAGDFPFIVSISRNGGP----WCGGSLLNANTVLTAAHCV---SGYAQSGFQI 53
Query: 707 QLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPP 766
+ G R S + VR H Y + ++ND+A+ +L + ++ L
Sbjct: 54 RAGSLSRTSGGITSSLSSVR---VHPSY---SGNNNDLAILKLSTSIPSGGNIGYARLAA 107
Query: 767 PNYELAPGTRCTVIGWGKREDTRVSEYETAVN--EVEVPIITRDICNKWLNNRELNVTLG 824
+ G+ TV GWG + S T VN +V VPI++R C +T
Sbjct: 108 SGSDPVAGSSATVAGWGATSEGGSS---TPVNLLKVTVPIVSRATCRAQYGTSA--ITNQ 162
Query: 825 MVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYV 881
M CAG GGKD+CQGDSGGP++ S+ + G VSWG CA P+ GVYA V
Sbjct: 163 MFCAGVSSGGKDSCQGDSGGPIVDSSNT------LIGAVSWGNGCARPNYSGVYASV 213
>pdb|2Y5F|A Chain A, Factor Xa - Cation Inhibitor Complex
pdb|2Y5G|A Chain A, Factor Xa - Cation Inhibitor Complex
pdb|2Y5H|A Chain A, Factor Xa - Cation Inhibitor Complex
Length = 234
Score = 114 bits (285), Expect = 2e-25, Method: Compositional matrix adjust.
Identities = 82/249 (32%), Positives = 123/249 (49%), Gaps = 22/249 (8%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG E G+ P+ ALL E +C G ++S+ ++LTAAHC+ + V++
Sbjct: 1 IVGGQECKDGECPW-QALLINEENEGFCGGTILSEFYILTAAHCL-----YQAKRFKVRV 54
Query: 709 GVTRRNSYAFFGTR--FKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPP 766
G RN+ G +V V H+++ +D DIA+ +LK + F ++ P CLP
Sbjct: 55 G--DRNTEQEEGGEAVHEVEVVIKHNRFT-KETYDFDIAVLRLKTPITFRMNVAPACLPE 111
Query: 767 PNYE---LAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTL 823
++ L V G+G+ + E T + +EVP + R+ C + +T
Sbjct: 112 RDWAESTLMTQKTGIVSGFGRTHEK--GEQSTRLKMLEVPYVDRNSCKL---SSSFIITQ 166
Query: 824 GMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPK 883
M CAGY +DACQGDSGGP + R + FV GIVSWG CA G+Y V
Sbjct: 167 NMFCAGYDTKQEDACQGDSGGPHVTRFKDTY---FVTGIVSWGEGCARKGKYGIYTKVTA 223
Query: 884 YVTWIQDIM 892
++ WI M
Sbjct: 224 FLKWIDRSM 232
>pdb|1OWD|A Chain A, Substituted 2-naphthamidine Inhibitors Of Urokinase
pdb|1OWI|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1OWJ|A Chain A, Substituted 2-naphthamidine Inhibitors Of Urokinase
pdb|1OWK|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1SQT|A Chain A, Substituted 2-naphthamidine Inhibitors Of Urokinase
pdb|1U6Q|A Chain A, Substituted 2-naphthamadine Inhibitors Of Urokinase
Length = 245
Score = 114 bits (284), Expect = 3e-25, Method: Compositional matrix adjust.
Identities = 80/249 (32%), Positives = 122/249 (48%), Gaps = 15/249 (6%)
Query: 649 IIGGFESNPGDWPFLAALLG---GPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWT 705
IIGG + + P+ AA+ G + C G L+S WV++A HC + +++
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYP--KKEDYI 58
Query: 706 VQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGA-QHDNDIALFQLKQK----VKFNDHLL 760
V LG +R NS +F+V + H Y+ H NDIAL +++ K + + +
Sbjct: 59 VYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQ 118
Query: 761 PVCLPPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELN 820
+CLP + GT C + G+GK E++ Y + V +I+ C + +
Sbjct: 119 TICLPSMYNDPQFGTSCEITGFGK-ENSTDYLYPEQLKMTVVKLISHRECQQ-PHYYGSE 176
Query: 821 VTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAY 880
VT M+CA P+ D+CQGDSGGPL+C + GIVSWG CA PGVY
Sbjct: 177 VTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMT---LTGIVSWGRGCALKDKPGVYTR 233
Query: 881 VPKYVTWIQ 889
V ++ WI+
Sbjct: 234 VSHFLPWIR 242
>pdb|2ZGC|A Chain A, Crystal Structure Of Active Human Granzyme M
pdb|2ZGH|A Chain A, Crystal Structure Of Active Granzyme M Bound To Its
Product
pdb|2ZKS|A Chain A, Structural Insights Into The Proteolytic Machinery Of
Apoptosis- Inducing Granzyme M
Length = 240
Score = 114 bits (284), Expect = 3e-25, Method: Composition-based stats.
Identities = 79/250 (31%), Positives = 125/250 (50%), Gaps = 24/250 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
IIGG E P P++A+L + C GVL+ +WVLTAAHC+ + + + L
Sbjct: 1 IIGGREVIPHSRPYMASLQRNGSHL--CGGVLVHPKWVLTAAHCLAQ----RMAQLRLVL 54
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
G+ +S G F ++ H +Y +ND+AL QL KVK + + P+ LP
Sbjct: 55 GLHTLDSP---GLTFHIKAAIQHPRYKPVPALENDLALLQLDGKVKPSRTIRPLALPSKR 111
Query: 769 YELAPGTRCTVIGWG-KREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTL--GM 825
+A GTRC++ GWG + R+S + E+++ ++ +CN N+R N +L M
Sbjct: 112 QVVAAGTRCSMAGWGLTHQGGRLSR---VLRELDLQVLDTRMCN---NSRFWNGSLSPSM 165
Query: 826 VCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIK-CAHPHLPGVYAYVPKY 884
VC + C+GDSGGPL+C + G++S+ + C P V V Y
Sbjct: 166 VCLAADSKDQAPCKGDSGGPLVCGKGR-----VLAGVLSFSSRVCTDIFKPPVATAVAPY 220
Query: 885 VTWIQDIMDK 894
V+WI+ + +
Sbjct: 221 VSWIRKVTGR 230
>pdb|1GI8|B Chain B, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI7|B Chain B, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI9|B Chain B, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
Length = 245
Score = 114 bits (284), Expect = 3e-25, Method: Compositional matrix adjust.
Identities = 80/250 (32%), Positives = 120/250 (48%), Gaps = 15/250 (6%)
Query: 649 IIGGFESNPGDWPFLAALLG---GPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWT 705
IIGG + + P+ AA+ G + C G L+S WV++A HC + +++
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYP--KKEDYI 58
Query: 706 VQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGA-QHDNDIALFQLKQK----VKFNDHLL 760
V LG +R NS +F+V + H Y+ H NDIAL +++ K + + +
Sbjct: 59 VYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQ 118
Query: 761 PVCLPPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELN 820
+CLP + GT C + G+GK T Y + V +I+ C + +
Sbjct: 119 TICLPSMYNDPQFGTSCEITGFGKEASTDYL-YPEQLKMTVVKLISHRECQQ-PHYYGSE 176
Query: 821 VTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAY 880
VT M+CA P+ D+CQGDSGGPL+C + GIVSWG CA PGVY
Sbjct: 177 VTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMT---LTGIVSWGRGCALKDKPGVYTR 233
Query: 881 VPKYVTWIQD 890
V ++ WI+
Sbjct: 234 VSHFLPWIRS 243
>pdb|1LMW|B Chain B, Lmw U-Pa Structure Complexed With Egrcmk (Glu-Gly-Arg
Chloromethyl Ketone)
pdb|1LMW|D Chain D, Lmw U-Pa Structure Complexed With Egrcmk (Glu-Gly-Arg
Chloromethyl Ketone)
Length = 253
Score = 113 bits (283), Expect = 4e-25, Method: Compositional matrix adjust.
Identities = 80/249 (32%), Positives = 122/249 (48%), Gaps = 15/249 (6%)
Query: 649 IIGGFESNPGDWPFLAALLG---GPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWT 705
IIGG + + P+ AA+ G + C G L+S WV++A HC + +++
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYP--KKEDYI 58
Query: 706 VQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGA-QHDNDIALFQLKQK----VKFNDHLL 760
V LG +R NS +F+V + H Y+ H NDIAL +++ K + + +
Sbjct: 59 VYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQ 118
Query: 761 PVCLPPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELN 820
+CLP + GT C + G+GK E++ Y + V +I+ C + +
Sbjct: 119 TICLPSMYNDPQFGTSCEITGFGK-ENSTDYLYPEQLKMTVVKLISHRECQQ-PHYYGSE 176
Query: 821 VTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAY 880
VT M+CA P+ D+CQGDSGGPL+C + GIVSWG CA PGVY
Sbjct: 177 VTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMT---LTGIVSWGRGCALKDKPGVYTR 233
Query: 881 VPKYVTWIQ 889
V ++ WI+
Sbjct: 234 VSHFLPWIR 242
>pdb|1GJ7|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJ8|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJA|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJB|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1O3P|B Chain B, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1C5W|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5X|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5Y|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5Z|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1GJ9|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJD|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJC|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
Length = 253
Score = 113 bits (283), Expect = 4e-25, Method: Compositional matrix adjust.
Identities = 80/249 (32%), Positives = 120/249 (48%), Gaps = 15/249 (6%)
Query: 649 IIGGFESNPGDWPFLAALLG---GPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWT 705
IIGG + + P+ AA+ G + C G L+S WV++A HC + +++
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYP--KKEDYI 58
Query: 706 VQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGA-QHDNDIALFQLKQK----VKFNDHLL 760
V LG +R NS +F+V + H Y+ H NDIAL +++ K + + +
Sbjct: 59 VYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQ 118
Query: 761 PVCLPPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELN 820
+CLP + GT C + G+GK T Y + V +I+ C + +
Sbjct: 119 TICLPSMYNDPQFGTSCEITGFGKEASTDYL-YPEQLKMTVVKLISHRECQQ-PHYYGSE 176
Query: 821 VTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAY 880
VT M+CA P+ D+CQGDSGGPL+C + GIVSWG CA PGVY
Sbjct: 177 VTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMT---LTGIVSWGRGCALKDKPGVYTR 233
Query: 881 VPKYVTWIQ 889
V ++ WI+
Sbjct: 234 VSHFLPWIR 242
>pdb|1SGF|G Chain G, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
pdb|1SGF|Z Chain Z, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
Length = 237
Score = 113 bits (283), Expect = 4e-25, Method: Compositional matrix adjust.
Identities = 79/257 (30%), Positives = 116/257 (45%), Gaps = 33/257 (12%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GGF+ P+ A+ +++ C GVL+ WVLTAAHC D + V L
Sbjct: 1 IVGGFKCEKNSQPWHVAVYRYTQYL--CGGVLLDPNWVLTAAHCYD-------DNYKVWL 51
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQ----------HDNDIALFQLKQKVKFNDH 758
G V H +N+ + ND+ L +L + D
Sbjct: 52 GKNNLFKDEPSAQHRFVSKAIPHPGFNMSLMRKHIRFLEYDYSNDLMLLRLSKPADITDT 111
Query: 759 LLPVCLPPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRE 818
+ P+ LP +L G+ C GWG T+ ++ + V + ++ + C K
Sbjct: 112 VKPITLPTEEPKL--GSTCLASGWGSITPTKF-QFTDDLYCVNLKLLPNEDCAK---AHI 165
Query: 819 LNVTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWG-IKCAHPHLPGV 877
VT M+CAG +GGKD C+GDSGGPL+C + GI SWG C P +PGV
Sbjct: 166 EKVTDAMLCAGEMDGGKDTCKGDSGGPLICDG-------VLQGITSWGHTPCGEPDMPGV 218
Query: 878 YAYVPKYVTWIQDIMDK 894
Y + K+ +WI+D M K
Sbjct: 219 YTKLNKFTSWIKDTMAK 235
>pdb|1HJ9|A Chain A, Atomic Resolution Structures Of Trypsin Provide Insight
Into Structural Radiation Damage
Length = 223
Score = 113 bits (283), Expect = 5e-25, Method: Compositional matrix adjust.
Identities = 77/244 (31%), Positives = 114/244 (46%), Gaps = 24/244 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+ P+ +L G F C G LI+ QWV++AAHC +G+ + +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF---CGGSLINSQWVVSAAHCY--KSGIQVRLGEDNI 55
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
V N ++ V H YN +NDI L +LK N + + LP
Sbjct: 56 NVVEGNEQFISASKSIV-----HPSYN-SNTLNNDIMLIKLKSAASLNSRVASISLPTS- 108
Query: 769 YELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVCA 828
+ GT+C + GWG + + S Y + ++ PI++ C + +T M CA
Sbjct: 109 -CASAGTQCLISGWGNTKSSGTS-YPDVLKCLKAPILSDSSCKSAYPGQ---ITSNMFCA 163
Query: 829 GYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTWI 888
EG D+CQGDSGGP++C + GIVSWG C + PGVY V YV+WI
Sbjct: 164 YGLEGKGDSCQGDSGGPVVCSGK-------LQGIVSWGSGCQAKNKPGVYTKVCNYVSWI 216
Query: 889 QDIM 892
+ +
Sbjct: 217 KQTI 220
>pdb|1C5M|D Chain D, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
Length = 255
Score = 113 bits (282), Expect = 6e-25, Method: Compositional matrix adjust.
Identities = 81/249 (32%), Positives = 122/249 (48%), Gaps = 22/249 (8%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG E G+ P+ ALL E +C G ++S+ ++LTAAHC+ + V++
Sbjct: 1 IVGGQECKDGECPW-QALLINEENEGFCGGTILSEFYILTAAHCL-----YQAKRFKVRV 54
Query: 709 GVTRRNSYAFFGTR--FKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPP 766
G RN+ G +V V H+++ +D DIA+ +LK + F ++ P CLP
Sbjct: 55 G--DRNTEQEEGGEAVHEVEVVIKHNRFT-KETYDFDIAVLRLKTPITFRMNVAPACLPE 111
Query: 767 PNYE---LAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTL 823
++ L V G+G+ + T + +EVP + R+ C + +T
Sbjct: 112 RDWAESTLMTQKTGIVSGFGRTHEK--GRQSTRLKMLEVPYVDRNSCKL---SSSFIITQ 166
Query: 824 GMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPK 883
M CAGY +DACQGDSGGP + R + FV GIVSWG CA G+Y V
Sbjct: 167 NMFCAGYDTKQEDACQGDSGGPHVTRFKDTY---FVTGIVSWGEGCARKGKYGIYTKVTA 223
Query: 884 YVTWIQDIM 892
++ WI M
Sbjct: 224 FLKWIDRSM 232
>pdb|1PPZ|A Chain A, Trypsin Complexes At Atomic And Ultra-High Resolution
pdb|1PQA|A Chain A, Trypsin With Pmsf At Atomic Resolution
Length = 224
Score = 112 bits (281), Expect = 6e-25, Method: Composition-based stats.
Identities = 80/237 (33%), Positives = 117/237 (49%), Gaps = 28/237 (11%)
Query: 649 IIGGFESNPGDWPFLAALL--GGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTV 706
I+GG ++ GD+PF+ ++ GGP +C G L++ VLTAAHCV +G + +
Sbjct: 1 IVGGTSASAGDFPFIVSISRNGGP----WCGGSLLNANTVLTAAHCV---SGYAQSGFQI 53
Query: 707 QLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPP 766
+ G R S + VR H Y + ++ND+A+ +L + ++ L
Sbjct: 54 RAGSLSRTSGGITSSLSSVR---VHPSY---SGNNNDLAILKLSTSIPSGGNIGYARLAA 107
Query: 767 PNYELAPGTRCTVIGWGKREDTRVSEYETAVN--EVEVPIITRDICNKWLNNRELNVTLG 824
+ G+ TV GWG + S T VN +V VPI++R C +T
Sbjct: 108 SGSDPVAGSSATVAGWGATSEGGSS---TPVNLLKVTVPIVSRATCRAQYGTSA--ITNQ 162
Query: 825 MVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYV 881
M CAG GGKD+CQGD GGP++ S+ + G VSWG CA P+ GVYA V
Sbjct: 163 MFCAGVSSGGKDSCQGDXGGPIVDSSNT------LIGAVSWGNGCARPNYSGVYASV 213
>pdb|1EZQ|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr128515
pdb|1F0R|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr208815
pdb|1F0S|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr208707
pdb|1KSN|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Fxv673
pdb|1NFU|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr132747
pdb|1NFW|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr209685
pdb|1NFX|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr208944
pdb|1NFY|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr200095
pdb|1LPG|B Chain B, Crystal Structure Of Fxa In Complex With 79.
pdb|1LPK|B Chain B, Crystal Structure Of Fxa In Complex With 125.
pdb|1LPZ|B Chain B, Crystal Structure Of Fxa In Complex With 41.
pdb|1LQD|B Chain B, Crystal Structure Of Fxa In Complex With 45.
pdb|1P0S|H Chain H, Crystal Structure Of Blood Coagulation Factor Xa In
Complex With Ecotin M84r
pdb|2BOH|B Chain B, Crystal Structure Of Factor Xa In Complex With Compound
"1"
pdb|2CJI|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J2U|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J34|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J38|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J4I|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J94|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J95|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2UWL|A Chain A, Selective And Dual Action Orally Active Inhibitors Of
Thrombin And Factor Xa
pdb|2UWO|A Chain A, Selective And Dual Action Orally Active Inhibitors Of
Thrombin And Factor Xa
pdb|2UWP|A Chain A, Factor Xa Inhibitor Complex
pdb|2VH0|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Biaryl Pyrrolidin-2-Ones Incorporating Basic
Heterocyclic Motifs
pdb|2VH6|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Biaryl P4 Motifs
pdb|2WYG|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Monoaryl P4 Motifs
pdb|2WYJ|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Monoaryl P4 Motifs
pdb|2Y7X|A Chain A, The Discovery Of Potent And Long-Acting Oral Factor Xa
Inhibitors With Tetrahydroisoquinoline And Benzazepine
P4 Motifs
pdb|2Y7Z|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|2Y80|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|2Y81|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|2Y82|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|4A7I|B Chain B, Factor Xa In Complex With A Potent 2-Amino-Ethane
Sulfonamide Inhibitor
Length = 254
Score = 112 bits (281), Expect = 6e-25, Method: Compositional matrix adjust.
Identities = 81/249 (32%), Positives = 122/249 (48%), Gaps = 22/249 (8%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG E G+ P+ ALL E +C G ++S+ ++LTAAHC+ + V++
Sbjct: 1 IVGGQECKDGECPW-QALLINEENEGFCGGTILSEFYILTAAHCL-----YQAKRFKVRV 54
Query: 709 GVTRRNSYAFFGTR--FKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPP 766
G RN+ G +V V H+++ +D DIA+ +LK + F ++ P CLP
Sbjct: 55 G--DRNTEQEEGGEAVHEVEVVIKHNRFT-KETYDFDIAVLRLKTPITFRMNVAPACLPE 111
Query: 767 PNYE---LAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTL 823
++ L V G+G+ + T + +EVP + R+ C + +T
Sbjct: 112 RDWAESTLMTQKTGIVSGFGRTHEK--GRQSTRLKMLEVPYVDRNSCKL---SSSFIITQ 166
Query: 824 GMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPK 883
M CAGY +DACQGDSGGP + R + FV GIVSWG CA G+Y V
Sbjct: 167 NMFCAGYDTKQEDACQGDSGGPHVTRFKDTY---FVTGIVSWGEGCARKGKYGIYTKVTA 223
Query: 884 YVTWIQDIM 892
++ WI M
Sbjct: 224 FLKWIDRSM 232
>pdb|1MD8|A Chain A, Monomeric Structure Of The Active Catalytic Domain Of
Complement Protease C1r
Length = 329
Score = 112 bits (281), Expect = 7e-25, Method: Compositional matrix adjust.
Identities = 85/263 (32%), Positives = 123/263 (46%), Gaps = 24/263 (9%)
Query: 641 NNFKARKRIIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCV-----GN 695
N + R+RIIGG ++ G++P+ G L+ D+W+LTAAH +
Sbjct: 82 NPVEQRQRIIGGQKAKMGNFPWQVFT----NIHGRGGGALLGDRWILTAAHTLYPKEHEA 137
Query: 696 LTGLNIDEWTVQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQH--DNDIALFQLKQKV 753
+ ++D V LG T G +R V H Y + + DIAL +L+ V
Sbjct: 138 QSNASLD---VFLGHTNVEELMKLGNH-PIRRVSVHPDYRQDESYNFEGDIALLELENSV 193
Query: 754 KFNDHLLPVCLPPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKW 813
+LLP+CLP + G V G+G E+ + + V +P+ C W
Sbjct: 194 TLGPNLLPICLPDNDTFYDLGLMGYVSGFGVMEEKIAHD----LRFVRLPVANPQACENW 249
Query: 814 L--NNRELNVTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAH 871
L NR + M CAG+P +DACQGDSGG R N ++W GIVSWGI C+
Sbjct: 250 LRGKNRMDVFSQNMFCAGHPSLKQDACQGDSGGVFAVRDP-NTDRWVATGIVSWGIGCSR 308
Query: 872 PHLPGVYAYVPKYVTWIQDIMDK 894
+ G Y V YV WI+ M++
Sbjct: 309 GY--GFYTKVLNYVDWIKKEMEE 329
>pdb|1HCG|A Chain A, Structure Of Human Des(1-45) Factor Xa At 2.2 Angstroms
Resolution
pdb|3KL6|A Chain A, Discovery Of Tetrahydropyrimidin-2(1h)-One Derivative
Tak-44 Potent, Selective And Orally Active Factor Xa
Inhibitor
pdb|2XBW|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XBX|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XBY|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XC0|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XC4|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XC5|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
Length = 241
Score = 112 bits (281), Expect = 7e-25, Method: Compositional matrix adjust.
Identities = 81/249 (32%), Positives = 122/249 (48%), Gaps = 22/249 (8%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG E G+ P+ ALL E +C G ++S+ ++LTAAHC+ + V++
Sbjct: 1 IVGGQECKDGECPW-QALLINEENEGFCGGTILSEFYILTAAHCL-----YQAKRFKVRV 54
Query: 709 GVTRRNSYAFFGTR--FKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPP 766
G RN+ G +V V H+++ +D DIA+ +LK + F ++ P CLP
Sbjct: 55 G--DRNTEQEEGGEAVHEVEVVIKHNRFT-KETYDFDIAVLRLKTPITFRMNVAPACLPE 111
Query: 767 PNYE---LAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTL 823
++ L V G+G+ + T + +EVP + R+ C + +T
Sbjct: 112 RDWAESTLMTQKTGIVSGFGRTHEK--GRQSTRLKMLEVPYVDRNSCKL---SSSFIITQ 166
Query: 824 GMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPK 883
M CAGY +DACQGDSGGP + R + FV GIVSWG CA G+Y V
Sbjct: 167 NMFCAGYDTKQEDACQGDSGGPHVTRFKDTY---FVTGIVSWGEGCARKGKYGIYTKVTA 223
Query: 884 YVTWIQDIM 892
++ WI M
Sbjct: 224 FLKWIDRSM 232
>pdb|1XVM|A Chain A, Trypsin From Fusarium Oxysporum- Room Temperature To
Atomic Resolution
pdb|1XVO|A Chain A, Trypsin From Fusarium Oxysporum At Ph 6
pdb|1FY5|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1GDN|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1FY4|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1FN8|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1GDQ|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
Length = 224
Score = 112 bits (281), Expect = 7e-25, Method: Composition-based stats.
Identities = 80/236 (33%), Positives = 117/236 (49%), Gaps = 28/236 (11%)
Query: 650 IGGFESNPGDWPFLAALL--GGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQ 707
+GG ++ GD+PF+ ++ GGP +C G L++ VLTAAHCV +G + ++
Sbjct: 2 VGGTSASAGDFPFIVSISRNGGP----WCGGSLLNANTVLTAAHCV---SGYAQSGFQIR 54
Query: 708 LGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPP 767
G R S + VR H Y + ++ND+A+ +L + ++ L
Sbjct: 55 AGSLSRTSGGITSSLSSVR---VHPSY---SGNNNDLAILKLSTSIPSGGNIGYARLAAS 108
Query: 768 NYELAPGTRCTVIGWGKREDTRVSEYETAVN--EVEVPIITRDICNKWLNNRELNVTLGM 825
+ G+ TV GWG + S T VN +V VPI++R C +T M
Sbjct: 109 GSDPVAGSSATVAGWGATSEGGSS---TPVNLLKVTVPIVSRATCRAQYGTSA--ITNQM 163
Query: 826 VCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYV 881
CAG GGKD+CQGDSGGP++ S+ + G VSWG CA P+ GVYA V
Sbjct: 164 FCAGVSSGGKDSCQGDSGGPIVDSSNT------LIGAVSWGNGCARPNYSGVYASV 213
>pdb|1XKA|C Chain C, Factor Xa Complexed With A Synthetic Inhibitor
Fx-2212a,(2s)-(3'-
Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid
pdb|1XKB|C Chain C, Factor Xa Complexed With A Synthetic Inhibitor
Fx-2212a,(2s)-(3'-
Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid
pdb|1XKB|D Chain D, Factor Xa Complexed With A Synthetic Inhibitor
Fx-2212a,(2s)-(3'-
Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid
pdb|1G2L|A Chain A, Factor Xa Inhibitor Complex
pdb|1G2M|A Chain A, Factor Xa Inhibitor Complex
pdb|1IOE|A Chain A, Human Coagulation Factor Xa In Complex With M55532
pdb|1IQE|A Chain A, Human Coagulation Factor Xa In Complex With M55590
pdb|1IQF|A Chain A, Human Coagulation Factor Xa In Complex With M55165
pdb|1IQG|A Chain A, Human Coagulation Factor Xa In Complex With M55159
pdb|1IQH|A Chain A, Human Coagulation Factor Xa In Complex With M55143
pdb|1IQI|A Chain A, Human Coagulation Factor Xa In Complex With M55125
pdb|1IQJ|A Chain A, Human Coagulation Factor Xa In Complex With M55124
pdb|1IQK|A Chain A, Human Coagulation Factor Xa In Complex With M55113
pdb|1IQL|A Chain A, Human Coagulation Factor Xa In Complex With M54476
pdb|1IQM|A Chain A, Human Coagulation Factor Xa In Complex With M54471
pdb|1IQN|A Chain A, Human Coagulation Factor Xa In Complex With M55192
pdb|2P3F|H Chain H, Crystal Structure Of The Factor XaNAP5 COMPLEX
Length = 235
Score = 112 bits (281), Expect = 7e-25, Method: Compositional matrix adjust.
Identities = 81/249 (32%), Positives = 122/249 (48%), Gaps = 22/249 (8%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG E G+ P+ ALL E +C G ++S+ ++LTAAHC+ + V++
Sbjct: 1 IVGGQECKDGECPW-QALLINEENEGFCGGTILSEFYILTAAHCL-----YQAKRFKVRV 54
Query: 709 GVTRRNSYAFFGTR--FKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPP 766
G RN+ G +V V H+++ +D DIA+ +LK + F ++ P CLP
Sbjct: 55 G--DRNTEQEEGGEAVHEVEVVIKHNRFT-KETYDFDIAVLRLKTPITFRMNVAPACLPE 111
Query: 767 PNYE---LAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTL 823
++ L V G+G+ + T + +EVP + R+ C + +T
Sbjct: 112 RDWAESTLMTQKTGIVSGFGRTHEK--GRQSTRLKMLEVPYVDRNSCKL---SSSFIITQ 166
Query: 824 GMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPK 883
M CAGY +DACQGDSGGP + R + FV GIVSWG CA G+Y V
Sbjct: 167 NMFCAGYDTKQEDACQGDSGGPHVTRFKDTY---FVTGIVSWGEGCARKGKYGIYTKVTA 223
Query: 884 YVTWIQDIM 892
++ WI M
Sbjct: 224 FLKWIDRSM 232
>pdb|4FU7|A Chain A, Crystal Structure Of The Urokinase
pdb|4FU8|A Chain A, Crystal Structure Of The Urokinase
pdb|4FU9|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUB|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUC|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUD|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUE|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUF|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUG|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUH|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUI|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUJ|A Chain A, Crystal Structure Of The Urokinase
pdb|4DVA|U Chain U, The Crystal Structure Of Human Urokinase-type Plasminogen
Activator Catalytic Domain
pdb|4DW2|U Chain U, The Crystal Structure Of Upa In Complex With The Fab
Fragment Of Mab- 112
Length = 246
Score = 112 bits (280), Expect = 8e-25, Method: Compositional matrix adjust.
Identities = 80/249 (32%), Positives = 120/249 (48%), Gaps = 15/249 (6%)
Query: 649 IIGGFESNPGDWPFLAALLG---GPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWT 705
IIGG + + P+ AA+ G + C G LIS WV++A HC + +++
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYP--KKEDYI 58
Query: 706 VQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGA-QHDNDIALFQLKQK----VKFNDHLL 760
V LG +R NS +F+V + H Y+ H NDIAL +++ K + + +
Sbjct: 59 VYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQ 118
Query: 761 PVCLPPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELN 820
+ LP + GT C + G+GK + T Y + V +I+ C + +
Sbjct: 119 TIALPSMYNDPQFGTSCEITGFGKEQSTDYL-YPEQLKMTVVKLISHRECQQ-PHYYGSE 176
Query: 821 VTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAY 880
VT M+CA P+ D+CQGDSGGPL+C + GIVSWG CA PGVY
Sbjct: 177 VTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMT---LTGIVSWGRGCALKDKPGVYTR 233
Query: 881 VPKYVTWIQ 889
V ++ WI+
Sbjct: 234 VSHFLPWIR 242
>pdb|1MQ5|A Chain A, Crystal Structure Of
3-chloro-n-[4-chloro-2-[[(4-chlorophenyl)
Amino]carbonyl]phenyl]-4-[(4-methyl-1-
piperazinyl)methyl]-2- Thiophenecarboxamide Complexed
With Human Factor Xa
pdb|1MQ6|A Chain A, Crystal Structure Of
3-Chloro-N-[4-Chloro-2-[[(5-Chloro-2-Pyridinyl)
Amino]carbonyl]-6-Methoxyphenyl]-4-[[(4,
5-Dihydro-2-Oxazolyl)
Methylamino]methyl]-2-Thiophenecarboxamide Complexed
With Human Factor Xa
pdb|1V3X|A Chain A, Factor Xa In Complex With The Inhibitor
1-[6-Methyl-4,5,6,7-
Tetrahydrothiazolo(5,4-C)pyridin-2-Yl] Carbonyl-2-
Carbamoyl-4-(6-Chloronaphth-2-Ylsulphonyl)piperazine
pdb|1WU1|A Chain A, Factor Xa In Complex With The Inhibitor
4-[(5-Chloroindol-2-Yl)
Sulfonyl]-2-(2-Methylpropyl)-1-[[5-(Pyridin-4-Yl)
Pyrimidin-2- Yl]carbonyl]piperazine
pdb|2D1J|A Chain A, Factor Xa In Complex With The Inhibitor 2-[[4-[(5-
Chloroindol-2-Yl)sulfonyl]piperazin-1-Yl]
Carbonyl]thieno[3,2-B]pyridine N-Oxide
pdb|2H9E|H Chain H, Crystal Structure Of FxaSELECTIDENAPC2 TERNARY COMPLEX
pdb|2P3U|B Chain B, Crystal Structure Of Human Factor Xa Complexed With 3-
Chloro-N-(4-Chloro-2-{[(5-Chloropyridin-2-Yl)
Amino]carbonyl}-6-Methoxyphenyl)-4-[(1-Methyl-1h-
Imidazol- 2-Yl)methyl]thiophene-2-Carboxamide {pfizer
320663}
pdb|2P3T|B Chain B, Crystal Structure Of Human Factor Xa Complexed With 3-
Chloro-4-(2-Methylamino-Imidazol-1-Ylmethyl)-Thiophene-
2- Carboxylic Acid [4-Chloro-2-(5-Chloro-Pyridin-2-
Ylcarbamoyl)-6-Methoxy-Phenyl]-Amide
pdb|2EI6|A Chain A, Factor Xa In Complex With The Inhibitor (-)-Cis-N1-[(5-
Chloroindol-2-Yl)carbonyl]-N2-[(5-Methyl-4,5,6,7-
Tetrahydrothiazolo[5,4-C]pyridin-2-Yl)carbonyl]-1,2-
Cyclohexanediamine
pdb|2EI7|A Chain A, Factor Xa In Complex With The Inhibitor Trans-N1-[(5-
Chloroindol-2-Yl)carbonyl]-N2-[(5-Methyl-4,5,6,7-
Tetrahydrothiazolo[5,4-C]pyridin-2-Yl)carbonyl]-1,2-
Cyclohexanediamine
pdb|2EI8|A Chain A, Factor Xa In Complex With The Inhibitor (1s,2r,4s)-N1-[(5-
Chloroindol-2-Yl)carbonyl]-4-(N,N-Dimethylcarbamoyl)-N2-
[(5-Methyl-4,5,6,7-Tetrahydrothiazolo[5,
4-C]pyridin-2-Yl) Carbonyl]-1,2-Cyclohexanediamine
pdb|3IIT|A Chain A, Factor Xa In Complex With A Cis-1,2-Diaminocyclohexane
Derivative
pdb|3Q3K|A Chain A, Factor Xa In Complex With A Phenylenediamine Derivative
pdb|3TK5|A Chain A, Factor Xa In Complex With D102-4380
pdb|3TK6|A Chain A, Factor Xa In Complex With D46-5241
Length = 233
Score = 112 bits (280), Expect = 8e-25, Method: Compositional matrix adjust.
Identities = 81/249 (32%), Positives = 122/249 (48%), Gaps = 22/249 (8%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG E G+ P+ ALL E +C G ++S+ ++LTAAHC+ + V++
Sbjct: 1 IVGGQECKDGECPW-QALLINEENEGFCGGTILSEFYILTAAHCL-----YQAKRFKVRV 54
Query: 709 GVTRRNSYAFFGTR--FKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPP 766
G RN+ G +V V H+++ +D DIA+ +LK + F ++ P CLP
Sbjct: 55 G--DRNTEQEEGGEAVHEVEVVIKHNRFT-KETYDFDIAVLRLKTPITFRMNVAPACLPE 111
Query: 767 PNYE---LAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTL 823
++ L V G+G+ + T + +EVP + R+ C + +T
Sbjct: 112 RDWAESTLMTQKTGIVSGFGRTHEK--GRQSTRLKMLEVPYVDRNSCKL---SSSFIITQ 166
Query: 824 GMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPK 883
M CAGY +DACQGDSGGP + R + FV GIVSWG CA G+Y V
Sbjct: 167 NMFCAGYDTKQEDACQGDSGGPHVTRFKDTY---FVTGIVSWGEGCARKGKYGIYTKVTA 223
Query: 884 YVTWIQDIM 892
++ WI M
Sbjct: 224 FLKWIDRSM 232
>pdb|1FJS|A Chain A, Crystal Structure Of The Inhibitor Zk-807834 (Ci-1031)
Complexed With Factor Xa
pdb|1Z6E|A Chain A, Factor Xa In Complex With The Inhibitor
1-(3'-Amino-1,2-Benzisoxazol-
5'-Yl)-N-(4-(2'-((Dimethylamino)methyl)-1h-Imidazol-1-
Yl)-2-
Fluorophenyl)-3-(Trifluoromethyl)-1h-Pyrazole-5-
Carboxamide (Razaxaban; Dpc906; Bms-561389)
pdb|2BMG|B Chain B, Crystal Structure Of Factor Xa In Complex With 50
pdb|2FZZ|A Chain A, Factor Xa In Complex With The Inhibitor 1-(3-Amino-1,2-
Benzisoxazol-5-Yl)-6-(2'-(((3r)-3-Hydroxy-1-
Pyrrolidinyl)
Methyl)-4-Biphenylyl)-3-(Trifluoromethyl)-1,4,5,6-
Tetrahydro-7h-Pyrazolo[3,4-C]pyridin-7-One
pdb|2G00|A Chain A, Factor Xa In Complex With The Inhibitor 3-(6-(2'-
((Dimethylamino)methyl)-4-Biphenylyl)-7-Oxo-3-
(Trifluoromethyl)-4,5,6,7-Tetrahydro-1h-Pyrazolo[3,4-
C]pyridin-1-Yl)benzamide
pdb|2P93|A Chain A, Factor Xa In Complex With The Inhibitor
5-Chloro-N-(2-(4-(2-
Oxopyridin-1(2h)-Yl)benzamido)ethyl)thiophene-2-
Carboxamide
pdb|2P94|A Chain A, Factor Xa In Complex With The Inhibitor
3-Chloro-N-((1r,2s)-
2-(4-(2-Oxopyridin-1(2h)-Yl)benzamido)cyclohexyl)-1h-
Indole-6-Carboxamide
pdb|2P95|A Chain A, Factor Xa In Complex With The Inhibitor
5-Chloro-N-((1r,2s)-
2-(4-(2-Oxopyridin-1(2h)-Yl)benzamido) Cyclopentyl)
Thiophene-2-Carboxamide
pdb|2PR3|A Chain A, Factor Xa Inhibitor
pdb|2Q1J|A Chain A, The Discovery Of Glycine And Related Amino Acid-Based
Factor Xa Inhibitors
pdb|2P16|A Chain A, Factor Xa In Complex With The Inhibitor Apixaban (Bms-
562247) Aka 1-(4-Methoxyphenyl)-7-Oxo-6-(4-(2-Oxo-1-
Piperidinyl)phenyl)-4,5,6,7-Tetrahydro-1h-Pyrazolo[3, 4-
C]pyridine-3-Carboxamide
pdb|2RA0|A Chain A, X-Ray Structure Of Fxa In Complex With 7-Fluoroindazole
pdb|2PHB|A Chain A, An Orally Efficacious Factor Xa Inhibitor
pdb|3CEN|A Chain A, Factor Xa In Complex With The Inhibitor
N-(2-(((5-Chloro-2- Pyridinyl)
Amino)sulfonyl)phenyl)-4-(2-Oxo-1(2h)-
Pyridinyl)benzamide
pdb|3CS7|A Chain A, Factor Xa In Complex With The Inhibitor
1-(4-Methoxyphenyl)-
6-(4-(1-(Pyrrolidin-1-Ylmethyl)cyclopropyl)phenyl)-3-
(Trifluoromethyl)-5,6-Dihydro-1h-Pyrazolo[3,4-C]pyridin-
7(4h)-One
pdb|2W26|A Chain A, Factor Xa In Complex With Bay59-7939
pdb|2W3I|A Chain A, Crystal Structure Of Fxa In Complex With 4,4-disubstituted
Pyrrolidine-1,2-dicarboxamide Inhibitor 2
pdb|2W3K|A Chain A, Crystal Structure Of Fxa In Complex With 4,4-Disubstituted
Pyrrolidine-1,2-Dicarboxamide Inhibitor 1
pdb|3FFG|A Chain A, Factor Xa In Complex With The Inhibitor (R)-6-(2'-((3-
Hydroxypyrrolidin-1-Yl)methyl)biphenyl-4-Yl)-1-(3-(5-
Oxo-4, 5-Dihydro-1h-1,2,4-Triazol-3-Yl)phenyl)-3-
(Trifluoromethyl)-5,6-Dihydro-1h-Pyrazolo[3,4-C]pyridin-
7(4h)-One
pdb|3KQB|A Chain A, Factor Xa In Complex With The Inhibitor N-(3-Fluoro-2'-
(Methylsulfonyl)biphenyl-4-Yl)-1-(3-(5-Oxo-4,
5-Dihydro-1h-
Triazol-3-Yl)phenyl)-3-(Trifluoromethyl)-1h-
Pyrazole-5-Car
pdb|3KQC|A Chain A, Factor Xa In Complex With The Inhibitor 6-(2'-
(Methylsulfon Biphenyl-4-Yl)-1-(3-(5-Oxo-4,5-Dihydro-1h-
1,2,4-Triazol-3- Phenyl)-3-(Trifluoromethyl)-5,6-
Dihydro-1h-Pyrazolo[3,4-C] 7(4h)-One
pdb|3KQD|A Chain A, Factor Xa In Complex With The Inhibitor 1-(3-(5-Oxo-4,5-
Dih 2,4-Triazol-3-Yl)phenyl)-6-(2'-(Pyrrolidin-1-
Ylmethyl)biph Yl)-3-(Trifluoromethyl)-5,6-Dihydro-
1h-Pyrazolo[3,4-C]pyri One
pdb|3KQE|A Chain A, Factor Xa In Complex With The Inhibitor 3-Methyl-1-(3-(5-
Ox Dihydro-1h-1,2,4-Triazol-3-Yl)phenyl)-6-(2'-
(Pyrrolidin-1- Biphenyl-4-Yl)-5,6-Dihydro-1h-
Pyrazolo[3,4-C]pyridin-7(4h)
pdb|3LIW|A Chain A, Factor Xa In Complex With
(R)-2-(1-Adamantylcarbamoylamino)-
3-(3-Carbamidoyl-Phenyl)-N-Phenethyl-Propionic Acid
Amide
pdb|3M36|A Chain A, Factor Xa In Complex With The Inhibitor 1-[3-(Aminomethyl)
Phenyl]-N-[3-Fluoro-2'-(Methylsulfonyl)biphenyl-4-Yl]-3-
(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide (Dpc423)
pdb|3M37|A Chain A, Factor Xa In Complex With The Inhibitor 1-[2-(Aminomethyl)
Phenyl]-N-(3-Fluoro-2'-Sulfamoylbiphenyl-4-Yl)-3-
(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide (Dpc602)
Length = 234
Score = 112 bits (280), Expect = 8e-25, Method: Compositional matrix adjust.
Identities = 81/249 (32%), Positives = 122/249 (48%), Gaps = 22/249 (8%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG E G+ P+ ALL E +C G ++S+ ++LTAAHC+ + V++
Sbjct: 1 IVGGQECKDGECPW-QALLINEENEGFCGGTILSEFYILTAAHCL-----YQAKRFKVRV 54
Query: 709 GVTRRNSYAFFGTR--FKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPP 766
G RN+ G +V V H+++ +D DIA+ +LK + F ++ P CLP
Sbjct: 55 G--DRNTEQEEGGEAVHEVEVVIKHNRFT-KETYDFDIAVLRLKTPITFRMNVAPACLPE 111
Query: 767 PNYE---LAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTL 823
++ L V G+G+ + T + +EVP + R+ C + +T
Sbjct: 112 RDWAESTLMTQKTGIVSGFGRTHEK--GRQSTRLKMLEVPYVDRNSCKL---SSSFIITQ 166
Query: 824 GMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPK 883
M CAGY +DACQGDSGGP + R + FV GIVSWG CA G+Y V
Sbjct: 167 NMFCAGYDTKQEDACQGDSGGPHVTRFKDTY---FVTGIVSWGEGCARKGKYGIYTKVTA 223
Query: 884 YVTWIQDIM 892
++ WI M
Sbjct: 224 FLKWIDRSM 232
>pdb|3ENS|B Chain B, Crystal Structure Of Human Fxa In Complex With Methyl
(2z)-3-[(3-
Chloro-1h-indol-7-yl)amino]-2-cyano-3-{[(3s)-2-oxo-1-(2-
oxo-2- Pyrrolidin-1-ylethyl)azepan-3-yl]amino}acrylate
pdb|3ENS|D Chain D, Crystal Structure Of Human Fxa In Complex With Methyl
(2z)-3-[(3-
Chloro-1h-indol-7-yl)amino]-2-cyano-3-{[(3s)-2-oxo-1-(2-
oxo-2- Pyrrolidin-1-ylethyl)azepan-3-yl]amino}acrylate
pdb|3HPT|B Chain B, Crystal Structure Of Human Fxa In Complex With
(S)-2-Cyano-1-(2-
Methylbenzofuran-5-Yl)-3-(2-Oxo-1-(2-Oxo-2-(Pyrrolidin-
1-Yl)ethyl) Azepan-3-Yl)guanidine
pdb|3HPT|D Chain D, Crystal Structure Of Human Fxa In Complex With
(S)-2-Cyano-1-(2-
Methylbenzofuran-5-Yl)-3-(2-Oxo-1-(2-Oxo-2-(Pyrrolidin-
1-Yl)ethyl) Azepan-3-Yl)guanidine
pdb|3K9X|B Chain B, X-Ray Crystal Structure Of Human Fxa In Complex With
(S)-N-((2- Methylbenzofuran-5-Ylamino)(2-Oxo-1-(2-Oxo-2-
(Pyrrolidin-1-Yl) Ethyl)azepan-3-
Ylamino)methylene)nicotinamide
pdb|3K9X|D Chain D, X-Ray Crystal Structure Of Human Fxa In Complex With
(S)-N-((2- Methylbenzofuran-5-Ylamino)(2-Oxo-1-(2-Oxo-2-
(Pyrrolidin-1-Yl) Ethyl)azepan-3-
Ylamino)methylene)nicotinamide
pdb|3SW2|B Chain B, X-Ray Crystal Structure Of Human Fxa In Complex With
6-Chloro-N-((3s)-
2-Oxo-1-(2-Oxo-2-((5s)-8-Oxo-5,6-Dihydro-1h-1,
5-Methanopyrido[1,2-
A][1,5]diazocin-3(2h,4h,
8h)-Yl)ethyl)piperidin-3-Yl)naphthalene-2- Sulfonamide
Length = 238
Score = 112 bits (280), Expect = 9e-25, Method: Compositional matrix adjust.
Identities = 81/249 (32%), Positives = 122/249 (48%), Gaps = 22/249 (8%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG E G+ P+ ALL E +C G ++S+ ++LTAAHC+ + V++
Sbjct: 1 IVGGQECKDGECPW-QALLINEENEGFCGGTILSEFYILTAAHCL-----YQAKRFKVRV 54
Query: 709 GVTRRNSYAFFGTR--FKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPP 766
G RN+ G +V V H+++ +D DIA+ +LK + F ++ P CLP
Sbjct: 55 G--DRNTEQEEGGEAVHEVEVVIKHNRFT-KETYDFDIAVLRLKTPITFRMNVAPACLPE 111
Query: 767 PNYE---LAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTL 823
++ L V G+G+ + T + +EVP + R+ C + +T
Sbjct: 112 RDWAESTLMTQKTGIVSGFGRTHEK--GRQSTRLKMLEVPYVDRNSCKL---SSSFIITQ 166
Query: 824 GMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPK 883
M CAGY +DACQGDSGGP + R + FV GIVSWG CA G+Y V
Sbjct: 167 NMFCAGYDTKQEDACQGDSGGPHVTRFKDTY---FVTGIVSWGEGCARKGKYGIYTKVTA 223
Query: 884 YVTWIQDIM 892
++ WI M
Sbjct: 224 FLKWIDRSM 232
>pdb|2NWN|A Chain A, New Pharmacophore For Serine Protease Inhibition Revealed
By Crystal Structure Of Human Urokinase-Type Plasminogen
Activator Complexed With A Cyclic Peptidyl Inhibitor,
Upain-1
pdb|2O8T|A Chain A, Crystal Structure And Binding Epitopes Of Urokinase-Type
Plasminogen Activator (C122aN145Q) IN COMPLEX WITH
Inhibitors
pdb|3KGP|A Chain A, Crystal Structures Of Urokinase-Type Plasminogen Activator
In Complex With 4-(Aminomethyl) Benzoic Acid And 4-
(Aminomethyl-Phenyl)-Methanol
pdb|3KHV|A Chain A, Crystal Structures Of Urokinase-Type Plasminogen Activator
In Complex With 4-(Aminomethyl) Benzoic Acid And 4-
(Aminomethyl-Phenyl)-Methanol
pdb|3KID|U Chain U, The Crystal Structures Of 2-Aminobenzothiazole-Based
Inhibitors In Complexes With Urokinase-Type Plasminogen
Activator
pdb|3M61|U Chain U, Crystal Structure Of Complex Of Urokinase And A Upain-1
Variant(W3a) In Ph4.6 Condition
pdb|3OX7|U Chain U, The Crystal Structure Of Upa Complex With Peptide
Inhibitor Mh027 At Ph4.6
pdb|3OY5|U Chain U, The Crystal Structure Of Upa Complex With Peptide
Inhibitor Mh027 At Ph7.4
pdb|3OY6|U Chain U, The Crystal Structure Of Upa Complex With Peptide
Inhibitor Mh036 At Ph4.6
pdb|3QN7|A Chain A, Potent And Selective Bicyclic Peptide Inhibitor (Uk18) Of
Human Urokinase-Type Plasminogen Activator(Upa)
Length = 253
Score = 112 bits (280), Expect = 1e-24, Method: Compositional matrix adjust.
Identities = 80/249 (32%), Positives = 120/249 (48%), Gaps = 15/249 (6%)
Query: 649 IIGGFESNPGDWPFLAALLG---GPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWT 705
IIGG + + P+ AA+ G + C G LIS WV++A HC + +++
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYP--KKEDYI 58
Query: 706 VQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGA-QHDNDIALFQLKQK----VKFNDHLL 760
V LG +R NS +F+V + H Y+ H NDIAL +++ K + + +
Sbjct: 59 VYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQ 118
Query: 761 PVCLPPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELN 820
+ LP + GT C + G+GK + T Y + V +I+ C + +
Sbjct: 119 TIALPSMYNDPQFGTSCEITGFGKEQSTDYL-YPEQLKMTVVKLISHRECQQ-PHYYGSE 176
Query: 821 VTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAY 880
VT M+CA P+ D+CQGDSGGPL+C + GIVSWG CA PGVY
Sbjct: 177 VTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMT---LTGIVSWGRGCALKDKPGVYTR 233
Query: 881 VPKYVTWIQ 889
V ++ WI+
Sbjct: 234 VSHFLPWIR 242
>pdb|2ZGJ|A Chain A, Crystal Structure Of D86n-gzmm Complexed With Its Optimal
Synthesized Substrate
Length = 240
Score = 112 bits (279), Expect = 1e-24, Method: Composition-based stats.
Identities = 78/250 (31%), Positives = 125/250 (50%), Gaps = 24/250 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
IIGG E P P++A+L + C GVL+ +WVLTAAHC+ + + + L
Sbjct: 1 IIGGREVIPHSRPYMASLQRNGSHL--CGGVLVHPKWVLTAAHCLAQ----RMAQLRLVL 54
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
G+ +S G F ++ H +Y +N++AL QL KVK + + P+ LP
Sbjct: 55 GLHTLDSP---GLTFHIKAAIQHPRYKPVPALENNLALLQLDGKVKPSRTIRPLALPSKR 111
Query: 769 YELAPGTRCTVIGWG-KREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTL--GM 825
+A GTRC++ GWG + R+S + E+++ ++ +CN N+R N +L M
Sbjct: 112 QVVAAGTRCSMAGWGLTHQGGRLSR---VLRELDLQVLDTRMCN---NSRFWNGSLSPSM 165
Query: 826 VCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIK-CAHPHLPGVYAYVPKY 884
VC + C+GDSGGPL+C + G++S+ + C P V V Y
Sbjct: 166 VCLAADSKDQAPCKGDSGGPLVCGKGR-----VLAGVLSFSSRVCTDIFKPPVATAVAPY 220
Query: 885 VTWIQDIMDK 894
V+WI+ + +
Sbjct: 221 VSWIRKVTGR 230
>pdb|1GPZ|A Chain A, The Crystal Structure Of The Zymogen Catalytic Domain Of
Complement Protease C1r
pdb|1GPZ|B Chain B, The Crystal Structure Of The Zymogen Catalytic Domain Of
Complement Protease C1r
Length = 399
Score = 111 bits (278), Expect = 1e-24, Method: Compositional matrix adjust.
Identities = 84/263 (31%), Positives = 123/263 (46%), Gaps = 24/263 (9%)
Query: 641 NNFKARKRIIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCV-----GN 695
N + R++IIGG ++ G++P+ G L+ D+W+LTAAH +
Sbjct: 150 NPVEQRQQIIGGQKAKMGNFPWQVFT----NIHGRGGGALLGDRWILTAAHTLYPKEHEA 205
Query: 696 LTGLNIDEWTVQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQH--DNDIALFQLKQKV 753
+ ++D V LG T G +R V H Y + + DIAL +L+ V
Sbjct: 206 QSNASLD---VFLGHTNVEELMKLGNH-PIRRVSVHPDYRQDESYNFEGDIALLELENSV 261
Query: 754 KFNDHLLPVCLPPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKW 813
+LLP+CLP + G V G+G E+ + + V +P+ C W
Sbjct: 262 TLGPNLLPICLPDNDTFYDLGLMGYVSGFGVMEEKIAHD----LRFVRLPVANPQACENW 317
Query: 814 L--NNRELNVTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAH 871
L NR + M CAG+P +DACQGDSGG R N ++W GIVSWGI C+
Sbjct: 318 LRGKNRMDVFSQNMFCAGHPSLKQDACQGDSGGVFAVRDP-NTDRWVATGIVSWGIGCSR 376
Query: 872 PHLPGVYAYVPKYVTWIQDIMDK 894
+ G Y V YV WI+ M++
Sbjct: 377 GY--GFYTKVLNYVDWIKKEMEE 397
>pdb|2GD4|H Chain H, Crystal Structure Of The Antithrombin-S195a Factor
Xa-Pentasaccharide Complex
pdb|2GD4|B Chain B, Crystal Structure Of The Antithrombin-S195a Factor
Xa-Pentasaccharide Complex
Length = 241
Score = 111 bits (278), Expect = 1e-24, Method: Compositional matrix adjust.
Identities = 80/249 (32%), Positives = 122/249 (48%), Gaps = 22/249 (8%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG E G+ P+ ALL E +C G ++S+ ++LTAAHC+ + V++
Sbjct: 1 IVGGQECKDGECPW-QALLINEENEGFCGGTILSEFYILTAAHCL-----YQAKRFKVRV 54
Query: 709 GVTRRNSYAFFGTR--FKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPP 766
G RN+ G +V V H+++ +D DIA+ +LK + F ++ P CLP
Sbjct: 55 G--DRNTEQEEGGEAVHEVEVVIKHNRFT-KETYDFDIAVLRLKTPITFRMNVAPACLPE 111
Query: 767 PNYE---LAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTL 823
++ L V G+G+ + T + +EVP + R+ C + +T
Sbjct: 112 RDWAESTLMTQKTGIVSGFGRTHEK--GRQSTRLKMLEVPYVDRNSCKL---SSSFIITQ 166
Query: 824 GMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPK 883
M CAGY +DACQGD+GGP + R + FV GIVSWG CA G+Y V
Sbjct: 167 NMFCAGYDTKQEDACQGDAGGPHVTRFKDTY---FVTGIVSWGEGCARKGKYGIYTKVTA 223
Query: 884 YVTWIQDIM 892
++ WI M
Sbjct: 224 FLKWIDRSM 232
>pdb|3MWI|U Chain U, The Complex Crystal Structure Of Urokianse And
5-Nitro-1h-Indole-2- Amidine
Length = 246
Score = 111 bits (278), Expect = 2e-24, Method: Compositional matrix adjust.
Identities = 80/249 (32%), Positives = 121/249 (48%), Gaps = 15/249 (6%)
Query: 649 IIGGFESNPGDWPFLAALLG---GPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWT 705
IIGG + + P+ AA+ G + C G LIS WV++A HC + +++
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYP--KKEDYI 58
Query: 706 VQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGA-QHDNDIALFQLKQK----VKFNDHLL 760
V LG +R NS +F+V + H Y+ H NDIAL +++ K + + +
Sbjct: 59 VYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQ 118
Query: 761 PVCLPPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELN 820
+ LP + GT C + G+GK E++ Y + V +I+ C + +
Sbjct: 119 TIALPSMYNDPQFGTSCEITGFGK-ENSTDYLYPEQLKMTVVKLISHRECQQ-PHYYGSE 176
Query: 821 VTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAY 880
VT M+CA P+ D+CQGDSGGPL+C + GIVSWG CA PGVY
Sbjct: 177 VTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMT---LTGIVSWGRGCALKDKPGVYTR 233
Query: 881 VPKYVTWIQ 889
V ++ WI+
Sbjct: 234 VSHFLPWIR 242
>pdb|1W0Z|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W10|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W11|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W12|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W13|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W14|U Chain U, Urokinase Type Plasminogen Activator
pdb|3MHW|U Chain U, The Complex Crystal Structure Of Urokianse And 2-
Aminobenzothiazole
Length = 247
Score = 111 bits (278), Expect = 2e-24, Method: Compositional matrix adjust.
Identities = 80/249 (32%), Positives = 121/249 (48%), Gaps = 15/249 (6%)
Query: 649 IIGGFESNPGDWPFLAALLG---GPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWT 705
IIGG + + P+ AA+ G + C G LIS WV++A HC + +++
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYP--KKEDYI 58
Query: 706 VQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGA-QHDNDIALFQLKQK----VKFNDHLL 760
V LG +R NS +F+V + H Y+ H NDIAL +++ K + + +
Sbjct: 59 VYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQ 118
Query: 761 PVCLPPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELN 820
+ LP + GT C + G+GK E++ Y + V +I+ C + +
Sbjct: 119 TISLPSMYNDPQFGTSCEITGFGK-ENSTDYLYPEQLKMTVVKLISHRECQQ-PHYYGSE 176
Query: 821 VTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAY 880
VT M+CA P+ D+CQGDSGGPL+C + GIVSWG CA PGVY
Sbjct: 177 VTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMT---LTGIVSWGRGCALKDKPGVYTR 233
Query: 881 VPKYVTWIQ 889
V ++ WI+
Sbjct: 234 VSHFLPWIR 242
>pdb|1MD7|A Chain A, Monomeric Structure Of The Zymogen Of Complement Protease
C1r
Length = 328
Score = 111 bits (277), Expect = 2e-24, Method: Compositional matrix adjust.
Identities = 84/262 (32%), Positives = 122/262 (46%), Gaps = 24/262 (9%)
Query: 641 NNFKARKRIIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCV-----GN 695
N + R+RIIGG ++ G++P+ G L+ D+W+LTAAH +
Sbjct: 82 NPVEQRQRIIGGQKAKMGNFPWQVFT----NIHGRGGGALLGDRWILTAAHTLYPKEHEA 137
Query: 696 LTGLNIDEWTVQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQH--DNDIALFQLKQKV 753
+ ++D V LG T G +R V H Y + + DIAL +L+ V
Sbjct: 138 QSNASLD---VFLGHTNVEELMKLGNH-PIRRVSVHPDYRQDESYNFEGDIALLELENSV 193
Query: 754 KFNDHLLPVCLPPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKW 813
+LLP+CLP + G V G+G E+ + + V +P+ C W
Sbjct: 194 TLGPNLLPICLPDNDTFYDLGLMGYVSGFGVMEEKIAHD----LRFVRLPVANPQACENW 249
Query: 814 L--NNRELNVTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAH 871
L NR + M CAG+P +DACQGD+GG R N ++W GIVSWGI C+
Sbjct: 250 LRGKNRMDVFSQNMFCAGHPSLKQDACQGDAGGVFAVRDP-NTDRWVATGIVSWGIGCSR 308
Query: 872 PHLPGVYAYVPKYVTWIQDIMD 893
+ G Y V YV WI+ M+
Sbjct: 309 GY--GFYTKVLNYVDWIKKEME 328
>pdb|1EJN|A Chain A, Urokinase Plasminogen Activator B-Chain Inhibitor Complex
pdb|1F5K|U Chain U, Urokinase Plasminogen Activator B-Chain-Benzamidine
Complex
pdb|1F5L|A Chain A, Urokinase Plasminogen Activator B-Chain-Amiloride Complex
pdb|1F92|A Chain A, Urokinase Plasminogen Activator B Chain-Uki-1d Complex
pdb|2R2W|U Chain U, Urokinase Plasminogen Activator B-Chain-Gppe Complex
pdb|2VIN|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIO|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIP|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIQ|A Chain A, Fragment-based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-type
Plasminogen Activator
pdb|2VIV|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIW|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
Length = 253
Score = 111 bits (277), Expect = 2e-24, Method: Compositional matrix adjust.
Identities = 80/249 (32%), Positives = 121/249 (48%), Gaps = 15/249 (6%)
Query: 649 IIGGFESNPGDWPFLAALLG---GPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWT 705
IIGG + + P+ AA+ G + C G LIS WV++A HC + +++
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYP--KKEDYI 58
Query: 706 VQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGA-QHDNDIALFQLKQK----VKFNDHLL 760
V LG +R NS +F+V + H Y+ H NDIAL +++ K + + +
Sbjct: 59 VYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQ 118
Query: 761 PVCLPPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELN 820
+ LP + GT C + G+GK E++ Y + V +I+ C + +
Sbjct: 119 TISLPSMYNDPQFGTSCEITGFGK-ENSTDYLYPEQLKMTVVKLISHRECQQ-PHYYGSE 176
Query: 821 VTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAY 880
VT M+CA P+ D+CQGDSGGPL+C + GIVSWG CA PGVY
Sbjct: 177 VTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMT---LTGIVSWGRGCALKDKPGVYTR 233
Query: 881 VPKYVTWIQ 889
V ++ WI+
Sbjct: 234 VSHFLPWIR 242
>pdb|2O8U|A Chain A, Crystal Structure And Binding Epitopes Of Urokinase-Type
Plasminogen Activator (C122aN145QS195A) IN COMPLEX WITH
Inhibitors
pdb|2O8W|A Chain A, Crystal Structure And Binding Epitopes Of Urokinase-Type
Plasminogen Activator (C122aN145QS195A) IN COMPLEX WITH
Inhibitors
pdb|3PB1|E Chain E, Crystal Structure Of A Michaelis Complex Between
Plasminogen Activator Inhibitor-1 And Urokinase-Type
Plasminogen Activator
Length = 253
Score = 111 bits (277), Expect = 2e-24, Method: Compositional matrix adjust.
Identities = 79/249 (31%), Positives = 120/249 (48%), Gaps = 15/249 (6%)
Query: 649 IIGGFESNPGDWPFLAALLG---GPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWT 705
IIGG + + P+ AA+ G + C G LIS WV++A HC + +++
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYP--KKEDYI 58
Query: 706 VQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGA-QHDNDIALFQLKQK----VKFNDHLL 760
V LG +R NS +F+V + H Y+ H NDIAL +++ K + + +
Sbjct: 59 VYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQ 118
Query: 761 PVCLPPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELN 820
+ LP + GT C + G+GK + T Y + V +I+ C + +
Sbjct: 119 TIALPSMYNDPQFGTSCEITGFGKEQSTDYL-YPEQLKMTVVKLISHRECQQ-PHYYGSE 176
Query: 821 VTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAY 880
VT M+CA P+ D+CQGD+GGPL+C + GIVSWG CA PGVY
Sbjct: 177 VTTKMLCAADPQWKTDSCQGDAGGPLVCSLQGRMT---LTGIVSWGRGCALKDKPGVYTR 233
Query: 881 VPKYVTWIQ 889
V ++ WI+
Sbjct: 234 VSHFLPWIR 242
>pdb|3S9A|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V
(Closed-Form)
pdb|3S9B|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V (Open-Form)
pdb|3S9C|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V In Complex
With The Fragment (Residues 1533-1546) Of Human Factor V
pdb|3SBK|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V
(Ppack-Bound Form)
Length = 234
Score = 110 bits (276), Expect = 2e-24, Method: Compositional matrix adjust.
Identities = 82/250 (32%), Positives = 117/250 (46%), Gaps = 32/250 (12%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
++GG E N + PFL AL +CAG LI+ +WVLTAAHC + ++L
Sbjct: 1 VVGGDECNINEHPFLVALYTSASSTIHCAGALINREWVLTAAHC-------DRRNIRIKL 53
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
G+ +N RG + D DI L +L++ V ++ H+ PV L P+
Sbjct: 54 GMHSKNIRNEDEQIRVPRGKYFCLNTKFPNGLDKDIMLIRLRRPVTYSTHIAPVSL--PS 111
Query: 769 YELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICN---KWL--NNRELNVTL 823
G+RC ++GWGK T + N + I+ C W+ ++R L
Sbjct: 112 RSRGVGSRCRIMGWGKISTTTYPDVPHCTN---IFIVKHKWCEPLYPWVPADSRTL---- 164
Query: 824 GMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHL-PGVYAYVP 882
CAG +GG+D C GDSGGPL+C + GIV+ G + HL P VY V
Sbjct: 165 ---CAGILKGGRDTCHGDSGGPLICNGEMH-------GIVAGGSEPCGQHLKPAVYTKVF 214
Query: 883 KYVTWIQDIM 892
Y WIQ I+
Sbjct: 215 DYNNWIQSII 224
>pdb|2TLD|E Chain E, Crystal Structure Of An Engineered Subtilisin Inhibitor
Complexed With Bovine Trypsin
Length = 220
Score = 110 bits (276), Expect = 3e-24, Method: Compositional matrix adjust.
Identities = 80/244 (32%), Positives = 117/244 (47%), Gaps = 27/244 (11%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+ P+ +L G F C G LI+ QWV++AAHC +G+ + +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF---CGGSLINSQWVVSAAHCY--KSGIQVRLGEDNI 55
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
V N ++ V H YN +NDI L +LK N + + LP
Sbjct: 56 NVVEGNEQFISASKSIV-----HPSYN-SNTLNNDIMLIKLKSAASLNSRVASISLPTS- 108
Query: 769 YELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVCA 828
+ GT+C + GWG + + S Y + ++ PI++ C + +T M CA
Sbjct: 109 -CASAGTQCLISGWGNTKSSGTS-YPDVLKCLKAPILSDSSCKSAYPGQ---ITSNMFCA 163
Query: 829 GYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTWI 888
G EGG D+CQGDSGGP++C + GIVSWG CA + PGVY V YV+WI
Sbjct: 164 GL-EGG-DSCQGDSGGPVVCSGK-------LQGIVSWGSGCAK-NKPGVYTKVCNYVSWI 213
Query: 889 QDIM 892
+ +
Sbjct: 214 KQTI 217
>pdb|1FV9|A Chain A, Crystal Structure Of Human Microurokinase In Complex With
2- Amino-5-Hydroxy-Benzimidazole
Length = 245
Score = 110 bits (275), Expect = 3e-24, Method: Compositional matrix adjust.
Identities = 79/249 (31%), Positives = 121/249 (48%), Gaps = 15/249 (6%)
Query: 649 IIGGFESNPGDWPFLAALLG---GPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWT 705
IIGG + + P+ AA+ G + C G L+S WV++A HC + +++
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYP--KKEDYI 58
Query: 706 VQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGA-QHDNDIALFQLKQK----VKFNDHLL 760
V LG +R NS +F+V + H Y+ H NDIAL +++ K + + +
Sbjct: 59 VYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQ 118
Query: 761 PVCLPPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELN 820
+ LP + GT C + G+GK E++ Y + V +I+ C + +
Sbjct: 119 TIALPSMYNDPQFGTSCEITGFGK-ENSTDYLYPEQLKMTVVKLISHRECQQ-PHYYGSE 176
Query: 821 VTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAY 880
VT M+CA P+ D+CQGDSGGPL+C + GIVSWG CA PGVY
Sbjct: 177 VTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMT---LTGIVSWGRGCALKDKPGVYTR 233
Query: 881 VPKYVTWIQ 889
V ++ WI+
Sbjct: 234 VSHFLPWIR 242
>pdb|1H9H|E Chain E, Complex Of Eeti-Ii With Porcine Trypsin
Length = 231
Score = 110 bits (275), Expect = 4e-24, Method: Compositional matrix adjust.
Identities = 81/250 (32%), Positives = 116/250 (46%), Gaps = 28/250 (11%)
Query: 649 IIGGFE-SNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQ 707
I+GG+ S P+ +L G F G LI+ QWV++AAHC + +Q
Sbjct: 1 IVGGYTCSAANSIPYQVSLNSGSHFCS--GGSLINSQWVVSAAHCS--------YKSRIQ 50
Query: 708 LGVTRRNSYAFFGTR--FKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLP 765
+ + N G + H +N G DNDI L +L N + V LP
Sbjct: 51 VRLGEHNIDVLEGNEQFINAAKIITHPNFN-GNTLDNDIMLIKLSSPATLNSRVATVSLP 109
Query: 766 PPNYELAPGTRCTVI-GWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLG 824
A GT C++I GWG + + S ++ P+++ C + +T
Sbjct: 110 RS--CAAAGTECSLISGWGNTKSSGSSYPSLLQCSLKAPVLSDSSCKS---SYPGQITGN 164
Query: 825 MVCAGYPEGGKDAC-QGDSGGPLLCRSSHNFEQWFVGGIVSWGIKC-AHPHLPGVYAYVP 882
M+C G+ EGGKD+C QGDSGGP++C + + GIVSWG C A + PGVY V
Sbjct: 165 MICVGFLEGGKDSCSQGDSGGPVVCSNGQ------LQGIVSWGYGCSAQKNKPGVYTKVC 218
Query: 883 KYVTWIQDIM 892
YV WIQ +
Sbjct: 219 NYVNWIQQTI 228
>pdb|1AO5|A Chain A, Mouse Glandular Kallikrein-13 (Prorenin Converting Enzyme)
pdb|1AO5|B Chain B, Mouse Glandular Kallikrein-13 (Prorenin Converting Enzyme)
Length = 237
Score = 109 bits (272), Expect = 7e-24, Method: Compositional matrix adjust.
Identities = 77/257 (29%), Positives = 118/257 (45%), Gaps = 33/257 (12%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
++GGF P+ A+ E + C GVL+ WVLTAAHC +D++ V L
Sbjct: 1 VVGGFNCEKNSQPWQVAVYYQKEHI--CGGVLLDRNWVLTAAHCY-------VDQYEVWL 51
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNI----------GAQHDNDIALFQLKQKVKFNDH 758
G + V F H +N+ GA +D+ L +L + D
Sbjct: 52 GKNKLFQEEPSAQHRLVSKSFPHPGFNMSLLMLQTIPPGADFSDDLMLLRLSKPADITDV 111
Query: 759 LLPVCLPPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRE 818
+ P+ LP E PG++C GWG TR + + + V + ++ + C K +
Sbjct: 112 VKPIALP--TKEPKPGSKCLASGWGSITPTRWQKPDD-LQCVFITLLPNENCAKVYLQKV 168
Query: 819 LNVTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWG-IKCAHPHLPGV 877
+V M+CAG GGKD C+ DSGGPL+C + G S+G + C P +P +
Sbjct: 169 TDV---MLCAGEMGGGKDTCRDDSGGPLICDG-------ILQGTTSYGPVPCGKPGVPAI 218
Query: 878 YAYVPKYVTWIQDIMDK 894
Y + K+ +WI+D M K
Sbjct: 219 YTNLIKFNSWIKDTMMK 235
>pdb|1FI8|A Chain A, Rat Granzyme B [n66q] Complexed To Ecotin [81-84 Iepd]
pdb|1FI8|B Chain B, Rat Granzyme B [n66q] Complexed To Ecotin [81-84 Iepd]
Length = 228
Score = 108 bits (271), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 79/248 (31%), Positives = 113/248 (45%), Gaps = 23/248 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVF--YCAGVLISDQWVLTAAHCVGNLTGLNIDEWTV 706
IIGG E+ P P++A L E+ C G LI + +VLTAAHC G+ + V
Sbjct: 1 IIGGHEAKPHSRPYMAYLQIMDEYSGSKKCGGFLIREDFVLTAAHCSGS-------KIQV 53
Query: 707 QLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPP 766
LG V + H YN NDI L +LK K K + + P+ LP
Sbjct: 54 TLGAHNIKEQEKMQQIIPVVKIIPHPAYN-SKTISNDIMLLKLKSKAKRSSAVKPLNLPR 112
Query: 767 PNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMV 826
N ++ PG C V GWGK + +Y + EVE+ + C +L N +
Sbjct: 113 RNVKVKPGDVCYVAGWGKLGP--MGKYSDTLQEVELTVQEDQKCESYLKNYFDKAN--EI 168
Query: 827 CAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVT 886
CAG P+ + + +GDSGGPL+C+ GIVS+G P + V +++
Sbjct: 169 CAGDPKIKRASFRGDSGGPLVCKK-------VAAGIVSYGQNDG--STPRAFTKVSTFLS 219
Query: 887 WIQDIMDK 894
WI+ M K
Sbjct: 220 WIKKTMKK 227
>pdb|2PSX|A Chain A, Crystal Structure Of Human Kallikrein 5 In Complex With
Leupeptin
pdb|2PSY|A Chain A, Crystal Structure Of Human Kallikrein 5 In Complex With
Leupeptin And Zinc
Length = 227
Score = 108 bits (270), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 75/249 (30%), Positives = 127/249 (51%), Gaps = 23/249 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
II G + + P+ AALL P YC VL+ QW+LTAAHC + + + +++
Sbjct: 1 IINGSDCDMHTQPWQAALLLRPN-QLYCGAVLVHPQWLLTAAHCRKKVFRVRLGHYSLS- 58
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
V F G + ++H H ND+ L +L ++++ + P+ + +
Sbjct: 59 PVYESGQQMFQGVKSIPHPGYSH------PGHSNDLMLIKLNRRIRPTKDVRPINVS--S 110
Query: 769 YELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVCA 828
+ + GT+C V GWG + +V + + + + ++++ C R+++ T M CA
Sbjct: 111 HCPSAGTKCLVSGWGTTKSPQV-HFPKVLQCLNISVLSQKRCED-AYPRQIDDT--MFCA 166
Query: 829 GYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWG-IKCAHPHLPGVYAYVPKYVTW 887
G + G+D+CQGDSGGP++C S + G+VSWG CA P+ PGVY + K+ W
Sbjct: 167 G-DKAGRDSCQGDSGGPVVCNGS-------LQGLVSWGDYPCARPNRPGVYTNLCKFTKW 218
Query: 888 IQDIMDKYS 896
IQ+ + S
Sbjct: 219 IQETIQANS 227
>pdb|1L2E|A Chain A, Human Kallikrein 6 (Hk6) Active Form With Benzamidine
Inhibitor
pdb|1LO6|A Chain A, Human Kallikrein 6 (Hk6) Active Form With Benzamidine
Inhibitor At 1.56 A Resolution
Length = 223
Score = 108 bits (269), Expect = 2e-23, Method: Compositional matrix adjust.
Identities = 80/233 (34%), Positives = 114/233 (48%), Gaps = 26/233 (11%)
Query: 661 PFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQLGVTRRNSYAFFG 720
P+ AAL + C GVLI WVLTAAHC N+ + + + +R S
Sbjct: 13 PYQAALYTSGHLL--CGGVLIHPLWVLTAAHC----KKPNLQVFLGKHNLRQRESSQEQS 66
Query: 721 TRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPNYELAPGTRCTVI 780
+ VR V H Y+ A HD DI L +L + K ++ + P LP A T C ++
Sbjct: 67 S--VVRAVI-HPDYD-AASHDQDIMLLRLARPAKLSELIQP--LPLERDCSANTTSCHIL 120
Query: 781 GWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVCAGYPEGGKDACQG 840
GWGK D ++ + + +++R+ C + +T M+CAG + GKD+CQG
Sbjct: 121 GWGKTAD---GDFPDTIQCAYIHLVSREECEHAYPGQ---ITQNMLCAGDEKYGKDSCQG 174
Query: 841 DSGGPLLCRSSHNFEQWFVGGIVSWG-IKCAHPHLPGVYAYVPKYVTWIQDIM 892
DSGGPL+C + G+VSWG I C PGVY V +Y WIQ +
Sbjct: 175 DSGGPLVCGD-------HLRGLVSWGNIPCGSKEKPGVYTNVCRYTNWIQKTI 220
>pdb|1GVL|A Chain A, Human Prokallikrein 6 (Hk6) PROZYME PROPROTEASE M
Proneurosin
Length = 223
Score = 107 bits (268), Expect = 3e-23, Method: Compositional matrix adjust.
Identities = 79/246 (32%), Positives = 112/246 (45%), Gaps = 26/246 (10%)
Query: 648 RIIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQ 707
+++ G + P+ AAL + C GVLI WVLTAAHC V
Sbjct: 1 KLVHGGPCDKTSHPYQAALYTSGHLL--CGGVLIHPLWVLTAAHC-------KKPNLQVF 51
Query: 708 LGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPP 767
LG + V H Y+ A HD DI L +L + K ++ + P LP
Sbjct: 52 LGKHNLRQQESSQEQSSVVRAVIHPDYD-AASHDQDIMLLRLARPAKLSELIQP--LPLE 108
Query: 768 NYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVC 827
A T C ++GWGK D ++ + + +++R+ C + +T M+C
Sbjct: 109 RDCSAQTTSCHILGWGKTAD---GDFPDTIQCAYIHLVSREECEHAYPGQ---ITQNMLC 162
Query: 828 AGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWG-IKCAHPHLPGVYAYVPKYVT 886
AG + GKD+CQGDSGGPL+C + G+VSWG I C PGVY V +Y
Sbjct: 163 AGDEKYGKDSCQGDSGGPLVCGD-------HLRGLVSWGNIPCGSKEKPGVYTNVCRYTN 215
Query: 887 WIQDIM 892
WIQ +
Sbjct: 216 WIQKTI 221
>pdb|1TON|A Chain A, Rat Submaxillary Gland Serine Protease, Tonin. Structure
Solution And Refinement At 1.8 Angstroms Resolution
Length = 235
Score = 107 bits (267), Expect = 3e-23, Method: Compositional matrix adjust.
Identities = 83/259 (32%), Positives = 116/259 (44%), Gaps = 39/259 (15%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG++ P+ A++ + C GVLI WV+TAAHC N + V L
Sbjct: 1 IVGGYKCEKNSQPWQVAVINE----YLCGGVLIDPSWVITAAHCYSN-------NYQVLL 49
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQY------NIGAQ----HDNDIALFQLKQKVKFNDH 758
G F R VR F H Y N Q H ND+ L L +
Sbjct: 50 GRNNLFKDEPFAQRRLVRQSFRHPDYIPLIVTNDTEQPVHDHSNDLMLLHLSEPADITGG 109
Query: 759 LLPVCLPPPNYELAPGTRCTVIGWGKREDTRVSEYETA--VNEVEVPIITRDICNKWLNN 816
+ + LP E G+ C GWG T SE + + V + +++ + C +
Sbjct: 110 VKVIDLP--TKEPKVGSTCLASGWGS---TNPSEMVVSHDLQCVNIHLLSNEKC---IET 161
Query: 817 RELNVTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIK-CAHPHLP 875
+ NVT M+CAG EGGKD C GDSGGPL+C + GI S G CA P P
Sbjct: 162 YKDNVTDVMLCAGEMEGGKDTCAGDSGGPLICDG-------VLQGITSGGATPCAKPKTP 214
Query: 876 GVYAYVPKYVTWIQDIMDK 894
+YA + K+ +WI+ +M +
Sbjct: 215 AIYAKLIKFTSWIKKVMKE 233
>pdb|1SPJ|A Chain A, Structure Of Mature Human Tissue Kallikrein (Human
Kallikrein 1 Or Klk1) At 1.70 Angstrom Resolution With
Vacant Active Site
Length = 238
Score = 107 bits (267), Expect = 3e-23, Method: Compositional matrix adjust.
Identities = 84/262 (32%), Positives = 118/262 (45%), Gaps = 38/262 (14%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+E P+ AAL F C G+L+ QWVLTAAHC+ + QL
Sbjct: 1 IVGGWECEQHSQPWQAALYHFS--TFQCGGILVHRQWVLTAAHCISD---------NYQL 49
Query: 709 GVTRRNSYAFFGTR--FKVRGVFAHSQYNIG----------AQHDNDIALFQLKQKV-KF 755
+ R N + T V F H +N+ + +D+ L +L +
Sbjct: 50 WLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTI 109
Query: 756 NDHLLPVCLPPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLN 815
D + V LP E+ G+ C GWG E S + + V++ I+ D C K
Sbjct: 110 TDAVKVVELPTEEPEV--GSTCLASGWGSIEPENFS-FPDDLQCVDLKILPNDECKK--- 163
Query: 816 NRELNVTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWG-IKCAHPHL 874
VT M+C G+ EGGKD C GDSGGPL+C + G+ SWG + C P+
Sbjct: 164 AHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDG-------VLQGVTSWGYVPCGTPNK 216
Query: 875 PGVYAYVPKYVTWIQDIMDKYS 896
P V V YV WI+D + + S
Sbjct: 217 PSVAVRVLSYVKWIEDTIAENS 238
>pdb|1EUF|A Chain A, Bovine Duodenase(New Serine Protease), Crystal Structure
Length = 227
Score = 107 bits (266), Expect = 4e-23, Method: Compositional matrix adjust.
Identities = 78/250 (31%), Positives = 112/250 (44%), Gaps = 27/250 (10%)
Query: 649 IIGGFESNPGDWPFLAALL---GGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWT 705
IIGG E+ P P++A LL G + C G L+ + +VLTAAHC+G+
Sbjct: 1 IIGGHEAKPHSRPYMAFLLFKTSGKSHI--CGGFLVREDFVLTAAHCLGS-------SIN 51
Query: 706 VQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLP 765
V LG VR H YN NDI L +L +K D + P+ LP
Sbjct: 52 VTLGAHNIMERERTQQVIPVRRPIPHPDYN-DETLANDIMLLKLTRKADITDKVSPINLP 110
Query: 766 PPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGM 825
E+ PG C+V GWG+ S + + EV++ + + + C N +
Sbjct: 111 RSLAEVKPGMMCSVAGWGRLGVNMPSTDK--LQEVDLEVQSEEKCIARFKNY---IPFTQ 165
Query: 826 VCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYV 885
+CAG P K++ GDSGGPL+C GIVS+G P VY + ++
Sbjct: 166 ICAGDPSKRKNSFSGDSGGPLVCNG-------VAQGIVSYGRNDG--TTPDVYTRISSFL 216
Query: 886 TWIQDIMDKY 895
+WI M +Y
Sbjct: 217 SWIHSTMRRY 226
>pdb|4D8N|A Chain A, Human Kallikrein 6 Inhibitors With A
Para-Amidobenzylanmine P1 Group Carry A High Binding
Efficiency
pdb|3VFE|A Chain A, Virtual Screening And X-Ray Crystallography For Human
Kallikrein 6 Inhibitors With An Amidinothiophene P1
Group
Length = 223
Score = 106 bits (265), Expect = 4e-23, Method: Compositional matrix adjust.
Identities = 78/233 (33%), Positives = 107/233 (45%), Gaps = 26/233 (11%)
Query: 661 PFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQLGVTRRNSYAFFG 720
P+ AAL + C GVLI WVLTAAHC V LG
Sbjct: 13 PYQAALYTSGHLL--CGGVLIHPLWVLTAAHC-------KKPNLQVFLGKHNLGQQESSQ 63
Query: 721 TRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPNYELAPGTRCTVI 780
+ V H Y+ A HD DI L +L + K ++ + P LP A T C ++
Sbjct: 64 EQSSVVRAVIHPDYD-AASHDQDIMLLRLARPAKLSELIQP--LPLERDCSAQTTSCHIL 120
Query: 781 GWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVCAGYPEGGKDACQG 840
GWGK D ++ + + +++R+ C + +T M+CAG + GKD+CQG
Sbjct: 121 GWGKTAD---GDFPDTIQCAYIHLVSREECEHAYPGQ---ITQNMLCAGDEKYGKDSCQG 174
Query: 841 DSGGPLLCRSSHNFEQWFVGGIVSWG-IKCAHPHLPGVYAYVPKYVTWIQDIM 892
DSGGPL+C + G+VSWG I C PGVY V +Y WIQ +
Sbjct: 175 DSGGPLVCGD-------HLRGLVSWGNIPCGSKEKPGVYTNVCRYTNWIQKTI 220
>pdb|3RP2|A Chain A, The Structure Of Rat Mast Cell Protease Ii At
1.9-Angstroms Resolution
pdb|3RP2|B Chain B, The Structure Of Rat Mast Cell Protease Ii At
1.9-Angstroms Resolution
Length = 224
Score = 106 bits (265), Expect = 5e-23, Method: Compositional matrix adjust.
Identities = 85/247 (34%), Positives = 113/247 (45%), Gaps = 25/247 (10%)
Query: 649 IIGGFESNPGDWPFLAAL--LGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTV 706
IIGG ES P P++A L + C G LIS Q+VLTAAHC G E TV
Sbjct: 1 IIGGVESIPHSRPYMAHLDIVTEKGLRVICGGFLISRQFVLTAAHCKGR-------EITV 53
Query: 707 QLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPP 766
LG + KV H YN + +DI L +L++KV+ + V LP
Sbjct: 54 ILGAHDVRKRESTQQKIKVEKQIIHESYN-SVPNLHDIMLLKLEKKVELTPAVNVVPLPS 112
Query: 767 PNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMV 826
P+ + PG C GWGK + Y + EVE+ I+ C ++ R V
Sbjct: 113 PSDFIHPGAMCWAAGWGKTGVRDPTSY--TLREVELRIMDEKAC---VDYRYYEYKF-QV 166
Query: 827 CAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVT 886
C G P + A GDSGGPLLC + GIVS+G A P P ++ V YV
Sbjct: 167 CVGSPTTLRAAFMGDSGGPLLCAGVAH-------GIVSYGHPDAKP--PAIFTRVSTYVP 217
Query: 887 WIQDIMD 893
WI +++
Sbjct: 218 WINAVIN 224
>pdb|1BRU|P Chain P, Structure Of Porcine Pancreatic Elastase Complexed With
The Elastase Inhibitor Gr143783
Length = 241
Score = 106 bits (264), Expect = 7e-23, Method: Compositional matrix adjust.
Identities = 76/251 (30%), Positives = 118/251 (47%), Gaps = 20/251 (7%)
Query: 649 IIGGFESNPGDWPFLAALL--GGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTV 706
++GG ++ P WP+ +L ++ C G L+ WVLTAAHC+ + + V
Sbjct: 1 VVGGEDARPNSWPWQVSLQYDSSGQWRHTCGGTLVDQSWVLTAAHCIS-----SSRTYRV 55
Query: 707 QLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGA-QHDNDIALFQLKQKVKFNDHLLPVCLP 765
LG ++ KV + H +N + NDIAL +L V D + CLP
Sbjct: 56 VLGRHSLSTNEPGSLAVKVSKLVVHQDWNSNQLSNGNDIALLKLASPVSLTDKIQLGCLP 115
Query: 766 PPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNK--WLNNRELNVTL 823
L C V GWG+ + S + + ++ ++ C+K W + V
Sbjct: 116 AAGTILPNNYVCYVTGWGRLQTNGAS--PDILQQGQLLVVDYATCSKPGWWGS---TVKT 170
Query: 824 GMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWG--IKCAHPHLPGVYAYV 881
M+CAG +G +C GDSGGPL C+ ++ QW V GIVS+G + C + H P V+ V
Sbjct: 171 NMICAG-GDGIISSCNGDSGGPLNCQGANG--QWQVHGIVSFGSSLGCNYYHKPSVFTRV 227
Query: 882 PKYVTWIQDIM 892
Y+ WI ++
Sbjct: 228 SNYIDWINSVI 238
>pdb|1DST|A Chain A, Mutant Of Factor D With Enhanced Catalytic Activity
Length = 228
Score = 106 bits (264), Expect = 7e-23, Method: Composition-based stats.
Identities = 75/252 (29%), Positives = 121/252 (48%), Gaps = 33/252 (13%)
Query: 649 IIGGFESNPGDWPFLAAL-LGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQ 707
I+GG E+ P++A++ L G C GVL+++QWVL+AAHC+ + + V
Sbjct: 1 ILGGREAEAHARPYMASVQLNGAHL---CGGVLVAEQWVLSAAHCLEDAADGKVQ---VL 54
Query: 708 LGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPP 767
LG + + V H Y D+D+ L QL +K + P+
Sbjct: 55 LGAHSLSQPEPSKRLYDVLRAVPHPDYQPDTI-DHDLLLLQLSEKATLGPAVRPLPWQRV 113
Query: 768 NYELAPGTRCTVIGW------GKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNV 821
+ ++APGT C V GW G+R D+ + V +P++ R CN+ + + +
Sbjct: 114 DRDVAPGTLCDVAGWGIVNHAGRRPDS--------LQHVLLPVLDRATCNR-RTHHDGAI 164
Query: 822 TLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIK-CAHPHLPGVYAY 880
T ++CA +D+C+GDSGGPL+C + G+VSWG + C + PG+Y
Sbjct: 165 TERLMCA--ESNRRDSCKGDSGGPLVCGG-------VLEGVVSWGSRVCGNRKKPGIYTR 215
Query: 881 VPKYVTWIQDIM 892
V Y WI ++
Sbjct: 216 VASYAAWIDSVL 227
>pdb|2ZCH|P Chain P, Crystal Structure Of Human Prostate Specific Antigen
Complexed With An Activating Antibody
pdb|2ZCK|P Chain P, Crystal Structure Of A Ternary Complex Between Psa, A
Substrat-Acyl Intermediate And An Activating Antibody
pdb|2ZCL|P Chain P, Crystal Structure Of Human Prostate Specific Antigen
Complexed With An Activating Antibody
pdb|3QUM|P Chain P, Crystal Structure Of Human Prostate Specific Antigen (Psa)
In Fab Sandwich With A High Affinity And A Pca Selective
Antibody
pdb|3QUM|Q Chain Q, Crystal Structure Of Human Prostate Specific Antigen (Psa)
In Fab Sandwich With A High Affinity And A Pca Selective
Antibody
Length = 237
Score = 105 bits (263), Expect = 9e-23, Method: Compositional matrix adjust.
Identities = 87/261 (33%), Positives = 118/261 (45%), Gaps = 45/261 (17%)
Query: 649 IIGGFE----SNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEW 704
I+GG+E S P W L A G C GVL+ QWVLTAAHC+ N +
Sbjct: 1 IVGGWECEKHSQP--WQVLVASRGRA----VCGGVLVHPQWVLTAAHCIRNKS------- 47
Query: 705 TVQLGVTRRNSYAFFGTRFKVRGVFAHSQYNI----------GAQHDNDIALFQLKQKVK 754
+ LG G F+V F H Y++ G +D+ L +L + +
Sbjct: 48 VILLGRHSLFHPEDTGQVFQVSHSFPHPLYDMSLLKNRFLRPGDDSSHDLMLLRLSEPAE 107
Query: 755 FNDHLLPVCLPPPNYELAPGTRCTVIGWGKREDTRVSEYET--AVNEVEVPIITRDICNK 812
D + + LP E A GT C GWG E E+ T + V++ +I+ D+C +
Sbjct: 108 LTDAVKVMDLP--TQEPALGTTCYASGWGSIEP---EEFLTPKKLQCVDLHVISNDVCAQ 162
Query: 813 WLNNRELNVTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIK-CAH 871
VT M+CAG GGK C GDSGGPL+C + GI SWG + CA
Sbjct: 163 ---VHPQKVTKFMLCAGRWTGGKSTCSGDSGGPLVCNG-------VLQGITSWGSEPCAL 212
Query: 872 PHLPGVYAYVPKYVTWIQDIM 892
P P +Y V Y WI+D +
Sbjct: 213 PERPSLYTKVVHYRKWIKDTI 233
>pdb|2QY0|B Chain B, Active Dimeric Structure Of The Catalytic Domain Of C1r
Reveals Enzyme-product Like Contacts
pdb|2QY0|D Chain D, Active Dimeric Structure Of The Catalytic Domain Of C1r
Reveals Enzyme-product Like Contacts
Length = 242
Score = 105 bits (263), Expect = 1e-22, Method: Compositional matrix adjust.
Identities = 82/255 (32%), Positives = 118/255 (46%), Gaps = 24/255 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCV-----GNLTGLNIDE 703
IIGG ++ G++P+ G L+ D+W+LTAAH + + ++D
Sbjct: 1 IIGGQKAKMGNFPWQVF----TNIHGRGGGALLGDRWILTAAHTLYPKEHEAQSNASLD- 55
Query: 704 WTVQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQH--DNDIALFQLKQKVKFNDHLLP 761
V LG T G +R V H Y + + DIAL +L+ V +LLP
Sbjct: 56 --VFLGHTNVEELMKLGNH-PIRRVSVHPDYRQDESYNFEGDIALLELENSVTLGPNLLP 112
Query: 762 VCLPPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWL--NNREL 819
+CLP + G V G+G E+ + + V +P+ C WL NR
Sbjct: 113 ICLPDNDTFYDLGLMGYVSGFGVMEEKIAHD----LRFVRLPVANPQACENWLRGKNRMD 168
Query: 820 NVTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYA 879
+ M CAG+P +DACQGDSGG R N ++W GIVSWGI C+ + G Y
Sbjct: 169 VFSQNMFCAGHPSLKQDACQGDSGGVFAVRDP-NTDRWVATGIVSWGIGCSRGY--GFYT 225
Query: 880 YVPKYVTWIQDIMDK 894
V YV WI+ M++
Sbjct: 226 KVLNYVDWIKKEMEE 240
>pdb|2XXL|A Chain A, Crystal Structure Of Drosophila Grass Clip Serine Protease
Of Toll Pathway
pdb|2XXL|B Chain B, Crystal Structure Of Drosophila Grass Clip Serine Protease
Of Toll Pathway
Length = 408
Score = 105 bits (261), Expect = 1e-22, Method: Compositional matrix adjust.
Identities = 92/289 (31%), Positives = 134/289 (46%), Gaps = 50/289 (17%)
Query: 630 NIQCGTRRHLHNNFKARKRIIGGFESNPGDWPFLAAL----LGGPEFVFYCAGVLISDQW 685
N CG NF + +R+ G+E P++A L G E F C G +IS+++
Sbjct: 108 NFDCG-------NFLS-QRVSNGYEVKLSSRPWMALLRYQQFG--ESRFLCGGAMISERY 157
Query: 686 VLTAAHCVGNLTGLNIDEWTVQLG------------VTRRNSYAFFGTRFKVRGVFAHSQ 733
+LTAAHCV GL D + ++LG R+ A + H +
Sbjct: 158 ILTAAHCV---HGLQNDLYEIRLGEHRISTEEDCRQQGRKKKCAPPVVNVGIEKHLIHEK 214
Query: 734 YNIGAQH-DNDIALFQLKQKVKFNDHLLPVCLPPPNYELAPGTRCT---VIGWGKREDTR 789
Y+ A+H +DIAL +L + V F H+ P+CLP + + + V GWG E+
Sbjct: 215 YD--ARHIMHDIALLKLNRSVPFQKHIKPICLPITDELKEKAEQISTYFVTGWGTTENGS 272
Query: 790 VSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVCAGYPEGG--KDACQGDSGGPLL 847
S+ N VP+ R C++ V L +C G GG +D+C+GDSGGPL
Sbjct: 273 SSDVLLQAN---VPLQPRSACSQAYRR---AVPLSQLCVG---GGDLQDSCKGDSGGPLQ 323
Query: 848 CRSSHNFE---QWFVGGIVSWG-IKCAHPHLPGVYAYVPKYVTWIQDIM 892
+ + E + GIVS G + C LPG+Y V +YV WI D M
Sbjct: 324 APAQYLGEYAPKMVEFGIVSQGVVTCGQISLPGLYTNVGEYVQWITDTM 372
>pdb|1SGT|A Chain A, Refined Crystal Structure Of Streptomyces Griseus Trypsin
At 1.7 Angstroms Resolution
Length = 223
Score = 104 bits (259), Expect = 3e-22, Method: Composition-based stats.
Identities = 89/252 (35%), Positives = 112/252 (44%), Gaps = 48/252 (19%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCV---GNLTGLNIDEWT 705
++GG + G++PF+ L G C G L + VLTAAHCV GN T + T
Sbjct: 1 VVGGTRAAQGEFPFMVRLSMG------CGGALYAQDIVLTAAHCVSGSGNNTSI-----T 49
Query: 706 VQLGVTRRNSYAFFGTRFKVRG--VFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVC 763
GV S G KVR V YN + D AL +L Q +
Sbjct: 50 ATGGVVDLQS----GAAVKVRSTKVLQAPGYNGTGK---DWALIKLAQPIN--------- 93
Query: 764 LPPPNYELAPGT-----RCTVIGWG-KREDTRVSEYETAVNEVEVPIITRDICNKWLNNR 817
P ++A T TV GWG RE Y N VP ++ C N
Sbjct: 94 --QPTLKIATTTAYNQGTFTVAGWGANREGGSQQRYLLKAN---VPFVSDAACRSAYGN- 147
Query: 818 ELNVTLGMVCAGYPE-GGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPG 876
EL V +CAGYP+ GG D CQGDSGGP+ + N ++W GIVSWG CA P PG
Sbjct: 148 EL-VANEEICAGYPDTGGVDTCQGDSGGPMFRKD--NADEWIQVGIVSWGYGCARPGYPG 204
Query: 877 VYAYVPKYVTWI 888
VY V + + I
Sbjct: 205 VYTEVSTFASAI 216
>pdb|4GSO|A Chain A, Structure Of Jararacussin-I
Length = 232
Score = 103 bits (258), Expect = 3e-22, Method: Compositional matrix adjust.
Identities = 76/244 (31%), Positives = 109/244 (44%), Gaps = 28/244 (11%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
++GG E + + PFLA L ++C LI+ +WV+TAAHC + + +QL
Sbjct: 1 VLGGDECDINEHPFLAFLY---SHGYFCGLTLINQEWVVTAAHC-------DSTNFQMQL 50
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLP--P 766
GV + + F N+ D DI L +L + + + H+ P+ LP P
Sbjct: 51 GVHSKKVLNEDEQTRNPKEKFICPNKNMSEVLDKDIMLIKLDKPISNSKHIAPLSLPSNP 110
Query: 767 PNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMV 826
P+ G+ C ++GWG Y + ++ ++C N TL
Sbjct: 111 PSV----GSVCRIMGWGSITIPN-ETYPDVPYCANINLVDYEVCQGAYNGLPAKTTL--- 162
Query: 827 CAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGI-KCAHPHLPGVYAYVPKYV 885
CAG EGGKD C GDSGGPL+C GIVS+G C PG+Y V Y
Sbjct: 163 CAGVLEGGKDTCVGDSGGPLICNGQFQ-------GIVSYGAHSCGQGPKPGIYTNVFDYT 215
Query: 886 TWIQ 889
WIQ
Sbjct: 216 DWIQ 219
>pdb|4GAW|A Chain A, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|B Chain B, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|C Chain C, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|D Chain D, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|E Chain E, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|F Chain F, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|G Chain G, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|H Chain H, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|I Chain I, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|J Chain J, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|K Chain K, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|L Chain L, Crystal Structure Of Active Human Granzyme H
Length = 226
Score = 103 bits (258), Expect = 3e-22, Method: Compositional matrix adjust.
Identities = 75/254 (29%), Positives = 116/254 (45%), Gaps = 37/254 (14%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFY--------CAGVLISDQWVLTAAHCVGNLTGLN 700
IIGG E+ P P++A FV + C G+L+ +VLTAAHC G+ +
Sbjct: 1 IIGGHEAKPHSRPYMA-------FVQFLQEKSRKRCGGILVRKDFVLTAAHCQGSSINVT 53
Query: 701 IDEWTVQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLL 760
+ ++ + + F V+ H YN NDI L QL++K K+ +
Sbjct: 54 LGAHNIK---EQERTQQFI----PVKRPIPHPAYN-PKNFSNDIMLLQLERKAKWTTAVR 105
Query: 761 PVCLPPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELN 820
P+ LP ++ PG C+V GWG +S T + EV + + C + +
Sbjct: 106 PLRLPSSKAQVKPGQLCSVAGWGY---VSMSTLATTLQEVLLTVQKDCQCERLFHGNYSR 162
Query: 821 VTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAY 880
T +C G P+ + +GDSGGPL+C+ GI+S+G K P PGVY
Sbjct: 163 AT--EICVGDPKKTQTGFKGDSGGPLVCKD-------VAQGILSYGNKKGTP--PGVYIK 211
Query: 881 VPKYVTWIQDIMDK 894
V ++ WI+ M +
Sbjct: 212 VSHFLPWIKRTMKR 225
>pdb|3I77|A Chain A, 3599170-Loops Of Fxa In Sgt
Length = 230
Score = 103 bits (258), Expect = 3e-22, Method: Composition-based stats.
Identities = 83/250 (33%), Positives = 114/250 (45%), Gaps = 37/250 (14%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCV---GNLTGLNIDEWT 705
++GG + G++PF+ L+ E +C G L + VLTAAHCV GN T +
Sbjct: 1 VVGGTRAAQGEFPFMVRLIN-EENEGFCGGALYAQDIVLTAAHCVSGSGNNTSITATGGV 59
Query: 706 VQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLP 765
V L ++S A KV ++ G D AL +L Q +
Sbjct: 60 VDL----QSSSAVKVRSTKVLQAPGFTKETYG----KDWALIKLAQPIN----------- 100
Query: 766 PPNYELAPGT-----RCTVIGWG-KREDTRVSEYETAVNEVEVPIITRDICNKWLNNREL 819
P ++A T TV GWG RE Y N VP ++ C ++ +
Sbjct: 101 QPTLKIATTTAYNQGTFTVAGWGANREGGSQQRYLLKAN---VPFVSDAACRS--SSSFI 155
Query: 820 NVTLGMVCAGYPE-GGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVY 878
V M+CAGYP+ GG D CQGDSGGP+ + N ++W GIVSWG CA P PGVY
Sbjct: 156 LVANEMICAGYPDTGGVDTCQGDSGGPMFRKD--NADEWIQVGIVSWGYGCARPGYPGVY 213
Query: 879 AYVPKYVTWI 888
V + + I
Sbjct: 214 TEVSTFASAI 223
>pdb|1ELV|A Chain A, Crystal Structure Of The Catalytic Domain Of Human
Complement C1s Protease
Length = 333
Score = 103 bits (256), Expect = 6e-22, Method: Compositional matrix adjust.
Identities = 87/280 (31%), Positives = 130/280 (46%), Gaps = 37/280 (13%)
Query: 633 CGTRRHLHNNFKARKRIIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHC 692
CG R F+ ++RIIGG +++ ++P+ P + G LI++ WVLTAAH
Sbjct: 70 CGVPRE---PFEEKQRIIGGSDADIKNFPW-QVFFDNP----WAGGALINEYWVLTAAHV 121
Query: 693 V-GNLTGLNIDEWTVQLGVTRRNSYAFFGTRFKV-RGVFAHSQYNIGA------QHDNDI 744
V GN E T+ +G T + ++ VF H + + A DNDI
Sbjct: 122 VEGN------REPTMYVGSTSVQTSRLAKSKMLTPEHVFIHPGWKLLAVPEGRTNFDNDI 175
Query: 745 ALFQLKQKVKFNDHLLPVCLP--PPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEV 802
AL +LK VK + P+CLP +Y L G + GWG+ E + + +
Sbjct: 176 ALVRLKDPVKMGPTVSPICLPGTSSDYNLMDGDLGLISGWGRTEK---RDRAVRLKAARL 232
Query: 803 PIITRDICN-----KWLNNRELNV-TLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQ 856
P+ C K + E V T M+CAG E G D+C+GDSGG + ++ +
Sbjct: 233 PVAPLRKCKEVKVEKPTADAEAYVFTPNMICAG-GEKGMDSCKGDSGGAFAVQDPNDKTK 291
Query: 857 WFVGGIVSWGIKCAHPHLPGVYAYVPKYVTWIQDIMDKYS 896
++ G+VSWG +C G+Y V YV WI M + S
Sbjct: 292 FYAAGLVSWGPQCG---TYGLYTRVKNYVDWIMKTMQENS 328
>pdb|4H4F|A Chain A, Crystal Structure Of Human Chymotrypsin C (ctrc) Bound To
Inhibitor Eglin C From Hirudo Medicinalis
Length = 249
Score = 102 bits (254), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 78/248 (31%), Positives = 114/248 (45%), Gaps = 15/248 (6%)
Query: 649 IIGGFESNPGDWPFLAAL--LGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTV 706
++GG ++ P WP+ +L L + C G LI+ +VLTAAHC+ N +
Sbjct: 1 VVGGEDARPHSWPWQISLQYLKNDTWRHTCGGTLIASNFVLTAAHCISNTRTYRVAVGKN 60
Query: 707 QLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPP 766
L V F G V + H ++N NDIAL +L + V+ +D + CLP
Sbjct: 61 NLEVEDEEGSLFVG----VDTIHVHKRWN-ALLLRNDIALIKLAEHVELSDTIQVACLPE 115
Query: 767 PNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMV 826
+ L C V GWG+ + + P++ C++ ++ V MV
Sbjct: 116 KDSLLPKDYPCYVTGWGRLWTN--GPIADKLQQGLQPVVDHATCSR-IDWWGFRVKKTMV 172
Query: 827 CAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIK--CAHPHLPGVYAYVPKY 884
CAG +G AC GDSGGPL C+ + W V GIVS+G + C P VY V Y
Sbjct: 173 CAG-GDGVISACNGDSGGPLNCQLENG--SWEVFGIVSFGSRRGCNTRKKPVVYTRVSAY 229
Query: 885 VTWIQDIM 892
+ WI + M
Sbjct: 230 IDWINEKM 237
>pdb|1FQ3|A Chain A, Crystal Structure Of Human Granzyme B
pdb|1FQ3|B Chain B, Crystal Structure Of Human Granzyme B
Length = 227
Score = 102 bits (253), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 79/248 (31%), Positives = 113/248 (45%), Gaps = 22/248 (8%)
Query: 649 IIGGFESNPGDWPFLAALL-GGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQ 707
IIGG E+ P P++A L+ + + C G LI D +VLTAAHC G + +N V
Sbjct: 1 IIGGHEAKPHSRPYMAYLMIWDQKSLKRCGGFLIQDDFVLTAAHCWG--SSIN-----VT 53
Query: 708 LGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPP 767
LG V+ H YN NDI L QL++K K + P+ LP
Sbjct: 54 LGAHNIKEQEPTQQFIPVKRPIPHPAYN-PKNFSNDIMLLQLERKAKRTRAVQPLRLPSN 112
Query: 768 NYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVC 827
++ PG C+V GWG + + ++ + EV++ + C L R + +C
Sbjct: 113 KAQVKPGQTCSVAGWG--QTAPLGKHSHTLQEVKMTVQEDRKCESDL--RHYYDSTIELC 168
Query: 828 AGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTW 887
G PE K + +GDSGGPL+C GIVS+G P P V +V W
Sbjct: 169 VGDPEIKKTSFKGDSGGPLVCNK-------VAQGIVSYGRNNGMP--PRACTKVSSFVHW 219
Query: 888 IQDIMDKY 895
I+ M +Y
Sbjct: 220 IKKTMKRY 227
>pdb|3TJU|A Chain A, Crystal Structure Of Human Granzyme H With An Inhibitor
pdb|3TJV|A Chain A, Crystal Structure Of Human Granzyme H With A Peptidyl
Substrate
pdb|3TK9|A Chain A, Crystal Structure Of Human Granzyme H
Length = 226
Score = 102 bits (253), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 74/254 (29%), Positives = 116/254 (45%), Gaps = 37/254 (14%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFY--------CAGVLISDQWVLTAAHCVGNLTGLN 700
IIGG E+ P P++A FV + C G+L+ +VLTAAHC G+ +
Sbjct: 1 IIGGHEAKPHSRPYMA-------FVQFLQEKSRKRCGGILVRKDFVLTAAHCQGSSINVT 53
Query: 701 IDEWTVQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLL 760
+ ++ + + F V+ H YN N+I L QL++K K+ +
Sbjct: 54 LGAHNIK---EQERTQQFI----PVKRPIPHPAYN-PKNFSNNIMLLQLERKAKWTTAVR 105
Query: 761 PVCLPPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELN 820
P+ LP ++ PG C+V GWG +S T + EV + + C + +
Sbjct: 106 PLRLPSSKAQVKPGQLCSVAGWGY---VSMSTLATTLQEVLLTVQKDCQCERLFHGNYSR 162
Query: 821 VTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAY 880
T +C G P+ + +GDSGGPL+C+ GI+S+G K P PGVY
Sbjct: 163 AT--EICVGDPKKTQTGFKGDSGGPLVCKD-------VAQGILSYGNKKGTP--PGVYIK 211
Query: 881 VPKYVTWIQDIMDK 894
V ++ WI+ M +
Sbjct: 212 VSHFLPWIKRTMKR 225
>pdb|1IAU|A Chain A, Human Granzyme B In Complex With Ac-Iepd-Cho
Length = 227
Score = 102 bits (253), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 79/248 (31%), Positives = 113/248 (45%), Gaps = 22/248 (8%)
Query: 649 IIGGFESNPGDWPFLAALL-GGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQ 707
IIGG E+ P P++A L+ + + C G LI D +VLTAAHC G + +N V
Sbjct: 1 IIGGHEAKPHSRPYMAYLMIWDQKSLKRCGGFLIRDDFVLTAAHCWG--SSIN-----VT 53
Query: 708 LGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPP 767
LG V+ H YN NDI L QL++K K + P+ LP
Sbjct: 54 LGAHNIKEQEPTQQFIPVKRPIPHPAYN-PKNFSNDIMLLQLERKAKRTRAVQPLRLPSN 112
Query: 768 NYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVC 827
++ PG C+V GWG + + ++ + EV++ + C L R + +C
Sbjct: 113 KAQVKPGQTCSVAGWG--QTAPLGKHSHTLQEVKMTVQEDRKCESDL--RHYYDSTIELC 168
Query: 828 AGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTW 887
G PE K + +GDSGGPL+C GIVS+G P P V +V W
Sbjct: 169 VGDPEIKKTSFKGDSGGPLVCNK-------VAQGIVSYGRNNGMP--PRACTKVSSFVHW 219
Query: 888 IQDIMDKY 895
I+ M +Y
Sbjct: 220 IKKTMKRY 227
>pdb|1OS8|A Chain A, Recombinant Streptomyces Griseus Trypsin
Length = 223
Score = 102 bits (253), Expect = 1e-21, Method: Composition-based stats.
Identities = 85/250 (34%), Positives = 111/250 (44%), Gaps = 44/250 (17%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCV---GNLTGLNIDEWT 705
++GG + G++PF+ L G C G L + VLTAAHCV GN T + T
Sbjct: 1 VVGGTRAAQGEFPFMVRLSMG------CGGALYAQDIVLTAAHCVSGSGNNTSI-----T 49
Query: 706 VQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLP 765
GV S + + + V YN + D AL +L Q +
Sbjct: 50 ATGGVVDLQSSS--AVKVRSTKVLQAPGYNGTGK---DWALIKLAQPIN----------- 93
Query: 766 PPNYELAPGT-----RCTVIGWG-KREDTRVSEYETAVNEVEVPIITRDICNKWLNNREL 819
P ++A T TV GWG RE Y N VP ++ C N EL
Sbjct: 94 QPTLKIATTTAYNQGTFTVAGWGANREGGSQQRYLLKAN---VPFVSDAACRSAYGN-EL 149
Query: 820 NVTLGMVCAGYPE-GGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVY 878
V +CAGYP+ GG D CQGDSGGP+ + N ++W GIVSWG CA P PGVY
Sbjct: 150 -VANEEICAGYPDTGGVDTCQGDSGGPMFRKD--NADEWIQVGIVSWGYGCARPGYPGVY 206
Query: 879 AYVPKYVTWI 888
V + + I
Sbjct: 207 TEVSTFASAI 216
>pdb|1KYN|B Chain B, Cathepsin-G
pdb|1KYN|A Chain A, Cathepsin-G
Length = 235
Score = 101 bits (252), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 82/248 (33%), Positives = 119/248 (47%), Gaps = 24/248 (9%)
Query: 649 IIGGFESNPGDWPFLAAL-LGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQ 707
IIGG ES P P++A L + P C G L+ + +VLTAAHC G+ + + +Q
Sbjct: 1 IIGGRESRPHSRPYMAYLQIQSPAGQSRCGGFLVREDFVLTAAHCWGSNINVTLGAHNIQ 60
Query: 708 LGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPP 767
R N+ R +R H QYN NDI L QL ++V+ N ++ PV LP
Sbjct: 61 ---RRENTQQHITARRAIR----HPQYN-QRTIQNDIMLLQLSRRVRRNRNVNPVALPRA 112
Query: 768 NYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVC 827
L PGT CTV GWG+ R ++ + EV++ + C + + + +C
Sbjct: 113 QEGLRPGTLCTVAGWGRVSMRRGTD---TLREVQLRVQRDRQCLRIFGSYDPRR---QIC 166
Query: 828 AGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTW 887
G K A +GDSGGPLLC + + GIVS+G P P V+ V ++ W
Sbjct: 167 VGDRRERKAAFKGDSGGPLLCNNVAH-------GIVSYGKSSGVP--PEVFTRVSSFLPW 217
Query: 888 IQDIMDKY 895
I+ M +
Sbjct: 218 IRTTMRSF 225
>pdb|1ELT|A Chain A, Structure Of Native Pancreatic Elastase From North
Atlantic Salmon At 1.61 Angstroms Resolution
Length = 236
Score = 101 bits (252), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 76/251 (30%), Positives = 108/251 (43%), Gaps = 22/251 (8%)
Query: 649 IIGGFESNPGDWPFLAALL--GGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTV 706
++GG + P WP+ +L G + C G LI WV+TAAHCV + W V
Sbjct: 1 VVGGRVAQPNSWPWQISLQYKSGSSYYHTCGGSLIRQGWVMTAAHCVD-----SARTWRV 55
Query: 707 QLGVTRRNSYAFFGTRFKVRGVFAHSQYNI-GAQHDNDIALFQLKQKVKFNDHLLPVCLP 765
LG N+ V VF HS +N DIAL +L + N + LP
Sbjct: 56 VLGEHNLNTNEGKEQIMTVNSVFIHSGWNSDDVAGGYDIALLRLNTQASLNSAVQLAALP 115
Query: 766 PPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNK--WLNNRELNVTL 823
P N L C + GWGK ++ + +P + C+ W + V
Sbjct: 116 PSNQILPNNNPCYITGWGKTSTG--GPLSDSLKQAWLPSVDHATCSSSGWWGST---VKT 170
Query: 824 GMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSW--GIKCAHPHLPGVYAYV 881
MVCAG G C GDSGGPL C+ + ++ +V G+ S+ C P V+ V
Sbjct: 171 TMVCAG--GGANSGCNGDSGGPLNCQVNGSY---YVHGVTSFVSSSGCNASKKPTVFTRV 225
Query: 882 PKYVTWIQDIM 892
Y++W+ IM
Sbjct: 226 SAYISWMNGIM 236
>pdb|1OSS|A Chain A, T190p Streptomyces Griseus Trypsin In Complex With
Benzamidine
Length = 223
Score = 101 bits (251), Expect = 2e-21, Method: Composition-based stats.
Identities = 85/250 (34%), Positives = 111/250 (44%), Gaps = 44/250 (17%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCV---GNLTGLNIDEWT 705
++GG + G++PF+ L G C G L + VLTAAHCV GN T + T
Sbjct: 1 VVGGTRAAQGEFPFMVRLSMG------CGGALYAQDIVLTAAHCVSGSGNNTSI-----T 49
Query: 706 VQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLP 765
GV S + + + V YN + D AL +L Q +
Sbjct: 50 ATGGVVDLQSSS--AVKVRSTKVLQAPGYNGTGK---DWALIKLAQPIN----------- 93
Query: 766 PPNYELAPGT-----RCTVIGWG-KREDTRVSEYETAVNEVEVPIITRDICNKWLNNREL 819
P ++A T TV GWG RE Y N VP ++ C N EL
Sbjct: 94 QPTLKIATTTAYNQGTFTVAGWGANREGGSQQRYLLKAN---VPFVSDAACRSAYGN-EL 149
Query: 820 NVTLGMVCAGYPE-GGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVY 878
V +CAGYP+ GG D CQGDSGGP+ + N ++W GIVSWG CA P PGVY
Sbjct: 150 -VANEEICAGYPDTGGVDPCQGDSGGPMFRKD--NADEWIQVGIVSWGYGCARPGYPGVY 206
Query: 879 AYVPKYVTWI 888
V + + I
Sbjct: 207 TEVSTFASAI 216
>pdb|1SGF|A Chain A, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
pdb|1SGF|X Chain X, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
Length = 240
Score = 100 bits (250), Expect = 3e-21, Method: Compositional matrix adjust.
Identities = 68/230 (29%), Positives = 102/230 (44%), Gaps = 31/230 (13%)
Query: 674 FYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQLGVTRRNSYAFFGTRFKVRGVFAHSQ 733
+ C GVL+ WVLTAAHC D++ V LG V H
Sbjct: 27 YQCGGVLLDRNWVLTAAHCYN-------DKYQVWLGKNNFLEDEPSDQHRLVSKAIPHPD 79
Query: 734 YNIGA----------QHDNDIALFQLKQKVKFNDHLLPVCLPPPNYELAPGTRCTVIGWG 783
+N+ + ND+ L +L + D + P+ LP +L G+ C GWG
Sbjct: 80 FNMSLLNEHTPQPEDDYSNDLMLLRLSKPADITDVVKPITLPTEEPKL--GSTCLASGWG 137
Query: 784 KREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVCAGYPEGGKDACQGDSG 843
+ +Y + V + ++ + C+K E+ VT M+CAG +GG C+ DSG
Sbjct: 138 STTPIKF-KYPDDLQCVNLKLLPNEDCDK---AHEMKVTDAMLCAGEMDGGSYTCEHDSG 193
Query: 844 GPLLCRSSHNFEQWFVGGIVSWGIK-CAHPHLPGVYAYVPKYVTWIQDIM 892
GPL+C + GI SWG + C P P VY + K+ +WI++ M
Sbjct: 194 GPLICDG-------ILQGITSWGPEPCGEPTEPSVYTKLIKFSSWIRETM 236
>pdb|1PJP|A Chain A, The 2.2 A Crystal Structure Of Human Chymase In Complex
With Succinyl- Ala-Ala-Pro-Phe-Chloromethylketone
pdb|1T31|A Chain A, A Dual Inhibitor Of The Leukocyte Proteases Cathepsin G
And Chymase With Therapeutic Efficacy In Animals Models
Of Inflammation
pdb|2HVX|A Chain A, Discovery Of Potent, Orally Active, Nonpeptide Inhibitors
Of Human Mast Cell Chymase By Using Structure-Based Drug
Design
pdb|3S0N|A Chain A, Crystal Structure Of Human Chymase With Benzimidazolone
Inhibitor
Length = 226
Score = 100 bits (250), Expect = 3e-21, Method: Compositional matrix adjust.
Identities = 79/249 (31%), Positives = 110/249 (44%), Gaps = 29/249 (11%)
Query: 649 IIGGFESNPGDWPFLAAL----LGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEW 704
IIGG E P P++A L GP +C G LI +VLTAAHC G
Sbjct: 1 IIGGTECKPHSRPYMAYLEIVTSNGPSK--FCGGFLIRRNFVLTAAHCAGR-------SI 51
Query: 705 TVQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCL 764
TV LG + +V F H +YN H +DI L +LK+K + +
Sbjct: 52 TVTLGAHNITEEEDTWQKLEVIKQFRHPKYNTSTLH-HDIMLLKLKEKASLTLAVGTLPF 110
Query: 765 PPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLG 824
P + PG C V GWG+ + + EV++ ++ C+ + R+ + L
Sbjct: 111 PSQKNFVPPGRMCRVAGWGRTGVLKPGS--DTLQEVKLRLMDPQACSHF---RDFDHNL- 164
Query: 825 MVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKY 884
+C G P K A +GDSGGPLLC + GIVS+G A P P V+ + Y
Sbjct: 165 QLCVGNPRKTKSAFKGDSGGPLLCAGAAQ-------GIVSYGRSDAKP--PAVFTRISHY 215
Query: 885 VTWIQDIMD 893
WI I+
Sbjct: 216 QPWINQILQ 224
>pdb|1KLT|A Chain A, Crystal Structure Of Pmsf-Treated Human Chymase At 1.9
Angstroms Resolution
Length = 226
Score = 100 bits (249), Expect = 3e-21, Method: Compositional matrix adjust.
Identities = 80/249 (32%), Positives = 110/249 (44%), Gaps = 29/249 (11%)
Query: 649 IIGGFESNPGDWPFLAAL----LGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEW 704
IIGG ES P P++A L GP +C G LI +VLTAAHC G
Sbjct: 1 IIGGTESKPHSRPYMAYLEIVTSNGPSK--FCGGFLIRRNFVLTAAHCAGR-------SI 51
Query: 705 TVQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCL 764
TV LG + +V F H +YN H +DI L +LK+K + +
Sbjct: 52 TVTLGAHNITEEEDTWQKLEVIKQFRHPKYNTSTLH-HDIMLLKLKEKASLTLAVGTLPF 110
Query: 765 PPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLG 824
P + PG C V GWG+ + + EV++ ++ C+ + R+ + L
Sbjct: 111 PSQFNFVPPGRMCRVAGWGRTGVLKPGS--DTLQEVKLRLMDPQACSHF---RDFDHNL- 164
Query: 825 MVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKY 884
+C G P K A +GDSGGPLLC GIVS+G A P P V+ + Y
Sbjct: 165 QLCVGNPRKTKSAFKGDSGGPLLCAG-------VAQGIVSYGRSDAKP--PAVFTRISHY 215
Query: 885 VTWIQDIMD 893
WI I+
Sbjct: 216 RPWINQILQ 224
>pdb|2AIP|A Chain A, Crystal Structure Of Native Protein C Activator From The
Venom Of Copperhead Snake Agkistrodon Contortrix
Contortrix
pdb|2AIQ|A Chain A, Crystal Structure Of Benzamidine-Inhibited Protein C
Activator From The Venom Of Copperhead Snake Agkistrodon
Contortrix Contortrix
Length = 231
Score = 99.8 bits (247), Expect = 7e-21, Method: Compositional matrix adjust.
Identities = 79/246 (32%), Positives = 113/246 (45%), Gaps = 27/246 (10%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
+IGG E N + FLA + C G LI+ +WVLTA HC + + I L
Sbjct: 1 VIGGDECNINEHRFLALVYANGSL---CGGTLINQEWVLTARHC--DRGNMRIYLGMHNL 55
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLP--P 766
V +++ RF F + N D DI L +L + V+ + H+ P+ LP P
Sbjct: 56 KVLNKDAL----RRFPKEKYFCLNTRN-DTIWDKDIMLIRLNRPVRNSAHIAPLSLPSNP 110
Query: 767 PNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMV 826
P+ G+ C ++GWG + + + + I+ +C + L T +
Sbjct: 111 PSV----GSVCRIMGWGTITSPNATLPDVP-HCANINILDYAVCQAAY--KGLAAT--TL 161
Query: 827 CAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVT 886
CAG EGGKD C+GDSGGPL+C F G + G CA P PG+Y V Y
Sbjct: 162 CAGILEGGKDTCKGDSGGPLICNGQ------FQGILSVGGNPCAQPRKPGIYTKVFDYTD 215
Query: 887 WIQDIM 892
WIQ I+
Sbjct: 216 WIQSII 221
>pdb|1FDP|A Chain A, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
pdb|1FDP|B Chain B, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
pdb|1FDP|C Chain C, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
pdb|1FDP|D Chain D, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
Length = 235
Score = 99.4 bits (246), Expect = 7e-21, Method: Composition-based stats.
Identities = 74/255 (29%), Positives = 121/255 (47%), Gaps = 33/255 (12%)
Query: 646 RKRIIGGFESNPGDWPFLAAL-LGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEW 704
R RI+GG E+ P++A++ L G C GVL+++QWVL+AAHC+ + +
Sbjct: 5 RGRILGGREAEAHARPYMASVQLNGAHL---CGGVLVAEQWVLSAAHCLEDAADGKVQ-- 59
Query: 705 TVQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCL 764
V LG + + V H D+D+ L QL +K + P+
Sbjct: 60 -VLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTI-DHDLLLLQLSEKATLGPAVRPLPW 117
Query: 765 PPPNYELAPGTRCTVIGW------GKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRE 818
+ ++APGT C V GW G+R D+ + V +P++ R CN+ + +
Sbjct: 118 QRVDRDVAPGTLCDVAGWGIVNHAGRRPDS--------LQHVLLPVLDRATCNR-RTHHD 168
Query: 819 LNVTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIK-CAHPHLPGV 877
+T ++CA +D+C+GDSGGPL+C + G+V+ G + C + PG+
Sbjct: 169 GAITERLMCA--ESNRRDSCKGDSGGPLVCGG-------VLEGVVTSGSRVCGNRKKPGI 219
Query: 878 YAYVPKYVTWIQDIM 892
Y V Y WI ++
Sbjct: 220 YTRVASYAAWIDSVL 234
>pdb|3N7O|A Chain A, X-Ray Structure Of Human Chymase In Complex With Small
Molecule Inhibitor
Length = 226
Score = 99.4 bits (246), Expect = 8e-21, Method: Compositional matrix adjust.
Identities = 79/249 (31%), Positives = 110/249 (44%), Gaps = 29/249 (11%)
Query: 649 IIGGFESNPGDWPFLAAL----LGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEW 704
IIGG E P P++A L GP +C G LI +VLTAAHC G
Sbjct: 1 IIGGTECKPHSRPYMAYLEIVTSNGPSK--FCGGFLIRRNFVLTAAHCAGR-------SI 51
Query: 705 TVQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCL 764
TV LG + +V F H +YN H +DI L +LK+K + +
Sbjct: 52 TVTLGAHNITEEEDTWQKLEVIKQFRHPKYNTSTLH-HDIMLLKLKEKASLTLAVGTLPF 110
Query: 765 PPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLG 824
P + PG C V GWG+ + + EV++ ++ C+ + R+ + L
Sbjct: 111 PSQFNFVPPGRMCRVAGWGRTGVLKPGS--DTLQEVKLRLMDPQACSHF---RDFDHNL- 164
Query: 825 MVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKY 884
+C G P K A +GDSGGPLLC + GIVS+G A P P V+ + Y
Sbjct: 165 QLCVGNPRKTKSAFKGDSGGPLLCAGAAQ-------GIVSYGRSDAKP--PAVFTRISHY 215
Query: 885 VTWIQDIMD 893
WI I+
Sbjct: 216 QPWINQILQ 224
>pdb|2EST|E Chain E, Crystallographic Study Of The Binding Of A Trifluoroacetyl
Dipeptide Anilide Inhibitor With Elastase
pdb|4EST|E Chain E, Crystal Structure Of The Covalent Complex Formed By A
Peptidyl Alpha, Alpha-Difluoro-Beta-Keto Amide With
Porcine Pancreatic Elastase At 1.78-Angstroms Resolution
pdb|5EST|E Chain E, Crystallographic Analysis Of The Inhibition Of Porcine
Pancreatic Elastase By A Peptidyl Boronic Acid:
Structure Of A Reaction Intermediate
pdb|7EST|E Chain E, Interaction Of The Peptide Cf3-Leu-Ala-Nh-C6h4-Cf3(Tfla)
With Porcine Pancreatic Elastase. X-Ray Studies At 1.8
Angstroms
pdb|8EST|E Chain E, Reaction Of Porcine Pancreatic Elastase With 7-substituted
3-alkoxy-4-chloroisocoumarins: Design Of Potent
Inhibitors Using The Crystal Structure Of The Complex
Formed With 4- Chloro-3-ethoxy-7-guanidino-isocoumarin
pdb|1ELA|A Chain A, Analogous Inhibitors Of Elastase Do Not Always Bind
Analogously
pdb|1ELC|A Chain A, Analogous Inhibitors Of Elastase Do Not Always Bind
Analogously
pdb|1ELB|A Chain A, Analogous Inhibitors Of Elastase Do Not Always Bind
Analogously
pdb|1ELD|E Chain E, Structural Analysis Of The Active Site Of Porcine
Pancreatic Elastase Based On The X-Ray Crystal
Structures Of Complexes With
Trifluoroacetyl-Dipeptide-Anilide Inhibitors
pdb|1ELE|E Chain E, Structural Analysis Of The Active Site Of Porcine
Pancreatic Elastase Based On The X-Ray Crystal
Structures Of Complexes With
Trifluoroacetyl-Dipeptide-Anilide Inhibitors
pdb|1NES|E Chain E, Structure Of The Product Complex Of Acetyl-ala-pro-ala
With Porcine Pancreatic Elastase At 1.65 Angstroms
Resolution
pdb|1BMA|A Chain A, Benzyl Methyl Aminimide Inhibitor Complexed To Porcine
Pancreatic Elastase
pdb|1FLE|E Chain E, Crystal Structure Of Elafin Complexed With Porcine
Pancreatic Elastase
pdb|1B0E|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase With Mdl
101,146
pdb|1QGF|A Chain A, Porcine Pancreatic Elastase Complexed With (3r, 4s)n-Para-
Toluenesulphonyl-3-Ethyl-4-(Carboxylic
Acid)pyrrolidin-2- One
pdb|1QIX|B Chain B, Porcine Pancreatic Elastase Complexed With Human
Beta-casomorphin-7
pdb|1QR3|E Chain E, Structure Of Porcine Pancreatic Elastase In Complex With
Fr901277, A Novel Macrocyclic Inhibitor Of Elastases At
1.6 Angstrom Resolution
pdb|1E34|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Toluenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2- One Soaked In Ph 9 Buffer For One Minute
pdb|1E35|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Toluenesulphonyl-3-Ethyl-4-(Carboxylic
Acid)pyrrolidin-2- One Soaked In Ph 9 Buffer For Two
Minutes
pdb|1E36|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Nitrobenzenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2-One
pdb|1E37|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Nitrobenzenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2-One Soaked In Ph 9 Buffer For 1 Minute
pdb|1E38|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Nitrobenzenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2-One Soaked In Ph 9 Buffer For 2 Minutes
pdb|1HAZ|B Chain B, Snapshots Of Serine Protease Catalysis: (c) Acyl-enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-casomorphin-7 Jumped To Ph 9 For 1 Minute
pdb|1H9L|B Chain B, Porcine Pancreatic Elastase Complexed With
Acetyl-Val-Glu-Pro-Ile-Cooh
pdb|1OKX|A Chain A, Binding Structure Of Elastase Inhibitor Scyptolin A
pdb|1OKX|B Chain B, Binding Structure Of Elastase Inhibitor Scyptolin A
pdb|2FO9|A Chain A, Structure Of Porcine Pancreatic Elastase In 95% Acetone
pdb|2FOA|A Chain A, Structure Of Porcine Pancreatic Elastase In 405010 %
BENZENE
pdb|2FOB|A Chain A, Structure Of Porcine Pancreatic Elastase In 405010
CYCLOHEXANE
pdb|2FOC|A Chain A, Structure Of Porcine Pancreatic Elastase In 55%
Dimethylformamide
pdb|2FOD|A Chain A, Structure Of Porcine Pancreatic Elastase In 80% Ethanol
pdb|2FOE|A Chain A, Structure Of Porcine Pancreatic Elastase In 80% Hexane
pdb|2FOF|A Chain A, Structure Of Porcine Pancreatic Elastase In 80%
Isopropanol
pdb|2FOG|A Chain A, Structure Of Porcine Pancreatic Elastase In 40%
Trifluoroethanol
pdb|2FOH|A Chain A, Structure Of Porcine Pancreatic Elastase In 40%
Trifluoroethanol
pdb|2BD4|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin- 7 And Lys-Ser At Ph 5.0
pdb|2BD5|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Lys- Ser At Ph 5 And Immersed In
Ph 9 Buffer For 30 Seconds
pdb|2BD9|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-casomorphin-7 And Arg- Phe At Ph 5.0 (50 Min Soak)
And Immersed In Ph 9 Buffer For 28 Seconds (2nd Ph Jump)
pdb|2BDC|A Chain A, Porcine Pancreatic Elastase Complexed With Asn-pro-ile At
Ph 5.0
pdb|2H1U|A Chain A, Porcine Pancreatic Elastase Complexed With Metpheleuglu At
Ph 5.0
pdb|1BTU|A Chain A, Porcine Pancreatic Elastase Complexed With (3s, 4r)-1-
Toluenesulphonyl-3-Ethyl-Azetidin-2-One-4-Carboxylic
Acid
pdb|1EAS|A Chain A, Nonpeptidic Inhibitors Of Human Leukocyte Elastase. 3.
Design, Synthesis, X-Ray Crystallographic Analysis, And
Structure-Activity Relationships For A Series Of Orally
Active 3-Amino-6-Phenylpyridin- 2-One Trifluoromethyl
Ketones
pdb|1EAT|A Chain A, Nonpeptidic Inhibitors Of Human Leukocyte Elastase. 5.
Design, Synthesis, And X-Ray Crystallography Of A Series
Of Orally Active 5- Amino-Pyrimidin-6-One-Containing
Trifluoromethylketones
pdb|1EAU|A Chain A, Nonpeptidic Inhibitors Of Human Leukocyte Elastase. 6.
Design Of A Potent, Intratracheally Active,
Pyridone-Based Trifluoromethyl Ketone
pdb|1ELF|A Chain A, Nature Of The Inactivation Of Elastase By N-Peptidyl-O-
Aroyl Hydroxylamine As A Function Of Ph
pdb|1ELG|A Chain A, Nature Of The Inactivation Of Elastase By N-Peptidyl-O-
Aroyl Hydroxylamine As A Function Of Ph
pdb|1ESA|A Chain A, Direct Structure Observation Of An Acyl-Enzyme
Intermediate In The Hydrolysis Of An Ester Substrate By
Elastase
pdb|1EST|A Chain A, The Atomic Structure Of Crystalline Porcine Pancreatic
Elastase At 2.5 Angstroms Resolution. Comparisons With
The Structure Of Alpha- Chymotrypsin
pdb|1INC|A Chain A, Crystal Structures Of The Complex Of Porcine Pancreatic
Elastase With Two Valine-Derived Benzoxazinone
Inhibitors
pdb|1JIM|A Chain A, Stereospecific Reaction Of 3-Methoxy-4-Chloro-7-
Aminoisocoumarin With Crystalline Porcine Pancreatic
Elastase
pdb|1LVY|A Chain A, Porcine Elastase
pdb|3EST|A Chain A, Structure Of Native Porcine Pancreatic Elastase At 1.65
Angstroms Resolution
pdb|6EST|A Chain A, Interaction Of The Peptide Cf3-Leu-Ala-Nh-C6h4-Cf3(Tfla)
With Porcine Pancreatic Elastase. X-Ray Studies At 1.8
Angstroms
pdb|9EST|A Chain A, Structural Study Of Porcine Pancreatic Elastase Complexed
With 7- Amino-3-(2-Bromoethoxy)-4-Chloroisocoumarin As A
Nonreactivatable Doubly Covalent Enzyme-Inhibitor
Complex
pdb|1GVK|B Chain B, Porcine Pancreatic Elastase Acyl Enzyme At 0.95 A
Resolution
pdb|3E3T|A Chain A, Structure Of Porcine Pancreatic Elastase With The Magic
Triangle I3c
pdb|3MNB|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. First Stage Of
Radiation Damage
pdb|3MNC|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Second Stage Of
Radiation Damage
pdb|3MNS|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Third Stage Of
Radiation Damage
pdb|3MNX|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Fourth Stage Of
Radiation Damage
pdb|3MO3|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Fifth Stage Of
Radiation Damage
pdb|3MO6|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Sixth Stage Of
Radiation Damage
pdb|3MO9|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Seventh Stage Of
Radiation Damage
pdb|3MOC|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Eighth Stage Of
Radiation Damage
pdb|3MTY|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. First Step Of Radiation
Damage
pdb|3MU0|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. Third Step Of Radiation
Damage
pdb|3MU1|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. Fifth Step Of Radiation
Damage
pdb|3MU4|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. First Step Of Radiation
Damage
pdb|3MU5|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. Third Step Of Radiation
Damage
pdb|3MU8|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. Fifth Step Of Radiation
Damage
pdb|3ODD|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. Second Step Of Radiation
Damage
pdb|3ODF|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. Second Step Of Radiation
Damage
pdb|2BB4|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Asp- Phe At Ph 5.0
pdb|2BD2|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-casomorphin-7 And Arg- Phe At Ph 5.0
pdb|2BD3|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-casomorphin-7 And Lys- Ala-nh2 At Ph 5.0
pdb|2BD7|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Arg- Phe At Ph 5.0 (50 Min Soak)
pdb|2BD8|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Arg- Phe At Ph 5.0 (50 Min Soak)
And Immersed In Ph 9 Buffer For 30 Seconds
pdb|2BDA|A Chain A, Porcine Pancreatic Elastase Complexed With N-Acetyl-Npi
And Ala-Ala At Ph 5.0
pdb|2BDB|A Chain A, Porcine Pancreatic Elastase Complexed With Asn-pro-ile And
Ala-ala At Ph 5.0
pdb|1ESB|A Chain A, Direct Structure Observation Of An Acyl-Enzyme
Intermediate In The Hydrolysis Of An Ester Substrate By
Elastase
pdb|4GVU|A Chain A, Lyngbyastatin 7-porcine Pancreatic Elastase Co-crystal
Structure
Length = 240
Score = 98.6 bits (244), Expect = 1e-20, Method: Composition-based stats.
Identities = 78/257 (30%), Positives = 120/257 (46%), Gaps = 33/257 (12%)
Query: 649 IIGGFESNPGDWPFLAALL--GGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTV 706
++GG E+ WP +L G + C G LI WV+TAAHCV E T
Sbjct: 1 VVGGTEAQRNSWPSQISLQYRSGSSWAHTCGGTLIRQNWVMTAAHCVDR-------ELTF 53
Query: 707 QLGVTRRNSYAFFGTR--FKVRGVFAHSQYN---IGAQHDNDIALFQLKQKVKFNDHLLP 761
++ V N GT V+ + H +N + A + DIAL +L Q V N ++
Sbjct: 54 RVVVGEHNLNQNNGTEQYVGVQKIVVHPYWNTDDVAAGY--DIALLRLAQSVTLNSYVQL 111
Query: 762 VCLPPPNYELAPGTRCTVIGWG-KREDTRVSEYETAVNEVEVPIITRDICNK---WLNNR 817
LP LA + C + GWG R + ++++ + + +P + IC+ W +
Sbjct: 112 GVLPRAGTILANNSPCYITGWGLTRTNGQLAQ---TLQQAYLPTVDYAICSSSSYWGS-- 166
Query: 818 ELNVTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSW--GIKCAHPHLP 875
V MVCAG +G + CQGDSGGPL C + Q+ V G+ S+ + C P
Sbjct: 167 --TVKNSMVCAG-GDGVRSGCQGDSGGPLHCLVNG---QYAVHGVTSFVSRLGCNVTRKP 220
Query: 876 GVYAYVPKYVTWIQDIM 892
V+ V Y++WI +++
Sbjct: 221 TVFTRVSAYISWINNVI 237
>pdb|4AFQ|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFQ|B Chain B, Human Chymase - Fynomer Complex
pdb|4AFS|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFU|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFU|B Chain B, Human Chymase - Fynomer Complex
pdb|4AFZ|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFZ|B Chain B, Human Chymase - Fynomer Complex
pdb|4AG1|A Chain A, Human Chymase - Fynomer Complex
pdb|4AG2|A Chain A, Human Chymase - Fynomer Complex
pdb|4AG2|B Chain B, Human Chymase - Fynomer Complex
Length = 226
Score = 98.2 bits (243), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 79/249 (31%), Positives = 109/249 (43%), Gaps = 29/249 (11%)
Query: 649 IIGGFESNPGDWPFLAAL----LGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEW 704
IIGG E P P++A L GP +C G LI +VLTAAHC G
Sbjct: 1 IIGGTECKPHSRPYMAYLEIVTSNGPSK--FCGGFLIRRNFVLTAAHCAGR-------SI 51
Query: 705 TVQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCL 764
TV LG + +V F H +YN H +DI L +LK+K + +
Sbjct: 52 TVTLGAHNITEEEDTWQKLEVIKQFRHPKYNTSTLH-HDIMLLKLKEKASLTLAVGTLPF 110
Query: 765 PPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLG 824
P + PG C V GWG+ + + EV++ ++ C+ + R+ + L
Sbjct: 111 PSQFNFVPPGRMCRVAGWGRTGVLKPGS--DTLQEVKLRLMDPQACSHF---RDFDHNL- 164
Query: 825 MVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKY 884
+C G P K A +GDSGGPLLC GIVS+G A P P V+ + Y
Sbjct: 165 QLCVGNPRKTKSAFKGDSGGPLLCAG-------VAQGIVSYGRSDAKP--PAVFTRISHY 215
Query: 885 VTWIQDIMD 893
WI I+
Sbjct: 216 RPWINQILQ 224
>pdb|1EAI|A Chain A, Complex Of Ascaris Chymotrpsin/elastase Inhibitor With
Porcine Elastase
pdb|1EAI|B Chain B, Complex Of Ascaris Chymotrpsin/elastase Inhibitor With
Porcine Elastase
pdb|1C1M|A Chain A, Porcine Elastase Under Xenon Pressure (8 Bar)
pdb|1HV7|A Chain A, Porcine Pancreatic Elastase Complexed With Gw311616a
pdb|1FZZ|A Chain A, The Crystal Structure Of The Complex Of Non-Peptidic
Inhibitor Ono-6818 And Porcine Pancreatic Elastase.
pdb|1GWA|A Chain A, Triiodide Derivative Of Porcine Pancreas Elastase
pdb|1L0Z|A Chain A, The Structure Of Porcine Pancreatic Elastase Complexed
With Xenon And Bromide, Cryoprotected With Dry Paraffin
Oil
pdb|1L1G|A Chain A, The Structure Of Porcine Pancreatic Elastase Complexed
With Xenon And Bromide, Cryoprotected With Glycerol
pdb|1LKA|A Chain A, Porcine Pancreatic ElastaseCA-Complex
pdb|1LKB|A Chain A, Porcine Pancreatic Elastase/na-complex
pdb|1MMJ|N Chain N, Porcine Pancreatic Elastase Complexed With A Potent
Peptidyl Inhibitor, Fr136706
pdb|1MCV|A Chain A, Crystal Structure Analysis Of A Hybrid Squash Inhibitor In
Complex With Porcine Pancreatic Elastase
pdb|1UO6|A Chain A, Porcine Pancreatic ElastaseXE-Complex
pdb|1UVO|A Chain A, Structure Of The Complex Of Porcine Pancreatic Elastase In
Complex With Cadmium Refined At 1.85 A Resolution
(crystal A)
pdb|1UVP|A Chain A, Structure Of The Complex Of Porcine Pancreatic Elastase In
Complex With Cadmium Refined At 1.85 A Resolution
(Crystal B)
pdb|2A7C|A Chain A, On The Routine Use Of Soft X-rays In Macromolecular
Crystallography, Part Iii- The Optimal Data Collection
Wavelength
pdb|2A7J|A Chain A, On The Routine Use Of Soft X-Rays In Macromolecular
Crystallography, Part Iii- The Optimal Data Collection
Wavelength
pdb|2BLO|A Chain A, Elastase Before A High Dose X-Ray "burn"
pdb|2BLQ|A Chain A, Elastase After A High Dose X-Ray "burn"
pdb|2D26|C Chain C, Active Site Distortion Is Sufficient For Proteinase
Inhibit Second Crystal Structure Of Covalent
Serpin-Proteinase Complex
pdb|2CV3|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase Complexed
With A Macroclyclic Peptide Inhibitor
pdb|2DE8|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase With A
Unique Conformation Induced By Tris
pdb|2DE9|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase Complexed
With Tris After Soaking A Tris-Free Solution
pdb|2G4T|A Chain A, Anomalous Substructure Of Porcine Pancreatic Elastase (na)
pdb|2G4U|A Chain A, Anomalous Substructure Of Porcine Pancreatic Elastaase
(ca)
pdb|2OQU|A Chain A, High Pressure Cryocooling Of Capillary Sample
Cryoprotection And Diffraction Phasing At Long
Wavelengths
pdb|1QNJ|A Chain A, The Structure Of Native Porcine Pancreatic Elastase At
Atomic Resolution (1.1 A)
pdb|2IOT|A Chain A, Clavulanic Acid Bound To Elastase
pdb|2V0B|A Chain A, Sad Structure Solution Porcine Pancreatic Elastase From A
Selenate Derivative
pdb|2V35|A Chain A, Porcine Pancreatic Elastase In Complex With Inhibitor Jm54
pdb|3HGP|A Chain A, Structure Of Porcine Pancreatic Elastase Complexed With A
Potent Peptidyl Inhibitor Fr130180 Determined By High
Resolution Crystallography
pdb|3HGN|A Chain A, Structure Of Porcine Pancreatic Elastase Complexed With A
Potent Peptidyl Inhibitor Fr130180 Determined By Neutron
Crystallography
pdb|3UOU|A Chain A, Crystal Structure Of The Kunitz-Type Protease Inhibitor
Shpi-1 Lys13leu Mutant In Complex With Pancreatic
Elastase
Length = 240
Score = 98.2 bits (243), Expect = 2e-20, Method: Composition-based stats.
Identities = 78/257 (30%), Positives = 120/257 (46%), Gaps = 33/257 (12%)
Query: 649 IIGGFESNPGDWPFLAALL--GGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTV 706
++GG E+ WP +L G + C G LI WV+TAAHCV E T
Sbjct: 1 VVGGTEAQRNSWPSQISLQYRSGSSWAHTCGGTLIRQNWVMTAAHCVDR-------ELTF 53
Query: 707 QLGVTRRNSYAFFGTR--FKVRGVFAHSQYN---IGAQHDNDIALFQLKQKVKFNDHLLP 761
++ V N GT V+ + H +N + A + DIAL +L Q V N ++
Sbjct: 54 RVVVGEHNLNQNDGTEQYVGVQKIVVHPYWNTDDVAAGY--DIALLRLAQSVTLNSYVQL 111
Query: 762 VCLPPPNYELAPGTRCTVIGWG-KREDTRVSEYETAVNEVEVPIITRDICNK---WLNNR 817
LP LA + C + GWG R + ++++ + + +P + IC+ W +
Sbjct: 112 GVLPRAGTILANNSPCYITGWGLTRTNGQLAQ---TLQQAYLPTVDYAICSSSSYWGS-- 166
Query: 818 ELNVTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSW--GIKCAHPHLP 875
V MVCAG +G + CQGDSGGPL C + Q+ V G+ S+ + C P
Sbjct: 167 --TVKNSMVCAG-GDGVRSGCQGDSGGPLHCLVNG---QYAVHGVTSFVSRLGCNVTRKP 220
Query: 876 GVYAYVPKYVTWIQDIM 892
V+ V Y++WI +++
Sbjct: 221 TVFTRVSAYISWINNVI 237
>pdb|1NN6|A Chain A, Human Pro-Chymase
Length = 228
Score = 98.2 bits (243), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 79/249 (31%), Positives = 109/249 (43%), Gaps = 29/249 (11%)
Query: 649 IIGGFESNPGDWPFLAAL----LGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEW 704
IIGG E P P++A L GP +C G LI +VLTAAHC G
Sbjct: 3 IIGGTECKPHSRPYMAYLEIVTSNGPSK--FCGGFLIRRNFVLTAAHCAGR-------SI 53
Query: 705 TVQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCL 764
TV LG + +V F H +YN H +DI L +LK+K + +
Sbjct: 54 TVTLGAHNITEEEDTWQKLEVIKQFRHPKYNTSTLH-HDIMLLKLKEKASLTLAVGTLPF 112
Query: 765 PPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLG 824
P + PG C V GWG+ + + EV++ ++ C+ + R+ + L
Sbjct: 113 PSQFNFVPPGRMCRVAGWGRTGVLKPGS--DTLQEVKLRLMDPQACSHF---RDFDHNL- 166
Query: 825 MVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKY 884
+C G P K A +GDSGGPLLC GIVS+G A P P V+ + Y
Sbjct: 167 QLCVGNPRKTKSAFKGDSGGPLLCAG-------VAQGIVSYGRSDAKP--PAVFTRISHY 217
Query: 885 VTWIQDIMD 893
WI I+
Sbjct: 218 RPWINQILQ 226
>pdb|1PYT|D Chain D, Ternary Complex Of Procarboxypeptidase A, Proproteinase E,
And Chymotrypsinogen C
Length = 251
Score = 97.4 bits (241), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 80/249 (32%), Positives = 113/249 (45%), Gaps = 24/249 (9%)
Query: 648 RIIGGFESNPGDWPFLAAL--LGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWT 705
R++GG ++ P WP+ +L L + C G LI+ VLTAAHC+ N +
Sbjct: 13 RVVGGEDAIPHSWPWQISLQYLRDNTWRHTCGGTLITPNHVLTAAHCISNTLTYRVALGK 72
Query: 706 VQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLP 765
L V + G V +F H ++N NDIAL +L + V+ D + CLP
Sbjct: 73 NNLEVEDEAGSLYVG----VDTIFVHEKWN-SFLVRNDIALIKLAETVELGDTIQVACLP 127
Query: 766 PPNYELAPGTRCTVIGWGK--REDTRVSEYETAVNEVEVPIITRDICNK--WLNNRELNV 821
L C V GWG+ +E + + P++ C++ W V
Sbjct: 128 SEGSLLPQDYPCFVTGWGRLYTNGPIAAELQQGLQ----PVVDYATCSQRDWWGT---TV 180
Query: 822 TLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSW--GIKCAHPHLPGVYA 879
MVCAG +G AC GDSGGPL C++ QW V GIVS+ G+ C P V+
Sbjct: 181 KETMVCAG-GDGVISACNGDSGGPLNCQADG---QWDVRGIVSFGSGLSCNTFKKPTVFT 236
Query: 880 YVPKYVTWI 888
V Y+ WI
Sbjct: 237 RVSAYIDWI 245
>pdb|1AU8|A Chain A, Human Cathepsin G
pdb|1T32|A Chain A, A Dual Inhibitor Of The Leukocyte Proteases Cathepsin G
And Chymase With Therapeutic Efficacy In Animals Models
Of Inflammation
pdb|1CGH|A Chain A, Human Cathepsin G
Length = 224
Score = 97.4 bits (241), Expect = 3e-20, Method: Composition-based stats.
Identities = 82/245 (33%), Positives = 118/245 (48%), Gaps = 24/245 (9%)
Query: 649 IIGGFESNPGDWPFLAAL-LGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQ 707
IIGG ES P P++A L + P C G L+ + +VLTAAHC G+ + + +Q
Sbjct: 1 IIGGRESRPHSRPYMAYLQIQSPAGQSRCGGFLVREDFVLTAAHCWGSNINVTLGAHNIQ 60
Query: 708 LGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPP 767
R N+ R +R H QYN NDI L QL ++V+ N ++ PV LP
Sbjct: 61 ---RRENTQQHITARRAIR----HPQYN-QRTIQNDIMLLQLSRRVRRNRNVNPVALPRA 112
Query: 768 NYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVC 827
L PGT CTV GWG+ R ++ + EV++ + C + + + +C
Sbjct: 113 QEGLRPGTLCTVAGWGRVSMRRGTD---TLREVQLRVQRDRQCLRIFGSYD---PRRQIC 166
Query: 828 AGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTW 887
G K A +GDSGGPLLC + + GIVS+G P P V+ V ++ W
Sbjct: 167 VGDRRERKAAFKGDSGGPLLCNNVAH-------GIVSYGKSSGVP--PEVFTRVSSFLPW 217
Query: 888 IQDIM 892
I+ M
Sbjct: 218 IRTTM 222
>pdb|3G01|A Chain A, Structure Of Grc Mutant E192rE193G
pdb|3G01|B Chain B, Structure Of Grc Mutant E192rE193G
Length = 227
Score = 97.1 bits (240), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 75/248 (30%), Positives = 110/248 (44%), Gaps = 27/248 (10%)
Query: 649 IIGGFESNPGDWPFLAAL----LGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEW 704
IIGG E +P P++A +GG + +C G L+ D++VLTAAHC G
Sbjct: 1 IIGGNEISPHSRPYMAYYEFLKVGGKKM--FCGGFLVRDKFVLTAAHCKGR-------SM 51
Query: 705 TVQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCL 764
TV LG + V H YN NDI L +L + K + P+ L
Sbjct: 52 TVTLGAHNIKAKEETQQIIPVAKAIPHPDYNPD-DRSNDIMLLKLVRNAKRTRAVRPLNL 110
Query: 765 PPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLG 824
P N + PG C V GWGK T E+ ++EV++ + +C +
Sbjct: 111 PRRNAHVKPGDECYVAGWGKV--TPDGEFPKTLHEVKLTVQKDQVCESQFQSSYNRAN-- 166
Query: 825 MVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKY 884
+C G + + +GDSGGPL+C+ + GIVS+G P V+ V +
Sbjct: 167 EICVGDSKIKGASFRGDSGGPLVCKRA-------AAGIVSYG--QTDGSAPQVFTRVLSF 217
Query: 885 VTWIQDIM 892
V+WI+ M
Sbjct: 218 VSWIKKTM 225
>pdb|1DSU|A Chain A, Human Factor D, Complement Activating Enzyme
pdb|1DSU|B Chain B, Human Factor D, Complement Activating Enzyme
pdb|1DFP|A Chain A, Factor D Inhibited By Diisopropyl Fluorophosphate
pdb|1DFP|B Chain B, Factor D Inhibited By Diisopropyl Fluorophosphate
pdb|1DIC|A Chain A, Structure Of 3,4-Dichloroisocoumarin-Inhibited Factor D
pdb|1BIO|A Chain A, Human Complement Factor D In Complex With Isatoic
Anhydride Inhibitor
pdb|1HFD|A Chain A, Human Complement Factor D In A P21 Crystal Form
pdb|4D9R|A Chain A, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
pdb|4D9R|B Chain B, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
Length = 228
Score = 96.3 bits (238), Expect = 7e-20, Method: Composition-based stats.
Identities = 72/252 (28%), Positives = 119/252 (47%), Gaps = 33/252 (13%)
Query: 649 IIGGFESNPGDWPFLAAL-LGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQ 707
I+GG E+ P++A++ L G C GVL+++QWVL+AAHC+ + + V
Sbjct: 1 ILGGREAEAHARPYMASVQLNGAHL---CGGVLVAEQWVLSAAHCLEDAADGKVQ---VL 54
Query: 708 LGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPP 767
LG + + V H D+D+ L QL +K + P+
Sbjct: 55 LGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTI-DHDLLLLQLSEKATLGPAVRPLPWQRV 113
Query: 768 NYELAPGTRCTVIGW------GKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNV 821
+ ++APGT C V GW G+R D+ + V +P++ R CN+ + + +
Sbjct: 114 DRDVAPGTLCDVAGWGIVNHAGRRPDS--------LQHVLLPVLDRATCNR-RTHHDGAI 164
Query: 822 TLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIK-CAHPHLPGVYAY 880
T ++CA +D+C+GDSGGPL+C + G+V+ G + C + PG+Y
Sbjct: 165 TERLMCA--ESNRRDSCKGDSGGPLVCGG-------VLEGVVTSGSRVCGNRKKPGIYTR 215
Query: 881 VPKYVTWIQDIM 892
V Y WI ++
Sbjct: 216 VASYAAWIDSVL 227
>pdb|1HAX|B Chain B, Snapshots Of Serine Protease Catalysis: (A) Acyl-Enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-Casomorphin-7 At Ph 5
pdb|1HAY|B Chain B, Snapshots Of Serine Protease Catalysis: (B) Acyl-Enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-Casomorphin-7 Jumped To Ph 10 For 10 Seconds
pdb|1HB0|B Chain B, Snapshots Of Serine Protease Catalysis: (D) Acyl-Enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-Casomorphin-7 Jumped To Ph 10 For 2 Minutes
Length = 240
Score = 96.3 bits (238), Expect = 7e-20, Method: Composition-based stats.
Identities = 77/257 (29%), Positives = 119/257 (46%), Gaps = 33/257 (12%)
Query: 649 IIGGFESNPGDWPFLAALL--GGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTV 706
++GG E+ WP +L G + C G LI WV+TAAHCV E T
Sbjct: 1 VVGGTEAQRNSWPSQISLQYRSGSSWAHTCGGTLIRQNWVMTAAHCVDR-------ELTF 53
Query: 707 QLGVTRRNSYAFFGTR--FKVRGVFAHSQYN---IGAQHDNDIALFQLKQKVKFNDHLLP 761
++ V N GT V+ + H +N + A + DIAL +L Q V N ++
Sbjct: 54 RVVVGEHNLNQNNGTEQYVGVQKIVVHPYWNTDDVAAGY--DIALLRLAQSVTLNSYVQL 111
Query: 762 VCLPPPNYELAPGTRCTVIGWG-KREDTRVSEYETAVNEVEVPIITRDICNK---WLNNR 817
LP L + C + GWG R + ++++ + + +P + IC+ W +
Sbjct: 112 GVLPRAGTILRNNSPCYITGWGLTRTNGQLAQ---TLQQAYLPTVDYAICSSSSYWGS-- 166
Query: 818 ELNVTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSW--GIKCAHPHLP 875
V MVCAG +G + CQGDSGGPL C + Q+ V G+ S+ + C P
Sbjct: 167 --TVKNSMVCAG-GDGVRSGCQGDSGGPLHCLVNG---QYAVHGVTSFVSRLGCNVTRKP 220
Query: 876 GVYAYVPKYVTWIQDIM 892
V+ V Y++WI +++
Sbjct: 221 TVFTRVSAYISWINNVI 237
>pdb|1YM0|A Chain A, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component B: A Novel, Glycosylated Two-chained Trypsin
Length = 238
Score = 95.9 bits (237), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 76/250 (30%), Positives = 122/250 (48%), Gaps = 21/250 (8%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCV-GNLTGLNIDEWTVQ 707
I+GG E+ P ++P+ ++ +C G +I+D+WV+ AAHC+ G L V
Sbjct: 1 IVGGIEARPYEFPWQVSVRRKSSDSHFCGGSIINDRWVVCAAHCMQGEAPAL------VS 54
Query: 708 LGVTRRNSYAFFGTR--FKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLP 765
L V +S A R V +F + Y+ A +ND+++ + + F+ ++ P+C P
Sbjct: 55 LVVGEHDSSAASTVRQTHDVDSIFVNENYD-PATLENDVSVIKTAVAITFDINVGPICAP 113
Query: 766 -PPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLG 824
P N + ++C+ GWG V + V + I T C+ + +
Sbjct: 114 DPANDYVYRKSQCS--GWGTINSGGVC-CPAVLRYVTLNITTNAFCDAVYTSD--TIYDD 168
Query: 825 MVCAGYPEG--GKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVP 882
M+CA G +D+CQGDSGGPL + + + GIVSWGI CA + PGVY+ V
Sbjct: 169 MICATDNTGMTDRDSCQGDSGGPLSVKDGSGI--FSLVGIVSWGIGCASGY-PGVYSRVG 225
Query: 883 KYVTWIQDIM 892
+ WI D +
Sbjct: 226 FHAGWITDTI 235
>pdb|2XW9|A Chain A, Crystal Structure Of Complement Factor D Mutant S183a
pdb|2XWB|I Chain I, Crystal Structure Of Complement C3b In Complex With
Factors B And D
pdb|2XWB|J Chain J, Crystal Structure Of Complement C3b In Complex With
Factors B And D
Length = 228
Score = 95.5 bits (236), Expect = 1e-19, Method: Composition-based stats.
Identities = 71/252 (28%), Positives = 119/252 (47%), Gaps = 33/252 (13%)
Query: 649 IIGGFESNPGDWPFLAAL-LGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQ 707
I+GG E+ P++A++ L G C GVL+++QWVL+AAHC+ + + V
Sbjct: 1 ILGGREAEAHARPYMASVQLNGAHL---CGGVLVAEQWVLSAAHCLEDAADGKVQ---VL 54
Query: 708 LGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPP 767
LG + + V H D+D+ L QL +K + P+
Sbjct: 55 LGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTI-DHDLLLLQLSEKATLGPAVRPLPWQRV 113
Query: 768 NYELAPGTRCTVIGW------GKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNV 821
+ ++APGT C V GW G+R D+ + V +P++ R CN+ + + +
Sbjct: 114 DRDVAPGTLCDVAGWGIVNHAGRRPDS--------LQHVLLPVLDRATCNR-RTHHDGAI 164
Query: 822 TLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIK-CAHPHLPGVYAY 880
T ++CA +D+C+GD+GGPL+C + G+V+ G + C + PG+Y
Sbjct: 165 TERLMCA--ESNRRDSCKGDAGGPLVCGG-------VLEGVVTSGSRVCGNRKKPGIYTR 215
Query: 881 VPKYVTWIQDIM 892
V Y WI ++
Sbjct: 216 VASYAAWIDSVL 227
>pdb|4D9Q|A Chain A, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
pdb|4D9Q|B Chain B, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
Length = 228
Score = 95.5 bits (236), Expect = 1e-19, Method: Composition-based stats.
Identities = 69/245 (28%), Positives = 115/245 (46%), Gaps = 19/245 (7%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG E+ P++A++ E + C GVL+++QWVL+AAHC+ + + V L
Sbjct: 1 ILGGREAEAHARPYMASVQVNGEHL--CGGVLVAEQWVLSAAHCLEDAADGKVQ---VLL 55
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
G + + V H D+D+ L QL +K + P+ +
Sbjct: 56 GAHSLSQPEPSKRLYDVLRAVPHPDSRPDTI-DHDLLLLQLSEKATLGPAVRPLPWQRVD 114
Query: 769 YELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVCA 828
++ PGT C V GWG + + V +P++ R CN+ + + +T M+CA
Sbjct: 115 RDVEPGTLCDVAGWGIV--SHAGRRPDRLQHVLLPVLDRATCNR-RTHHDGAITQRMMCA 171
Query: 829 GYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIK-CAHPHLPGVYAYVPKYVTW 887
+D+C+GDSGGPL+C + G+V+ G + C + PG+Y V Y W
Sbjct: 172 --ESNRRDSCKGDSGGPLVCGG-------VLEGVVTSGSRVCGNRKKPGIYTRVASYAAW 222
Query: 888 IQDIM 892
I ++
Sbjct: 223 IDSVL 227
>pdb|2XWA|A Chain A, Crystal Structure Of Complement Factor D Mutant R202a
pdb|2XWA|B Chain B, Crystal Structure Of Complement Factor D Mutant R202a
Length = 228
Score = 95.1 bits (235), Expect = 1e-19, Method: Composition-based stats.
Identities = 71/251 (28%), Positives = 115/251 (45%), Gaps = 31/251 (12%)
Query: 649 IIGGFESNPGDWPFLAAL-LGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQ 707
I+GG E+ P++A++ L G C GVL+++QWVL+AAHC+ + + V
Sbjct: 1 ILGGREAEAHARPYMASVQLNGAHL---CGGVLVAEQWVLSAAHCLEDAADGKVQ---VL 54
Query: 708 LGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPP 767
LG + + V H D+D+ L QL +K + P+
Sbjct: 55 LGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTI-DHDLLLLQLSEKATLGPAVRPLPWQRV 113
Query: 768 NYELAPGTRCTVIGW------GKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNV 821
+ ++APGT C V GW G+R D+ + V +P++ R CN+ + + +
Sbjct: 114 DRDVAPGTLCDVAGWGIVNHAGRRPDS--------LQHVLLPVLDRATCNR-RTHHDGAI 164
Query: 822 TLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYV 881
T ++CA +D+C+GDSGGPL+C G + S C + PG+Y V
Sbjct: 165 TERLMCA--ESNRRDSCKGDSGGPLVCGGV------LEGVVTSGSAVCGNRKKPGIYTRV 216
Query: 882 PKYVTWIQDIM 892
Y WI ++
Sbjct: 217 ASYAAWIDSVL 227
>pdb|3FZZ|A Chain A, Structure Of Grc
pdb|3FZZ|B Chain B, Structure Of Grc
Length = 227
Score = 94.7 bits (234), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 74/248 (29%), Positives = 109/248 (43%), Gaps = 27/248 (10%)
Query: 649 IIGGFESNPGDWPFLAAL----LGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEW 704
IIGG E +P P++A +GG + +C G L+ D++VLTAAHC G
Sbjct: 1 IIGGNEISPHSRPYMAYYEFLKVGGKKM--FCGGFLVRDKFVLTAAHCKGR-------SM 51
Query: 705 TVQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCL 764
TV LG + V H YN NDI L +L + K + P+ L
Sbjct: 52 TVTLGAHNIKAKEETQQIIPVAKAIPHPDYNPD-DRSNDIMLLKLVRNAKRTRAVRPLNL 110
Query: 765 PPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLG 824
P N + PG C V GWGK T E+ ++EV++ + +C +
Sbjct: 111 PRRNAHVKPGDECYVAGWGKV--TPDGEFPKTLHEVKLTVQKDQVCESQFQSSYNRAN-- 166
Query: 825 MVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKY 884
+C G + + + DSGGPL+C+ + GIVS+G P V+ V +
Sbjct: 167 EICVGDSKIKGASFEEDSGGPLVCKRA-------AAGIVSYG--QTDGSAPQVFTRVLSF 217
Query: 885 VTWIQDIM 892
V+WI+ M
Sbjct: 218 VSWIKKTM 225
>pdb|2FMJ|A Chain A, 220-Loop Mutant Of Streptomyces Griseus Trypsin
Length = 222
Score = 93.6 bits (231), Expect = 4e-19, Method: Composition-based stats.
Identities = 82/249 (32%), Positives = 107/249 (42%), Gaps = 43/249 (17%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCV---GNLTGLNIDEWT 705
++GG + G++PF+ L G C G L + VLTAAHCV GN T + T
Sbjct: 1 VVGGTRAAQGEFPFMVRLSMG------CGGALYAQDIVLTAAHCVSGSGNNTSI-----T 49
Query: 706 VQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLP 765
GV S + + + V YN + D AL +L Q +
Sbjct: 50 ATGGVVDLQSSS--AVKVRSTKVLQAPGYNGTGK---DWALIKLAQPIN----------- 93
Query: 766 PPNYELAPGT-----RCTVIGWG-KREDTRVSEYETAVNEVEVPIITRDICNKWLNNREL 819
P ++A T TV GWG RE Y N VP ++ C N EL
Sbjct: 94 QPTLKIATTTAYNQGTFTVAGWGANREGGSQQRYLLKAN---VPFVSDAACRSAYGN-EL 149
Query: 820 NVTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYA 879
V +CAGY GG D CQGDSGGP+ + N ++W GIVSWG CA GVY
Sbjct: 150 -VANEEICAGYDTGGVDTCQGDSGGPMFRKD--NADEWIQVGIVSWGEGCARKGKYGVYT 206
Query: 880 YVPKYVTWI 888
V + + I
Sbjct: 207 EVSTFASAI 215
>pdb|2ASU|B Chain B, Crystal Structure Of The Beta-Chain Of HgflMSP
Length = 234
Score = 92.8 bits (229), Expect = 8e-19, Method: Composition-based stats.
Identities = 73/248 (29%), Positives = 114/248 (45%), Gaps = 27/248 (10%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGN----LTGLNIDEW 704
++GG +PG+ P+ +L + +C G L+ +QW+LTA C + LTG +
Sbjct: 1 VVGG---HPGNSPWTVSLRN-RQGQHFCGGSLVKEQWILTARQCFSSCHMPLTG-----Y 51
Query: 705 TVQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCL 764
V LG +N G R A + + + L +L++ V N + +CL
Sbjct: 52 EVWLGTLFQNPQ--HGEPSLQRVPVAKM---VCGPSGSQLVLLKLERSVTLNQRVALICL 106
Query: 765 PPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLG 824
PP Y + PGT+C + GWG +T+ + +T +N + +I+ CN R V
Sbjct: 107 PPEWYVVPPGTKCEIAGWG---ETKGTGNDTVLNVALLNVISNQECNIKHRGR---VRES 160
Query: 825 MVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKY 884
+C AC+GD GGPL C +HN W + GI+ CA P V+ V +
Sbjct: 161 EMCTEGLLAPVGACEGDYGGPLAC-FTHN--SWVLEGIIIPNRVCARSRWPAVFTRVSVF 217
Query: 885 VTWIQDIM 892
V WI +M
Sbjct: 218 VDWIHKVM 225
>pdb|1BQY|A Chain A, Plasminogen Activator (tsv-pa) From Snake Venom
pdb|1BQY|B Chain B, Plasminogen Activator (tsv-pa) From Snake Venom
Length = 234
Score = 92.4 bits (228), Expect = 9e-19, Method: Compositional matrix adjust.
Identities = 81/250 (32%), Positives = 114/250 (45%), Gaps = 32/250 (12%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGN----LTGLNIDEW 704
+ GG E N + L L F+ C G LI+ WV+TAAHC N L G++ +
Sbjct: 1 VFGGDECNINEHRSLVVLFNSNGFL--CGGTLINQDWVVTAAHCDSNNFQLLFGVHSKKI 58
Query: 705 TVQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCL 764
+ TR FF K + D DI L +L V ++H+ P+ L
Sbjct: 59 LNEDEQTRDPKEKFFCPNRKKD-----------DEVDKDIMLIKLDSSVSNSEHIAPLSL 107
Query: 765 PPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNREL-NVTL 823
P + G+ C ++GWGK T+ Y + + I+ +C + R++ N TL
Sbjct: 108 PSSPPSV--GSVCRIMGWGKTIPTK-EIYPDVPHCANINILDHAVCRTAYSWRQVANTTL 164
Query: 824 GMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIK-CAHPHLPGVYAYVP 882
CAG +GG+D C DSGGPL+C GIVSWG C P PGVY V
Sbjct: 165 ---CAGILQGGRDTCHFDSGGPLICNG-------IFQGIVSWGGHPCGQPGEPGVYTKVF 214
Query: 883 KYVTWIQDIM 892
Y+ WI+ I+
Sbjct: 215 DYLDWIKSII 224
>pdb|3S69|A Chain A, Crystal Structure Of Saxthrombin
Length = 234
Score = 92.0 bits (227), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 77/245 (31%), Positives = 110/245 (44%), Gaps = 22/245 (8%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
+IGG E N + L A F +C+G LI+++WVLTAAHC + + ++L
Sbjct: 1 VIGGDECNINEHRSLVAFFNSTGF--FCSGTLINEEWVLTAAHC-------DNTNFQMKL 51
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
GV + + F D DI L +L +V ++H+ V L P+
Sbjct: 52 GVHSKKVLNEDEQTRNPKEKFICPNKKNDEVLDKDIMLIKLDSRVSNSEHI--VPLSLPS 109
Query: 769 YELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVCA 828
+ G+ C ++GWG +V+ Y + ++ +C EL +CA
Sbjct: 110 SPPSVGSVCHIMGWGSITPIKVT-YPDVPYCAYINLLDDAVCQA--GYPELLTEYRTLCA 166
Query: 829 GYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIK-CAHPHLPGVYAYVPKYVTW 887
G EGGKD C GDSGGPL+C GIVS+G C PGVY V Y W
Sbjct: 167 GILEGGKDTCGGDSGGPLICNGQFQ-------GIVSFGAHPCGQGLKPGVYTKVFDYNHW 219
Query: 888 IQDIM 892
IQ I+
Sbjct: 220 IQSII 224
>pdb|2RDL|A Chain A, Hamster Chymase 2
pdb|2RDL|B Chain B, Hamster Chymase 2
Length = 226
Score = 91.3 bits (225), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 73/247 (29%), Positives = 114/247 (46%), Gaps = 27/247 (10%)
Query: 649 IIGGFESNPGDWPFLAAL-LGGPE-FVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTV 706
IIGG E P P++A L + PE + C+G LI +V+TAAHC G TV
Sbjct: 1 IIGGTECRPHARPYMAYLEIVTPENHLSACSGFLIRRNFVMTAAHCAGR-------SITV 53
Query: 707 QLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPP 766
LG + + +V F H +Y+ NDI L +LK+K + + +
Sbjct: 54 LLGAHNKKVKEDTWQKLEVEKQFPHPKYD-DRLVLNDIMLLKLKEKANLTLGVGTLPISA 112
Query: 767 PNYELAPGTRCTVIGWGKREDTRVSEYET-AVNEVEVPIITRDICNKWLNNRELNVTLGM 825
+ + PG C +GWG+ T V+E + + EV++ I+ C + + +
Sbjct: 113 KSNSIPPGRVCRAVGWGR---TNVNEPPSDTLQEVKMRILDPQACKHFEDFHQEP----Q 165
Query: 826 VCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYV 885
+C G P+ ++ +GDSGGPLLC GI S+ ++ A P P V+ + Y
Sbjct: 166 LCVGNPKKIRNVYKGDSGGPLLCAG-------IAQGIASYVLRNAKP--PSVFTRISHYR 216
Query: 886 TWIQDIM 892
WI I+
Sbjct: 217 PWINKIL 223
>pdb|3I78|A Chain A, 3599170186220-Loops Of Fxa In Sgt
Length = 229
Score = 89.7 bits (221), Expect = 6e-18, Method: Composition-based stats.
Identities = 78/249 (31%), Positives = 109/249 (43%), Gaps = 36/249 (14%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCV---GNLTGLNIDEWT 705
++GG + G++PF+ L+ E +C G L + VLTAAHCV GN T +
Sbjct: 1 VVGGTRAAQGEFPFMVRLIN-EENEGFCGGALYAQDIVLTAAHCVSGSGNNTSITATGGV 59
Query: 706 VQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLP 765
V L ++S A KV ++ G D AL +L Q +
Sbjct: 60 VDL----QSSSAVKVRSTKVLQAPGFTKETYG----KDWALIKLAQPIN----------- 100
Query: 766 PPNYELAPGT-----RCTVIGWG-KREDTRVSEYETAVNEVEVPIITRDICNKWLNNREL 819
P ++A T TV GWG RE Y N VP ++ C ++ +
Sbjct: 101 QPTLKIATTTAYNQGTFTVAGWGANREGGSQQRYLLKAN---VPFVSDAACRS--SSSFI 155
Query: 820 NVTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYA 879
V M+CAGY +D CQGDSGGP+ + N ++W GIVSWG CA GVY
Sbjct: 156 LVANEMICAGYDTKQEDTCQGDSGGPMFRKD--NADEWVQVGIVSWGEGCARKGKYGVYT 213
Query: 880 YVPKYVTWI 888
V + + I
Sbjct: 214 EVSTFASAI 222
>pdb|1AZZ|A Chain A, Fiddler Crab Collagenase Complexed To Ecotin
pdb|1AZZ|B Chain B, Fiddler Crab Collagenase Complexed To Ecotin
Length = 226
Score = 89.4 bits (220), Expect = 8e-18, Method: Composition-based stats.
Identities = 74/242 (30%), Positives = 107/242 (44%), Gaps = 24/242 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG E+ P WP AAL + +++C G LIS +W+LTAAHC+ +++ +
Sbjct: 1 IVGGVEAVPNSWPHQAALF--IDDMYFCGGSLISPEWILTAAHCMDGAGFVDVVLGAHNI 58
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
T F V H YN NDIA+ +L V + V L P+
Sbjct: 59 REDEATQVTIQSTDFTV-----HENYN-SFVISNDIAVIRLPVPVTLTAAIATVGL--PS 110
Query: 769 YELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVCA 828
++ GT T GWG D+ + + +V+VPI++ C+ VT G +C
Sbjct: 111 TDVGVGTVVTPTGWGLPSDSALG-ISDVLRQVDVPIMSNADCDAVYG----IVTDGNICI 165
Query: 829 GYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCA-HPHLPGVYAYVPKYVTW 887
GGK C GDSGGPL N+ GI S+G P + V ++ W
Sbjct: 166 D-STGGKGTCNGDSGGPL------NYNG-LTYGITSFGAAAGCEAGYPDAFTRVTYFLDW 217
Query: 888 IQ 889
IQ
Sbjct: 218 IQ 219
>pdb|3BEU|A Chain A, Na+-Dependent Allostery Mediates Coagulation Factor
Protease Active Site Selectivity
pdb|3BEU|B Chain B, Na+-Dependent Allostery Mediates Coagulation Factor
Protease Active Site Selectivity
Length = 224
Score = 88.6 bits (218), Expect = 2e-17, Method: Composition-based stats.
Identities = 78/249 (31%), Positives = 107/249 (42%), Gaps = 41/249 (16%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCV---GNLTGLNIDEWT 705
++GG + G++PF+ L G C G L + VLTAAHCV GN T +
Sbjct: 1 VVGGTRAAQGEFPFMVRLSMG------CGGALYAQDIVLTAAHCVSGSGNNTSITATGGV 54
Query: 706 VQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLP 765
V L ++S A KV ++ G D AL +L Q +
Sbjct: 55 VDL----QSSSAVKVRSTKVLQAPGFTKETYG----KDWALIKLAQPIN----------- 95
Query: 766 PPNYELAPGT-----RCTVIGWG-KREDTRVSEYETAVNEVEVPIITRDICNKWLNNREL 819
P ++A T TV GWG RE Y N VP ++ C ++ +
Sbjct: 96 QPTLKIATTTAYNQGTFTVAGWGANREGGSQQRYLLKAN---VPFVSDAACRS--SSSFI 150
Query: 820 NVTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYA 879
V M+CAGY +D CQGDSGGP+ + N ++W GIVSWG CA GVY
Sbjct: 151 LVANEMICAGYDTKQEDTCQGDSGGPMFRKD--NADEWVQVGIVSWGEGCARKGKYGVYT 208
Query: 880 YVPKYVTWI 888
V + + I
Sbjct: 209 EVSTFASAI 217
>pdb|1OP0|A Chain A, Crystal Structure Of Aav-sp-i, A Glycosylated Snake Venom
Serine Proteinase From Agkistrodon Acutus
Length = 234
Score = 88.2 bits (217), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 72/242 (29%), Positives = 106/242 (43%), Gaps = 22/242 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
+IGG E + + FL A F +C G LI+ +WV+TAAHC + ++ +QL
Sbjct: 1 VIGGNECDINEHRFLVAFFNTTGF--FCGGTLINPEWVVTAAHC-------DSTDFQMQL 51
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
GV + + F N D DI L +L + + + H+ P+ LP
Sbjct: 52 GVHSKKVLNEDEQTRNPKEKFICPNKNNNEVLDKDIMLIKLDKPISNSKHIAPLSLPSSP 111
Query: 769 YELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVCA 828
+ G+ C ++GWG + + + ++ +C EL +CA
Sbjct: 112 PSV--GSVCRIMGWGSITPVK-ETFPDVPYCANINLLDHAVCQAGY--PELLAEYRTLCA 166
Query: 829 GYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIK-CAHPHLPGVYAYVPKYVTW 887
G +GGKD C GDSGGPL+C GIVS+G C PG+Y V Y W
Sbjct: 167 GIVQGGKDTCGGDSGGPLICNGQFQ-------GIVSYGAHPCGQGPKPGIYTNVFDYTDW 219
Query: 888 IQ 889
IQ
Sbjct: 220 IQ 221
>pdb|1OP2|A Chain A, Crystal Structure Of Aav-Sp-Ii, A Glycosylated Snake Venom
Serine Proteinase From Agkistrodon Acutus
Length = 234
Score = 87.8 bits (216), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 72/242 (29%), Positives = 105/242 (43%), Gaps = 22/242 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
+IGG E + + FL A F +C G LI+ +WV+TAAHC + + +QL
Sbjct: 1 VIGGNECDINEHRFLVAFFNTTGF--FCGGTLINPEWVVTAAHC-------DSTNFQMQL 51
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
GV + + F N D DI L +L + + + H+ P+ LP
Sbjct: 52 GVHSKKVLNEDEQTRNPKEKFICPNKNNNEVLDKDIMLIKLDKPISNSKHIAPLSLPSSP 111
Query: 769 YELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVCA 828
+ G+ C ++GWG + + + ++ +C EL +CA
Sbjct: 112 PSV--GSVCRIMGWGSITPVK-ETFPDVPYCANINLLDHAVCQAGY--PELLAEYRTLCA 166
Query: 829 GYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIK-CAHPHLPGVYAYVPKYVTW 887
G +GGKD C GDSGGPL+C GIVS+G C PG+Y V Y W
Sbjct: 167 GIVQGGKDTCGGDSGGPLICNGQFQ-------GIVSYGAHPCGQGPKPGIYTNVFDYTDW 219
Query: 888 IQ 889
IQ
Sbjct: 220 IQ 221
>pdb|1EQ9|A Chain A, Crystal Structure Of Fire Ant Chymotrypsin Complexed To
Pmsf
pdb|1EQ9|B Chain B, Crystal Structure Of Fire Ant Chymotrypsin Complexed To
Pmsf
Length = 222
Score = 86.3 bits (212), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 76/248 (30%), Positives = 115/248 (46%), Gaps = 28/248 (11%)
Query: 649 IIGGFESNPGDWPFLAAL-LGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQ 707
I+GG ++ G +P+ +L L G C ++ + VLTAAHCV L+ LN V
Sbjct: 1 IVGGKDAPVGKYPYQVSLRLSGSH---RCGASILDNNNVLTAAHCVDGLSNLN--RLKVH 55
Query: 708 LGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPP 767
+G N + G + V + Y+ ND+AL L +KFND + P+ L
Sbjct: 56 VGT---NYLSESGDVYDVEDAVVNKNYDDFLLR-NDVALVHLTNPIKFNDLVQPIKLSTN 111
Query: 768 NYELAPGTRCTVIGWGKREDTRV-SEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMV 826
+ +L CT+ GWG TR+ A+ E+E+ + + C + + V +
Sbjct: 112 DEDLES-NPCTLTGWGS---TRLGGNTPNALQEIELIVHPQKQCER----DQWRVIDSHI 163
Query: 827 CAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVT 886
C + G+ AC GDSGGPL+ + GIVS+G CA P VY V +V+
Sbjct: 164 CT-LTKRGEGACHGDSGGPLVANGAQI-------GIVSFGSPCALGE-PDVYTRVSSFVS 214
Query: 887 WIQDIMDK 894
WI + K
Sbjct: 215 WINANLKK 222
>pdb|2BDG|A Chain A, Human Kallikrein 4 Complex With Nickel And
P-aminobenzamidine
pdb|2BDG|B Chain B, Human Kallikrein 4 Complex With Nickel And
P-aminobenzamidine
pdb|2BDH|A Chain A, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDH|B Chain B, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDH|C Chain C, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDH|D Chain D, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDI|A Chain A, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|B Chain B, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|C Chain C, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|D Chain D, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|E Chain E, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|F Chain F, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|G Chain G, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|H Chain H, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|I Chain I, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|J Chain J, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|K Chain K, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|L Chain L, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|M Chain M, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|N Chain N, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|O Chain O, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|P Chain P, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
Length = 223
Score = 86.3 bits (212), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 74/243 (30%), Positives = 119/243 (48%), Gaps = 27/243 (11%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
II G + +P P+ AAL+ E +C+GVL+ QWVL+AAHC N +T+ L
Sbjct: 1 IINGEDCSPHSQPWQAALV--MENELFCSGVLVHPQWVLSAAHCFQN-------SYTIGL 51
Query: 709 GVTRRNSYAFFGTRFKVRGV-FAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPP 767
G+ + G++ + H +YN ND+ L +L + V +D + + +
Sbjct: 52 GLHSLEADQEPGSQMVEASLSVRHPEYNR-PLLANDLMLIKLDESVSESDTIRSISIA-- 108
Query: 768 NYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVC 827
+ G C V GWG + R+ T + V V +++ ++C+K + M C
Sbjct: 109 SQCPTAGNSCLVSGWGLLANGRM---PTVLQCVNVSVVSEEVCSKLYDPL---YHPSMFC 162
Query: 828 AGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWG-IKCAHPHLPGVYAYVPKYVT 886
AG + KD+C GDSGGPL+C ++ G+VS+G C +PGVY + K+
Sbjct: 163 AGGGQDQKDSCNGDSGGPLICNG-------YLQGLVSFGKAPCGQVGVPGVYTNLCKFTE 215
Query: 887 WIQ 889
WI+
Sbjct: 216 WIE 218
>pdb|1FUJ|A Chain A, Pr3 (Myeloblastin)
pdb|1FUJ|B Chain B, Pr3 (Myeloblastin)
pdb|1FUJ|C Chain C, Pr3 (Myeloblastin)
pdb|1FUJ|D Chain D, Pr3 (Myeloblastin)
Length = 221
Score = 82.8 bits (203), Expect = 7e-16, Method: Composition-based stats.
Identities = 75/256 (29%), Positives = 109/256 (42%), Gaps = 48/256 (18%)
Query: 649 IIGGFESNPGDWPFLAAL-LGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQ 707
I+GG E+ P P++A+L + G +C G LI +VLTAAHC+ ++ ++ V
Sbjct: 1 IVGGHEAQPHSRPYMASLQMRGNPGSHFCGGTLIHPSFVLTAAHCLRDIPQRLVN---VV 57
Query: 708 LGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHD-NDIALFQLKQKVKFNDHLLPVCLPP 766
LG + F V VF + N A++ NDI L QL + + V LP
Sbjct: 58 LGAHNVRTQEPTQQHFSVAQVFLN---NYDAENKLNDILLIQLSSPANLSASVATVQLPQ 114
Query: 767 PNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGM- 825
+ + GT+C +GWG RV ++ ++ ELNVT+
Sbjct: 115 QDQPVPHGTQCLAMGWG-----RVGAHDPPAQVLQ----------------ELNVTVVTF 153
Query: 826 ------VCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGI---VSWGIKCAHPHLPG 876
+C P C GDSGGPL+C + GI V WG CA P
Sbjct: 154 FCRPHNICTFVPRRKAGICFGDSGGPLICDG-------IIQGIDSFVIWG--CATRLFPD 204
Query: 877 VYAYVPKYVTWIQDIM 892
+ V YV WI+ +
Sbjct: 205 FFTRVALYVDWIRSTL 220
>pdb|1M9U|A Chain A, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component A From Eisenia Fetida
pdb|1M9U|B Chain B, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component A From Eisenia Fetida
pdb|1M9U|C Chain C, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component A From Eisenia Fetida
Length = 241
Score = 81.6 bits (200), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 70/245 (28%), Positives = 105/245 (42%), Gaps = 9/245 (3%)
Query: 649 IIGGFESNPGDWPF-LAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQ 707
+IGG ++PG++P+ L+ + C L+S L+A+HCV + NI V
Sbjct: 1 VIGGTNASPGEFPWQLSQQRQSGSWSHSCGASLLSSTSALSASHCVDGVLPNNI---RVI 57
Query: 708 LGVTRRNSYAFFGTRFKVRGVFAHSQYNIG-AQHDNDIALFQLKQKVKFNDHLLPVCLPP 766
G+ +++ + T V H Y G A + NDIA+ L + ++ LP
Sbjct: 58 AGLWQQSDTSGTQTA-NVDSYTMHENYGAGTASYSNDIAILHLATSISLGGNIQAAVLPA 116
Query: 767 PNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWL-NNRELNVTLGM 825
N GT C + GWG+ + T + + +P+IT C + N+
Sbjct: 117 NNNNDYAGTTCVISGWGRTDGTN--NLPDILQKSSIPVITTAQCTAAMVGVGGANIWDNH 174
Query: 826 VCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYV 885
+C P G AC GDSGGPL C +VS G+ P P VY V Y+
Sbjct: 175 ICVQDPAGNTGACNGDSGGPLNCPDGGTRVVGVTSWVVSSGLGACLPDYPSVYTRVSAYL 234
Query: 886 TWIQD 890
WI D
Sbjct: 235 GWIGD 239
>pdb|1MTN|B Chain B, Bovine Alpha-Chymotrypsin:bpti Crystallization
pdb|1MTN|F Chain F, Bovine Alpha-Chymotrypsin:bpti Crystallization
pdb|1AB9|B Chain B, Crystal Structure Of Bovine Gamma-Chymotrypsin
pdb|1CA0|B Chain B, Bovine Chymotrypsin Complexed To Appi
pdb|1CA0|G Chain G, Bovine Chymotrypsin Complexed To Appi
pdb|1CBW|B Chain B, Bovine Chymotrypsin Complexed To Bpti
pdb|1CBW|G Chain G, Bovine Chymotrypsin Complexed To Bpti
pdb|1AFQ|B Chain B, Crystal Structure Of Bovine Gamma-Chymotrypsin Complexed
With A Synthetic Inhibitor
pdb|1VGC|B Chain B, Gamma-Chymotrypsin L-Para-Chloro-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|2VGC|B Chain B, Gamma-Chymotrypsin D-Para-Chloro-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|3VGC|B Chain B, Gamma-Chymotrypsin L-Naphthyl-1-Acetamido Boronic Acid
Acid Inhibitor Complex
pdb|4VGC|B Chain B, Gamma-Chymotrypsin D-Naphthyl-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|1HJA|B Chain B, Lys 18 Variant Of Turkey Ovomucoid Inhibitor Third Domain
Complexed With Alpha-Chymotrypsin
pdb|1GG6|B Chain B, Crystal Stucture Of Gamma Chymotrypsin With N-Acetyl-
Phenylalanine Trifluoromethyl Ketone Bound At The Active
Site
pdb|1GGD|B Chain B, Crystal Stucture Of Gamma Chymotrypsin With
N-Acetyl-Leucil- Phenylalanine Aldehyde Bound At The
Active Site
pdb|1N8O|B Chain B, Crystal Structure Of A Complex Between Bovine Chymotrypsin
And Ecotin
pdb|1YPH|C Chain C, High Resolution Structure Of Bovine Alpha-Chymotrypsin
pdb|1YPH|D Chain D, High Resolution Structure Of Bovine Alpha-Chymotrypsin
pdb|2P8O|B Chain B, Crystal Structure Of A Benzohydroxamic AcidVANADATE
Complex Bound To Chymotrypsin A
pdb|1GMH|F Chain F, Refined Crystal Structure Of "aged" And "non-Aged"
Organophosphoryl Conjugates Of Gamma-Chymotrypsin
pdb|2CHA|B Chain B, The Structure Of Crystalline Alpha-Chymotrypsin, v.The
Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2
Angstroms Resolution
pdb|2CHA|F Chain F, The Structure Of Crystalline Alpha-Chymotrypsin, v.The
Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2
Angstroms Resolution
pdb|2GCH|F Chain F, Refined Crystal Structure Of Gamma-chymotrypsin At 1.9
Angstroms Resolution
pdb|4GCH|F Chain F, Structure And Activity Of Two Photoreversible Cinnamates
Bound To Chymotrypsin
pdb|5GCH|F Chain F, Chemistry Of Caged Enzymes II. Photoactivation Of
Inhibited Chymotrypsin
pdb|6GCH|F Chain F, Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor
Complexes. Comparison Of Slowly And Rapidly
Equilibrating Inhibitors
pdb|7GCH|F Chain F, Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor
Complexes. Comparison Of Slowly And Rapidly
Equilibrating Inhibitors
pdb|1CHO|F Chain F, Crystal And Molecular Structures Of The Complex Of Alpha-
Chymotrypsin With Its Inhibitor Turkey Ovomucoid Third
Domain At 1.8 Angstroms Resolution
pdb|1GHA|F Chain F, A Second Active Site In Chymotrypsin? The X-Ray Crystal
Structure Of N-Acetyl-D-Tryptophan Bound To
Gamma-Chymotrypsin
pdb|1GMC|F Chain F, The X-Ray Crystal Structure Of The Tetrahedral
Intermediate Of Gamma- Chymotrypsin In Hexane
pdb|1GMD|F Chain F, X-Ray Crystal Structure Of Gamma-Chymotrypsin In Hexane
pdb|3GCT|F Chain F, Structure Of Gamma-Chymotrypsin In The Range pH 2.0 To pH
10.5 Suggests That Gamma-Chymotrypsin Is A Covalent
Acyl-Enzyme Adduct At Low pH
pdb|4CHA|B Chain B, Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms
Resolution
pdb|4CHA|F Chain F, Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms
Resolution
pdb|5CHA|B Chain B, The Refinement And The Structure Of The Dimer Of Alpha-
Chymotrypsin At 1.67-Angstroms Resolution
pdb|5CHA|F Chain F, The Refinement And The Structure Of The Dimer Of Alpha-
Chymotrypsin At 1.67-Angstroms Resolution
pdb|6CHA|B Chain B, Structure Of A Tetrahedral Transition State Complex Of
Alpha-Chymotrypsin At 1.8-Angstroms Resolution
pdb|6CHA|F Chain F, Structure Of A Tetrahedral Transition State Complex Of
Alpha-Chymotrypsin At 1.8-Angstroms Resolution
pdb|8GCH|F Chain F, Gamma-Chymotrypsin Is A Complex Of Alpha-Chymotrypsin With
Its Own Autolysis Products
pdb|3BG4|B Chain B, The Crystal Structure Of Guamerin In Complex With
Chymotrypsin And The Development Of An Elastase-Specific
Inhibitor
pdb|1GCT|B Chain B, Is Gamma-Chymotrypsin A Tetrapeptide Acyl-Enzyme Adduct Of
Gamma- Chymotrypsin?
pdb|2GCT|B Chain B, Structure Of Gamma-Chymotrypsin In The Range Ph 2.0 To Ph
10.5 Suggests That Gamma-Chymotrypsin Is A Covalent
Acyl-Enzyme Adduct At Low Ph
pdb|1GHB|F Chain F, A Second Active Site In Chymotrypsin? The X-Ray Crystal
Structure Of N-Acetyl-D-Tryptophan Bound To
Gamma-Chymotrypsin
pdb|2GMT|B Chain B, Three-Dimensional Structure Of Chymotrypsin Inactivated
With (2s) N- Acetyl-L-Alanyl-L-Phenylalanyl-Chloroethyl
Ketone: Implications For The Mechanism Of Inactivation
Of Serine Proteases By Chloroketones
pdb|3GCH|B Chain B, Chemistry Of Caged Enzymes. Binding Of Photoreversible
Cinnamates To Chymotrypsin
pdb|3RU4|D Chain D, Crystal Structure Of The Bowman-Birk Serine Protease
Inhibitor Btci In Complex With Trypsin And Chymotrypsin
Length = 131
Score = 80.9 bits (198), Expect = 3e-15, Method: Composition-based stats.
Identities = 48/135 (35%), Positives = 69/135 (51%), Gaps = 8/135 (5%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+ G E+ PG WP+ +L F F C G LI++ WV+TAAHC G+ + V
Sbjct: 1 IVNGEEAVPGSWPWQVSLQDKTGFHF-CGGSLINENWVVTAAHC-----GVTTSDVVVA- 53
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
G + S + + K+ VF +S+YN +NDI L +L F+ + VCLP +
Sbjct: 54 GEFDQGSSSEKIQKLKIAKVFKNSKYN-SLTINNDITLLKLSTAASFSQTVSAVCLPSAS 112
Query: 769 YELAPGTRCTVIGWG 783
+ A GT C GWG
Sbjct: 113 DDFAAGTTCVTTGWG 127
>pdb|1SI5|H Chain H, Protease-Like Domain From 2-Chain Hepatocyte Growth Factor
Length = 240
Score = 79.7 bits (195), Expect = 7e-15, Method: Compositional matrix adjust.
Identities = 61/220 (27%), Positives = 98/220 (44%), Gaps = 15/220 (6%)
Query: 676 CAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQLGVTRRNSYAFFGTRFKVRGVFAHSQYN 735
C G LI + WVLTA C + + + W V R K + V SQ
Sbjct: 25 CGGSLIKESWVLTARQCFPSRDLKDYEAWLGIHDVHGRGDE-------KCKQVLNVSQLV 77
Query: 736 IGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPNYELAPGTRCTVIGWGKREDTRVSEYET 795
G + +D+ L +L + +D + + LP + T C+V GWG T + Y+
Sbjct: 78 YGPE-GSDLVLMKLARPAVLDDFVSTIDLPNYGSTIPEKTSCSVYGWGY---TGLINYDG 133
Query: 796 AVNEVEVPIITRDICNKWLNNRELNVTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFE 855
+ + I+ + C++ + ++ + +CAG + G C+GD GGPL+C H
Sbjct: 134 LLRVAHLYIMGNEKCSQ-HHRGKVTLNESEICAGAEKIGSGPCEGDYGGPLVC-EQHKMR 191
Query: 856 QWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTWIQDIMDKY 895
V G++ G CA P+ PG++ V Y WI I+ Y
Sbjct: 192 --MVLGVIVPGRGCAIPNRPGIFVRVAYYAKWIHKIILTY 229
>pdb|1SHY|A Chain A, The Crystal Structure Of Hgf Beta-Chain In Complex With
The Sema Domain Of The Met Receptor
Length = 234
Score = 79.7 bits (195), Expect = 7e-15, Method: Compositional matrix adjust.
Identities = 61/220 (27%), Positives = 98/220 (44%), Gaps = 15/220 (6%)
Query: 676 CAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQLGVTRRNSYAFFGTRFKVRGVFAHSQYN 735
C G LI + WVLTA C + + + W V R K + V SQ
Sbjct: 25 CGGSLIKESWVLTARQCFPSRDLKDYEAWLGIHDVHGRGDE-------KCKQVLNVSQLV 77
Query: 736 IGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPNYELAPGTRCTVIGWGKREDTRVSEYET 795
G + +D+ L +L + +D + + LP + T C+V GWG T + Y+
Sbjct: 78 YGPE-GSDLVLMKLARPAVLDDFVSTIDLPNYGSTIPEKTSCSVYGWGY---TGLINYDG 133
Query: 796 AVNEVEVPIITRDICNKWLNNRELNVTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFE 855
+ + I+ + C++ + ++ + +CAG + G C+GD GGPL+C H
Sbjct: 134 LLRVAHLYIMGNEKCSQ-HHRGKVTLNESEICAGAEKIGSGPCEGDYGGPLVC-EQHKMR 191
Query: 856 QWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTWIQDIMDKY 895
V G++ G CA P+ PG++ V Y WI I+ Y
Sbjct: 192 --MVLGVIVPGRGCAIPNRPGIFVRVAYYAKWIHKIILTY 229
>pdb|2KAI|B Chain B, Refined 2.5 Angstroms X-Ray Crystal Structure Of The
Complex Formed By Porcine Kallikrein A And The Bovine
Pancreatic Trypsin Inhibitor. Crystallization, Patterson
Search, Structure Determination, Refinement, Structure
And Comparison With Its Components And With The Bovine
Trypsin- Pancreatic Trypsin Inhibitor Complex
pdb|2PKA|B Chain B, Refined 2 Angstroms X-Ray Crystal Structure Of Porcine
Pancreatic Kallikrein A, A Specific Trypsin-Like Serine
Proteinase. Crystallization, Structure Determination,
Crystallographic Refinement, Structure And Its
Comparison With Bovine Trypsin
pdb|2PKA|Y Chain Y, Refined 2 Angstroms X-Ray Crystal Structure Of Porcine
Pancreatic Kallikrein A, A Specific Trypsin-Like Serine
Proteinase. Crystallization, Structure Determination,
Crystallographic Refinement, Structure And Its
Comparison With Bovine Trypsin
pdb|1HIA|B Chain B, Kallikrein Complexed With Hirustasin
pdb|1HIA|Y Chain Y, Kallikrein Complexed With Hirustasin
Length = 152
Score = 79.0 bits (193), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 51/158 (32%), Positives = 73/158 (46%), Gaps = 14/158 (8%)
Query: 737 GAQHDNDIALFQLKQKVKFNDHLLPVCLPPPNYELAPGTRCTVIGWGKREDTRVS-EYET 795
G + +D+ L +L+ K D + + LP EL G+ C GWG E E+
Sbjct: 3 GKDYSHDLMLLRLQSPAKITDAVKVLELPTQEPEL--GSTCEASGWGSIEPGPDDFEFPD 60
Query: 796 AVNEVEVPIITRDICNKWLNNRELNVTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFE 855
+ V++ ++ C + VT M+CAGY GGKD C GDSGGPL+C
Sbjct: 61 EIQCVQLTLLQNTFCA---DAHPDKVTESMLCAGYLPGGKDTCMGDSGGPLICNGMWQ-- 115
Query: 856 QWFVGGIVSWG-IKCAHPHLPGVYAYVPKYVTWIQDIM 892
GI SWG C + P +Y + Y+ WI D +
Sbjct: 116 -----GITSWGHTPCGSANKPSIYTKLIFYLDWIDDTI 148
>pdb|1UHB|B Chain B, Crystal Structure Of Porcine Alpha Trypsin Bound With Auto
Catalyticaly Produced Native Peptide At 2.15 A
Resolution
Length = 98
Score = 78.6 bits (192), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 40/102 (39%), Positives = 57/102 (55%), Gaps = 10/102 (9%)
Query: 791 SEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVCAGYPEGGKDACQGDSGGPLLCRS 850
S Y + + ++ P+++ C ++ +T M+C G+ EGGKD+CQGDSGGP++C
Sbjct: 4 SSYPSLLQCLKAPVLSDSSCK---SSYPGQITGNMICVGFLEGGKDSCQGDSGGPVVCNG 60
Query: 851 SHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTWIQDIM 892
GIVSWG CA + PGVY V YV WIQ +
Sbjct: 61 QLQ-------GIVSWGYGCAQKNKPGVYTKVCNYVNWIQQTI 95
>pdb|1EPT|C Chain C, Refined 1.8 Angstroms Resolution Crystal Structure Of
Porcine Epsilon-Trypsin
pdb|1AKS|B Chain B, Crystal Structure Of The First Active Autolysate Form Of
The Porcine Alpha Trypsin
Length = 98
Score = 78.2 bits (191), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 39/102 (38%), Positives = 57/102 (55%), Gaps = 10/102 (9%)
Query: 791 SEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVCAGYPEGGKDACQGDSGGPLLCRS 850
S Y + + ++ P+++ C ++ +T M+C G+ +GGKD+CQGDSGGP++C
Sbjct: 4 SSYPSLLQCLKAPVLSNSSCK---SSYPGQITGNMICVGFLQGGKDSCQGDSGGPVVCNG 60
Query: 851 SHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTWIQDIM 892
GIVSWG CA + PGVY V YV WIQ +
Sbjct: 61 QLQ-------GIVSWGYGCAQKNKPGVYTKVCNYVNWIQQTI 95
>pdb|1PYT|C Chain C, Ternary Complex Of Procarboxypeptidase A, Proproteinase E,
And Chymotrypsinogen C
Length = 253
Score = 78.2 bits (191), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 65/258 (25%), Positives = 109/258 (42%), Gaps = 23/258 (8%)
Query: 644 KARKRIIGGFESNPGDWPFLAALLGGPEFVFY--CAGVLISDQWVLTAAHCVGNLTGLNI 701
+ R++ G ++ P W + +L + F+ C G LI+ WV+TA HC+
Sbjct: 7 RPSSRVVNGEDAVPYSWSWQVSLQYEKDGAFHHTCGGSLIAPDWVVTAGHCISTSR---- 62
Query: 702 DEWTVQLGVTRRNSYAFFGTR----FKVRGVFAHSQYNIG-AQHDNDIALFQLKQKVKFN 756
T Q+ + + G+ +F H +N NDIAL +L + +
Sbjct: 63 ---TYQVVLGEYDRSVLQGSEQVIPINAGDLFVHPLWNSNCVACGNDIALVKLSRSAQLG 119
Query: 757 DHLLPVCLPPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNN 816
D + LPP L C + GWG+ + E +P++ + C+++ +
Sbjct: 120 DKVQLANLPPAGDILPNEAPCYISGWGRLYTG--GPLPDKLQEALLPVVDYEHCSQY-DW 176
Query: 817 RELNVTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSW--GIKCAHPHL 874
+ V MVCAG + C GDSGGPL C ++ W V G+ S+ C
Sbjct: 177 WGITVKKTMVCAGGDT--RSGCDGDSGGPLNCPAADG--SWQVHGVTSFVSAFGCNTIKK 232
Query: 875 PGVYAYVPKYVTWIQDIM 892
P V+ V ++ WI + +
Sbjct: 233 PTVFTRVSAFIDWINETI 250
>pdb|1B0F|A Chain A, Crystal Structure Of Human Neutrophil Elastase With Mdl
101, 146
Length = 218
Score = 76.6 bits (187), Expect = 5e-14, Method: Composition-based stats.
Identities = 72/248 (29%), Positives = 105/248 (42%), Gaps = 35/248 (14%)
Query: 649 IIGGFESNPGDWPFLAAL-LGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQ 707
I+GG + P WPF+ +L L G F C LI+ +V++AAHCV N+ +
Sbjct: 1 IVGGRRARPHAWPFMVSLQLAGGHF---CGATLIAPNFVMSAAHCVANVNVRAVRVVLGA 57
Query: 708 LGVTRRNSYAFFGTR--FKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLP 765
++RR TR F V+ +F + NDI + QL N ++ LP
Sbjct: 58 HNLSRREP-----TRQVFAVQRIFEDGYDPVNLL--NDIVILQLNGSATINANVQVAQLP 110
Query: 766 PPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGM 825
L G +C +GWG R + + E+ V ++T +C R NV
Sbjct: 111 AQGRRLGNGVQCLAMGWGLLGRNR--GIASVLQELNVTVVT-SLC------RRSNVC--T 159
Query: 826 VCAGYPEGGKDACQGDSGGPLLCRS-SHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKY 884
+ G G C GDSG PL+C H + GG CA P +A V ++
Sbjct: 160 LVRGRQAG---VCFGDSGSPLVCNGLIHGIASFVRGG-------CASGLYPDAFAPVAQF 209
Query: 885 VTWIQDIM 892
V WI I+
Sbjct: 210 VNWIDSII 217
>pdb|1PPF|E Chain E, X-Ray Crystal Structure Of The Complex Of Human Leukocyte
Elastase (Pmn Elastase) And The Third Domain Of The
Turkey Ovomucoid Inhibitor
Length = 218
Score = 76.3 bits (186), Expect = 7e-14, Method: Composition-based stats.
Identities = 72/248 (29%), Positives = 106/248 (42%), Gaps = 35/248 (14%)
Query: 649 IIGGFESNPGDWPFLAAL-LGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQ 707
I+GG + P WPF+ +L L G F C LI+ +V++AAHCV N+ +
Sbjct: 1 IVGGRRARPHAWPFMVSLQLRGGHF---CGATLIAPNFVMSAAHCVANVNVRAVRVVLGA 57
Query: 708 LGVTRRNSYAFFGTR--FKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLP 765
++RR TR F V+ +F + + NDI + QL N ++ LP
Sbjct: 58 HNLSRREP-----TRQVFAVQRIFENGYDPVNLL--NDIVILQLNGSATINANVQVAQLP 110
Query: 766 PPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGM 825
L G +C +GWG R + + E+ V ++T +C R NV
Sbjct: 111 AQGRRLGNGVQCLAMGWGLLGRNR--GIASVLQELNVTVVT-SLC------RRSNVC--T 159
Query: 826 VCAGYPEGGKDACQGDSGGPLLCRS-SHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKY 884
+ G G C GDSG PL+C H + GG CA P +A V ++
Sbjct: 160 LVRGRQAG---VCFGDSGSPLVCNGLIHGIASFVRGG-------CASGLYPDAFAPVAQF 209
Query: 885 VTWIQDIM 892
V WI I+
Sbjct: 210 VNWIDSII 217
>pdb|1PPG|E Chain E, The Refined 2.3 Angstroms Crystal Structure Of Human
Leukocyte Elastase In A Complex With A Valine
Chloromethyl Ketone Inhibitor
pdb|1H1B|A Chain A, Crystal Structure Of Human Neutrophil Elastase Complexed
With An Inhibitor (Gw475151)
pdb|1H1B|B Chain B, Crystal Structure Of Human Neutrophil Elastase Complexed
With An Inhibitor (Gw475151)
pdb|2Z7F|E Chain E, Crystal Structure Of The Complex Of Human Neutrophil
Elastase With 12SLPI
pdb|3Q76|A Chain A, Structure Of Human Neutrophil Elastase (uncomplexed)
pdb|3Q76|B Chain B, Structure Of Human Neutrophil Elastase (uncomplexed)
pdb|3Q77|A Chain A, Structure Of Human Neutrophil Elastase In Complex With A
Dihydropyrimidone Inhibitor
Length = 218
Score = 76.3 bits (186), Expect = 7e-14, Method: Composition-based stats.
Identities = 72/248 (29%), Positives = 106/248 (42%), Gaps = 35/248 (14%)
Query: 649 IIGGFESNPGDWPFLAAL-LGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQ 707
I+GG + P WPF+ +L L G F C LI+ +V++AAHCV N+ +
Sbjct: 1 IVGGRRARPHAWPFMVSLQLRGGHF---CGATLIAPNFVMSAAHCVANVNVRAVRVVLGA 57
Query: 708 LGVTRRNSYAFFGTR--FKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLP 765
++RR TR F V+ +F + + NDI + QL N ++ LP
Sbjct: 58 HNLSRREP-----TRQVFAVQRIFENGYDPVNLL--NDIVILQLNGSATINANVQVAQLP 110
Query: 766 PPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGM 825
L G +C +GWG R + + E+ V ++T +C R NV
Sbjct: 111 AQGRRLGNGVQCLAMGWGLLGRNR--GIASVLQELNVTVVT-SLC------RRSNVC--T 159
Query: 826 VCAGYPEGGKDACQGDSGGPLLCRS-SHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKY 884
+ G G C GDSG PL+C H + GG CA P +A V ++
Sbjct: 160 LVRGRQAG---VCFGDSGSPLVCNGLIHGIASFVRGG-------CASGLYPDAFAPVAQF 209
Query: 885 VTWIQDIM 892
V WI I+
Sbjct: 210 VNWIDSII 217
>pdb|1BBR|H Chain H, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1UCY|H Chain H, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1VIT|F Chain F, Thrombin:hirudin 51-65 Complex
pdb|1YCP|K Chain K, The Crystal Structure Of Fibrinogen-Aa Peptide 1-23 (F8y)
Bound To Bovine Thrombin Explains Why The Mutation Of
Phe-8 To Tyrosine Strongly Inhibits Normal Cleavage At
Arginine-16
Length = 150
Score = 76.3 bits (186), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 49/150 (32%), Positives = 73/150 (48%), Gaps = 13/150 (8%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCV------GNLTGLNID 702
I+ G ++ G P+ L C LISD+WVLTAAHC+ N T +D
Sbjct: 1 IVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFT---VD 57
Query: 703 EWTVQLGVTRRNSYAFFGTRFK-VRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLP 761
+ V++G R Y + + ++ H +YN D DIAL +LK+ ++ +D++ P
Sbjct: 58 DLLVRIGKHSRTRYERKVEKISMLDKIYIHPRYNWKENLDRDIALLKLKRPIELSDYIHP 117
Query: 762 VCLPPPNYE---LAPGTRCTVIGWGKREDT 788
VCLP L G + V GWG R +T
Sbjct: 118 VCLPDKQTAAKLLHAGFKGRVTGWGNRRET 147
>pdb|1HNE|E Chain E, Structure Of Human Neutrophil Elastase In Complex With A
Peptide Chloromethyl Ketone Inhibitor At 1.84-Angstroms
Resolution
Length = 218
Score = 75.9 bits (185), Expect = 1e-13, Method: Composition-based stats.
Identities = 72/248 (29%), Positives = 105/248 (42%), Gaps = 35/248 (14%)
Query: 649 IIGGFESNPGDWPFLAAL-LGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQ 707
I+GG + P WPF+ +L L G F C LI+ +V++AAHCV N+ +
Sbjct: 1 IVGGRRARPHAWPFMVSLQLRGGHF---CGATLIAPNFVMSAAHCVANVNVRAVRVVLGA 57
Query: 708 LGVTRRNSYAFFGTR--FKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLP 765
++RR TR F V+ +F + NDI + QL N ++ LP
Sbjct: 58 HNLSRREP-----TRQVFAVQRIFEDGYDPVNLL--NDIVILQLNGSATINANVQVAQLP 110
Query: 766 PPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGM 825
L G +C +GWG R + + E+ V ++T +C R NV
Sbjct: 111 AQGRRLGNGVQCLAMGWGLLGRNR--GIASVLQELNVTVVT-SLC------RRSNVC--T 159
Query: 826 VCAGYPEGGKDACQGDSGGPLLCRS-SHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKY 884
+ G G C GDSG PL+C H + GG CA P +A V ++
Sbjct: 160 LVRGRQAG---VCFGDSGSPLVCNGLIHGIASFVRGG-------CASGLYPDAFAPVAQF 209
Query: 885 VTWIQDIM 892
V WI I+
Sbjct: 210 VNWIDSII 217
>pdb|4F4O|C Chain C, Structure Of The Haptoglobin-Haemoglobin Complex
pdb|4F4O|F Chain F, Structure Of The Haptoglobin-Haemoglobin Complex
pdb|4F4O|I Chain I, Structure Of The Haptoglobin-Haemoglobin Complex
pdb|4F4O|L Chain L, Structure Of The Haptoglobin-Haemoglobin Complex
Length = 347
Score = 75.1 bits (183), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 67/261 (25%), Positives = 110/261 (42%), Gaps = 32/261 (12%)
Query: 647 KRIIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNL-TGLNIDEWT 705
+RI+GG G +P+ A ++ LI++QW+LT A NL G D
Sbjct: 101 QRIMGGSLDAKGSFPWQAKMISHHNLT--SGATLINEQWLLTTAK---NLRLGHKNDTKA 155
Query: 706 VQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLP 765
+ T R Y ++ V H DI L +LKQKV N+ ++P+CLP
Sbjct: 156 KDIAPTLR-LYVGKKQEVEIEKVIFHPD-----NSTVDIGLIKLKQKVPVNERVMPICLP 209
Query: 766 PPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNREL------ 819
+Y + G V GWG+ + +E+ + V +P+ ++ C ++ +
Sbjct: 210 SKDY-VNVGLVGYVSGWGRNANLNFTEH---LKYVMLPVADQEKCVQYYEGSTVPEKKTP 265
Query: 820 NVTLGM--------VCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAH 871
+G+ CAG + +D C GD+G + + W+ GI+S+ C
Sbjct: 266 KSPVGVQPILNEHTFCAGLSKYQEDTCYGDAGSAFAVHDKDD-DTWYAAGILSFDKSCRT 324
Query: 872 PHLPGVYAYVPKYVTWIQDIM 892
GVY V + WIQ +
Sbjct: 325 AEY-GVYVRVTSILDWIQTTI 344
>pdb|2HNT|F Chain F, Crystallographic Structure Of Human Gamma-Thrombin
pdb|1BHX|F Chain F, X-Ray Structure Of The Complex Of Human Alpha Thrombin
With The Inhibitor Sdz 229-357
pdb|1RIW|C Chain C, Thrombin In Complex With Natural Product Inhibitor
Oscillarin
Length = 105
Score = 74.7 bits (182), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 40/105 (38%), Positives = 61/105 (58%), Gaps = 7/105 (6%)
Query: 795 TAVNEVEVPIITRDICNKWLNNRELNVTLGMVCAGY-PEGGK--DACQGDSGGPLLCRSS 851
+ + V +PI+ R +C ++ + +T M CAGY P+ GK DAC+GDSGGP + +S
Sbjct: 4 SVLQVVNLPIVERPVCK---DSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSP 60
Query: 852 HNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTWIQDIMDKYS 896
N +W+ GIVSWG C G Y +V + WIQ ++D++
Sbjct: 61 FN-NRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFG 104
>pdb|2RG3|A Chain A, Covalent Complex Structure Of Elastase
Length = 218
Score = 74.7 bits (182), Expect = 2e-13, Method: Composition-based stats.
Identities = 71/248 (28%), Positives = 105/248 (42%), Gaps = 35/248 (14%)
Query: 649 IIGGFESNPGDWPFLAAL-LGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQ 707
I+GG + P WPF+ +L L G F C LI+ +V++AAHCV N+ +
Sbjct: 1 IVGGRRARPHAWPFMVSLQLRGGHF---CGATLIAPNFVMSAAHCVANVNVRAVRVVLGA 57
Query: 708 LGVTRRNSYAFFGTR--FKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLP 765
++RR TR F V+ +F + + NDI + QL N ++ LP
Sbjct: 58 HNLSRREP-----TRQVFAVQRIFENGYDPVNLL--NDIVILQLNGSATINANVQVAQLP 110
Query: 766 PPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGM 825
L G +C +GWG R + + E+ V ++T +C R NV
Sbjct: 111 AQGRRLGNGVQCLAMGWGLLGRNR--GIASVLQELNVTVVT-SLC------RRSNVC--T 159
Query: 826 VCAGYPEGGKDACQGDSGGPLLCRS-SHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKY 884
+ G G C GD G PL+C H + GG CA P +A V ++
Sbjct: 160 LVRGRQAG---VCFGDXGSPLVCNGLIHGIASFVRGG-------CASGLYPDAFAPVAQF 209
Query: 885 VTWIQDIM 892
V WI I+
Sbjct: 210 VNWIDSII 217
>pdb|1FON|A Chain A, Crystal Structure Of Bovine Procarboxypeptidase A-S6
Subunit Iii, A Highly Structured Truncated Zymogen E
pdb|1FON|B Chain B, Crystal Structure Of Bovine Procarboxypeptidase A-S6
Subunit Iii, A Highly Structured Truncated Zymogen E
Length = 240
Score = 73.9 bits (180), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 64/250 (25%), Positives = 104/250 (41%), Gaps = 23/250 (9%)
Query: 652 GFESNPGDWPFLAALLGGPEFVFY--CAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQLG 709
G ++ P W + +L + F+ C G LI+ WV+TA HC+ T Q+
Sbjct: 2 GEDAVPYSWSWQVSLQYEKDGAFHHTCGGSLIAPDWVVTAGHCISTSR-------TYQVV 54
Query: 710 VTRRNSYAFFGTR----FKVRGVFAHSQYNIG-AQHDNDIALFQLKQKVKFNDHLLPVCL 764
+ + G+ +F H +N NDIAL +L + + D + L
Sbjct: 55 LGEYDRSVLEGSEQVIPINAGDLFVHPLWNSNCVACGNDIALVKLSRSAQLGDKVQLANL 114
Query: 765 PPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLG 824
PP L C + GWG+ + + +P + + C++W + + V
Sbjct: 115 PPAGDILPNEAPCYISGWGRLYTG--GPLPDKLQQALLPTVDYEHCSQW-DWWGITVKKT 171
Query: 825 MVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSW--GIKCAHPHLPGVYAYVP 882
MVCAG + C GDSGGPL C ++ W V G+ S+ C P V+ V
Sbjct: 172 MVCAGGDT--RSGCNGDSGGPLNCPAADG--SWQVHGVTSFVSAFGCNTIKKPTVFTRVS 227
Query: 883 KYVTWIQDIM 892
++ WI + +
Sbjct: 228 AFIDWIDETI 237
>pdb|2PKS|C Chain C, Thrombin In Complex With Inhibitor
pdb|3PO1|C Chain C, Thrombin In Complex With Benzothiazole Guanidine
Length = 102
Score = 73.2 bits (178), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 40/103 (38%), Positives = 60/103 (58%), Gaps = 7/103 (6%)
Query: 795 TAVNEVEVPIITRDICNKWLNNRELNVTLGMVCAGY-PEGGK--DACQGDSGGPLLCRSS 851
+ + V +PI+ R +C ++ + +T M CAGY P+ GK DAC+GDSGGP + +S
Sbjct: 4 SVLQVVNLPIVERPVCK---DSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSP 60
Query: 852 HNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTWIQDIMDK 894
N +W+ GIVSWG C G Y +V + WIQ ++D+
Sbjct: 61 FN-NRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQ 102
>pdb|1BHX|B Chain B, X-Ray Structure Of The Complex Of Human Alpha Thrombin
With The Inhibitor Sdz 229-357
pdb|1RIW|B Chain B, Thrombin In Complex With Natural Product Inhibitor
Oscillarin
pdb|2PKS|B Chain B, Thrombin In Complex With Inhibitor
pdb|3PO1|B Chain B, Thrombin In Complex With Benzothiazole Guanidine
Length = 147
Score = 73.2 bits (178), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 49/150 (32%), Positives = 72/150 (48%), Gaps = 13/150 (8%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCV------GNLTGLNID 702
I+ G ++ G P+ L C LISD+WVLTAAHC+ N T ++
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL- 59
Query: 703 EWTVQLGVTRRNSYAFFGTRFK-VRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLP 761
V++G R Y + + ++ H +YN D DIAL +LK+ V F+D++ P
Sbjct: 60 --LVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP 117
Query: 762 VCLPPPNYE---LAPGTRCTVIGWGKREDT 788
VCLP L G + V GWG ++T
Sbjct: 118 VCLPDRETAASLLQAGYKGRVTGWGNLKET 147
>pdb|1FY3|A Chain A, [g175q]hbp, A Mutant Of Human Heparin Binding Protein
(cap37)
Length = 225
Score = 73.2 bits (178), Expect = 7e-13, Method: Composition-based stats.
Identities = 70/251 (27%), Positives = 105/251 (41%), Gaps = 39/251 (15%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG ++ P +PFLA++ + +C G LI ++V+TAA C N TV L
Sbjct: 1 IVGGRKARPRQFPFLASIQN--QGRHFCGGALIHARFVMTAASC---FQSQNPGVSTVVL 55
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGA----QHDNDIALFQLKQKVKFNDHLLPVCL 764
G +Y + R F+ S + Q+ ND+ L QL ++ + + L
Sbjct: 56 G-----AYDLRRRERQSRQTFSISSMSENGYDPQQNLNDLMLLQLDREANLTSSVTILPL 110
Query: 765 PPPNYELAPGTRCTVIGWG-KREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTL 823
P N + GTRC V GWG +R R+S + VN V + D C NN
Sbjct: 111 PLQNATVEAGTRCQVAGWGSQRSGGRLSRFPRFVN---VTVTPEDQCRP--NN------- 158
Query: 824 GMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGI-KCAHPHLPGVYAYVP 882
VC G C GD G PL+C G+ S+ + C P + V
Sbjct: 159 --VCTGVLTRRGGICNGDQGTPLVCEG-------LAHGVASFSLGPCGRG--PDFFTRVA 207
Query: 883 KYVTWIQDIMD 893
+ WI +++
Sbjct: 208 LFRDWIDGVLN 218
>pdb|1A7S|A Chain A, Atomic Resolution Structure Of Hbp
pdb|1AE5|A Chain A, Human Heparin Binding Protein
Length = 225
Score = 72.8 bits (177), Expect = 8e-13, Method: Composition-based stats.
Identities = 70/251 (27%), Positives = 105/251 (41%), Gaps = 39/251 (15%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG ++ P +PFLA++ + +C G LI ++V+TAA C N TV L
Sbjct: 1 IVGGRKARPRQFPFLASIQN--QGRHFCGGALIHARFVMTAASC---FQSQNPGVSTVVL 55
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGA----QHDNDIALFQLKQKVKFNDHLLPVCL 764
G +Y + R F+ S + Q+ ND+ L QL ++ + + L
Sbjct: 56 G-----AYDLRRRERQSRQTFSISSMSENGYDPQQNLNDLMLLQLDREANLTSSVTILPL 110
Query: 765 PPPNYELAPGTRCTVIGWG-KREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTL 823
P N + GTRC V GWG +R R+S + VN V + D C NN
Sbjct: 111 PLQNATVEAGTRCQVAGWGSQRSGGRLSRFPRFVN---VTVTPEDQCRP--NN------- 158
Query: 824 GMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGI-KCAHPHLPGVYAYVP 882
VC G C GD G PL+C G+ S+ + C P + V
Sbjct: 159 --VCTGVLTRRGGICNGDGGTPLVCEG-------LAHGVASFSLGPCGRG--PDFFTRVA 207
Query: 883 KYVTWIQDIMD 893
+ WI +++
Sbjct: 208 LFRDWIDGVLN 218
>pdb|2JET|B Chain B, Crystal Structure Of A Trypsin-Like Mutant (S189d, A226g)
Chymotrypsin
Length = 128
Score = 72.8 bits (177), Expect = 8e-13, Method: Composition-based stats.
Identities = 45/141 (31%), Positives = 68/141 (48%), Gaps = 24/141 (17%)
Query: 652 GFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNI--------DE 703
G ++ PG WP+ +L F F C G LIS+ WV+TAAHC + + + DE
Sbjct: 1 GEDAIPGSWPWQVSLQDKTGFHF-CGGSLISEDWVVTAAHCGVKTSDVVVAGEFDQGSDE 59
Query: 704 WTVQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVC 763
+Q+ K+ VF + ++N+ NDI L +L +F++ + VC
Sbjct: 60 ENIQV--------------LKIAQVFKNPKFNMFTVR-NDITLLKLATPAQFSETVSAVC 104
Query: 764 LPPPNYELAPGTRCTVIGWGK 784
LP + + PGT C GWGK
Sbjct: 105 LPNVDDDFPPGTVCATTGWGK 125
>pdb|1GVZ|A Chain A, Prostate Specific Antigen (Psa) From Stallion Seminal
Plasma
Length = 237
Score = 72.8 bits (177), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 68/259 (26%), Positives = 111/259 (42%), Gaps = 33/259 (12%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
IIGG+E P+ A+ F C GVL+ QWVLTAAHC+ D++ + L
Sbjct: 1 IIGGWECEKHSKPWQVAVYHQGHF--QCGGVLVHPQWVLTAAHCMS-------DDYQIWL 51
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQH----------DNDIALFQLKQKVKFNDH 758
G + +V F Q+++ +D+ L +L Q + D
Sbjct: 52 GRHNLSKDEDTAQFHQVSDSFLDPQFDLSLLKKKYLRPYDDISHDLMLLRLAQPARITDA 111
Query: 759 LLPVCLPPPNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRE 818
+ + LP +L G+ C GWG T + + VE+ + + + C + +
Sbjct: 112 VKILDLPTQEPKL--GSTCYTSGWGLIS-TFTNRGSGTLQCVELRLQSNEKCARAYPEK- 167
Query: 819 LNVTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGI-KCAHPHLPGV 877
+T ++CA + + C GDSGG L+C GI SWG +CA + V
Sbjct: 168 --MTEFVLCATHRDDSGSICLGDSGGALICDGVFQ-------GITSWGYSECADFNDNFV 218
Query: 878 YAYVPKYVTWIQDIMDKYS 896
+ V + WI++ ++K S
Sbjct: 219 FTKVMPHKKWIKETIEKNS 237
>pdb|1BBR|E Chain E, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1UCY|E Chain E, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1VIT|G Chain G, Thrombin:hirudin 51-65 Complex
pdb|1YCP|M Chain M, The Crystal Structure Of Fibrinogen-Aa Peptide 1-23 (F8y)
Bound To Bovine Thrombin Explains Why The Mutation Of
Phe-8 To Tyrosine Strongly Inhibits Normal Cleavage At
Arginine-16
Length = 109
Score = 72.0 bits (175), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 42/109 (38%), Positives = 64/109 (58%), Gaps = 8/109 (7%)
Query: 790 VSEYETAVNEV-EVPIITRDICNKWLNNRELNVTLGMVCAGYPEG-GK--DACQGDSGGP 845
V+E + +V +V +P++ R +C + + +T M CAGY G GK DAC+GDSGGP
Sbjct: 2 VAEVQPSVLQVVNLPLVERPVCKA---STRIRITDNMFCAGYKPGEGKRGDACEGDSGGP 58
Query: 846 LLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTWIQDIMDK 894
+ +S +N +W+ GIVSWG C G Y +V + WIQ ++D+
Sbjct: 59 FVMKSPYN-NRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDR 106
>pdb|1KDQ|A Chain A, Crystal Structure Analysis Of The Mutant S189d Rat
Chymotrypsin
Length = 131
Score = 72.0 bits (175), Expect = 1e-12, Method: Composition-based stats.
Identities = 45/144 (31%), Positives = 69/144 (47%), Gaps = 24/144 (16%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNI------- 701
I+ G ++ PG WP+ +L F F C G LIS+ WV+TAAHC + + +
Sbjct: 1 IVNGEDAIPGSWPWQVSLQDKTGFHF-CGGSLISEDWVVTAAHCGVKTSDVVVAGEFDQG 59
Query: 702 -DEWTVQLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLL 760
DE +Q+ K+ VF + ++N+ NDI L +L +F++ +
Sbjct: 60 SDEENIQV--------------LKIAQVFKNPKFNMFTVR-NDITLLKLATPAQFSETVS 104
Query: 761 PVCLPPPNYELAPGTRCTVIGWGK 784
V LP + + PGT C GWGK
Sbjct: 105 AVSLPNVDDDFPPGTVCATTGWGK 128
>pdb|1FY1|A Chain A, [r23s,F25e]hbp, A Mutant Of Human Heparin Binding Protein
(Cap37)
Length = 225
Score = 71.6 bits (174), Expect = 2e-12, Method: Composition-based stats.
Identities = 72/253 (28%), Positives = 105/253 (41%), Gaps = 43/253 (16%)
Query: 649 IIGGFESNPGDWPFLAALL--GGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTV 706
I+GG ++ P +PFLA++ G E C G LI ++V+TAA C N TV
Sbjct: 1 IVGGRKARPRQFPFLASIQNQGSHE----CGGALIHARFVMTAASC---FQSQNPGVSTV 53
Query: 707 QLGVTRRNSYAFFGTRFKVRGVFAHSQYNIGA----QHDNDIALFQLKQKVKFNDHLLPV 762
LG +Y + R F+ S + Q+ ND+ L QL ++ + +
Sbjct: 54 VLG-----AYDLRRRERQSRQTFSISSMSENGYDPQQNLNDLMLLQLDREANLTSSVTIL 108
Query: 763 CLPPPNYELAPGTRCTVIGWG-KREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNV 821
LP N + GTRC V GWG +R R+S + VN V + D C NN
Sbjct: 109 PLPLQNATVEAGTRCQVAGWGSQRSGGRLSRFPRFVN---VTVTPEDQCRP--NN----- 158
Query: 822 TLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGI-KCAHPHLPGVYAY 880
VC G C GD G PL+C G+ S+ + C P +
Sbjct: 159 ----VCTGVLTRRGGICNGDGGTPLVCEG-------LAHGVASFSLGPCGRG--PDFFTR 205
Query: 881 VPKYVTWIQDIMD 893
V + WI +++
Sbjct: 206 VALFRDWIDGVLN 218
>pdb|2I6Q|A Chain A, Complement Component C2a
pdb|2I6S|A Chain A, Complement Component C2a
Length = 517
Score = 68.9 bits (167), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 66/221 (29%), Positives = 95/221 (42%), Gaps = 40/221 (18%)
Query: 676 CAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQLGVTRRNSYAFFGTRFKVR--------G 727
C G LISDQWVLTAAHC + G + W V +G + + +G F +
Sbjct: 257 CRGALISDQWVLTAAHCFRD--GNDHSLWRVNVG----DPKSQWGKEFLIEKAVISPGFD 310
Query: 728 VFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLP---PPNYELA--PGTRCTVIGW 782
VFA I + +DIAL +L QKVK + H P+CLP N L G+ C
Sbjct: 311 VFAKKNQGILEFYGDDIALLKLAQKVKMSTHARPICLPCTMEANLALRRPQGSTCRDHEN 370
Query: 783 GKREDTRVSEYETAVNEVEVPIITRDICNKW----------------LNNRELNVTLGMV 826
V + A+N ++ I + + +W L + VT +
Sbjct: 371 ELLNKQSVPAHFVALNGSKLNINLK-MGVEWTSCAEVVSQEKTMFPNLTDVREVVTDQFL 429
Query: 827 CAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGI 867
C+G E + C+G+SGG + F F G+VSWG+
Sbjct: 430 CSGTQE-DESPCKGESGGAVFLERRFRF---FQVGLVSWGL 466
>pdb|2ODP|A Chain A, Complement Component C2a, The Catalytic Fragment Of C3-
And C5- Convertase Of Human Complement
pdb|2ODQ|A Chain A, Complement Component C2a, The Catalytic Fragment Of C3-
And C5- Convertase Of Human Complement
Length = 509
Score = 68.9 bits (167), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 66/221 (29%), Positives = 95/221 (42%), Gaps = 40/221 (18%)
Query: 676 CAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQLGVTRRNSYAFFGTRFKVR--------G 727
C G LISDQWVLTAAHC + G + W V +G + + +G F +
Sbjct: 249 CRGALISDQWVLTAAHCFRD--GNDHSLWRVNVG----DPKSQWGKEFLIEKAVISPGFD 302
Query: 728 VFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLP---PPNYELA--PGTRCTVIGW 782
VFA I + +DIAL +L QKVK + H P+CLP N L G+ C
Sbjct: 303 VFAKKNQGILEFYGDDIALLKLAQKVKMSTHARPICLPCTMEANLALRRPQGSTCRDHEN 362
Query: 783 GKREDTRVSEYETAVNEVEVPIITRDICNKW----------------LNNRELNVTLGMV 826
V + A+N ++ I + + +W L + VT +
Sbjct: 363 ELLNKQSVPAHFVALNGSKLNINLK-MGVEWTSCAEVVSQEKTMFPNLTDVREVVTDQFL 421
Query: 827 CAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGI 867
C+G E + C+G+SGG + F F G+VSWG+
Sbjct: 422 CSGTQE-DESPCKGESGGAVFLERRFRF---FQVGLVSWGL 458
>pdb|3M0C|C Chain C, The X-Ray Crystal Structure Of Pcsk9 In Complex With The
Ldl Receptor
Length = 791
Score = 68.2 bits (165), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 44/118 (37%), Positives = 58/118 (49%), Gaps = 16/118 (13%)
Query: 425 DDMKYPDVKCVGHKQV-----------QEEKIRAMNKICLEG-FQCD--VNRCIPLDWQC 470
++ + D KC+ +K V E + ++ C G F C VNRCIP W+C
Sbjct: 27 NEFQCQDGKCISYKWVCDGSAECQDGSDESQETCLSVTCKSGDFSCGGRVNRCIPQFWRC 86
Query: 471 DGHIDCQDQTDELNCEP--CKADEIHCGLNKCISDYHVCDGKVDCPWGQDERNCLQLS 526
DG +DC + +DE C P C DE C KCIS VCD DC G DE +C L+
Sbjct: 87 DGQVDCDNGSDEQGCPPKTCSQDEFRCHDGKCISRQFVCDSDRDCLDGSDEASCPVLT 144
Score = 55.1 bits (131), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 39/125 (31%), Positives = 53/125 (42%), Gaps = 32/125 (25%)
Query: 425 DDMKYPDVKCVGHKQVQEEKIRAMNKICLEG---------------FQCDVNRCIPLDWQ 469
D+ + D KC+ + V + ++ CL+G FQC+ + CIP W
Sbjct: 109 DEFRCHDGKCISRQFVCDS-----DRDCLDGSDEASCPVLTCGPASFQCNSSTCIPQLWA 163
Query: 470 CDGHIDCQDQTDEL------------NCEPCKADEIHCGLNKCISDYHVCDGKVDCPWGQ 517
CD DC+D +DE + PC A E HC +CI CDG DC
Sbjct: 164 CDNDPDCEDGSDEWPQRCRGLYVFQGDSSPCSAFEFHCLSGECIHSSWRCDGGPDCKDKS 223
Query: 518 DERNC 522
DE NC
Sbjct: 224 DEENC 228
Score = 53.9 bits (128), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 29/77 (37%), Positives = 38/77 (49%), Gaps = 2/77 (2%)
Query: 456 FQCDVNRCIPLDWQCDGHIDCQDQTDELNC--EPCKADEIHCGLNKCISDYHVCDGKVDC 513
F C CI W+CDG DC+D++DE NC C+ DE C CI CD + DC
Sbjct: 199 FHCLSGECIHSSWRCDGGPDCKDKSDEENCAVATCRPDEFQCSDGNCIHGSRQCDREYDC 258
Query: 514 PWGQDERNCLQLSGMMG 530
DE C+ ++ G
Sbjct: 259 KDMSDEVGCVNVTLCEG 275
Score = 36.6 bits (83), Expect = 0.072, Method: Compositional matrix adjust.
Identities = 34/110 (30%), Positives = 50/110 (45%), Gaps = 27/110 (24%)
Query: 418 ENCNLY---PDDMKYPDVKCV-GHKQVQEE--------KIRAMNKICLEG---FQCDVNR 462
ENC + PD+ + D C+ G +Q E ++ +N EG F+C
Sbjct: 226 ENCAVATCRPDEFQCSDGNCIHGSRQCDREYDCKDMSDEVGCVNVTLCEGPNKFKCHSGE 285
Query: 463 CIPLDWQCDGHIDCQDQTDELNCEPCKADEIHCGLNKCISD----YHVCD 508
CI LD C+ DC+D +D EP K CG N+C+ + HVC+
Sbjct: 286 CITLDKVCNMARDCRDWSD----EPIK----ECGTNECLDNNGGCSHVCN 327
Score = 36.2 bits (82), Expect = 0.091, Method: Compositional matrix adjust.
Identities = 20/50 (40%), Positives = 26/50 (52%), Gaps = 2/50 (4%)
Query: 488 CKADEIHCGLNKCISDYHVCDGKVDCPWGQDE--RNCLQLSGMMGDVAKG 535
C+ +E C KCIS VCDG +C G DE CL ++ GD + G
Sbjct: 24 CERNEFQCQDGKCISYKWVCDGSAECQDGSDESQETCLSVTCKSGDFSCG 73
>pdb|2JET|C Chain C, Crystal Structure Of A Trypsin-Like Mutant (S189d, A226g)
Chymotrypsin
Length = 99
Score = 67.0 bits (162), Expect = 4e-11, Method: Composition-based stats.
Identities = 35/97 (36%), Positives = 52/97 (53%), Gaps = 8/97 (8%)
Query: 797 VNEVEVPIITRDICNKWLNNRELNVTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQ 856
+ + +PI++ C K ++ +V M CAG G D+C GDSGGPL+C+
Sbjct: 9 LQQAALPIVSEADCKKSWGSKITDV---MTCAG--ASGVDSCMGDSGGPLVCQKDG---V 60
Query: 857 WFVGGIVSWGIKCAHPHLPGVYAYVPKYVTWIQDIMD 893
W + GIVSWG PGVY+ V + W+Q I++
Sbjct: 61 WTLAGIVSWGSGVCSTSTPGVYSRVTALMPWVQQILE 97
>pdb|1N7D|A Chain A, Extracellular Domain Of The Ldl Receptor
Length = 699
Score = 66.6 bits (161), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 44/118 (37%), Positives = 58/118 (49%), Gaps = 16/118 (13%)
Query: 425 DDMKYPDVKCVGHKQV-----------QEEKIRAMNKICLEG-FQCD--VNRCIPLDWQC 470
++ + D KC+ +K V E + ++ C G F C VNRCIP W+C
Sbjct: 9 NEFQCQDGKCISYKWVCDGSAECQDGSDESQETCLSVTCKSGDFSCGGRVNRCIPQFWRC 68
Query: 471 DGHIDCQDQTDELNCEP--CKADEIHCGLNKCISDYHVCDGKVDCPWGQDERNCLQLS 526
DG +DC + +DE C P C DE C KCIS VCD DC G DE +C L+
Sbjct: 69 DGQVDCDNGSDEQGCPPKTCSQDEFRCHDGKCISRQFVCDSDRDCLDGSDEASCPVLT 126
Score = 53.9 bits (128), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 39/125 (31%), Positives = 53/125 (42%), Gaps = 32/125 (25%)
Query: 425 DDMKYPDVKCVGHKQVQEEKIRAMNKICLEG---------------FQCDVNRCIPLDWQ 469
D+ + D KC+ + V + ++ CL+G FQC+ + CIP W
Sbjct: 91 DEFRCHDGKCISRQFVCDS-----DRDCLDGSDEASCPVLTCGPASFQCNSSTCIPQLWA 145
Query: 470 CDGHIDCQDQTDEL------------NCEPCKADEIHCGLNKCISDYHVCDGKVDCPWGQ 517
CD DC+D +DE + PC A E HC +CI CDG DC
Sbjct: 146 CDNDPDCEDGSDEWPQRCRGLYVFQGDSSPCSAFEFHCLSGECIHSSWRCDGGPDCKDKS 205
Query: 518 DERNC 522
DE NC
Sbjct: 206 DEENC 210
Score = 53.1 bits (126), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 29/77 (37%), Positives = 38/77 (49%), Gaps = 2/77 (2%)
Query: 456 FQCDVNRCIPLDWQCDGHIDCQDQTDELNC--EPCKADEIHCGLNKCISDYHVCDGKVDC 513
F C CI W+CDG DC+D++DE NC C+ DE C CI CD + DC
Sbjct: 181 FHCLSGECIHSSWRCDGGPDCKDKSDEENCAVATCRPDEFQCSDGNCIHGSRQCDREYDC 240
Query: 514 PWGQDERNCLQLSGMMG 530
DE C+ ++ G
Sbjct: 241 KDMSDEVGCVNVTLCEG 257
Score = 35.8 bits (81), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 20/50 (40%), Positives = 26/50 (52%), Gaps = 2/50 (4%)
Query: 488 CKADEIHCGLNKCISDYHVCDGKVDCPWGQDE--RNCLQLSGMMGDVAKG 535
C+ +E C KCIS VCDG +C G DE CL ++ GD + G
Sbjct: 6 CERNEFQCQDGKCISYKWVCDGSAECQDGSDESQETCLSVTCKSGDFSCG 55
Score = 35.4 bits (80), Expect = 0.16, Method: Compositional matrix adjust.
Identities = 34/110 (30%), Positives = 50/110 (45%), Gaps = 27/110 (24%)
Query: 418 ENCNLY---PDDMKYPDVKCV-GHKQVQEE--------KIRAMNKICLEG---FQCDVNR 462
ENC + PD+ + D C+ G +Q E ++ +N EG F+C
Sbjct: 208 ENCAVATCRPDEFQCSDGNCIHGSRQCDREYDCKDMSDEVGCVNVTLCEGPNKFKCHSGE 267
Query: 463 CIPLDWQCDGHIDCQDQTDELNCEPCKADEIHCGLNKCISD----YHVCD 508
CI LD C+ DC+D +D EP K CG N+C+ + HVC+
Sbjct: 268 CITLDKVCNMARDCRDWSD----EPIK----ECGTNECLDNNGGCSHVCN 309
>pdb|1DLE|A Chain A, Factor B Serine Protease Domain
pdb|1DLE|B Chain B, Factor B Serine Protease Domain
Length = 298
Score = 66.6 bits (161), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 63/228 (27%), Positives = 96/228 (42%), Gaps = 53/228 (23%)
Query: 676 CAGVLISDQWVLTAAHCVGNLTGLNIDE----WTVQLGVTRRNSYAFFGTRFKVRGVFAH 731
C G ++S+ +VLTAAHC +D+ V +G +R+ ++ V H
Sbjct: 45 CMGAVVSEYFVLTAAHC------FTVDDKEHSIKVSVGGEKRD--------LEIEVVLFH 90
Query: 732 SQYNIGAQ--------HDNDIALFQLKQKVKFNDHLLPVCLP-----PPNYELAPGTRCT 778
YNI + +D D+AL +LK K+K+ + P+CLP L P T C
Sbjct: 91 PNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPICLPCTEGTTRALRLPPTTTCQ 150
Query: 779 -----VIGWGKREDTRVSEYETAVNEVEVPIITRD---ICNK---------WLNNRELNV 821
++ + VSE E + EV I D C + + + V
Sbjct: 151 QQKEELLPAQDIKALFVSEEEKKLTRKEVYIKNGDKKGSCERDAQYAPGYDKVKDISEVV 210
Query: 822 TLGMVCAG--YPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGI 867
T +C G P + C+GDSGGPL+ F Q G++SWG+
Sbjct: 211 TPRFLCTGGVSPYADPNTCRGDSGGPLIVHKRSRFIQV---GVISWGV 255
>pdb|1MTN|C Chain C, Bovine Alpha-Chymotrypsin:bpti Crystallization
pdb|1MTN|G Chain G, Bovine Alpha-Chymotrypsin:bpti Crystallization
pdb|1AB9|C Chain C, Crystal Structure Of Bovine Gamma-Chymotrypsin
pdb|1CA0|C Chain C, Bovine Chymotrypsin Complexed To Appi
pdb|1CA0|H Chain H, Bovine Chymotrypsin Complexed To Appi
pdb|1CBW|C Chain C, Bovine Chymotrypsin Complexed To Bpti
pdb|1CBW|H Chain H, Bovine Chymotrypsin Complexed To Bpti
pdb|1VGC|C Chain C, Gamma-Chymotrypsin L-Para-Chloro-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|2VGC|C Chain C, Gamma-Chymotrypsin D-Para-Chloro-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|3VGC|C Chain C, Gamma-Chymotrypsin L-Naphthyl-1-Acetamido Boronic Acid
Acid Inhibitor Complex
pdb|4VGC|C Chain C, Gamma-Chymotrypsin D-Naphthyl-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|1HJA|C Chain C, Lys 18 Variant Of Turkey Ovomucoid Inhibitor Third Domain
Complexed With Alpha-Chymotrypsin
pdb|1GG6|C Chain C, Crystal Stucture Of Gamma Chymotrypsin With N-Acetyl-
Phenylalanine Trifluoromethyl Ketone Bound At The Active
Site
pdb|1GGD|C Chain C, Crystal Stucture Of Gamma Chymotrypsin With
N-Acetyl-Leucil- Phenylalanine Aldehyde Bound At The
Active Site
pdb|1N8O|C Chain C, Crystal Structure Of A Complex Between Bovine Chymotrypsin
And Ecotin
pdb|1YPH|E Chain E, High Resolution Structure Of Bovine Alpha-Chymotrypsin
pdb|1YPH|F Chain F, High Resolution Structure Of Bovine Alpha-Chymotrypsin
pdb|2P8O|C Chain C, Crystal Structure Of A Benzohydroxamic AcidVANADATE
Complex Bound To Chymotrypsin A
pdb|1GMH|G Chain G, Refined Crystal Structure Of "aged" And "non-Aged"
Organophosphoryl Conjugates Of Gamma-Chymotrypsin
pdb|2CHA|C Chain C, The Structure Of Crystalline Alpha-Chymotrypsin, v.The
Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2
Angstroms Resolution
pdb|2CHA|G Chain G, The Structure Of Crystalline Alpha-Chymotrypsin, v.The
Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2
Angstroms Resolution
pdb|2GCH|G Chain G, Refined Crystal Structure Of Gamma-chymotrypsin At 1.9
Angstroms Resolution
pdb|4GCH|G Chain G, Structure And Activity Of Two Photoreversible Cinnamates
Bound To Chymotrypsin
pdb|5GCH|G Chain G, Chemistry Of Caged Enzymes II. Photoactivation Of
Inhibited Chymotrypsin
pdb|6GCH|G Chain G, Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor
Complexes. Comparison Of Slowly And Rapidly
Equilibrating Inhibitors
pdb|7GCH|G Chain G, Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor
Complexes. Comparison Of Slowly And Rapidly
Equilibrating Inhibitors
pdb|1CHO|G Chain G, Crystal And Molecular Structures Of The Complex Of Alpha-
Chymotrypsin With Its Inhibitor Turkey Ovomucoid Third
Domain At 1.8 Angstroms Resolution
pdb|1GHA|G Chain G, A Second Active Site In Chymotrypsin? The X-Ray Crystal
Structure Of N-Acetyl-D-Tryptophan Bound To
Gamma-Chymotrypsin
pdb|1GMC|G Chain G, The X-Ray Crystal Structure Of The Tetrahedral
Intermediate Of Gamma- Chymotrypsin In Hexane
pdb|1GMD|G Chain G, X-Ray Crystal Structure Of Gamma-Chymotrypsin In Hexane
pdb|3GCT|G Chain G, Structure Of Gamma-Chymotrypsin In The Range pH 2.0 To pH
10.5 Suggests That Gamma-Chymotrypsin Is A Covalent
Acyl-Enzyme Adduct At Low pH
pdb|4CHA|C Chain C, Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms
Resolution
pdb|4CHA|G Chain G, Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms
Resolution
pdb|5CHA|C Chain C, The Refinement And The Structure Of The Dimer Of Alpha-
Chymotrypsin At 1.67-Angstroms Resolution
pdb|5CHA|G Chain G, The Refinement And The Structure Of The Dimer Of Alpha-
Chymotrypsin At 1.67-Angstroms Resolution
pdb|6CHA|C Chain C, Structure Of A Tetrahedral Transition State Complex Of
Alpha-Chymotrypsin At 1.8-Angstroms Resolution
pdb|6CHA|G Chain G, Structure Of A Tetrahedral Transition State Complex Of
Alpha-Chymotrypsin At 1.8-Angstroms Resolution
pdb|8GCH|G Chain G, Gamma-Chymotrypsin Is A Complex Of Alpha-Chymotrypsin With
Its Own Autolysis Products
pdb|3BG4|C Chain C, The Crystal Structure Of Guamerin In Complex With
Chymotrypsin And The Development Of An Elastase-Specific
Inhibitor
pdb|1GCT|C Chain C, Is Gamma-Chymotrypsin A Tetrapeptide Acyl-Enzyme Adduct Of
Gamma- Chymotrypsin?
pdb|2GCT|C Chain C, Structure Of Gamma-Chymotrypsin In The Range Ph 2.0 To Ph
10.5 Suggests That Gamma-Chymotrypsin Is A Covalent
Acyl-Enzyme Adduct At Low Ph
pdb|1GHB|G Chain G, A Second Active Site In Chymotrypsin? The X-Ray Crystal
Structure Of N-Acetyl-D-Tryptophan Bound To
Gamma-Chymotrypsin
pdb|2GMT|C Chain C, Three-Dimensional Structure Of Chymotrypsin Inactivated
With (2s) N- Acetyl-L-Alanyl-L-Phenylalanyl-Chloroethyl
Ketone: Implications For The Mechanism Of Inactivation
Of Serine Proteases By Chloroketones
pdb|3GCH|C Chain C, Chemistry Of Caged Enzymes. Binding Of Photoreversible
Cinnamates To Chymotrypsin
Length = 97
Score = 65.9 bits (159), Expect = 9e-11, Method: Composition-based stats.
Identities = 33/96 (34%), Positives = 50/96 (52%), Gaps = 8/96 (8%)
Query: 797 VNEVEVPIITRDICNKWLNNRELNVTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQ 856
+ + +P+++ C K+ + + M+CAG G +C GDSGGPL+C+ +
Sbjct: 7 LQQASLPLLSNTNCKKYWGTK---IKDAMICAG--ASGVSSCMGDSGGPLVCKKNG---A 58
Query: 857 WFVGGIVSWGIKCAHPHLPGVYAYVPKYVTWIQDIM 892
W + GIVSWG PGVYA V V W+Q +
Sbjct: 59 WTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL 94
>pdb|1AFQ|C Chain C, Crystal Structure Of Bovine Gamma-Chymotrypsin Complexed
With A Synthetic Inhibitor
pdb|3RU4|E Chain E, Crystal Structure Of The Bowman-Birk Serine Protease
Inhibitor Btci In Complex With Trypsin And Chymotrypsin
Length = 96
Score = 65.9 bits (159), Expect = 9e-11, Method: Composition-based stats.
Identities = 33/96 (34%), Positives = 50/96 (52%), Gaps = 8/96 (8%)
Query: 797 VNEVEVPIITRDICNKWLNNRELNVTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQ 856
+ + +P+++ C K+ + + M+CAG G +C GDSGGPL+C+ +
Sbjct: 6 LQQASLPLLSNTNCKKYWGTK---IKDAMICAG--ASGVSSCMGDSGGPLVCKKNG---A 57
Query: 857 WFVGGIVSWGIKCAHPHLPGVYAYVPKYVTWIQDIM 892
W + GIVSWG PGVYA V V W+Q +
Sbjct: 58 WTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL 93
>pdb|1RRK|A Chain A, Crystal Structure Analysis Of The Bb Segment Of Factor B
pdb|1RS0|A Chain A, Crystal Structure Analysis Of The Bb Segment Of Factor B
Complexed With Di-Isopropyl-Phosphate (Dip)
pdb|1RTK|A Chain A, Crystal Structure Analysis Of The Bb Segment Of Factor B
Complexed With 4-Guanidinobenzoic Acid
Length = 497
Score = 65.5 bits (158), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 63/228 (27%), Positives = 96/228 (42%), Gaps = 53/228 (23%)
Query: 676 CAGVLISDQWVLTAAHCVGNLTGLNIDE----WTVQLGVTRRNSYAFFGTRFKVRGVFAH 731
C G ++S+ +VLTAAHC +D+ V +G +R+ ++ V H
Sbjct: 244 CMGAVVSEYFVLTAAHC------FTVDDKEHSIKVSVGGEKRD--------LEIEVVLFH 289
Query: 732 SQYNIGAQ--------HDNDIALFQLKQKVKFNDHLLPVCLP-----PPNYELAPGTRCT 778
YNI + +D D+AL +LK K+K+ + P+CLP L P T C
Sbjct: 290 PNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPICLPCTEGTTRALRLPPTTTCQ 349
Query: 779 -----VIGWGKREDTRVSEYETAVNEVEVPIITRD---ICNK---------WLNNRELNV 821
++ + VSE E + EV I D C + + + V
Sbjct: 350 QQKEELLPAQDIKALFVSEEEKKLTRKEVYIKNGDKKGSCERDAQYAPGYDKVKDISEVV 409
Query: 822 TLGMVCAG--YPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGI 867
T +C G P + C+GDSGGPL+ F Q G++SWG+
Sbjct: 410 TPRFLCTGGVSPYADPNTCRGDSGGPLIVHKRSRFIQ---VGVISWGV 454
>pdb|2WIN|I Chain I, C3 Convertase (C3bbb) Stabilized By Scin
pdb|2WIN|J Chain J, C3 Convertase (C3bbb) Stabilized By Scin
pdb|2WIN|K Chain K, C3 Convertase (C3bbb) Stabilized By Scin
pdb|2WIN|L Chain L, C3 Convertase (C3bbb) Stabilized By Scin
Length = 507
Score = 65.5 bits (158), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 63/228 (27%), Positives = 96/228 (42%), Gaps = 53/228 (23%)
Query: 676 CAGVLISDQWVLTAAHCVGNLTGLNIDE----WTVQLGVTRRNSYAFFGTRFKVRGVFAH 731
C G ++S+ +VLTAAHC +D+ V +G +R+ ++ V H
Sbjct: 252 CMGAVVSEYFVLTAAHC------FTVDDKEHSIKVSVGGEKRD--------LEIEVVLFH 297
Query: 732 SQYNIGAQ--------HDNDIALFQLKQKVKFNDHLLPVCLP-----PPNYELAPGTRCT 778
YNI + +D D+AL +LK K+K+ + P+CLP L P T C
Sbjct: 298 PNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPICLPCTEGTTRALRLPPTTTCQ 357
Query: 779 -----VIGWGKREDTRVSEYETAVNEVEVPIITRD---ICNK---------WLNNRELNV 821
++ + VSE E + EV I D C + + + V
Sbjct: 358 QQKEELLPAQDIKALFVSEEEKKLTRKEVYIKNGDKKGSCERDAQYAPGYDKVKDISEVV 417
Query: 822 TLGMVCAG--YPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGI 867
T +C G P + C+GDSGGPL+ F Q G++SWG+
Sbjct: 418 TPRFLCTGGVSPYADPNTCRGDSGGPLIVHKRSRFIQ---VGVISWGV 462
>pdb|2XWB|F Chain F, Crystal Structure Of Complement C3b In Complex With
Factors B And D
pdb|2XWB|H Chain H, Crystal Structure Of Complement C3b In Complex With
Factors B And D
Length = 732
Score = 65.1 bits (157), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 63/228 (27%), Positives = 96/228 (42%), Gaps = 53/228 (23%)
Query: 676 CAGVLISDQWVLTAAHCVGNLTGLNIDE----WTVQLGVTRRNSYAFFGTRFKVRGVFAH 731
C G ++S+ +VLTAAHC +D+ V +G +R+ ++ V H
Sbjct: 477 CMGAVVSEYFVLTAAHC------FTVDDKEHSIKVSVGGEKRD--------LEIEVVLFH 522
Query: 732 SQYNIGAQ--------HDNDIALFQLKQKVKFNDHLLPVCLP-----PPNYELAPGTRCT 778
YNI + +D D+AL +LK K+K+ + P+CLP L P T C
Sbjct: 523 PNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPICLPCTEGTTRALRLPPTTTCQ 582
Query: 779 -----VIGWGKREDTRVSEYETAVNEVEVPIITRD---ICNK---------WLNNRELNV 821
++ + VSE E + EV I D C + + + V
Sbjct: 583 QQKEELLPAQDIKALFVSEEEKKLTRKEVYIKNGDKKGSCERDAQYAPGYDKVKDISEVV 642
Query: 822 TLGMVCAG--YPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGI 867
T +C G P + C+GDSGGPL+ F Q G++SWG+
Sbjct: 643 TPRFLCTGGVSPYADPNTCRGDSGGPLIVHKRSRFIQV---GVISWGV 687
>pdb|3HRZ|D Chain D, Cobra Venom Factor (Cvf) In Complex With Human Factor B
pdb|3HS0|D Chain D, Cobra Venom Factor (Cvf) In Complex With Human Factor B
pdb|3HS0|I Chain I, Cobra Venom Factor (Cvf) In Complex With Human Factor B
pdb|2XWJ|I Chain I, Crystal Structure Of Complement C3b In Complex With Factor
B
pdb|2XWJ|J Chain J, Crystal Structure Of Complement C3b In Complex With Factor
B
pdb|2XWJ|K Chain K, Crystal Structure Of Complement C3b In Complex With Factor
B
pdb|2XWJ|L Chain L, Crystal Structure Of Complement C3b In Complex With Factor
B
Length = 741
Score = 65.1 bits (157), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 63/228 (27%), Positives = 96/228 (42%), Gaps = 53/228 (23%)
Query: 676 CAGVLISDQWVLTAAHCVGNLTGLNIDE----WTVQLGVTRRNSYAFFGTRFKVRGVFAH 731
C G ++S+ +VLTAAHC +D+ V +G +R+ ++ V H
Sbjct: 486 CMGAVVSEYFVLTAAHC------FTVDDKEHSIKVSVGGEKRD--------LEIEVVLFH 531
Query: 732 SQYNIGAQ--------HDNDIALFQLKQKVKFNDHLLPVCLP-----PPNYELAPGTRCT 778
YNI + +D D+AL +LK K+K+ + P+CLP L P T C
Sbjct: 532 PNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPICLPCTEGTTRALRLPPTTTCQ 591
Query: 779 -----VIGWGKREDTRVSEYETAVNEVEVPIITRD---ICNK---------WLNNRELNV 821
++ + VSE E + EV I D C + + + V
Sbjct: 592 QQKEELLPAQDIKALFVSEEEKKLTRKEVYIKNGDKKGSCERDAQYAPGYDKVKDISEVV 651
Query: 822 TLGMVCAG--YPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGI 867
T +C G P + C+GDSGGPL+ F Q G++SWG+
Sbjct: 652 TPRFLCTGGVSPYADPNTCRGDSGGPLIVHKRSRFIQV---GVISWGV 696
>pdb|2OK5|A Chain A, Human Complement Factor B
Length = 752
Score = 65.1 bits (157), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 63/228 (27%), Positives = 96/228 (42%), Gaps = 53/228 (23%)
Query: 676 CAGVLISDQWVLTAAHCVGNLTGLNIDE----WTVQLGVTRRNSYAFFGTRFKVRGVFAH 731
C G ++S+ +VLTAAHC +D+ V +G +R+ ++ V H
Sbjct: 496 CMGAVVSEYFVLTAAHC------FTVDDKEHSIKVSVGGEKRD--------LEIEVVLFH 541
Query: 732 SQYNIGAQ--------HDNDIALFQLKQKVKFNDHLLPVCLP-----PPNYELAPGTRCT 778
YNI + +D D+AL +LK K+K+ + P+CLP L P T C
Sbjct: 542 PNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPICLPCTEGTTRALRLPPTTTCQ 601
Query: 779 -----VIGWGKREDTRVSEYETAVNEVEVPIITRD---ICNK---------WLNNRELNV 821
++ + VSE E + EV I D C + + + V
Sbjct: 602 QQKEELLPAQDIKALFVSEEEKKLTRKEVYIKNGDKKGSCERDAQYAPGYDKVKDISEVV 661
Query: 822 TLGMVCAG--YPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGI 867
T +C G P + C+GDSGGPL+ F Q G++SWG+
Sbjct: 662 TPRFLCTGGVSPYADPNTCRGDSGGPLIVHKRSRFIQV---GVISWGV 706
>pdb|1KDQ|B Chain B, Crystal Structure Analysis Of The Mutant S189d Rat
Chymotrypsin
Length = 99
Score = 64.7 bits (156), Expect = 2e-10, Method: Composition-based stats.
Identities = 34/97 (35%), Positives = 51/97 (52%), Gaps = 8/97 (8%)
Query: 797 VNEVEVPIITRDICNKWLNNRELNVTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQ 856
+ + +PI++ C K ++ +V M CAG G D+C GDSGGPL+C+
Sbjct: 9 LQQAALPIVSEADCKKSWGSKITDV---MTCAG--ASGVDSCMGDSGGPLVCQKDG---V 60
Query: 857 WFVGGIVSWGIKCAHPHLPGVYAYVPKYVTWIQDIMD 893
W + GIVSWG P VY+ V + W+Q I++
Sbjct: 61 WTLAGIVSWGSGVCSTSTPAVYSRVTALMPWVQQILE 97
>pdb|1HYL|A Chain A, The 1.8 A Structure Of Collagenase From Hypoderma Lineatum
pdb|1HYL|B Chain B, The 1.8 A Structure Of Collagenase From Hypoderma Lineatum
pdb|2HLC|A Chain A, Hl Collagenase Structure At 1.7a Resolution
pdb|2HLC|B Chain B, Hl Collagenase Structure At 1.7a Resolution
Length = 230
Score = 64.3 bits (155), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 70/258 (27%), Positives = 112/258 (43%), Gaps = 52/258 (20%)
Query: 649 IIGGFESNPGDWPFLAAL---LGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWT 705
II G+E+ G +P+ A L L V +C G LI ++W+LTAAHCV + + +
Sbjct: 1 IINGYEAYTGLFPYQAGLDITLQDQRRV-WCGGSLIDNKWILTAAHCVHDAVSVVV---- 55
Query: 706 VQLGVTRRNSYAFFGTRFKVRG--------VFAHSQYNIGAQHDNDIALFQLKQKVKFND 757
+ G+ + G + +HS +N + ND+AL ++ V++ D
Sbjct: 56 ------------YLGSAVQYEGEAVVNSERIISHSMFNPDT-YLNDVALIKIPH-VEYTD 101
Query: 758 HLLPVCLPPPNYELA---PGTRCTVIGWGKRE-DTRVSEYETAVNEVEVPIITRDICNKW 813
++ P+ LP EL TV GWG+ DT + +Y + +I D C +
Sbjct: 102 NIQPIRLPSGE-ELNNKFENIWATVSGWGQSNTDTVILQYTYNL------VIDNDRCAQ- 153
Query: 814 LNNRELNVTLGMVCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSW--GIKCAH 871
+ + G GK C GDSGGP + + + G+VS+ G C
Sbjct: 154 --EYPPGIIVESTICGDTSDGKSPCFGDSGGPFVLSDKN-----LLIGVVSFVSGAGCES 206
Query: 872 PHLPGVYAYVPKYVTWIQ 889
P ++ V Y+ WIQ
Sbjct: 207 GK-PVGFSRVTSYMDWIQ 223
>pdb|1AKS|A Chain A, Crystal Structure Of The First Active Autolysate Form Of
The Porcine Alpha Trypsin
pdb|1UHB|A Chain A, Crystal Structure Of Porcine Alpha Trypsin Bound With Auto
Catalyticaly Produced Native Peptide At 2.15 A
Resolution
Length = 125
Score = 59.7 bits (143), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 41/138 (29%), Positives = 59/138 (42%), Gaps = 13/138 (9%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
I+GG+ P+ +L G F C G LI+ QWV++AAHC + + + E +
Sbjct: 1 IVGGYTCAANSIPYQVSLNSGSHF---CGGSLINSQWVVSAAHCYKSRIQVRLGEHNID- 56
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPN 768
V N + + H +N G DNDI L +L N + V LP
Sbjct: 57 -VLEGNEQFINAAK-----IITHPNFN-GNTLDNDIMLIKLSSPATLNSRVATVSLPRS- 108
Query: 769 YELAPGTRCTVIGWGKRE 786
A GT C + GWG +
Sbjct: 109 -CAAAGTECLISGWGNTK 125
>pdb|3H7T|A Chain A, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-D1 (Smipp-S-D1)
pdb|3H7T|B Chain B, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-D1 (Smipp-S-D1)
Length = 235
Score = 56.6 bits (135), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 59/247 (23%), Positives = 106/247 (42%), Gaps = 22/247 (8%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
IIGG +S+ P+ +L + +C G +++ +V+TAA CV G + ++
Sbjct: 1 IIGGKKSDITKEPWAVGVLVDEKP--FCGGSILTANFVITAAQCV---DGTKPSDISIHY 55
Query: 709 GVTRRNSYAFFGTRFKVRGVFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLL-PVCLPPP 767
G + R + GT + ++ + + Q N+ A+ + + +K +D + LP
Sbjct: 56 GSSYRTTK---GTSVMAKKIYIVRYHPLTMQ--NNYAVIETEMPIKLDDKTTKKIELPSL 110
Query: 768 NYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTL--GM 825
Y+ P T V GWG + + EY + E ++ R C + E + + G+
Sbjct: 111 LYDPEPDTSVLVSGWGST-NFKSLEYSGDLMEANFTVVDRKSCEEQYKQIEADKYIYDGV 169
Query: 826 VCAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYV 885
CAG GD+G P + + + G+ S+ I P V+ V YV
Sbjct: 170 FCAGGEYDETYIGYGDAGDPAVQNGT-------LVGVASY-ISSMPSEFPSVFLRVGYYV 221
Query: 886 TWIQDIM 892
I+DI+
Sbjct: 222 LDIKDII 228
>pdb|1F5Y|A Chain A, Nmr Structure Of A Concatemer Of The First And Second
Ligand-Binding Modules Of The Human Ldl Receptor
Length = 85
Score = 55.1 bits (131), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 31/73 (42%), Positives = 41/73 (56%), Gaps = 6/73 (8%)
Query: 456 FQCDVNRCIPLDWQCDGHIDCQDQTDELN----CEPCKADEIHCG--LNKCISDYHVCDG 509
FQC +CI W CDG +CQD +DE CK+ + CG +N+CI + CDG
Sbjct: 13 FQCQDGKCISYKWVCDGSAECQDGSDESQETCLSVTCKSGDFSCGGRVNRCIPQFWRCDG 72
Query: 510 KVDCPWGQDERNC 522
+VDC G DE+ C
Sbjct: 73 QVDCDNGSDEQGC 85
Score = 38.9 bits (89), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 25/75 (33%), Positives = 37/75 (49%), Gaps = 14/75 (18%)
Query: 425 DDMKYPDVKCVGHKQV-----------QEEKIRAMNKICLEG-FQCD--VNRCIPLDWQC 470
++ + D KC+ +K V E + ++ C G F C VNRCIP W+C
Sbjct: 11 NEFQCQDGKCISYKWVCDGSAECQDGSDESQETCLSVTCKSGDFSCGGRVNRCIPQFWRC 70
Query: 471 DGHIDCQDQTDELNC 485
DG +DC + +DE C
Sbjct: 71 DGQVDCDNGSDEQGC 85
Score = 33.1 bits (74), Expect = 0.66, Method: Compositional matrix adjust.
Identities = 20/52 (38%), Positives = 27/52 (51%), Gaps = 2/52 (3%)
Query: 486 EPCKADEIHCGLNKCISDYHVCDGKVDCPWGQDE--RNCLQLSGMMGDVAKG 535
+ C+ +E C KCIS VCDG +C G DE CL ++ GD + G
Sbjct: 6 DRCERNEFQCQDGKCISYKWVCDGSAECQDGSDESQETCLSVTCKSGDFSCG 57
>pdb|1IJY|A Chain A, Crystal Structure Of The Cysteine-Rich Domain Of Mouse
Frizzled 8 (Mfz8)
pdb|1IJY|B Chain B, Crystal Structure Of The Cysteine-Rich Domain Of Mouse
Frizzled 8 (Mfz8)
Length = 130
Score = 53.5 bits (127), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 32/130 (24%), Positives = 56/130 (43%), Gaps = 2/130 (1%)
Query: 312 GNPSKGKCVLLEVKFCLDHKVPYNYTLFPNYLGDFSQSDAQTDLEAYEAIIDVRCYELAS 371
G+ S + E+ L + Y YT PN +Q +A ++ + +++++C
Sbjct: 1 GSASAKELACQEITVPLCKGIGYEYTYMPNQFNHDTQDEAGLEVHQFWPLVEIQCSPDLK 60
Query: 372 LFLCAAMVPPC-SSQGFFLRPCRSLCQETKRRCGFFFDVFGLPLPSMENCNLYPDDMKYP 430
FLC+ P C L PCRS+C+ K C +G P C+ P+ P
Sbjct: 61 FFLCSMYTPICLEDYKKPLPPCRSVCERAKAGCAPLMRQYGFAWPDRMRCDRLPEQGN-P 119
Query: 431 DVKCVGHKQV 440
D C+ +++
Sbjct: 120 DTLCMDYERT 129
>pdb|3F1S|B Chain B, Crystal Structure Of Protein Z Complexed With Protein
Z-Dependent Inhibitor
Length = 283
Score = 52.8 bits (125), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 55/222 (24%), Positives = 95/222 (42%), Gaps = 26/222 (11%)
Query: 675 YCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQLGVTRRNSYAFFGTRFKVRGVFAHSQY 734
+C GV+I + +VLT A C +L NI TV+ R + K+ V H +Y
Sbjct: 78 FCGGVIIRENFVLTTAKC--SLLHRNI---TVKTYFNRTSQDPLM---IKITHVHVHMRY 129
Query: 735 NIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPNYE---LAPGTRCTVIGWGKREDTRVS 791
+ A +ND++L +L+ ++ LPVC P ++ L P TR + GW + +
Sbjct: 130 DADAG-ENDLSLLELEWPIQCPGAGLPVCTPEKDFAEHLLIPRTRGLLSGWARNG----T 184
Query: 792 EYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVCAGYPEGGKDACQGDSGGPLLCRSS 851
+ ++ V ++ + C + LN + VT C E A G ++ R
Sbjct: 185 DLGNSLTTRPVTLVEGEECGQVLN---VTVTTRTYC----ERSSVAAMHWMDGSVVTREH 237
Query: 852 HNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTWIQDIMD 893
WF+ G++ H+ + V +Y W + IM+
Sbjct: 238 RG--SWFLTGVLGSQPVGGQAHMV-LVTKVSRYSLWFKQIMN 276
>pdb|3H5C|B Chain B, X-Ray Structure Of Protein Z-Protein Z Inhibitor Complex
Length = 317
Score = 52.4 bits (124), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 55/222 (24%), Positives = 95/222 (42%), Gaps = 26/222 (11%)
Query: 675 YCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQLGVTRRNSYAFFGTRFKVRGVFAHSQY 734
+C GV+I + +VLT A C +L NI TV+ R + K+ V H +Y
Sbjct: 119 FCGGVIIRENFVLTTAKC--SLLHRNI---TVKTYFNRTSQDPLM---IKITHVHVHMRY 170
Query: 735 NIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPNYE---LAPGTRCTVIGWGKREDTRVS 791
+ A +ND++L +L+ ++ LPVC P ++ L P TR + GW + +
Sbjct: 171 DADAG-ENDLSLLELEWPIQCPGAGLPVCTPEKDFAEHLLIPRTRGLLSGWARNG----T 225
Query: 792 EYETAVNEVEVPIITRDICNKWLNNRELNVTLGMVCAGYPEGGKDACQGDSGGPLLCRSS 851
+ ++ V ++ + C + LN + VT C E A G ++ R
Sbjct: 226 DLGNSLTTRPVTLVEGEECGQVLN---VTVTTRTYC----ERSSVAAMHWMDGSVVTREH 278
Query: 852 HNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVTWIQDIMD 893
WF+ G++ H+ + V +Y W + IM+
Sbjct: 279 RG--SWFLTGVLGSQPVGGQAHMV-LVTKVSRYSLWFKQIMN 317
>pdb|4F0A|A Chain A, Crystal Structure Of Xwnt8 In Complex With The
Cysteine-Rich Domain Of Frizzled 8
Length = 132
Score = 52.0 bits (123), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 31/120 (25%), Positives = 52/120 (43%), Gaps = 2/120 (1%)
Query: 323 EVKFCLDHKVPYNYTLFPNYLGDFSQSDAQTDLEAYEAIIDVRCYELASLFLCAAMVPPC 382
E+ L + YNYT PN +Q +A ++ + +++++C FLC+ P C
Sbjct: 10 EITVPLCKGIGYNYTYMPNQFNHDTQDEAGLEVHQFWPLVEIQCSPDLKFFLCSMYTPIC 69
Query: 383 -SSQGFFLRPCRSLCQETKRRCGFFFDVFGLPLPSMENCNLYPDDMKYPDVKCVGHKQVQ 441
L PCRS+C+ K C +G P C+ P+ PD C+ ++
Sbjct: 70 LEDYKKPLPPCRSVCERAKAGCAPLMRQYGFAWPDRMRCDRLPEQGN-PDTLCMDAAALE 128
>pdb|2LGP|A Chain A, Solution Structure Of La45 From Ldlr
Length = 94
Score = 52.0 bits (123), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 31/79 (39%), Positives = 37/79 (46%), Gaps = 12/79 (15%)
Query: 456 FQCDVNRCIPLDWQCDGHIDCQDQTDEL------------NCEPCKADEIHCGLNKCISD 503
FQC+ + CIP W CD DC+D +DE + PC A E HC +CI
Sbjct: 12 FQCNSSTCIPQLWACDNDPDCEDGSDEWPQRCRGLYVFQGDSSPCSAFEFHCLSGECIHS 71
Query: 504 YHVCDGKVDCPWGQDERNC 522
CDG DC DE NC
Sbjct: 72 SWRCDGGPDCKDKSDEENC 90
>pdb|2HNT|E Chain E, Crystallographic Structure Of Human Gamma-Thrombin
Length = 81
Score = 50.4 bits (119), Expect = 5e-06, Method: Composition-based stats.
Identities = 25/64 (39%), Positives = 36/64 (56%), Gaps = 3/64 (4%)
Query: 728 VFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPNYE---LAPGTRCTVIGWGK 784
++ H +YN D DIAL +LK+ V F+D++ PVCLP L G + V GWG
Sbjct: 11 IYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGN 70
Query: 785 REDT 788
++T
Sbjct: 71 LKET 74
>pdb|3H7O|A Chain A, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-I1 (Smipp-S-I1)
pdb|3H7O|B Chain B, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-I1 (Smipp-S-I1)
Length = 228
Score = 49.3 bits (116), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 59/248 (23%), Positives = 106/248 (42%), Gaps = 26/248 (10%)
Query: 651 GGFESNPGDWPFLAALLGGP-EFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQLG 709
GG +++ P+ A+ P E C G ++S +VLTAAHCV + I
Sbjct: 2 GGEKTDIKQVPWTVAVRTYPGEESLTCGGAILSQWFVLTAAHCVFDQKPETI-------- 53
Query: 710 VTRRNSYAFFGTRFKVRGVFAHSQYNIGAQH--DNDIALFQLKQKVKFND-HLLPVCLPP 766
V + S + K +H + Q +NDIA+ +L + +K + P LP
Sbjct: 54 VIQYESTNLWEDPGKSDPYVSHVYLSFYRQETMENDIAILELSRPLKLDGLKSKPAKLPD 113
Query: 767 PNYELAPGTRCTVIGWGKREDTRVSEYETAVNEVEVPIITRDICNKWLNNRELNVTLGMV 826
+ G+ V G+G + +++ + ++ ++ D C + ++L +
Sbjct: 114 IEFRPKTGSDVLVSGYGDGQTMDPKDHD--LKSAQLTVVDLDECRT--KYGPIFLSLQVF 169
Query: 827 CAGYPEGGKDACQGDSGGPLLCRSSHNFEQWFVGGIVSWGIKCAHPHLPGVYAYVPKYVT 886
CA + G GD+G P + + + + G+ ++ K P V+ V YV+
Sbjct: 170 CA--QKVGVSLESGDAGDPTVQQDT-------LVGVAAYFPKRPE-GAPEVFTKVGSYVS 219
Query: 887 WIQDIMDK 894
WIQDI+ K
Sbjct: 220 WIQDIIKK 227
>pdb|1IJX|A Chain A, Crystal Structure Of The Cysteine-Rich Domain Of Secreted
Frizzled- Related Protein 3 (Sfrp-3;fzb)
pdb|1IJX|B Chain B, Crystal Structure Of The Cysteine-Rich Domain Of Secreted
Frizzled- Related Protein 3 (Sfrp-3;fzb)
pdb|1IJX|C Chain C, Crystal Structure Of The Cysteine-Rich Domain Of Secreted
Frizzled- Related Protein 3 (Sfrp-3;fzb)
pdb|1IJX|D Chain D, Crystal Structure Of The Cysteine-Rich Domain Of Secreted
Frizzled- Related Protein 3 (Sfrp-3;fzb)
pdb|1IJX|E Chain E, Crystal Structure Of The Cysteine-Rich Domain Of Secreted
Frizzled- Related Protein 3 (Sfrp-3;fzb)
pdb|1IJX|F Chain F, Crystal Structure Of The Cysteine-Rich Domain Of Secreted
Frizzled- Related Protein 3 (Sfrp-3;fzb)
Length = 127
Score = 47.4 bits (111), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 24/82 (29%), Positives = 43/82 (52%), Gaps = 2/82 (2%)
Query: 324 VKFCLDHKVPYNYTLFPNYLGDFSQSDAQTDLEAYEAIIDVRCYELASLFLCAAMVPPCS 383
V+ L +P+ T PN+L +Q++A +E +E ++ C FLCA P C+
Sbjct: 8 VRIPLCKSLPWEMTKMPNHLHHSTQANAILAMEQFEGLLGTHCSPDLLFFLCAMYAPICT 67
Query: 384 S--QGFFLRPCRSLCQETKRRC 403
Q ++PC+S+C+ ++ C
Sbjct: 68 IDFQHEPIKPCKSVCERARQGC 89
>pdb|2GTL|O Chain O, Lumbricus Erythrocruorin At 3.5a Resolution
Length = 215
Score = 45.1 bits (105), Expect = 2e-04, Method: Composition-based stats.
Identities = 30/85 (35%), Positives = 41/85 (48%), Gaps = 8/85 (9%)
Query: 479 QTDELNCEPCKADEIHCGLN--KCISDYHVCDGKVDCPWGQDERNCLQLS----GMMGDV 532
+ +EL C E CG + +CIS VCDG DC G+DE++C + +GDV
Sbjct: 46 RVEELEDPSCDEHEHQCGGDDPQCISKLFVCDGHNDCRNGEDEKDCTLPTKAGDKFIGDV 105
Query: 533 AKGVLELYRPEHKT--FHTSCITKY 555
RPEH T F +S I +
Sbjct: 106 CFDHCTKRRPEHMTLAFESSSIAAF 130
Score = 31.6 bits (70), Expect = 2.0, Method: Composition-based stats.
Identities = 18/43 (41%), Positives = 24/43 (55%), Gaps = 3/43 (6%)
Query: 457 QC--DVNRCIPLDWQCDGHIDCQDQTDELNCE-PCKADEIHCG 496
QC D +CI + CDGH DC++ DE +C P KA + G
Sbjct: 61 QCGGDDPQCISKLFVCDGHNDCRNGEDEKDCTLPTKAGDKFIG 103
>pdb|2KAI|A Chain A, Refined 2.5 Angstroms X-Ray Crystal Structure Of The
Complex Formed By Porcine Kallikrein A And The Bovine
Pancreatic Trypsin Inhibitor. Crystallization, Patterson
Search, Structure Determination, Refinement, Structure
And Comparison With Its Components And With The Bovine
Trypsin- Pancreatic Trypsin Inhibitor Complex
pdb|2PKA|A Chain A, Refined 2 Angstroms X-Ray Crystal Structure Of Porcine
Pancreatic Kallikrein A, A Specific Trypsin-Like Serine
Proteinase. Crystallization, Structure Determination,
Crystallographic Refinement, Structure And Its
Comparison With Bovine Trypsin
pdb|2PKA|X Chain X, Refined 2 Angstroms X-Ray Crystal Structure Of Porcine
Pancreatic Kallikrein A, A Specific Trypsin-Like Serine
Proteinase. Crystallization, Structure Determination,
Crystallographic Refinement, Structure And Its
Comparison With Bovine Trypsin
pdb|1HIA|A Chain A, Kallikrein Complexed With Hirustasin
pdb|1HIA|X Chain X, Kallikrein Complexed With Hirustasin
Length = 80
Score = 42.4 bits (98), Expect = 0.001, Method: Composition-based stats.
Identities = 32/92 (34%), Positives = 41/92 (44%), Gaps = 17/92 (18%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCVGNLTGLNIDEWTVQL 708
IIGG E P+ A+ F C GVL++ +WVLTAAHC D + V L
Sbjct: 1 IIGGRECEKNSHPWQVAIYHYSSF--QCGGVLVNPKWVLTAAHCKN-------DNYEVWL 51
Query: 709 G----VTRRNSYAFFGTRFKVRGVFAHSQYNI 736
G N+ FFG V F H +N+
Sbjct: 52 GRHNLFENENTAQFFG----VTADFPHPGFNL 79
>pdb|1CR8|A Chain A, Low Density Lipoprotein Receptor-Related Protein
Complement Repeat 8
Length = 42
Score = 39.7 bits (91), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 18/32 (56%), Positives = 23/32 (71%), Gaps = 1/32 (3%)
Query: 456 FQCDVNR-CIPLDWQCDGHIDCQDQTDELNCE 486
FQC ++ CIPL W+CDG DC D +DE +CE
Sbjct: 9 FQCRLDGLCIPLRWRCDGDTDCMDSSDEKSCE 40
>pdb|1EPT|A Chain A, Refined 1.8 Angstroms Resolution Crystal Structure Of
Porcine Epsilon-Trypsin
Length = 43
Score = 39.3 bits (90), Expect = 0.010, Method: Composition-based stats.
Identities = 18/44 (40%), Positives = 25/44 (56%), Gaps = 3/44 (6%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHC 692
I+GG+ P+ +L G F C G LI+ QWV++AAHC
Sbjct: 1 IVGGYTCAANSIPYQVSLNSGSHF---CGGSLINSQWVVSAAHC 41
>pdb|1LDR|A Chain A, Second Repeat Of The Ldl Receptor Ligand-Binding Domain
Length = 43
Score = 38.9 bits (89), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 15/26 (57%), Positives = 19/26 (73%)
Query: 460 VNRCIPLDWQCDGHIDCQDQTDELNC 485
VNRCIP W+CDG +DC + +DE C
Sbjct: 18 VNRCIPQFWRCDGQVDCDNGSDEQGC 43
Score = 36.6 bits (83), Expect = 0.069, Method: Compositional matrix adjust.
Identities = 17/37 (45%), Positives = 24/37 (64%), Gaps = 2/37 (5%)
Query: 488 CKADEIHCG--LNKCISDYHVCDGKVDCPWGQDERNC 522
CK+ + CG +N+CI + CDG+VDC G DE+ C
Sbjct: 7 CKSGDFSCGGRVNRCIPQFWRCDGQVDCDNGSDEQGC 43
>pdb|3T5O|A Chain A, Crystal Structure Of Human Complement Component C6
pdb|4A5W|B Chain B, Crystal Structure Of C5b6
pdb|4E0S|B Chain B, Crystal Structure Of C5b-6
Length = 913
Score = 38.1 bits (87), Expect = 0.022, Method: Compositional matrix adjust.
Identities = 17/39 (43%), Positives = 22/39 (56%)
Query: 452 CLEGFQCDVNRCIPLDWQCDGHIDCQDQTDELNCEPCKA 490
C F+CD RCI +C+G DC D +DE +C KA
Sbjct: 119 CKNKFRCDSGRCIARKLECNGENDCGDNSDERDCGRTKA 157
>pdb|1LDL|A Chain A, Three-Dimensional Structure Of A Cysteine-Rich Repeat From
The Low-Density Lipoprotein Receptor
Length = 48
Score = 37.7 bits (86), Expect = 0.028, Method: Composition-based stats.
Identities = 14/27 (51%), Positives = 17/27 (62%)
Query: 456 FQCDVNRCIPLDWQCDGHIDCQDQTDE 482
FQC +CI W CDG +CQD +DE
Sbjct: 13 FQCQDGKCISYKWVCDGSAECQDGSDE 39
Score = 34.3 bits (77), Expect = 0.33, Method: Composition-based stats.
Identities = 17/41 (41%), Positives = 22/41 (53%), Gaps = 2/41 (4%)
Query: 488 CKADEIHCGLNKCISDYHVCDGKVDCPWGQDE--RNCLQLS 526
C+ +E C KCIS VCDG +C G DE CL ++
Sbjct: 8 CERNEFQCQDGKCISYKWVCDGSAECQDGSDESQETCLSVT 48
>pdb|2FYJ|A Chain A, Nmr Solution Structure Of Calcium-Loaded Lrp Double Module
pdb|2FYL|B Chain B, Haddock Model Of The Complex Between Double Module Of Lrp,
Cr56, And First Domain Of Receptor Associated Protein,
Rap- D1
Length = 82
Score = 37.0 bits (84), Expect = 0.048, Method: Compositional matrix adjust.
Identities = 26/73 (35%), Positives = 32/73 (43%), Gaps = 8/73 (10%)
Query: 456 FQCDVNRCIPLDWQCDGHIDCQDQTDEL------NCEPCKADEIHCGLNKCISDYHVCDG 509
F C RCIP+ W CD DC D++DE C P + C +CI+ CD
Sbjct: 10 FSCASGRCIPISWTCDLDDDCGDRSDESASCAYPTCFP--LTQFTCNNGRCININWRCDN 67
Query: 510 KVDCPWGQDERNC 522
DC DE C
Sbjct: 68 DNDCGDNSDEAGC 80
Score = 35.4 bits (80), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 15/34 (44%), Positives = 20/34 (58%)
Query: 453 LEGFQCDVNRCIPLDWQCDGHIDCQDQTDELNCE 486
L F C+ RCI ++W+CD DC D +DE C
Sbjct: 48 LTQFTCNNGRCININWRCDNDNDCGDNSDEAGCS 81
>pdb|1J8E|A Chain A, Crystal Structure Of Ligand-Binding Repeat Cr7 From Lrp
Length = 44
Score = 37.0 bits (84), Expect = 0.050, Method: Compositional matrix adjust.
Identities = 15/28 (53%), Positives = 18/28 (64%)
Query: 456 FQCDVNRCIPLDWQCDGHIDCQDQTDEL 483
F+C+ RCIP W CDG DC D +DE
Sbjct: 10 FKCNSGRCIPEHWTCDGDNDCGDYSDET 37
>pdb|2HNT|C Chain C, Crystallographic Structure Of Human Gamma-Thrombin
Length = 70
Score = 36.6 bits (83), Expect = 0.067, Method: Compositional matrix adjust.
Identities = 18/45 (40%), Positives = 24/45 (53%)
Query: 649 IIGGFESNPGDWPFLAALLGGPEFVFYCAGVLISDQWVLTAAHCV 693
I+ G ++ G P+ L C LISD+WVLTAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCL 45
>pdb|1EPT|B Chain B, Refined 1.8 Angstroms Resolution Crystal Structure Of
Porcine Epsilon-Trypsin
Length = 82
Score = 35.8 bits (81), Expect = 0.097, Method: Composition-based stats.
Identities = 20/56 (35%), Positives = 25/56 (44%), Gaps = 3/56 (5%)
Query: 728 VFAHSQYNIGAQHDNDIALFQLKQKVKFNDHLLPVCLPPPNYELAPGTRCTVIGWG 783
+ H +N G DNDI L +L N + V LP A GT C + GWG
Sbjct: 27 IITHPNFN-GNTLDNDIMLIKLSSPATLNSRVATVSLPRSC--AAAGTECLISGWG 79
>pdb|1AJJ|A Chain A, Ldl Receptor Ligand-Binding Module 5, Calcium-Coordinating
Length = 37
Score = 35.8 bits (81), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 15/30 (50%), Positives = 19/30 (63%)
Query: 456 FQCDVNRCIPLDWQCDGHIDCQDQTDELNC 485
F C CI W+CDG DC+D++DE NC
Sbjct: 7 FHCLSGECIHSSWRCDGGPDCKDKSDEENC 36
Score = 32.0 bits (71), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 17/36 (47%), Positives = 18/36 (50%)
Query: 487 PCKADEIHCGLNKCISDYHVCDGKVDCPWGQDERNC 522
PC A E HC +CI CDG DC DE NC
Sbjct: 1 PCSAFEFHCLSGECIHSSWRCDGGPDCKDKSDEENC 36
>pdb|1K7B|A Chain A, Nmr Solution Structure Of Stva47, The Viral-Binding Domain
Of Tva
Length = 47
Score = 35.0 bits (79), Expect = 0.18, Method: Compositional matrix adjust.
Identities = 14/25 (56%), Positives = 14/25 (56%)
Query: 461 NRCIPLDWQCDGHIDCQDQTDELNC 485
C P DW CDGH DC D DE C
Sbjct: 22 GECYPQDWLCDGHPDCDDGRDEWGC 46
>pdb|1JRF|A Chain A, Nmr Solution Structure Of The Viral Receptor Domain Of Tva
Length = 47
Score = 35.0 bits (79), Expect = 0.18, Method: Compositional matrix adjust.
Identities = 14/25 (56%), Positives = 14/25 (56%)
Query: 461 NRCIPLDWQCDGHIDCQDQTDELNC 485
C P DW CDGH DC D DE C
Sbjct: 20 GECYPQDWLCDGHPDCDDGRDEWGC 44
>pdb|3A7Q|B Chain B, Structural Basis For Specific Recognition Of Reelin By Its
Receptors
Length = 44
Score = 34.7 bits (78), Expect = 0.21, Method: Compositional matrix adjust.
Identities = 16/30 (53%), Positives = 19/30 (63%)
Query: 456 FQCDVNRCIPLDWQCDGHIDCQDQTDELNC 485
FQC RCIP W+CD DC D +DE +C
Sbjct: 13 FQCRNERCIPSVWRCDEDDDCLDHSDEDDC 42
>pdb|2FCW|B Chain B, Structure Of A Complex Between The Pair Of The Ldl
Receptor Ligand-Binding Modules 3-4 And The Receptor
Associated Protein (Rap)
Length = 80
Score = 34.7 bits (78), Expect = 0.26, Method: Compositional matrix adjust.
Identities = 23/66 (34%), Positives = 29/66 (43%), Gaps = 2/66 (3%)
Query: 456 FQCDVNRCIPLDWQCDGHIDCQDQTDELNCE--PCKADEIHCGLNKCISDYHVCDGKVDC 513
F+C +CI + CD DC D +DE +C C C + CI CD DC
Sbjct: 8 FRCHDGKCISRQFVCDSDRDCLDGSDEASCPVLTCGPASFQCNSSTCIPQLWACDNDPDC 67
Query: 514 PWGQDE 519
G DE
Sbjct: 68 EDGSDE 73
>pdb|3OJY|A Chain A, Crystal Structure Of Human Complement Component C8
Length = 554
Score = 34.7 bits (78), Expect = 0.27, Method: Compositional matrix adjust.
Identities = 17/45 (37%), Positives = 25/45 (55%), Gaps = 1/45 (2%)
Query: 452 CLEGFQC-DVNRCIPLDWQCDGHIDCQDQTDELNCEPCKADEIHC 495
C + FQC + RC+ C+G DC D +DE +CE +A + C
Sbjct: 66 CGQDFQCKETGRCLKRHLVCNGDQDCLDGSDEDDCEDVRAIDEDC 110
>pdb|3OJY|B Chain B, Crystal Structure Of Human Complement Component C8
Length = 537
Score = 34.3 bits (77), Expect = 0.33, Method: Compositional matrix adjust.
Identities = 16/33 (48%), Positives = 19/33 (57%), Gaps = 1/33 (3%)
Query: 454 EGFQC-DVNRCIPLDWQCDGHIDCQDQTDELNC 485
EGF C RC+ C+G DC DQ+DE NC
Sbjct: 69 EGFVCAQTGRCVNRRLLCNGDNDCGDQSDEANC 101
>pdb|2KRI|B Chain B, Structure Of A Complex Between Domain V Of Beta2-
Glycoprotein I And The Fourth Ligand-Binding Module From
Ldlr Determined With Haddock
Length = 40
Score = 33.5 bits (75), Expect = 0.53, Method: Compositional matrix adjust.
Identities = 14/28 (50%), Positives = 18/28 (64%)
Query: 456 FQCDVNRCIPLDWQCDGHIDCQDQTDEL 483
FQC+ + CIP W CD DC+D +DE
Sbjct: 7 FQCNSSTCIPQLWACDNDPDCEDGSDEW 34
>pdb|1V9U|5 Chain 5, Human Rhinovirus 2 Bound To A Fragment Of Its Cellular
Receptor Protein
Length = 41
Score = 33.5 bits (75), Expect = 0.56, Method: Compositional matrix adjust.
Identities = 13/24 (54%), Positives = 16/24 (66%)
Query: 462 RCIPLDWQCDGHIDCQDQTDELNC 485
+CIP+ W+CDG DC DE NC
Sbjct: 16 QCIPVSWRCDGENDCDSGEDEENC 39
Score = 30.4 bits (67), Expect = 4.5, Method: Compositional matrix adjust.
Identities = 17/37 (45%), Positives = 22/37 (59%), Gaps = 2/37 (5%)
Query: 488 CKADEIHCGLN--KCISDYHVCDGKVDCPWGQDERNC 522
C+ EI CG + +CI CDG+ DC G+DE NC
Sbjct: 3 CRIHEISCGAHSTQCIPVSWRCDGENDCDSGEDEENC 39
>pdb|2GTL|N Chain N, Lumbricus Erythrocruorin At 3.5a Resolution
Length = 220
Score = 33.5 bits (75), Expect = 0.61, Method: Composition-based stats.
Identities = 16/34 (47%), Positives = 18/34 (52%), Gaps = 2/34 (5%)
Query: 488 CKADEIHCGLNK--CISDYHVCDGKVDCPWGQDE 519
C+ CG N+ CISD VCDG DC DE
Sbjct: 53 CEKRTFQCGGNEQECISDLLVCDGHKDCHNAHDE 86
>pdb|3DPR|E Chain E, Human Rhinovirus 2 Bound To A Concatamer Of The Vldl
Receptor Module V3
Length = 39
Score = 33.1 bits (74), Expect = 0.66, Method: Compositional matrix adjust.
Identities = 13/24 (54%), Positives = 16/24 (66%)
Query: 462 RCIPLDWQCDGHIDCQDQTDELNC 485
+CIP+ W+CDG DC DE NC
Sbjct: 14 QCIPVSWRCDGENDCDSGEDEENC 37
Score = 30.0 bits (66), Expect = 5.9, Method: Compositional matrix adjust.
Identities = 17/37 (45%), Positives = 22/37 (59%), Gaps = 2/37 (5%)
Query: 488 CKADEIHCGLN--KCISDYHVCDGKVDCPWGQDERNC 522
C+ EI CG + +CI CDG+ DC G+DE NC
Sbjct: 1 CRIHEISCGAHSTQCIPVSWRCDGENDCDSGEDEENC 37
>pdb|2M0P|A Chain A, Solution Structure Of The Tenth Complement Type Repeat Of
Human Megalin
Length = 52
Score = 32.7 bits (73), Expect = 0.97, Method: Compositional matrix adjust.
Identities = 14/30 (46%), Positives = 19/30 (63%)
Query: 456 FQCDVNRCIPLDWQCDGHIDCQDQTDELNC 485
+ CD ++CI +W CD DC D +DE NC
Sbjct: 12 YTCDNHQCISKNWVCDTDNDCGDGSDEKNC 41
>pdb|3P5C|L Chain L, The Structure Of The LdlrPCSK9 COMPLEX REVEALS THE
RECEPTOR IN AN Extended Conformation
Length = 440
Score = 32.7 bits (73), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 21/57 (36%), Positives = 29/57 (50%), Gaps = 12/57 (21%)
Query: 456 FQCDVNRCIPLDWQCDGHIDCQDQTDELNCEPCKADEIHCGLNKCISD----YHVCD 508
F+C CI LD C+ DC+D +D EP K CG N+C+ + HVC+
Sbjct: 7 FKCHSGECITLDKVCNMARDCRDWSD----EPIK----ECGTNECLDNNGGCSHVCN 55
>pdb|1D2L|A Chain A, Nmr Solution Structure Of Complement-Like Repeat Cr3 From
The Low Density Lipoprotein Receptor-Related Protein
(Lrp) . Evidence For Specific Binding To The Receptor
Binding Domain Of Human Alpha-2 Macroglobulin
Length = 45
Score = 31.6 bits (70), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 14/27 (51%), Positives = 17/27 (62%)
Query: 456 FQCDVNRCIPLDWQCDGHIDCQDQTDE 482
F C +RCI W+CDG DC D +DE
Sbjct: 11 FACANSRCIQERWKCDGDNDCLDNSDE 37
>pdb|2KNY|A Chain A, Fusion Construct Of Cr17 From Lrp-1 And Apoe Residues
130-14
Length = 80
Score = 31.2 bits (69), Expect = 2.7, Method: Composition-based stats.
Identities = 11/20 (55%), Positives = 12/20 (60%)
Query: 463 CIPLDWQCDGHIDCQDQTDE 482
C+P W CDG DC D DE
Sbjct: 22 CVPERWLCDGDKDCADGADE 41
>pdb|2I1P|A Chain A, Solution Structure Of The Twelfth Cysteine-Rich Ligand-
Binding Repeat In Rat Megalin
Length = 48
Score = 30.4 bits (67), Expect = 4.2, Method: Compositional matrix adjust.
Identities = 14/31 (45%), Positives = 20/31 (64%), Gaps = 1/31 (3%)
Query: 456 FQC-DVNRCIPLDWQCDGHIDCQDQTDELNC 485
F+C D + CI ++CDG DC+D +DE C
Sbjct: 12 FKCADGSSCINSRYRCDGVYDCRDNSDEAGC 42
>pdb|1F8Z|A Chain A, Nmr Structure Of The Sixth Ligand-Binding Module Of The
Ldl Receptor
Length = 39
Score = 30.0 bits (66), Expect = 5.8, Method: Compositional matrix adjust.
Identities = 14/30 (46%), Positives = 17/30 (56%)
Query: 456 FQCDVNRCIPLDWQCDGHIDCQDQTDELNC 485
FQC CI QCD DC+D +DE+ C
Sbjct: 8 FQCSDGNCIHGSRQCDREYDCKDMSDEVGC 37
>pdb|1D2J|A Chain A, Ldl Receptor Ligand-Binding Module 6
Length = 40
Score = 29.6 bits (65), Expect = 7.8, Method: Compositional matrix adjust.
Identities = 14/30 (46%), Positives = 17/30 (56%)
Query: 456 FQCDVNRCIPLDWQCDGHIDCQDQTDELNC 485
FQC CI QCD DC+D +DE+ C
Sbjct: 9 FQCSDGNCIHGSRQCDREYDCKDLSDEVGC 38
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.320 0.137 0.438
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 28,516,329
Number of Sequences: 62578
Number of extensions: 1224773
Number of successful extensions: 3896
Number of sequences better than 100.0: 393
Number of HSP's better than 100.0 without gapping: 382
Number of HSP's successfully gapped in prelim test: 11
Number of HSP's that attempted gapping in prelim test: 2267
Number of HSP's gapped (non-prelim): 481
length of query: 897
length of database: 14,973,337
effective HSP length: 108
effective length of query: 789
effective length of database: 8,214,913
effective search space: 6481566357
effective search space used: 6481566357
T: 11
A: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.8 bits)
S2: 56 (26.2 bits)